{"meta":{"query_hash":"a0bb49e076ec","filters":{"venue":"The Lancet Diabetes & Endocrinology"},"cohort_total":247,"direct_labels_cover":3,"predictions_cover":247,"exported":247,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a0bb49e076ec","api":"https://metacan.xera.ac/api/v1/cohort?venue=The+Lancet+Diabetes+%26+Endocrinology"},"results":[{"id":"W1858444929","doi":"10.1016/s2213-8587(15)00076-5","title":"Prevalence of behavioural risk factors for cardiovascular disease in adolescents in low-income and middle-income countries: an individual participant data meta-analysis","year":2015,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Environmental health; Meta-analysis; Disease; Obesity; Demography; Gerontology; Internal medicine","score_opus":0.2893329745542987,"score_gpt":0.3796146050471501,"score_spread":0.09028163049285143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1858444929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01722333,0.9802373,0.00097244425,0.0001426083,0.0002761817,0.0001355748,0.00073954085,0.00004307077,0.0002299748],"genre_scores_gemma":[0.4452856,0.54527766,0.0049107545,0.0013116186,0.00028461477,0.00061152515,0.0016713243,0.00006917795,0.00057778426],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99409205,0.0025049401,0.0017160919,0.0008563268,0.0006054202,0.00022516926],"domain_scores_gemma":[0.9923228,0.0052281907,0.0011246381,0.0005709742,0.0006101823,0.00014327557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009427945,0.002256637,0.014255281,0.002799513,0.00045957413,0.0023714933,0.0018889299,0.0020473201,0.0023975405],"category_scores_gemma":[0.019488618,0.0020275002,0.03698833,0.0038268857,0.00050539995,0.0014004423,0.0018479141,0.002585761,0.0002795468],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021990747,0.000029842751,0.009368998,0.08005332,0.8987744,0.00007449572,0.00008483179,0.00026369374,0.00016102559,0.00007545678,0.00042945193,0.008485468],"study_design_scores_gemma":[0.0006533002,0.00013967474,0.009046168,0.0042734738,0.9844513,0.00007090546,0.00004522797,0.000108461914,0.00006382286,0.0000987637,0.0010254572,0.000023341947],"about_ca_topic_score_codex":0.008930621,"about_ca_topic_score_gemma":0.018733654,"teacher_disagreement_score":0.014255281,"about_ca_system_score_codex":0.0014310163,"about_ca_system_score_gemma":0.0017175424,"threshold_uncertainty_score":0.04986036},"labels":[],"label_agreement":null},{"id":"W1955483128","doi":"10.1016/s2213-8587(15)00329-0","title":"Heart failure: fatal, forgotten, and frequent in type 1 diabetes too","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Population; Disease; Macrovascular disease; Ageing; Cohort; Internal medicine; Pediatrics; Endocrinology","score_opus":0.034930682609626285,"score_gpt":0.27431237131636005,"score_spread":0.23938168870673376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955483128","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00061073963,0.004778371,0.000051879164,0.9751374,0.018173037,0.0000039836223,0.000037261365,0.0000110699775,0.001196263],"genre_scores_gemma":[0.006674618,0.0058917063,0.00014661804,0.8518636,0.13327605,0.000014549543,0.000034866644,0.000013821723,0.00208413],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99703777,0.00091467483,0.00046010135,0.0003415852,0.00086278474,0.00038308793],"domain_scores_gemma":[0.98972565,0.0054708654,0.0010447649,0.00030163207,0.001311327,0.0021457586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003166077,0.00077820686,0.0018257961,0.00076460163,0.00222655,0.0031378504,0.0010829577,0.028855644,0.005348129],"category_scores_gemma":[0.026474815,0.00059914455,0.0011936409,0.0006665546,0.0026305928,0.00445963,0.0017576439,0.03369391,0.0038314243],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018478831,0.00009072299,0.005679968,0.00024495373,0.000060089835,0.0028319848,0.00021968424,0.000047716105,0.00032146432,0.0025469717,0.9547488,0.033022963],"study_design_scores_gemma":[0.0008182432,0.00040630167,0.021968918,0.003730061,0.00024543455,0.013634839,0.002174857,0.0007865213,0.0003701614,0.02922298,0.926375,0.00026674848],"about_ca_topic_score_codex":0.0041401014,"about_ca_topic_score_gemma":0.009708082,"teacher_disagreement_score":0.028855644,"about_ca_system_score_codex":0.0022190772,"about_ca_system_score_gemma":0.0020913968,"threshold_uncertainty_score":0.017891228},"labels":[],"label_agreement":null},{"id":"W1960273689","doi":"10.1016/s2213-8587(15)00319-8","title":"Global health metrics and non-communicable diseases: the case of hypertension","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Libin Cardiovascular Institute of Alberta; University of Calgary","funders":"","keywords":"Medicine; Global health; Population; Non-communicable disease; Gerontology; Disease; Scopus; Health care; Diabetes mellitus; Environmental health; Public health; MEDLINE; Economic growth; Nursing; Internal medicine","score_opus":0.07062258934294062,"score_gpt":0.3199145073091296,"score_spread":0.249291917966189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1960273689","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018287786,0.001679505,0.000051268213,0.99261767,0.004450103,0.0000022551367,0.000022621123,0.0000033924648,0.0009902084],"genre_scores_gemma":[0.0064522414,0.0032421716,0.00023871916,0.9268485,0.06114933,0.000022825658,0.000021316268,0.000014648626,0.0020103194],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9925518,0.003395912,0.0008126261,0.00073032215,0.0015978714,0.00091136096],"domain_scores_gemma":[0.9459606,0.040306065,0.0027685317,0.0013950468,0.0037530442,0.005816733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010792522,0.0010300673,0.0018789753,0.0012972017,0.004392856,0.0066603445,0.0018539821,0.0687027,0.0077348975],"category_scores_gemma":[0.07067642,0.0009891244,0.0015751362,0.0013829337,0.008287423,0.0125479745,0.0046420335,0.0545691,0.0025108436],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006567688,0.000035310273,0.0017133175,0.000097455755,0.000034860048,0.0011091207,0.00042728023,0.000065990615,0.00007494936,0.020154463,0.96092474,0.015296739],"study_design_scores_gemma":[0.0002636577,0.00008421848,0.0053161974,0.001679943,0.000101163525,0.0021782422,0.0027354115,0.00093085755,0.00020286428,0.09849835,0.88782626,0.00018284019],"about_ca_topic_score_codex":0.021019742,"about_ca_topic_score_gemma":0.046536237,"teacher_disagreement_score":0.0687027,"about_ca_system_score_codex":0.0060417145,"about_ca_system_score_gemma":0.007678425,"threshold_uncertainty_score":0.05707699},"labels":[],"label_agreement":null},{"id":"W1968938093","doi":"10.1016/s2213-8587(14)70226-8","title":"Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":213,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Université de Montréal; McGill University Health Centre; Montreal Clinical Research Institute; McGill University","funders":"Canadian Diabetes Association; Juvenile Diabetes Research Foundation International","keywords":"Medicine; Artificial pancreas; Insulin; Diabetes mellitus; Crossover study; Glucagon; Internal medicine; Insulin pump; Endocrinology; Pancreas; Type 2 diabetes; Type 1 diabetes; Hormone; Gastroenterology; Pathology; Placebo","score_opus":0.06536605166457726,"score_gpt":0.3404041475937732,"score_spread":0.2750380959291959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968938093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776775,0.010664411,0.0014105963,0.0009256533,0.0024821726,0.003811199,0.0010343781,0.00018140947,0.0018127691],"genre_scores_gemma":[0.98424166,0.0040311706,0.0024342826,0.001017287,0.0014165584,0.0038106504,0.000869163,0.000041315136,0.0021378596],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9975509,0.0012064467,0.00022325513,0.00060467335,0.00015650509,0.0002582337],"domain_scores_gemma":[0.9967565,0.0015279187,0.00048122503,0.00031569184,0.0001893074,0.00072938815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040495563,0.0039481195,0.0107245585,0.00094431755,0.0008680472,0.0024283067,0.002339359,0.0043300814,0.011297183],"category_scores_gemma":[0.004636337,0.0019435486,0.00470029,0.0010225981,0.0029402003,0.0034787694,0.001048629,0.005559333,0.0015308172],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9964645,0.0012429976,0.00009357122,0.00024668677,0.00047319752,0.000008220399,0.000018854402,0.00005081958,0.00018927631,0.000030729298,0.00006864377,0.0011124836],"study_design_scores_gemma":[0.9889572,0.010191246,0.00025819713,0.000014560487,0.0002961668,0.000005018713,0.000008881001,0.00013045048,0.000037107326,0.000049011112,0.000045180783,0.00000697522],"about_ca_topic_score_codex":0.0019510912,"about_ca_topic_score_gemma":0.0018807844,"teacher_disagreement_score":0.011297183,"about_ca_system_score_codex":0.0015917791,"about_ca_system_score_gemma":0.0012455098,"threshold_uncertainty_score":0.03779286},"labels":[],"label_agreement":null},{"id":"W1984346612","doi":"10.1016/s2213-8587(14)70026-9","title":"Inducing thyrotoxicosis in the liver to treat raised cholesterol","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ezetimibe; Cholesterol; Internal medicine; Statin; Familial hypercholesterolemia; Population; Endocrinology; Pediatrics","score_opus":0.047250953375664276,"score_gpt":0.2867011758288138,"score_spread":0.23945022245314956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984346612","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009033386,0.003596819,0.00014335032,0.9673944,0.02432719,0.000014587399,0.000046638826,0.00004251782,0.0035310027],"genre_scores_gemma":[0.010060806,0.0035496813,0.00032639765,0.8721688,0.107479446,0.00003881095,0.000039534065,0.000025367712,0.006311245],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988907,0.0003628095,0.00015785982,0.00010278621,0.0003472302,0.00013860314],"domain_scores_gemma":[0.99717414,0.0016040938,0.00021503348,0.000093838906,0.0003777048,0.00053519814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012853881,0.00075795106,0.0013315064,0.0005423224,0.0013784143,0.0016392495,0.0009796913,0.026723538,0.004939581],"category_scores_gemma":[0.012411026,0.00052332156,0.0013094567,0.00037953068,0.0017184722,0.0018196088,0.00074456906,0.025052128,0.004913608],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033177756,0.00020843469,0.0020348167,0.00014900973,0.00007380801,0.0042670514,0.0000706468,0.00016879248,0.00077210367,0.003391305,0.95507586,0.033456333],"study_design_scores_gemma":[0.0015409964,0.0007044935,0.004856233,0.0008044326,0.00018984727,0.010571742,0.00034401187,0.0011805937,0.0012334592,0.017989898,0.9604474,0.00013686005],"about_ca_topic_score_codex":0.002583262,"about_ca_topic_score_gemma":0.004329066,"teacher_disagreement_score":0.026723538,"about_ca_system_score_codex":0.0024648905,"about_ca_system_score_gemma":0.0015303304,"threshold_uncertainty_score":0.017884135},"labels":[],"label_agreement":null},{"id":"W1991607561","doi":"10.1016/s2213-8587(14)70095-6","title":"The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cancer; Vitamin D and neurology; Internal medicine; MEDLINE; Oncology; Intensive care medicine; Biochemistry","score_opus":0.03202633226101352,"score_gpt":0.353065617794784,"score_spread":0.3210392855337705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991607561","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0064451736,0.0529163,0.00008898525,0.9058248,0.025792303,0.000027583335,0.001346747,0.000024255678,0.0075337086],"genre_scores_gemma":[0.04646417,0.025635684,0.0003083161,0.8484438,0.07441815,0.00010143188,0.00039913875,0.000018580633,0.004210739],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9932568,0.003269073,0.0009915852,0.0006769408,0.0013812752,0.0004243478],"domain_scores_gemma":[0.94722503,0.044664543,0.0024282662,0.0009910736,0.002784281,0.0019066932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009618133,0.00060690346,0.0026496274,0.00096750987,0.0013434119,0.0015612238,0.001808462,0.02108929,0.007916221],"category_scores_gemma":[0.06778509,0.00054671685,0.0025087472,0.0014411507,0.0017427879,0.0013579399,0.0010953236,0.0108280415,0.0026553352],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012570434,0.00040976927,0.02837711,0.0029500446,0.003085288,0.0017054012,0.0001875877,0.00015943669,0.0007169176,0.003189902,0.82960373,0.117044285],"study_design_scores_gemma":[0.027127704,0.004275616,0.11087362,0.014751015,0.016022662,0.0033967441,0.001210336,0.00086075714,0.0017130456,0.02696106,0.79239607,0.00041153305],"about_ca_topic_score_codex":0.010176932,"about_ca_topic_score_gemma":0.018820565,"teacher_disagreement_score":0.02108929,"about_ca_system_score_codex":0.0022471629,"about_ca_system_score_gemma":0.0025892192,"threshold_uncertainty_score":0.050866187},"labels":[],"label_agreement":null},{"id":"W1993971782","doi":"10.1016/s2213-8587(15)00049-2","title":"Diagnostic criteria for osteoporosis should be expanded","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Peter's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; FRAX; Osteoporosis; Bone mineral; Hip fracture; Bone density; Physical therapy; Osteoporotic fracture; Internal medicine","score_opus":0.18162541963200432,"score_gpt":0.41285192205753746,"score_spread":0.23122650242553314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993971782","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00494791,0.060439665,0.009099112,0.7158402,0.14834444,0.0004001948,0.002556014,0.0007077692,0.05766471],"genre_scores_gemma":[0.08727745,0.08466927,0.03873993,0.54776496,0.19228289,0.0011877158,0.010180349,0.0006737568,0.037223756],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913339,0.0015747574,0.0030636778,0.00050270633,0.002878036,0.0006468122],"domain_scores_gemma":[0.93588704,0.023047704,0.0034228666,0.0037384615,0.02899691,0.0049071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008830595,0.0013430465,0.003566816,0.0064971894,0.0019460522,0.0022439214,0.0027525772,0.008439212,0.012148292],"category_scores_gemma":[0.059652857,0.0007162696,0.0022216453,0.002609203,0.002684041,0.003493725,0.0028033268,0.012710843,0.008821108],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022141336,0.00013549037,0.0074573844,0.0014026704,0.000065904074,0.0022104615,0.0002657457,0.000160519,0.001136376,0.006614647,0.8114687,0.16886072],"study_design_scores_gemma":[0.00025169496,0.000106995554,0.03208254,0.0059623662,0.00021216115,0.012100212,0.0005963134,0.00043274558,0.0004697646,0.0223472,0.92526513,0.00017294667],"about_ca_topic_score_codex":0.0073212497,"about_ca_topic_score_gemma":0.009865923,"teacher_disagreement_score":0.012148292,"about_ca_system_score_codex":0.0015317876,"about_ca_system_score_gemma":0.005117525,"threshold_uncertainty_score":0.046701193},"labels":[],"label_agreement":null},{"id":"W1995388358","doi":"10.1016/s2213-8587(14)70054-3","title":"Treatment of severe hypertriglyceridaemia – Authors' reply","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine","score_opus":0.03521302912128351,"score_gpt":0.2850295492805223,"score_spread":0.2498165201592388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995388358","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001983659,0.002306429,0.00004582107,0.9708902,0.025677744,0.000004480816,0.000032815748,0.00001209622,0.00083189644],"genre_scores_gemma":[0.0025128021,0.0010491189,0.00009121342,0.94476116,0.04984712,0.000018235447,0.000017152588,0.000012245923,0.001690899],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99700063,0.0010767574,0.00043693473,0.00034053085,0.00079719466,0.00034799913],"domain_scores_gemma":[0.98964417,0.0062951753,0.00097267865,0.00031071663,0.0015182691,0.0012589978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030002354,0.0007056843,0.0018517043,0.0009906074,0.0020948758,0.0029693565,0.0016746847,0.052512683,0.0048489245],"category_scores_gemma":[0.028442586,0.0007770209,0.0014041307,0.0007181574,0.0028026775,0.0031099883,0.0017758615,0.0403004,0.003920013],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008964909,0.000034289515,0.0006304336,0.00008518035,0.00004094434,0.0018246429,0.0001059645,0.000072488314,0.00010637577,0.0014274798,0.98866105,0.0069215093],"study_design_scores_gemma":[0.0003919139,0.00013336881,0.0017269079,0.0006783823,0.00009182552,0.0034880056,0.00044093974,0.00035932672,0.00029971008,0.0077064615,0.98454696,0.0001361319],"about_ca_topic_score_codex":0.0022596258,"about_ca_topic_score_gemma":0.0032177703,"teacher_disagreement_score":0.052512683,"about_ca_system_score_codex":0.002689457,"about_ca_system_score_gemma":0.0021387606,"threshold_uncertainty_score":0.019513428},"labels":[],"label_agreement":null},{"id":"W2007374852","doi":"10.1016/s2213-8587(15)00044-3","title":"Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials","year":2015,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":252,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heart and Stroke Foundation; Women's College Hospital; University of Toronto; University Health Network","funders":"Women's College Research Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Type 2 diabetes; Internal medicine; Heart failure; Diabetes mellitus; Relative risk; Meta-analysis; Randomized controlled trial; Clinical endpoint; Cochrane Library; Endocrinology; Confidence interval","score_opus":0.1464167848642998,"score_gpt":0.3674972547904398,"score_spread":0.22108046992614003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007374852","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005581208,0.99275017,0.000572988,0.00014362627,0.00020454469,0.0001717135,0.00034104878,0.000031880914,0.00020280684],"genre_scores_gemma":[0.13711387,0.85668147,0.002987767,0.0011349444,0.00031547944,0.00048932433,0.0007291235,0.00004717662,0.00050085044],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99395436,0.0028773637,0.0016232899,0.00069554657,0.0005542108,0.0002952959],"domain_scores_gemma":[0.99041873,0.007385743,0.0013842095,0.00030584406,0.00033941623,0.0001660345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009243073,0.0034541094,0.019640941,0.0029128515,0.00040516938,0.0029468392,0.0024792745,0.0022022873,0.0042666276],"category_scores_gemma":[0.018782062,0.0017178064,0.03478392,0.0037703249,0.00067038916,0.0018516154,0.0015800371,0.0032971592,0.0003521884],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010263677,0.00004694435,0.0018727495,0.19708224,0.7726947,0.00008514958,0.000056180583,0.0005313319,0.00024632315,0.00014146607,0.00073405245,0.016245171],"study_design_scores_gemma":[0.0036551738,0.00025369343,0.0019740027,0.008669219,0.98354095,0.000057835812,0.000036641435,0.00013714256,0.00008447247,0.0002852292,0.0012805453,0.000025112322],"about_ca_topic_score_codex":0.0048976447,"about_ca_topic_score_gemma":0.010560459,"teacher_disagreement_score":0.019640941,"about_ca_system_score_codex":0.002046427,"about_ca_system_score_gemma":0.001716729,"threshold_uncertainty_score":0.048882604},"labels":[],"label_agreement":null},{"id":"W2019951267","doi":"10.1016/s2213-8587(14)70172-x","title":"The US diabetes epidemic: tip of the iceberg","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Scopus; Diabetes mellitus; Epidemiology; Type 2 diabetes; Obesity; MEDLINE; Gerontology; Demography; Internal medicine; Political science","score_opus":0.024894071144664888,"score_gpt":0.2574979926696367,"score_spread":0.2326039215249718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019951267","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014448001,0.002280508,0.000024741319,0.98963505,0.006922965,0.0000017480181,0.000034706667,0.000009194176,0.00094664074],"genre_scores_gemma":[0.0021786357,0.0026346263,0.00010225419,0.95319587,0.039981876,0.00001226329,0.000031481864,0.00001081136,0.0018521238],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955195,0.0017690519,0.00032843478,0.00037255528,0.0014756446,0.00053477346],"domain_scores_gemma":[0.9874341,0.0071213995,0.00081320165,0.00034449974,0.0017033438,0.002583487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054600746,0.00081207295,0.0017564078,0.0009744169,0.003564578,0.0054568,0.001747849,0.046333738,0.013018027],"category_scores_gemma":[0.029976813,0.00067572657,0.0013333148,0.00089185894,0.0041601337,0.0064922115,0.0030453901,0.03669201,0.006994251],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101616104,0.00004061763,0.00066736736,0.00006197644,0.000021512877,0.0002499173,0.0000630173,0.000038951704,0.00007356053,0.0028847351,0.98243195,0.013364882],"study_design_scores_gemma":[0.0002923631,0.000082214545,0.0031634097,0.00076707103,0.000063185646,0.00058585795,0.000855848,0.00031021913,0.00012150487,0.020757483,0.9729286,0.00007229424],"about_ca_topic_score_codex":0.009709604,"about_ca_topic_score_gemma":0.016464978,"teacher_disagreement_score":0.046333738,"about_ca_system_score_codex":0.004426697,"about_ca_system_score_gemma":0.0060233073,"threshold_uncertainty_score":0.043549716},"labels":[],"label_agreement":null},{"id":"W2039571658","doi":"10.1016/s2213-8587(13)70027-5","title":"Intensive insulin for type 2 diabetes: the risk of causing harm","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Type 2 diabetes; Scopus; Diabetes mellitus; Internal medicine; Insulin; Hazard ratio; Post-hoc analysis; MEDLINE; Endocrinology","score_opus":0.10492927098788356,"score_gpt":0.3586264788800713,"score_spread":0.25369720789218775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039571658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043468302,0.99882525,0.00004440814,0.0004447216,0.00021002055,0.0000019318938,0.0000113292435,0.0000036180409,0.00041526643],"genre_scores_gemma":[0.00059186615,0.9981654,0.000115116454,0.0006359035,0.0002899923,0.0000037279876,0.000010688603,0.0000012125082,0.0001862099],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993693,0.00013957414,0.000086972876,0.000065208915,0.0003008061,0.00003807595],"domain_scores_gemma":[0.99722266,0.0020632567,0.00039859046,0.000044898727,0.00019545628,0.00007520312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013745198,0.00083624094,0.0025629362,0.0017101658,0.00024356379,0.0014155748,0.0010951745,0.002112588,0.0058234646],"category_scores_gemma":[0.0030042287,0.0003223406,0.001242173,0.0021873624,0.000644121,0.0013800504,0.00085909176,0.0029552279,0.0012666055],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016219499,0.000040533436,0.0001877104,0.03630611,0.0007153707,0.00009884645,0.000037539994,0.00020688391,0.000383413,0.0031957345,0.03925677,0.91940886],"study_design_scores_gemma":[0.00021354877,0.00018994362,0.0026717575,0.056284092,0.002385163,0.0010778619,0.0001601557,0.0002059213,0.00030146615,0.0100075705,0.9264375,0.000065056185],"about_ca_topic_score_codex":0.001660423,"about_ca_topic_score_gemma":0.0033550411,"teacher_disagreement_score":0.0058234646,"about_ca_system_score_codex":0.0007427814,"about_ca_system_score_gemma":0.001121011,"threshold_uncertainty_score":0.01948142},"labels":[],"label_agreement":null},{"id":"W2067176839","doi":"10.1016/s2213-8587(14)70071-3","title":"Subconjunctival bevacizumab for iris neovascularisation – Authors' reply","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Herzig Eye Institute","funders":"","keywords":"Medicine; Bevacizumab; IRIS (biosensor); Ophthalmology; Optometry; Surgery; Artificial intelligence; Biometrics; Chemotherapy; Computer science","score_opus":0.04234987265080108,"score_gpt":0.30238818158025627,"score_spread":0.2600383089294552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067176839","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035895122,0.0020514503,0.000044375374,0.966343,0.030255632,0.0000068540985,0.00004068558,0.000016461678,0.0008825001],"genre_scores_gemma":[0.0033505426,0.0010309891,0.000078428464,0.94255376,0.04999921,0.000024871644,0.000022321648,0.000014152879,0.0029256619],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99739933,0.0007675839,0.00035680408,0.00035578714,0.00070075574,0.00041968352],"domain_scores_gemma":[0.99125457,0.0053616283,0.0008844902,0.0002612367,0.0012966339,0.00094144646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025733355,0.00068052777,0.0018703903,0.00084038236,0.0023847646,0.0036403493,0.0018662225,0.064043075,0.0059164404],"category_scores_gemma":[0.023090458,0.00084496796,0.001345652,0.00067694904,0.002798379,0.00314638,0.0020443352,0.040092524,0.0045022615],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000815578,0.000025788744,0.0005943931,0.000071771,0.000036024496,0.0022028275,0.00012213805,0.000053882206,0.0001712943,0.0011179558,0.9902407,0.005281691],"study_design_scores_gemma":[0.00032531543,0.00014789173,0.0019910051,0.0005489399,0.0001308002,0.0036383474,0.00075984845,0.0005118164,0.00047732427,0.0076634577,0.9836609,0.00014446332],"about_ca_topic_score_codex":0.0030658324,"about_ca_topic_score_gemma":0.004478465,"teacher_disagreement_score":0.064043075,"about_ca_system_score_codex":0.0033137563,"about_ca_system_score_gemma":0.0025323636,"threshold_uncertainty_score":0.024043024},"labels":[],"label_agreement":null},{"id":"W2067533175","doi":"10.1016/s2213-8587(14)70174-3","title":"Efficacy and safety of a fixed-ratio combination of insulin degludec and liraglutide (IDegLira) compared with its components given alone: results of a phase 3, open-label, randomised, 26-week, treat-to-target trial in insulin-naive patients with type 2 diabetes","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":362,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Novo Nordisk","keywords":"Insulin degludec; Liraglutide; Medicine; Metformin; Type 2 diabetes; Insulin; Pioglitazone; Clinical endpoint; Internal medicine; Diabetes mellitus; Urology; Endocrinology; Insulin glargine; Randomized controlled trial","score_opus":0.03207177693034416,"score_gpt":0.28331800456135975,"score_spread":0.25124622763101556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067533175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99274856,0.0040992447,0.00039063094,0.00034237618,0.00028285087,0.00046229846,0.00041097507,0.00012228599,0.0011408541],"genre_scores_gemma":[0.9940303,0.0018907547,0.0011015699,0.0004687169,0.00031205683,0.0004964241,0.0005759958,0.00003685619,0.0010872763],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99913484,0.00044052367,0.000062339794,0.0001744627,0.00006387403,0.00012405968],"domain_scores_gemma":[0.9990121,0.00035612867,0.00021295655,0.000091383285,0.00004038702,0.00028705504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002008789,0.0019534207,0.0042569432,0.0005814906,0.00032343031,0.0015361499,0.0013564174,0.0018738331,0.004979096],"category_scores_gemma":[0.0022041532,0.0010012067,0.0026748665,0.00053208246,0.0013207104,0.002072919,0.00052175863,0.004227049,0.001100502],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98455125,0.0032395527,0.00031010233,0.00018627667,0.0005604263,0.000015003971,0.000020995412,0.00021886716,0.0015964078,0.000025863888,0.00016735116,0.009107841],"study_design_scores_gemma":[0.9015938,0.09468457,0.0016409347,0.000020524853,0.00075359026,0.000036078003,0.000025269894,0.00053040765,0.0004421137,0.00007800076,0.00017342049,0.000021278958],"about_ca_topic_score_codex":0.0009869359,"about_ca_topic_score_gemma":0.0014687099,"teacher_disagreement_score":0.004979096,"about_ca_system_score_codex":0.000992189,"about_ca_system_score_gemma":0.00073417113,"threshold_uncertainty_score":0.016656756},"labels":[],"label_agreement":null},{"id":"W2068638936","doi":"10.1016/s2213-8587(13)70150-5","title":"Regression of iris neovascularisation secondary to diabetic retinopathy with subconjunctival anti-VEGF therapy","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Herzig Eye Institute","funders":"","keywords":"Medicine; Ophthalmology; Diabetic retinopathy; IRIS (biosensor); VEGF receptors; Retinopathy; Optometry; Diabetes mellitus; Internal medicine; Artificial intelligence; Endocrinology","score_opus":0.016948612111963315,"score_gpt":0.26530421005034466,"score_spread":0.24835559793838136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068638936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9788011,0.005482068,0.0027070998,0.0007645737,0.00030049068,0.00013659963,0.00008559141,0.0003192191,0.011403387],"genre_scores_gemma":[0.99429494,0.0013889319,0.0006526891,0.00016636765,0.0001722318,0.000025049769,0.000085564425,0.000028020908,0.0031863009],"study_design_codex":"bench_or_experimental","study_design_gemma":"case_report","domain_scores_codex":[0.99979955,0.000047688456,0.000021909205,0.000023114597,0.000056338347,0.000051412575],"domain_scores_gemma":[0.9997013,0.0000900097,0.00007075967,0.000059202037,0.000019298976,0.000059369508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040014487,0.00037449168,0.00077207305,0.00060149905,0.00030981287,0.00031578867,0.0004120774,0.00046815243,0.0017244107],"category_scores_gemma":[0.00061273563,0.00018394903,0.00064812176,0.00037973627,0.00046900712,0.00035657678,0.0001865501,0.001258251,0.0003419179],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040820528,0.005792268,0.010523027,0.0007219009,0.0004676205,0.022353746,0.00036106387,0.0015509267,0.5904565,0.0013857193,0.004152122,0.3214146],"study_design_scores_gemma":[0.013139501,0.08422405,0.31138906,0.00019291366,0.0015302363,0.1001273,0.0004637416,0.01376025,0.4318454,0.0014998477,0.04167311,0.00015459857],"about_ca_topic_score_codex":0.0009897844,"about_ca_topic_score_gemma":0.0013430172,"teacher_disagreement_score":0.0017244107,"about_ca_system_score_codex":0.00024887087,"about_ca_system_score_gemma":0.00032304358,"threshold_uncertainty_score":0.005768776},"labels":[],"label_agreement":null},{"id":"W2073789256","doi":"10.1016/s2213-8587(13)70090-1","title":"Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial","year":2013,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":91,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk","keywords":"Medicine; Insulin aspart; Post-prandial; Bolus (digestion); Clinical trial; Anesthesia; Randomized controlled trial; Insulin; Internal medicine; Diabetes mellitus; Endocrinology; Postprandial","score_opus":0.09021902719333778,"score_gpt":0.35477167714156554,"score_spread":0.26455264994822775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073789256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070823,0.0025386577,0.0007097717,0.0006418971,0.0007749464,0.0018052944,0.0007417146,0.00017114473,0.001908318],"genre_scores_gemma":[0.98802084,0.0016857788,0.0023469506,0.0010591381,0.0007194597,0.0022026869,0.00086947513,0.000051439907,0.003044357],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999032,0.00048668473,0.00006381072,0.00020158416,0.00006529168,0.00015059877],"domain_scores_gemma":[0.9983438,0.00062341103,0.0003350206,0.00024563645,0.00007206191,0.00037994768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018233157,0.0029576006,0.00566979,0.00045020354,0.00036340504,0.0014009705,0.0014214923,0.0021919946,0.0099864695],"category_scores_gemma":[0.0025599245,0.0010479535,0.0034809224,0.00049710827,0.0012761403,0.001714272,0.0008109103,0.0045386297,0.0016382617],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99342257,0.0018053744,0.00014136855,0.0002124459,0.0006224937,0.000009935981,0.000020777718,0.00012924263,0.0005682558,0.000042089992,0.00016617571,0.0028594607],"study_design_scores_gemma":[0.9710642,0.026238866,0.0012195598,0.000023938868,0.00069174287,0.0000107753685,0.000015912756,0.00026720704,0.00015505459,0.00013747677,0.00016169151,0.0000135505725],"about_ca_topic_score_codex":0.0012085923,"about_ca_topic_score_gemma":0.00141784,"teacher_disagreement_score":0.0099864695,"about_ca_system_score_codex":0.00076441694,"about_ca_system_score_gemma":0.0009692707,"threshold_uncertainty_score":0.033408046},"labels":[],"label_agreement":null},{"id":"W2093912425","doi":"10.1016/s2213-8587(14)70187-1","title":"Fetal growth and ethnic variation – Authors' reply","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Birth, Development, and Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Scopus; Medicine; Fetal growth; Ethnic group; Pooling; MEDLINE; Pregnancy; Fetus; Political science; Computer science; Artificial intelligence","score_opus":0.04578181969140841,"score_gpt":0.3041631926899599,"score_spread":0.25838137299855146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093912425","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013804383,0.0011332172,0.000034134475,0.9740669,0.024192477,0.0000042925853,0.000050220628,0.000010139124,0.00037055148],"genre_scores_gemma":[0.0012257469,0.00062626315,0.000069276895,0.96817386,0.02828766,0.00002153787,0.000017040198,0.000011870091,0.0015666789],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99533194,0.0015564894,0.00061310147,0.0007261375,0.0012392314,0.00053311844],"domain_scores_gemma":[0.9809827,0.012505124,0.0014277316,0.00064364745,0.0025318072,0.0019090043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071257893,0.0009027623,0.0024936479,0.0013178311,0.00369206,0.004180836,0.002600562,0.054639783,0.0055731614],"category_scores_gemma":[0.04218859,0.001335591,0.0017752107,0.0010924762,0.004335553,0.0046329405,0.0034201904,0.059847508,0.004038181],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006921324,0.000024772185,0.00069710193,0.00005842903,0.00004109612,0.00049222854,0.00019312729,0.000040266706,0.00006676203,0.0014312349,0.9918075,0.005078206],"study_design_scores_gemma":[0.00029353795,0.00009525402,0.0028944449,0.0006831373,0.00013691577,0.0010495388,0.0013735541,0.000320058,0.00026237598,0.011291756,0.9814136,0.00018595399],"about_ca_topic_score_codex":0.009158578,"about_ca_topic_score_gemma":0.012670563,"teacher_disagreement_score":0.054639783,"about_ca_system_score_codex":0.0032029995,"about_ca_system_score_gemma":0.0048408844,"threshold_uncertainty_score":0.037685275},"labels":[],"label_agreement":null},{"id":"W2101382476","doi":"10.1016/s2213-8587(14)70031-2","title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"University of Oxford; Medtronic; Teva Pharmaceutical Industries; Novartis; Roche; Novo Nordisk; Merck; Bayer; Servier; British Microcirculation Society; Amgen","keywords":"Medicine; Heart failure; Diabetes mellitus; Type 2 diabetes; Intensive care medicine; Internal medicine; Cardiology; Randomized controlled trial; Surrogate endpoint; Endocrinology","score_opus":0.030508690995126726,"score_gpt":0.2589968043897658,"score_spread":0.22848811339463906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101382476","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0055813547,0.22546391,0.0009219314,0.7033422,0.046233024,0.000009387522,0.00035093178,0.00012769178,0.017969443],"genre_scores_gemma":[0.12759463,0.36995414,0.0015130516,0.25139105,0.23723768,0.000048634087,0.0005834663,0.00010119901,0.011576192],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971541,0.00052775803,0.00034077885,0.00031883677,0.0011848189,0.0004736377],"domain_scores_gemma":[0.99038726,0.003356428,0.0010860865,0.0003593585,0.0015260717,0.0032847228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044034063,0.0011654394,0.0030718266,0.0011248238,0.0018362822,0.0049109017,0.001303693,0.007586121,0.007110341],"category_scores_gemma":[0.013512685,0.00042394214,0.00121107,0.0011271772,0.0036049972,0.006520386,0.003586316,0.012804887,0.0036412764],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010023327,0.00044856773,0.015125373,0.003622469,0.00074638333,0.0013900447,0.0006380363,0.0002055715,0.0013786849,0.03428879,0.5013051,0.4398486],"study_design_scores_gemma":[0.001231167,0.0012099615,0.06708002,0.011499682,0.001522252,0.002775245,0.00274911,0.00056006317,0.0006509831,0.1867847,0.7235482,0.00038867656],"about_ca_topic_score_codex":0.0041621746,"about_ca_topic_score_gemma":0.0064677903,"teacher_disagreement_score":0.007586121,"about_ca_system_score_codex":0.0018210668,"about_ca_system_score_gemma":0.004043802,"threshold_uncertainty_score":0.023786426},"labels":[],"label_agreement":null},{"id":"W2105575861","doi":"10.1016/s2213-8587(13)70006-8","title":"Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":257,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Insulin resistance; Internal medicine; Insulin; Diabetes mellitus; Meta-analysis; Type 2 diabetes; Type 2 Diabetes Mellitus; Homeostatic model assessment; Endocrinology","score_opus":0.11718134704544426,"score_gpt":0.35498969325980406,"score_spread":0.2378083462143598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105575861","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0047390345,0.99429363,0.00031514766,0.00008661561,0.00013809414,0.00009548002,0.00018615216,0.000016232509,0.00012943998],"genre_scores_gemma":[0.19114259,0.8040659,0.0023559358,0.0009560312,0.00028182822,0.0003879851,0.00043299326,0.000024985926,0.00035171025],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9942676,0.0023778342,0.0017818906,0.0006728262,0.0006537685,0.00024604294],"domain_scores_gemma":[0.9889713,0.007685225,0.0021711546,0.000407362,0.00055990915,0.00020511843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0086792875,0.0025142974,0.019523077,0.0035955186,0.00052007166,0.0025827277,0.0020602567,0.0023240082,0.0038715086],"category_scores_gemma":[0.017715087,0.0016430636,0.02944257,0.0052238237,0.0007100219,0.0020079883,0.0018907342,0.0024675205,0.00028463814],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036280958,0.000047509926,0.0034117913,0.2762502,0.701169,0.00011478959,0.00008813108,0.00034151308,0.00021272742,0.00008535808,0.0005032231,0.014147603],"study_design_scores_gemma":[0.0011740822,0.00022301658,0.0038330485,0.012583738,0.9807946,0.00007113709,0.00004644119,0.00011100648,0.000068273046,0.00011620915,0.0009537301,0.000024623128],"about_ca_topic_score_codex":0.0070074312,"about_ca_topic_score_gemma":0.02152563,"teacher_disagreement_score":0.019523077,"about_ca_system_score_codex":0.002197643,"about_ca_system_score_gemma":0.0023397964,"threshold_uncertainty_score":0.045901},"labels":[],"label_agreement":null},{"id":"W2117986945","doi":"10.1016/s2213-8587(15)00042-x","title":"Effect of diabetes on tuberculosis control in 13 countries with high tuberculosis: a modelling study","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Science Council; Wellcome Trust","keywords":"Medicine; Tuberculosis; Diabetes mellitus; Incidence (geometry); Epidemiology; Transmission (telecommunications); Environmental health; Internal medicine; Pathology; Endocrinology","score_opus":0.02763255295077844,"score_gpt":0.3062447165250641,"score_spread":0.27861216357428564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117986945","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960056,0.0006341398,0.0009259683,0.00040467628,0.000016184973,0.00004321129,0.0012372846,0.000030587962,0.00070247555],"genre_scores_gemma":[0.99797827,0.00025398275,0.00037174753,0.00005501433,0.00000943916,0.000048052083,0.0007744611,0.0000080201835,0.0005009482],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99553925,0.0030503774,0.0001538123,0.00034569966,0.00007868425,0.000832198],"domain_scores_gemma":[0.9862597,0.009164166,0.0018774545,0.00095838966,0.000586332,0.0011539381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050746123,0.0016138254,0.001995665,0.0009453097,0.0009855791,0.0023815494,0.003014005,0.003691704,0.004876054],"category_scores_gemma":[0.009036602,0.0015437418,0.0053504733,0.0019498429,0.0013434221,0.0014758938,0.0024272006,0.0031149609,0.0006511518],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017192472,0.004416206,0.6456535,0.00054518273,0.010370051,0.0021886658,0.0011583106,0.30648354,0.000513844,0.0027267807,0.002199421,0.0065520518],"study_design_scores_gemma":[0.006605318,0.0078551825,0.5317585,0.00043136146,0.009378108,0.00095414615,0.004548494,0.43178976,0.0006948436,0.003640977,0.0020298976,0.00031341822],"about_ca_topic_score_codex":0.13045764,"about_ca_topic_score_gemma":0.06666515,"teacher_disagreement_score":0.13045764,"about_ca_system_score_codex":0.0025227594,"about_ca_system_score_gemma":0.0021152564,"threshold_uncertainty_score":0.2593966},"labels":[],"label_agreement":null},{"id":"W2122104474","doi":"10.1016/s2213-8587(13)70089-5","title":"Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":217,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Libin Cardiovascular Institute of Alberta; University of Ottawa; University of Toronto; University Health Network; Trillium Health Centre; St. Michael's Hospital","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Medicine; Percutaneous coronary intervention; Conventional PCI; Diabetes mellitus; Internal medicine; Coronary artery disease; Randomized controlled trial; Coronary artery bypass surgery; Meta-analysis; Cardiology; Stent; Surgery; Artery; Myocardial infarction","score_opus":0.1395131283791794,"score_gpt":0.3776054172370421,"score_spread":0.2380922888578627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122104474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015413459,0.9817141,0.0012534324,0.00019717358,0.00039089995,0.0003075697,0.00038450852,0.00005481493,0.000284038],"genre_scores_gemma":[0.34242335,0.64833987,0.0048214765,0.0013269313,0.0005616577,0.0009219816,0.00091934757,0.000083113926,0.0006023452],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9885352,0.006322028,0.002486029,0.0013249657,0.000940671,0.00039111736],"domain_scores_gemma":[0.98129624,0.015110689,0.002182109,0.0006001283,0.00055274524,0.00025808232],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.013037935,0.0038863628,0.02597426,0.002852419,0.00051797676,0.003161278,0.0028325918,0.003031195,0.004150889],"category_scores_gemma":[0.02854103,0.002109758,0.03660119,0.0035274387,0.00093602104,0.0023812163,0.001644026,0.004098716,0.00033223318],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020429615,0.000042055508,0.0017877853,0.121747315,0.84662664,0.000068631634,0.000059026712,0.00052810815,0.00021882824,0.00011587704,0.00038221653,0.007993896],"study_design_scores_gemma":[0.008195802,0.00044989877,0.0022063602,0.0050096535,0.9827322,0.000054242482,0.000042219475,0.00022065063,0.000091816975,0.00029908319,0.0006709477,0.000027186254],"about_ca_topic_score_codex":0.0050393017,"about_ca_topic_score_gemma":0.009253423,"teacher_disagreement_score":0.9740257,"about_ca_system_score_codex":0.0023102763,"about_ca_system_score_gemma":0.0017705804,"threshold_uncertainty_score":0.068952024},"labels":[],"label_agreement":null},{"id":"W2123384152","doi":"10.1016/s2213-8587(15)00141-2","title":"Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Université de Montréal; McGill University Health Centre; Montreal Clinical Research Institute; McGill University","funders":"Fonds de Recherche du Québec - Santé; Canadian Diabetes Association","keywords":"Medicine; Artificial pancreas; Insulin; Diabetes mellitus; Type 2 diabetes; Internal medicine; Pancreas; Type 1 diabetes; Endocrinology; Hormone; Glucagon; Crossover study; Randomized controlled trial; Pediatrics; Placebo; Pathology","score_opus":0.057192812232807394,"score_gpt":0.29983249857646044,"score_spread":0.24263968634365304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123384152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984371,0.008967022,0.0006138094,0.00065101543,0.0010974263,0.0018134979,0.00083016895,0.00011528321,0.0015407376],"genre_scores_gemma":[0.9887899,0.004118697,0.0013007068,0.00071450445,0.00073599734,0.0023019053,0.0007138179,0.000020427453,0.0013040224],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991203,0.00040342315,0.00007467665,0.00019884206,0.00006623017,0.00013653592],"domain_scores_gemma":[0.9986615,0.000490584,0.00026866648,0.00009261916,0.000056354616,0.000430319],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013468278,0.0019844766,0.006253621,0.00045894724,0.00043548315,0.0011470638,0.0012086545,0.0026477997,0.007870143],"category_scores_gemma":[0.0021769924,0.0009577328,0.0030869495,0.0005846513,0.0014574004,0.0012330696,0.0006134661,0.004403145,0.0006659276],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9880413,0.0027631249,0.00063294236,0.0008745157,0.0009098525,0.000038280145,0.00003905079,0.000117576295,0.00040643202,0.000061252984,0.00033975154,0.0057758065],"study_design_scores_gemma":[0.9803538,0.017268753,0.0014325776,0.000048877893,0.0004630445,0.000016481546,0.000019817126,0.00016839548,0.000054597112,0.00004638531,0.00011974852,0.000007573154],"about_ca_topic_score_codex":0.0025103828,"about_ca_topic_score_gemma":0.0032189589,"teacher_disagreement_score":0.007870143,"about_ca_system_score_codex":0.0009264797,"about_ca_system_score_gemma":0.0008943477,"threshold_uncertainty_score":0.026328206},"labels":[],"label_agreement":null},{"id":"W2125012558","doi":"10.1016/s2213-8587(13)70191-8","title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":634,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Novo Nordisk Fonden; Western University; British Heart Foundation; Valeant Pharmaceuticals International; Canadian Institutes of Health Research; Danone; F. Hoffmann-La Roche; National Heart, Lung, and Blood Institute; Pfizer; Heart and Stroke Foundation of Canada; Kowa Company; Sanofi; Regeneron Pharmaceuticals; Novartis; Amgen; European Atherosclerosis Society; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; MEDLINE; Intensive care medicine","score_opus":0.06561073376839394,"score_gpt":0.3450392408922733,"score_spread":0.27942850712387934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125012558","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010056437,0.99838436,0.00014880222,0.0010049056,0.00013002992,0.0000015792655,0.000017918846,0.0000039237184,0.00020802021],"genre_scores_gemma":[0.0009645808,0.9979296,0.0001983783,0.0004457055,0.00033030828,0.0000030500312,0.000030101266,9.300748e-7,0.00009733892],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995529,0.000109503235,0.00007098673,0.00008695046,0.00014714952,0.00003242332],"domain_scores_gemma":[0.99836844,0.001133995,0.00019709526,0.000029305847,0.00019367556,0.00007758826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017190835,0.0009776652,0.0031506692,0.0018879771,0.00020090147,0.0012839859,0.0012544893,0.0012973766,0.0019361574],"category_scores_gemma":[0.0023446477,0.0002659502,0.000678206,0.0022871124,0.0010047379,0.001425655,0.0010516288,0.0020960514,0.0008244146],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012799817,0.000043529708,0.0017121345,0.009339482,0.00033300818,0.00041629196,0.00005106081,0.00030933387,0.00047490653,0.0046747355,0.020639978,0.9618775],"study_design_scores_gemma":[0.00014922256,0.00019859479,0.01647421,0.021286508,0.0015062575,0.00901246,0.00044189364,0.00063087355,0.00048683694,0.025582224,0.9240777,0.00015324264],"about_ca_topic_score_codex":0.002809779,"about_ca_topic_score_gemma":0.00369656,"teacher_disagreement_score":0.0031506692,"about_ca_system_score_codex":0.0008691571,"about_ca_system_score_gemma":0.0015693248,"threshold_uncertainty_score":0.0090914965},"labels":[],"label_agreement":null},{"id":"W2129884578","doi":"10.1016/s2213-8587(13)70013-5","title":"Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials","year":2013,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Insulin degludec; Insulin glargine; Insulin; Internal medicine; Diabetes mellitus; Type 2 diabetes; Metformin; Hypoglycemia; Endocrinology","score_opus":0.06192950866681248,"score_gpt":0.350071599731984,"score_spread":0.2881420910651715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129884578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98760647,0.008305921,0.00060529384,0.00047337878,0.00036469213,0.0008653276,0.0004534598,0.00009166991,0.0012336852],"genre_scores_gemma":[0.9904122,0.0037622463,0.0014834136,0.0009839335,0.00034312825,0.00092105585,0.0005530959,0.000038421433,0.0015025666],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99848205,0.00087996677,0.00012530769,0.00023017958,0.00011731536,0.00016517963],"domain_scores_gemma":[0.99806494,0.0008396577,0.0004810631,0.000179547,0.000074994656,0.00035985763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031802517,0.0018460847,0.0041079507,0.00063209294,0.0003786437,0.0017861768,0.0010755633,0.0025593548,0.0037149906],"category_scores_gemma":[0.0034012948,0.0010232955,0.0038575304,0.0007216088,0.0015845763,0.0020711669,0.00044343018,0.004134791,0.00078149344],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9818647,0.003165216,0.00034894826,0.00038584715,0.00077436643,0.000019117104,0.000043133805,0.00018916892,0.0015643049,0.000031981188,0.0001746431,0.011438475],"study_design_scores_gemma":[0.9429689,0.054102447,0.0014368976,0.000032007105,0.00049635716,0.000029446113,0.000028827706,0.00028412178,0.00032047852,0.000105753425,0.00017377309,0.000020959167],"about_ca_topic_score_codex":0.000704687,"about_ca_topic_score_gemma":0.0011309615,"teacher_disagreement_score":0.0041079507,"about_ca_system_score_codex":0.0009426892,"about_ca_system_score_gemma":0.0006987526,"threshold_uncertainty_score":0.016819},"labels":[],"label_agreement":null},{"id":"W2133596089","doi":"10.1016/s2213-8587(14)70062-2","title":"Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Sanofi; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; Insulin glargine; Diabetes mellitus; Placebo; Digit symbol substitution test; Type 2 diabetes; Insulin; Cognitive decline; Randomized controlled trial; Endocrinology; Disease; Dementia","score_opus":0.015669779618474978,"score_gpt":0.2877979056001723,"score_spread":0.27212812598169733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133596089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98961276,0.007365656,0.00015700927,0.0002948102,0.00023135393,0.00040375497,0.00090708217,0.00002923334,0.0009983972],"genre_scores_gemma":[0.99279916,0.0031019452,0.00031486878,0.00054437766,0.00038062956,0.0004882319,0.0011916906,0.000011730803,0.0011672444],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9992305,0.0003851188,0.00007790731,0.0001217527,0.00006496233,0.00011981311],"domain_scores_gemma":[0.99835443,0.00049799477,0.00033981728,0.00020619649,0.00017215913,0.00042944477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018639128,0.001744878,0.00495851,0.00039114637,0.0007626296,0.0014570014,0.0011989395,0.002048934,0.0025581466],"category_scores_gemma":[0.003162057,0.0008052058,0.004394762,0.00073314237,0.00082815374,0.0011648561,0.0009217045,0.0036223806,0.0005386565],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97059983,0.00264785,0.009084055,0.0008417181,0.007972408,0.00007816649,0.0001547828,0.00015818763,0.00077483826,0.00006897629,0.0005888405,0.0070303106],"study_design_scores_gemma":[0.8459322,0.05439722,0.07337692,0.00025839274,0.023020819,0.0001257924,0.00025172727,0.0005689307,0.0005173434,0.00039850787,0.0010587183,0.00009345931],"about_ca_topic_score_codex":0.007896346,"about_ca_topic_score_gemma":0.012154559,"teacher_disagreement_score":0.007896346,"about_ca_system_score_codex":0.00095429516,"about_ca_system_score_gemma":0.0009083533,"threshold_uncertainty_score":0.015700758},"labels":[],"label_agreement":null},{"id":"W2147391073","doi":"10.1016/s2213-8587(14)70137-8","title":"Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of British Columbia; University of Melbourne","keywords":"Medicine; Diabetes mellitus; Type 2 diabetes; Cohort; Cross-sectional study; Young adult; Population; Prospective cohort study; Pediatrics; JADE (particle detector); Age of onset; Cohort study; Internal medicine; Disease; Environmental health; Endocrinology; Pathology","score_opus":0.019454963442666968,"score_gpt":0.28496569375733155,"score_spread":0.2655107303146646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147391073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991887,0.00011131753,0.00002918428,0.00004550617,0.000006364856,0.000012844372,0.00042117847,0.0000018271618,0.00018305892],"genre_scores_gemma":[0.99899524,0.00014804203,0.00006447303,0.00007783721,0.000008075119,0.000029894007,0.00048804883,0.0000026196506,0.00018562858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994703,0.00014282082,0.000051641302,0.00011112263,0.00006198658,0.00016225029],"domain_scores_gemma":[0.9987564,0.00014095106,0.00041153614,0.00014383871,0.00013807778,0.00040905093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012395456,0.0005089855,0.00064767164,0.00061935943,0.0011229401,0.0013126895,0.0006683927,0.0010678291,0.0009239382],"category_scores_gemma":[0.001955963,0.00090582704,0.00089042145,0.0017931892,0.00040041353,0.0011410813,0.0012874729,0.0019253807,0.00023709801],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117101685,0.00016271065,0.9984101,0.000009608213,0.00008357459,0.00007345711,0.00042649367,0.000016571148,0.00009579919,0.000013966849,0.00009989784,0.0004908091],"study_design_scores_gemma":[0.000009783659,0.000091568065,0.998657,0.000007933589,0.000044094602,0.00007185355,0.0009728765,0.00005072611,0.000014378799,0.000010117954,0.00006511759,0.000004537436],"about_ca_topic_score_codex":0.041524287,"about_ca_topic_score_gemma":0.048654813,"teacher_disagreement_score":0.041524287,"about_ca_system_score_codex":0.0006357936,"about_ca_system_score_gemma":0.0009283154,"threshold_uncertainty_score":0.08256519},"labels":[],"label_agreement":null},{"id":"W2151947272","doi":"10.1016/s2213-8587(14)70213-x","title":"Mortality risk among sulfonylureas: a systematic review and network meta-analysis","year":2014,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Killam Trusts; Canadian Diabetes Association","keywords":"Medicine; Gliclazide; Glibenclamide; Glimepiride; Glipizide; Tolbutamide; Internal medicine; Chlorpropamide; Relative risk; Type 2 diabetes; Meta-analysis; Diabetes mellitus; Myocardial infarction; Stroke (engine); Confidence interval; Cardiology; Endocrinology; Insulin","score_opus":0.09578919385841846,"score_gpt":0.3540050939430012,"score_spread":0.2582159000845828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151947272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006943928,0.99108326,0.0005170841,0.00018214992,0.00019983765,0.00017059635,0.00066921907,0.000034239285,0.00019962525],"genre_scores_gemma":[0.26281503,0.7298458,0.003179129,0.0015516927,0.00040544488,0.00069995894,0.0009689964,0.00005488047,0.00047908587],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9918819,0.003588295,0.0023157094,0.0010439482,0.00080188905,0.00036818624],"domain_scores_gemma":[0.9858144,0.009697492,0.0027338497,0.0006508198,0.00088733266,0.00021616189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011238651,0.0034878019,0.01802117,0.0054134736,0.0006239527,0.0026245634,0.0021725313,0.0024684325,0.004619305],"category_scores_gemma":[0.027628269,0.0023472826,0.038689118,0.005844248,0.00075835665,0.0019876154,0.0024671014,0.0025542062,0.00038169578],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002092685,0.000023977038,0.004150911,0.1825572,0.8020622,0.00010037993,0.000070589,0.0002767807,0.0001682661,0.00007348225,0.00065648113,0.0077669905],"study_design_scores_gemma":[0.00066262006,0.000092145296,0.0026803107,0.006944891,0.98851657,0.00005243746,0.000027915217,0.00007455346,0.000044968117,0.00009633546,0.0007892456,0.000017904727],"about_ca_topic_score_codex":0.0099502755,"about_ca_topic_score_gemma":0.027193919,"teacher_disagreement_score":0.01802117,"about_ca_system_score_codex":0.0024750882,"about_ca_system_score_gemma":0.002978773,"threshold_uncertainty_score":0.05943638},"labels":[],"label_agreement":null},{"id":"W2156174833","doi":"10.1016/s2213-8587(13)70025-1","title":"Dysglycaemia, vasculopenia, and the chronic consequences of diabetes","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Population Health Research Institute; McMaster University; Hamilton Health Sciences","funders":"Association pour la Recherche sur le Diabète; Diabetes Canada; McMaster University; Canadian Diabetes Association","keywords":"Medicine; Retina; Diabetes mellitus; Diabetic retinopathy; Retinopathy; Internal medicine; Vasa vasorum; Endocrinology; Ophthalmology; Biology; Neuroscience","score_opus":0.04586101067304761,"score_gpt":0.33023359097107585,"score_spread":0.28437258029802825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156174833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023419983,0.99956113,0.00001653396,0.00014252208,0.00009984396,9.731515e-7,0.0000063508055,0.0000016058286,0.00014752701],"genre_scores_gemma":[0.00021156065,0.9993305,0.00004159655,0.0001240576,0.00016161732,0.0000016111701,0.000008849925,3.037351e-7,0.000119833545],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968374,0.0000508399,0.000046547495,0.000039349507,0.00015239313,0.000027098582],"domain_scores_gemma":[0.99927455,0.00039996713,0.00014625133,0.000013337248,0.00011433347,0.000051557578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009971833,0.0009988116,0.0024831211,0.0021988773,0.0002809485,0.0012197446,0.00089101936,0.0013693691,0.004045748],"category_scores_gemma":[0.0013885351,0.00034123682,0.00068394706,0.0031762514,0.0005897077,0.0011260214,0.00092142617,0.002256624,0.0012815618],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121247205,0.000059279122,0.00025933425,0.028290533,0.00028337046,0.00011469037,0.000039459388,0.0002213335,0.000477996,0.0026495242,0.038718667,0.9287646],"study_design_scores_gemma":[0.00009696354,0.00012832308,0.0029288314,0.019306347,0.00072241825,0.0011723182,0.00015323471,0.0001293685,0.00017582845,0.004430986,0.9707088,0.000046637862],"about_ca_topic_score_codex":0.0029427917,"about_ca_topic_score_gemma":0.007906671,"teacher_disagreement_score":0.004045748,"about_ca_system_score_codex":0.00075075385,"about_ca_system_score_gemma":0.0015342253,"threshold_uncertainty_score":0.013534427},"labels":[],"label_agreement":null},{"id":"W2157724073","doi":"10.1016/s2213-8587(13)70028-7","title":"Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure","year":2013,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Innovates; Wellcome Trust","keywords":"Medicine; Observational study; Drug; Diabetes mellitus; Epidemiology; Risk assessment; Intensive care medicine; MEDLINE; Cancer; Pharmacology; Internal medicine","score_opus":0.02911998042535419,"score_gpt":0.2965901894858524,"score_spread":0.26747020906049823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157724073","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037885897,0.9976144,0.0000879772,0.0015591386,0.00033021718,0.0000010229396,0.000013111883,0.00000287973,0.00035338468],"genre_scores_gemma":[0.00057374,0.9973213,0.00018712919,0.0009508208,0.00074464176,0.0000033523759,0.000015941485,0.0000017710953,0.00020133398],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99933165,0.00020621829,0.00007984312,0.000085296975,0.0002533364,0.00004361328],"domain_scores_gemma":[0.99705625,0.0022115707,0.00022128926,0.000057811485,0.0003521086,0.000101016936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020961552,0.0010641088,0.0037363041,0.0014696067,0.00032465893,0.0021254658,0.0013423273,0.0026156204,0.0036252027],"category_scores_gemma":[0.0032303052,0.00039952068,0.0010322325,0.002139243,0.0010753876,0.0021795034,0.0011527368,0.0049965205,0.0011388643],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001978974,0.000079294325,0.0008007236,0.011067139,0.0005530668,0.00018055421,0.000060997663,0.00042713812,0.00050780515,0.010194715,0.05539835,0.92053246],"study_design_scores_gemma":[0.0000636803,0.00009798785,0.0026228912,0.0076303636,0.00046795027,0.00072407746,0.0001380495,0.00018757995,0.00022921005,0.01650192,0.97127926,0.000057100835],"about_ca_topic_score_codex":0.0030898668,"about_ca_topic_score_gemma":0.0059188385,"teacher_disagreement_score":0.0037363041,"about_ca_system_score_codex":0.001285713,"about_ca_system_score_gemma":0.0020995121,"threshold_uncertainty_score":0.012127578},"labels":[],"label_agreement":null},{"id":"W2161569030","doi":"10.1016/s2213-8587(15)00040-6","title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","year":2015,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":897,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Heart, Lung, and Blood Institute; National Institutes of Health; National Center for Advancing Translational Sciences; Mitsubishi Tanabe Pharma Corporation; Kyowa Hakko Kirin; Servier; National Institute of Diabetes and Digestive and Kidney Diseases; Amgen; National Eye Institute; National Institute on Aging; Astellas Pharma; Alexion Pharmaceuticals; National Kidney Foundation; Sanofi; MSD","keywords":"Medicine; Albuminuria; Renal function; Proteinuria; Internal medicine; Kidney disease; Creatinine; Stroke (engine); Dipstick; Cardiology; Meta-analysis; Framingham Risk Score; Disease; Kidney; Urine","score_opus":0.4483719534108682,"score_gpt":0.4318365600653313,"score_spread":0.01653539334553694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161569030","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062308586,0.99036145,0.0020692686,0.00021190825,0.0002273021,0.00010825361,0.0005969323,0.000056379704,0.00013775661],"genre_scores_gemma":[0.24205768,0.7406586,0.0121899955,0.0012970325,0.00048688072,0.00059749896,0.0021529482,0.00014283687,0.00041659398],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98016536,0.012733427,0.0030278796,0.0020648087,0.0015929746,0.00041556056],"domain_scores_gemma":[0.95866936,0.03453146,0.0026152558,0.0022138688,0.0016438008,0.00032622242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02689112,0.003805226,0.018381989,0.004067332,0.0005052145,0.002886081,0.0034263607,0.0027562368,0.0021198883],"category_scores_gemma":[0.048995294,0.0022823405,0.05229485,0.00498695,0.0005256116,0.002011879,0.0021955832,0.0035924534,0.00032338346],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025653117,0.000027240816,0.0045874487,0.04922399,0.92256516,0.00007337926,0.000055065862,0.00075577095,0.00014287508,0.00012471808,0.00074397965,0.01913505],"study_design_scores_gemma":[0.0009808458,0.00017299374,0.0043393224,0.0038811334,0.9880285,0.00009395466,0.000027847364,0.0004455746,0.00009983534,0.0003792665,0.0015108661,0.00003993983],"about_ca_topic_score_codex":0.009168024,"about_ca_topic_score_gemma":0.016442861,"teacher_disagreement_score":0.02689112,"about_ca_system_score_codex":0.0017329422,"about_ca_system_score_gemma":0.0030701112,"threshold_uncertainty_score":0.14221555},"labels":[],"label_agreement":null},{"id":"W2168023382","doi":"10.1016/s2213-8587(14)70221-9","title":"Risks and benefits of childhood physical activity","year":2014,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Scopus; Physical activity; Childhood obesity; Sports medicine; Health professionals; Health benefits; Position statement; MEDLINE; Family medicine; Gerontology; Physical therapy; Health care; Obesity; Pathology","score_opus":0.04670530495986426,"score_gpt":0.2941253053526578,"score_spread":0.24742000039279355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168023382","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004869401,0.0025738368,0.000045889527,0.9813913,0.013469424,0.0000049675627,0.00011074622,0.000010250387,0.0019066249],"genre_scores_gemma":[0.0072543863,0.0036005094,0.00017709815,0.88664484,0.09719783,0.000041128966,0.00008523746,0.000017890476,0.0049810787],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99764496,0.00075677707,0.00029417305,0.00025612168,0.0007740345,0.00027392918],"domain_scores_gemma":[0.9894448,0.007506802,0.0005931133,0.00022955812,0.0010094414,0.0012163478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027022029,0.00082454423,0.0016210721,0.0006731633,0.002181485,0.0023933027,0.0012684267,0.035297465,0.0059048687],"category_scores_gemma":[0.0268099,0.00079367124,0.0012053532,0.0006933992,0.0025360738,0.0027414593,0.0013975838,0.03953286,0.0038504899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026282566,0.00008245959,0.0029478562,0.00011118353,0.00006137421,0.0010020594,0.00010487645,0.000073139076,0.00017987931,0.0028770373,0.9693829,0.022914456],"study_design_scores_gemma":[0.0007902879,0.00023324891,0.01251615,0.0011880327,0.000227479,0.002366301,0.0007101188,0.00071561255,0.0003735285,0.021916935,0.95880777,0.0001546082],"about_ca_topic_score_codex":0.014871952,"about_ca_topic_score_gemma":0.025841217,"teacher_disagreement_score":0.035297465,"about_ca_system_score_codex":0.003088511,"about_ca_system_score_gemma":0.0032719185,"threshold_uncertainty_score":0.029570758},"labels":[],"label_agreement":null},{"id":"W2168937840","doi":"10.1016/s2213-8587(14)70121-4","title":"The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional Study","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pregnancy and preeclampsia studies","field":"Medicine","cited_by":292,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Bill and Melinda Gates Foundation","keywords":"Medicine; Fetus; Intrauterine growth restriction; Population; Fetal growth; Gestation; Pregnancy; Obstetrics; Longitudinal study; Gestational age; Demography; Pediatrics; Environmental health; Biology; Pathology","score_opus":0.05272309607930561,"score_gpt":0.3470317788286238,"score_spread":0.2943086827493182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168937840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976284,0.00052972516,0.00022699535,0.0001870594,0.000027022656,0.000010232336,0.0009977686,0.0000061809155,0.00038671528],"genre_scores_gemma":[0.9982218,0.00021803954,0.00017276415,0.00010171567,0.000020669442,0.00002982344,0.00093809445,0.00001376417,0.00028332844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565226,0.0026032901,0.0002958054,0.00076473586,0.0003513825,0.0003326004],"domain_scores_gemma":[0.9887078,0.0032573103,0.0031318895,0.0024914462,0.0008263266,0.0015852296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0074988175,0.00054460374,0.00074743194,0.0010746005,0.001045602,0.0014647563,0.0017779209,0.0014686162,0.00087748794],"category_scores_gemma":[0.016614527,0.0007774653,0.0009993279,0.0020722314,0.0011825997,0.0016931107,0.002576233,0.0019081098,0.00019208771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024189583,0.000046081732,0.9970548,0.000014012927,0.0004114985,0.00006557402,0.00076260674,0.000053551823,0.0001611495,0.00008684812,0.00020959851,0.0008923955],"study_design_scores_gemma":[0.000009880845,0.00008744253,0.99880147,0.000009592521,0.0000822384,0.000092537746,0.0005852129,0.000067473564,0.000037909096,0.00004649852,0.00017067419,0.000009119596],"about_ca_topic_score_codex":0.030784544,"about_ca_topic_score_gemma":0.02919777,"teacher_disagreement_score":0.030784544,"about_ca_system_score_codex":0.0006043026,"about_ca_system_score_gemma":0.0006085699,"threshold_uncertainty_score":0.06121075},"labels":[],"label_agreement":null},{"id":"W2169497693","doi":"10.1016/s2213-8587(14)70229-3","title":"Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study","year":2014,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":219,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; University of Calgary; McGill University Health Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Overweight; Diabetes mellitus; Obesity; Type 2 diabetes; Years of potential life lost; Disease; National Health and Nutrition Examination Survey; Risk factor; Gerontology; Demography; Internal medicine; Population; Endocrinology; Environmental health; Life expectancy","score_opus":0.01844392281592022,"score_gpt":0.23514660279209618,"score_spread":0.21670267997617595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169497693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99403,0.00053964835,0.0022556172,0.00040024763,0.000029753313,0.00004097785,0.001918673,0.000041951615,0.00074314047],"genre_scores_gemma":[0.99438065,0.00038764038,0.0007923025,0.00007880749,0.000028464627,0.00012407219,0.0018026901,0.000028344462,0.0023771285],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99830127,0.0010444964,0.0000888752,0.00024736338,0.00007062224,0.00024733224],"domain_scores_gemma":[0.99072003,0.006706513,0.0008791763,0.0008246741,0.00028207345,0.0005875665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043265508,0.0015400104,0.0017275178,0.0010006288,0.00092974986,0.002228587,0.0038354723,0.0027961668,0.006590078],"category_scores_gemma":[0.008585376,0.0014159692,0.0060385684,0.0014989461,0.00080123567,0.0017761084,0.0016282689,0.0035139201,0.0011144095],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023750171,0.005988091,0.664657,0.0005666891,0.011667311,0.0019824838,0.0030873565,0.2634892,0.00067711517,0.0075716414,0.0041967765,0.012366285],"study_design_scores_gemma":[0.0025472231,0.0041206577,0.37597302,0.00038592177,0.0051258653,0.0016237395,0.0030842044,0.59497845,0.00026847908,0.00809553,0.0034725324,0.00032439496],"about_ca_topic_score_codex":0.056645863,"about_ca_topic_score_gemma":0.030795032,"teacher_disagreement_score":0.056645863,"about_ca_system_score_codex":0.0017515769,"about_ca_system_score_gemma":0.0012518389,"threshold_uncertainty_score":0.112632334},"labels":[],"label_agreement":null},{"id":"W2174912211","doi":"10.1016/s2213-8587(15)00368-x","title":"Ramipril versus placebo in kidney transplant patients with proteinuria: a multicentre, double-blind, randomised controlled trial","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; St. Michael's Hospital; University of Calgary; Vancouver General Hospital; University of Alberta; Dalhousie University; Western University; Queen's University; McMaster University; University of Ottawa; McGill University; Centre Hospitalier de l’Université de Montréal; University Health Network; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Proteinuria; Placebo; Ramipril; Renal function; Population; Internal medicine; Kidney disease; Clinical endpoint; Creatinine; Randomized controlled trial; Clinical trial; Urology; Surgery; Kidney; Blood pressure","score_opus":0.04848031869414648,"score_gpt":0.30316669990349776,"score_spread":0.2546863812093513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174912211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95035774,0.030775843,0.0020980432,0.0021804257,0.0036255394,0.0060957987,0.0015719748,0.0003966479,0.0028980386],"genre_scores_gemma":[0.9762574,0.008776969,0.002384972,0.0019521271,0.0015857314,0.004907904,0.00073507515,0.00004055117,0.0033592593],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9980082,0.0010560539,0.0002058847,0.00037389164,0.00011618118,0.00023964587],"domain_scores_gemma":[0.9982079,0.00070982066,0.0004739348,0.00016223322,0.00011182467,0.00033420388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035144412,0.0029450788,0.009416458,0.00068048853,0.0007296153,0.0019998348,0.001615555,0.0039201137,0.008299396],"category_scores_gemma":[0.0041145007,0.001408142,0.0042695114,0.0006624218,0.0019614487,0.0022180765,0.0008629194,0.0041320366,0.0012940568],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.994612,0.00064102607,0.00010456776,0.0009231246,0.001103924,0.000015569833,0.000019911366,0.000052219377,0.00037066411,0.000041582123,0.00017584217,0.0019396237],"study_design_scores_gemma":[0.99216896,0.0064636753,0.00029534992,0.000041460687,0.00070108054,0.000007273417,0.000009532684,0.00009976263,0.0000484184,0.000054563327,0.00010141719,0.000008501369],"about_ca_topic_score_codex":0.0014011139,"about_ca_topic_score_gemma":0.0018528327,"teacher_disagreement_score":0.009416458,"about_ca_system_score_codex":0.0009221679,"about_ca_system_score_gemma":0.00097611407,"threshold_uncertainty_score":0.02776432},"labels":[],"label_agreement":null},{"id":"W2196806522","doi":"10.1016/s2213-8587(15)00427-1","title":"Understanding EMPA-REG OUTCOME","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Medicine; Cardiology; Internal medicine; Heart failure; Asymptomatic; Diabetes mellitus; Diastole; Type 2 diabetes; Subclinical infection; Diabetic cardiomyopathy; Cardiomyopathy; Blood pressure; Endocrinology","score_opus":0.20224509148441888,"score_gpt":0.32123961387028116,"score_spread":0.11899452238586228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2196806522","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040249916,0.003977453,0.0000656882,0.9857641,0.0072590495,0.0000033901877,0.00013454727,0.000009907632,0.002383451],"genre_scores_gemma":[0.013730516,0.005163026,0.00019675388,0.8904718,0.08770478,0.000037926373,0.00019650019,0.000014464626,0.0024842971],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99443215,0.0020489097,0.0007249983,0.00054704666,0.001274469,0.00097242993],"domain_scores_gemma":[0.9752299,0.016060377,0.0019576945,0.0007120947,0.0027164698,0.0033234614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00738526,0.00059944956,0.0017307017,0.0009995778,0.00234576,0.0044003506,0.0015277569,0.024252571,0.0083765],"category_scores_gemma":[0.05130727,0.0005197894,0.0014372872,0.00086991803,0.00256832,0.0049340855,0.0030003595,0.031112466,0.004874973],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012382156,0.00006466336,0.0044593154,0.00015029895,0.00008309974,0.00066296855,0.00015094345,0.00011925861,0.000087355045,0.009448607,0.94151884,0.04313082],"study_design_scores_gemma":[0.0007703728,0.00026614664,0.017265158,0.0035660628,0.00041068878,0.0024316977,0.0011330206,0.0015852752,0.00042018027,0.16611803,0.80579203,0.0002413279],"about_ca_topic_score_codex":0.0058932696,"about_ca_topic_score_gemma":0.010161179,"teacher_disagreement_score":0.024252571,"about_ca_system_score_codex":0.005461163,"about_ca_system_score_gemma":0.004721261,"threshold_uncertainty_score":0.039623678},"labels":[],"label_agreement":null},{"id":"W2202092430","doi":"10.1016/s2213-8587(15)00369-1","title":"Is the artificial pancreas coming to a home near you?","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; McGill University","funders":"","keywords":"Medicine; Diabetes mellitus; Scopus; Type 2 diabetes; Evening; Artificial pancreas; MEDLINE; Type 1 diabetes; Randomized controlled trial; Intensive care medicine; Family medicine; Internal medicine; Endocrinology","score_opus":0.08551281787050605,"score_gpt":0.33004498534740645,"score_spread":0.2445321674769004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2202092430","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024560094,0.0014985632,0.00003792862,0.98419636,0.01274382,0.000002697388,0.000013878986,0.000007686892,0.001253342],"genre_scores_gemma":[0.0037876968,0.002244227,0.00012510722,0.94137746,0.048013825,0.000011871009,0.000015674694,0.000012924134,0.0044112103],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9973007,0.0007418715,0.00035970868,0.0003429092,0.000776721,0.0004781371],"domain_scores_gemma":[0.99419713,0.0027371044,0.00065120397,0.00015110387,0.000629522,0.0016338559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002520018,0.000780024,0.001532458,0.00063612056,0.0035354225,0.0039688284,0.0012920481,0.051692702,0.009486869],"category_scores_gemma":[0.024214335,0.0007253036,0.0015590065,0.0005264994,0.0034390665,0.006094878,0.001966214,0.051101808,0.0058109635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117417694,0.000063601285,0.0016496188,0.000103059894,0.000040727347,0.0050272956,0.0002006518,0.00005246119,0.00018045362,0.004215978,0.9718373,0.01651144],"study_design_scores_gemma":[0.0002813568,0.00024397542,0.0023578082,0.00116465,0.000114192924,0.011682822,0.0016121555,0.00042877454,0.0002881507,0.022231642,0.9594758,0.00011860468],"about_ca_topic_score_codex":0.0050975257,"about_ca_topic_score_gemma":0.008179809,"teacher_disagreement_score":0.051692702,"about_ca_system_score_codex":0.003914071,"about_ca_system_score_gemma":0.0036193528,"threshold_uncertainty_score":0.03173679},"labels":[],"label_agreement":null},{"id":"W2206181613","doi":"10.1016/s2213-8587(15)00324-1","title":"Myostatin inhibition for treatment of sarcopenia","year":2015,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Myostatin; Medicine; Sarcopenia; Muscle hypertrophy; Skeletal muscle; Endocrinology; Internal medicine","score_opus":0.03898680223898934,"score_gpt":0.2902058703422169,"score_spread":0.2512190681032276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2206181613","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002539054,0.04169238,0.0004712178,0.8895936,0.056413557,0.00004134718,0.00020815061,0.00011326648,0.008927423],"genre_scores_gemma":[0.031599257,0.03328727,0.0009197751,0.7598401,0.14444576,0.00014576652,0.0002140489,0.000058075442,0.029489946],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994273,0.00013641127,0.00007278265,0.000063514606,0.0002164729,0.00008356485],"domain_scores_gemma":[0.9988166,0.000740707,0.0000871125,0.00003564818,0.00013861268,0.00018136075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010147628,0.0006854655,0.0015134664,0.00045273796,0.00073166157,0.0010938992,0.00069174945,0.008888616,0.005076202],"category_scores_gemma":[0.004443582,0.000303827,0.0011025376,0.00026519212,0.0010234895,0.0009805934,0.00069565163,0.012874687,0.0038637947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009143154,0.00019243972,0.00073527655,0.00035303927,0.00011758905,0.0036309378,0.00005019463,0.0002078931,0.0015020554,0.005320467,0.88363427,0.10334142],"study_design_scores_gemma":[0.0028390023,0.0010118859,0.0034661063,0.00077447045,0.00016742949,0.0047237393,0.000101430334,0.0010698879,0.0014248639,0.016774628,0.96756357,0.00008295391],"about_ca_topic_score_codex":0.00073190295,"about_ca_topic_score_gemma":0.0022521922,"teacher_disagreement_score":0.008888616,"about_ca_system_score_codex":0.001185722,"about_ca_system_score_gemma":0.0006632228,"threshold_uncertainty_score":0.016981602},"labels":[],"label_agreement":null},{"id":"W2219637998","doi":"10.1016/s2213-8587(15)00488-x","title":"Beyond the opportunities of SDG 3: the risk for the NCDs agenda","year":2015,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Sustainable development; Vision; Politics; Medicine; Process (computing); Millennium Development Goals; Sustainability; Construct (python library); Economic growth; Environmental resource management; Political science; Developing country; Economics; Sociology; Ecology; Computer science","score_opus":0.15875164997272867,"score_gpt":0.32708746865243793,"score_spread":0.16833581867970926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2219637998","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0035180985,0.009889949,0.0012580886,0.96133584,0.0057049235,0.000011948274,0.00041865362,0.00007154267,0.017790921],"genre_scores_gemma":[0.228841,0.042195205,0.0061364505,0.6738982,0.034525514,0.00022168644,0.0010139798,0.00024725698,0.012920607],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99497414,0.0017070036,0.00022860787,0.00031837283,0.0015151002,0.0012568494],"domain_scores_gemma":[0.967431,0.015364846,0.0019826458,0.0016655104,0.0038325686,0.009723368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014061167,0.0008615638,0.0010961823,0.0016783752,0.0027067377,0.008200547,0.0019874196,0.014141254,0.020937037],"category_scores_gemma":[0.0360825,0.00031544533,0.0015126646,0.0015934487,0.008145355,0.01289932,0.010483436,0.020569362,0.0015265042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001883571,0.0001741603,0.00509467,0.00045139293,0.000089525725,0.00031617816,0.00095582125,0.0009807487,0.00031822006,0.55272794,0.35268348,0.08601952],"study_design_scores_gemma":[0.00007851976,0.0000628233,0.0055578053,0.0018864163,0.000049857535,0.00016647842,0.001996944,0.0009224402,0.00019594039,0.6122292,0.37676895,0.00008455799],"about_ca_topic_score_codex":0.022024719,"about_ca_topic_score_gemma":0.02364062,"teacher_disagreement_score":0.022024719,"about_ca_system_score_codex":0.0045512803,"about_ca_system_score_gemma":0.025470847,"threshold_uncertainty_score":0.07436347},"labels":[],"label_agreement":null},{"id":"W2233447513","doi":"10.1016/s2213-8587(15)00495-7","title":"INDEPTH Network: contributing to the data revolution","year":2016,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Global Health Research; University of Toronto","funders":"Wellcome Trust","keywords":"Medicine; MEDLINE; Data science","score_opus":0.08392349605258684,"score_gpt":0.3130773507607169,"score_spread":0.22915385470813007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2233447513","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005704172,0.0011883749,0.0001645744,0.9852798,0.011301114,0.00000575717,0.000092269285,0.000049038445,0.0018619846],"genre_scores_gemma":[0.0015207152,0.001452632,0.0005354722,0.93327886,0.057677977,0.000053816173,0.00011515575,0.00007644831,0.0052889623],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9697038,0.011651791,0.0018194685,0.0026869418,0.011903264,0.0022347136],"domain_scores_gemma":[0.8097126,0.12460634,0.008709714,0.009613327,0.014113504,0.03324452],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.041994847,0.0015127345,0.0022128515,0.00249923,0.005232511,0.017421937,0.0056663854,0.069544226,0.037329234],"category_scores_gemma":[0.19310562,0.0012209783,0.0019908368,0.002359561,0.012694803,0.025963103,0.010112138,0.060660765,0.019907441],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023040522,0.000009473412,0.000110063476,0.00003158705,0.000006878665,0.00008980532,0.00003728059,0.00002635816,0.000027313094,0.0044368147,0.9889088,0.0062925555],"study_design_scores_gemma":[0.000096513635,0.000018457826,0.000381435,0.000266135,0.000012878957,0.00018272847,0.00016761219,0.00033762763,0.00007291362,0.022508804,0.97590536,0.000049537088],"about_ca_topic_score_codex":0.0042161522,"about_ca_topic_score_gemma":0.008625344,"teacher_disagreement_score":0.9943336,"about_ca_system_score_codex":0.007818863,"about_ca_system_score_gemma":0.012065432,"threshold_uncertainty_score":0.22209269},"labels":[],"label_agreement":null},{"id":"W2257765661","doi":"10.1016/s2213-8587(15)00480-5","title":"Community health worker-based intervention for adherence to drugs and lifestyle change after acute coronary syndrome: a multicentre, open, randomised controlled trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"U.S. Public Health Service","keywords":"Medicine; Acute coronary syndrome; Randomized controlled trial; Physical therapy; Clinical trial; Blood pressure; Community health; Intervention (counseling); Internal medicine; Myocardial infarction; Public health; Nursing","score_opus":0.0758911750230868,"score_gpt":0.3667132912328758,"score_spread":0.29082211620978904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2257765661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97467583,0.004560097,0.0011769008,0.00097613846,0.0018010422,0.0133099,0.0014655683,0.00018993384,0.0018445125],"genre_scores_gemma":[0.97329706,0.002399236,0.0034000392,0.0013493411,0.0011947281,0.015196485,0.000798898,0.00002484615,0.0023393657],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99657553,0.0017097656,0.00033568134,0.0006466532,0.00026385183,0.00046837525],"domain_scores_gemma":[0.99745387,0.00084502646,0.0005160705,0.00023974951,0.0001972201,0.0007480917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032859098,0.0025590602,0.0056155478,0.00096970156,0.001281947,0.0014567176,0.0015055514,0.0051982626,0.009567421],"category_scores_gemma":[0.0056154206,0.001386155,0.0033918603,0.001034176,0.0017736414,0.0014731908,0.0014359416,0.0038943987,0.0010467496],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9760454,0.013119134,0.0005766553,0.0010761962,0.0020291263,0.000026543312,0.000079462254,0.00010400128,0.00036825464,0.000054714426,0.00040641043,0.0061140778],"study_design_scores_gemma":[0.97927517,0.01850195,0.0013520652,0.000051188323,0.00052932947,0.000005424555,0.000019432935,0.000086360975,0.000038291582,0.000032273234,0.000100406025,0.000008156613],"about_ca_topic_score_codex":0.0065837284,"about_ca_topic_score_gemma":0.007857714,"teacher_disagreement_score":0.009567421,"about_ca_system_score_codex":0.0013906183,"about_ca_system_score_gemma":0.0020579356,"threshold_uncertainty_score":0.032006145},"labels":[],"label_agreement":null},{"id":"W2289823333","doi":"10.1016/s2213-8587(14)70102-0","title":"Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment","year":2014,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":813,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"British Heart Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Medical Research Council; National Institute for Health and Care Research","keywords":"Medicine; Kidney disease; Diabetes mellitus; Disease; Type 2 diabetes; Intensive care medicine; Risk assessment; Internal medicine; Environmental health; Endocrinology","score_opus":0.05224403673869319,"score_gpt":0.3421681128012508,"score_spread":0.2899240760625576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2289823333","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.64472675,0.27939233,0.0055898274,0.001880906,0.00036380635,0.00028630873,0.06115876,0.00019316352,0.0064081666],"genre_scores_gemma":[0.9317002,0.039684072,0.004897247,0.00026555185,0.00021246112,0.00038758133,0.022373574,0.000029677989,0.00044959752],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99584347,0.0014347153,0.000558712,0.0008378475,0.0011357057,0.00018952471],"domain_scores_gemma":[0.9962574,0.0011075713,0.0011402669,0.00045402773,0.00089745875,0.00014325882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008828312,0.00087317923,0.0015351701,0.010600493,0.0003244937,0.0011093714,0.001110415,0.00067485974,0.0013546757],"category_scores_gemma":[0.009304626,0.00045968566,0.0061170473,0.011702007,0.00036763755,0.0006962091,0.0015145079,0.00057639554,0.0001835513],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017480177,0.00008523153,0.8472786,0.006065624,0.06356366,0.00020189071,0.00050664257,0.0057175267,0.00045705697,0.0017251042,0.0065618944,0.0660888],"study_design_scores_gemma":[0.00012776934,0.00019316566,0.96878093,0.0011026898,0.020495139,0.00036024378,0.00024539378,0.0019515395,0.00020697183,0.00047039142,0.0060077324,0.000057977446],"about_ca_topic_score_codex":0.039481588,"about_ca_topic_score_gemma":0.039917357,"teacher_disagreement_score":0.039481588,"about_ca_system_score_codex":0.0026130192,"about_ca_system_score_gemma":0.0014416133,"threshold_uncertainty_score":0.07850355},"labels":[],"label_agreement":null},{"id":"W2311523609","doi":"10.1016/s2213-8587(16)00049-8","title":"Heart failure event definitions in drug trials in patients with type 2 diabetes","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Saxagliptin; Heart failure; Diabetes mellitus; Myocardial infarction; Type 2 diabetes; Type 2 Diabetes Mellitus; Internal medicine; Intensive care medicine; Stroke (engine); Sitagliptin; Endocrinology","score_opus":0.03372443033758165,"score_gpt":0.2737029513498433,"score_spread":0.23997852101226164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2311523609","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25171494,0.6529048,0.028281467,0.021457775,0.007899137,0.007496191,0.0094767595,0.00032670994,0.020442167],"genre_scores_gemma":[0.90354854,0.03510119,0.02572707,0.009476482,0.004289913,0.011696895,0.00868516,0.00019186802,0.0012828491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6155236,0.32186326,0.042884026,0.007199638,0.010222901,0.0023065011],"domain_scores_gemma":[0.533304,0.3824796,0.06130805,0.009851806,0.008253618,0.0048029837],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21206613,0.002298711,0.0100676175,0.0039187265,0.0015146927,0.0060685216,0.0032110664,0.0034645381,0.0027399946],"category_scores_gemma":[0.28889477,0.002049443,0.010946168,0.0039375536,0.0025520725,0.006502261,0.0066469195,0.007533763,0.0002834893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16476195,0.00078797946,0.28303856,0.086275876,0.20562838,0.0004876163,0.002974996,0.0066375285,0.0010758068,0.02167287,0.050345585,0.17631288],"study_design_scores_gemma":[0.08983367,0.013899295,0.64038426,0.033488996,0.078784354,0.0018063579,0.0026657342,0.018144164,0.0016764437,0.046749108,0.071362115,0.0012054697],"about_ca_topic_score_codex":0.0012488764,"about_ca_topic_score_gemma":0.0050884723,"teacher_disagreement_score":0.7879339,"about_ca_system_score_codex":0.0024802266,"about_ca_system_score_gemma":0.0028740966,"threshold_uncertainty_score":0.97166276},"labels":[],"label_agreement":null},{"id":"W2326373086","doi":"10.1016/s2213-8587(16)00080-2","title":"Diagnosis of diabetes type in children and young people: challenges and recommendations","year":2016,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Diabetes mellitus; Scopus; Type 2 diabetes; Type 1 diabetes; MEDLINE; Childhood obesity; Pediatrics; Maturity onset diabetes of the young; Obesity; Family medicine; Gerontology; Internal medicine; Endocrinology; Overweight","score_opus":0.04784792248632218,"score_gpt":0.31863235979368926,"score_spread":0.27078443730736707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326373086","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000120089055,0.9822327,0.00021018376,0.015007541,0.0017433864,0.000008668332,0.00009090388,0.000013411749,0.0005731965],"genre_scores_gemma":[0.0015708247,0.98885065,0.0010033274,0.0056479434,0.002461453,0.000022348308,0.00014109163,0.0000040965488,0.00029820143],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99772614,0.000556364,0.0005731122,0.0003236346,0.0006660586,0.00015466868],"domain_scores_gemma":[0.9899042,0.0055019013,0.0011485864,0.00012028401,0.0026579588,0.00066699245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007005388,0.001303775,0.005686368,0.0037304389,0.0006363956,0.0036690999,0.002840633,0.0034127268,0.0042436155],"category_scores_gemma":[0.0140320975,0.0006746948,0.0024723255,0.0031615577,0.0012317636,0.0051599317,0.0022085432,0.0067020757,0.0015452272],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019103497,0.000091044174,0.0032610903,0.0234931,0.00058098667,0.00026046968,0.00021247809,0.0002743649,0.00017242499,0.004692078,0.1371319,0.829639],"study_design_scores_gemma":[0.00027596153,0.0002222435,0.011147181,0.14084354,0.0027393322,0.0018910125,0.0016686695,0.0007537238,0.00016786093,0.015927881,0.8241579,0.00020476781],"about_ca_topic_score_codex":0.0121407695,"about_ca_topic_score_gemma":0.021155065,"teacher_disagreement_score":0.0121407695,"about_ca_system_score_codex":0.002546568,"about_ca_system_score_gemma":0.0066818376,"threshold_uncertainty_score":0.03704852},"labels":[],"label_agreement":null},{"id":"W2342715909","doi":"10.1016/s2213-8587(16)30006-7","title":"The role of glucagon in the artificial pancreas","year":2016,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital; Université de Montréal; McGill University Health Centre; Montreal Clinical Research Institute; McGill University","funders":"","keywords":"Artificial pancreas; Medicine; Glucagon; Pancreas; Continuous glucose monitoring; Dosing; Diabetes mellitus; Blood Glucose Self-Monitoring; Type 1 diabetes; Intensive care medicine; Insulin; Internal medicine; Endocrinology","score_opus":0.06274600878356476,"score_gpt":0.3647426691679581,"score_spread":0.3019966603843933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342715909","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024797595,0.9991003,0.000023947185,0.00029138775,0.0002959756,9.0688013e-7,0.0000048069305,0.0000013371157,0.00025648653],"genre_scores_gemma":[0.00031066433,0.99863714,0.000060539263,0.00035141027,0.00046250987,0.0000017868299,0.000008499584,7.885694e-7,0.00016665192],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951816,0.00011471273,0.00008034079,0.000066219654,0.0001784922,0.00004213571],"domain_scores_gemma":[0.99854016,0.0010474254,0.00017574093,0.000028905328,0.00014187161,0.000065912085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001613562,0.0010213265,0.0022793661,0.0021099437,0.00025765758,0.0022093116,0.0010442303,0.0017827792,0.0044961446],"category_scores_gemma":[0.0023059403,0.00032430506,0.00091905874,0.002282586,0.0011314028,0.002549315,0.0013959862,0.0035612262,0.0016017533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021739832,0.000045252113,0.00016979442,0.027739903,0.00020689091,0.00027684376,0.000048260656,0.0003114485,0.00062691467,0.0066666687,0.034330472,0.9293602],"study_design_scores_gemma":[0.00007628001,0.00010592845,0.00062745094,0.010733811,0.0002680382,0.0009906535,0.00009701334,0.000086739645,0.0002121004,0.0053328443,0.98143816,0.000031053103],"about_ca_topic_score_codex":0.0010795647,"about_ca_topic_score_gemma":0.0017139268,"teacher_disagreement_score":0.0044961446,"about_ca_system_score_codex":0.0008401217,"about_ca_system_score_gemma":0.0014401438,"threshold_uncertainty_score":0.0150411725},"labels":[],"label_agreement":null},{"id":"W2346770749","doi":"10.1016/s2213-8587(16)00112-1","title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research; Government of Ontario; Physicians' Services Incorporated Foundation; Institute for Clinical Evaluative Sciences; Johns Hopkins University","keywords":"Medicine; Testosterone replacement; Database; Prostate cancer; Androgen deprivation therapy; Testosterone (patch); Comorbidity; Cohort; Population; Hormone replacement therapy (female-to-male); Cohort study; Internal medicine; Cancer; Androgen","score_opus":0.05578504886145688,"score_gpt":0.2914114295745438,"score_spread":0.23562638071308692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346770749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670947,0.0012615348,0.0003207087,0.000091020884,0.000063891064,0.000052145173,0.0011974943,0.0000161989,0.00028743068],"genre_scores_gemma":[0.99729687,0.00036164,0.00020830633,0.0001362267,0.00010061159,0.000053263364,0.0014064715,0.0000086951295,0.00042800725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983333,0.00070442015,0.00013354664,0.00040013817,0.00018403775,0.00024468484],"domain_scores_gemma":[0.9978557,0.00045734286,0.00062226894,0.0005303658,0.00016755203,0.0003666611],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023029384,0.00091962994,0.0021622684,0.0006586588,0.0009016288,0.0016539255,0.0012641714,0.0016203892,0.0013793041],"category_scores_gemma":[0.0026766416,0.0013963598,0.0040927003,0.0016215962,0.0007371742,0.0010913647,0.00067516655,0.0023586506,0.0003636055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019705774,0.0010388999,0.9649112,0.0001502827,0.008616816,0.0003234651,0.0002458372,0.00027470881,0.0013990122,0.00014074228,0.00081389496,0.0023793946],"study_design_scores_gemma":[0.0019364187,0.0017951326,0.9899687,0.000028012508,0.003930068,0.00020635745,0.00031194306,0.0010537979,0.00016835837,0.00012471876,0.00043463468,0.000041805644],"about_ca_topic_score_codex":0.0103665525,"about_ca_topic_score_gemma":0.008340727,"teacher_disagreement_score":0.0103665525,"about_ca_system_score_codex":0.00063169573,"about_ca_system_score_gemma":0.0008493513,"threshold_uncertainty_score":0.020612419},"labels":[],"label_agreement":null},{"id":"W2403716937","doi":"10.1016/s2213-8587(16)30096-1","title":"Supporting research leadership in Africa","year":2016,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Health and Surgery","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Capacity building; General partnership; Scopus; Medicine; Health care; Public relations; Medical education; Multidisciplinary approach; Political science; MEDLINE; Social science; Sociology","score_opus":0.3142364555807402,"score_gpt":0.40539834102066996,"score_spread":0.09116188543992976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403716937","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018140984,0.025957728,0.0006191292,0.59720933,0.3645572,0.000061254,0.00010789874,0.00015910655,0.011146935],"genre_scores_gemma":[0.013636262,0.043016404,0.002429544,0.533611,0.3590673,0.0002692347,0.00030992948,0.00065434613,0.04700603],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9279128,0.032238692,0.0058514206,0.0064098365,0.017658137,0.009929122],"domain_scores_gemma":[0.79029816,0.092322975,0.012880799,0.009037331,0.050798662,0.04466202],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.060237687,0.0026776067,0.0020762724,0.0047864662,0.00844605,0.03839495,0.005652426,0.02305731,0.047394246],"category_scores_gemma":[0.21552087,0.0013200408,0.0022724972,0.002930872,0.010594918,0.031160025,0.017274277,0.025844246,0.022251856],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003720826,0.00001477646,0.0000752435,0.0010549974,0.000023258832,0.0001729237,0.0009573367,0.000029460047,0.00012516612,0.01290295,0.9616582,0.022948494],"study_design_scores_gemma":[0.000021158774,0.000015322214,0.00006000812,0.0011810368,0.000011718766,0.00009619854,0.00075604086,0.000022630687,0.00006809148,0.004986338,0.9927665,0.000015039288],"about_ca_topic_score_codex":0.002165392,"about_ca_topic_score_gemma":0.0033367232,"teacher_disagreement_score":0.060237687,"about_ca_system_score_codex":0.00843695,"about_ca_system_score_gemma":0.052458495,"threshold_uncertainty_score":0.31857115},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"incentives","study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2405171365","doi":"10.1016/s2213-8587(16)30041-9","title":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","year":2016,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":418,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital; Western University","funders":"British Heart Foundation","keywords":"Medicine; Familial hypercholesterolemia; Subclinical infection; Disease; Internal medicine; Cholesterol; Myocardial infarction; Risk stratification; Ldl cholesterol","score_opus":0.12123139253369282,"score_gpt":0.3749064451119221,"score_spread":0.2536750525782293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405171365","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029769374,0.9751081,0.0005392167,0.02057789,0.002529901,0.00004383991,0.00018692696,0.00001007843,0.00070645846],"genre_scores_gemma":[0.002755429,0.98122716,0.0026741754,0.010207137,0.0020336595,0.00009523465,0.0005205577,0.000009293601,0.00047743032],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99696785,0.0006671119,0.001035269,0.00029817878,0.00085468893,0.0001769126],"domain_scores_gemma":[0.99167824,0.003396941,0.0011736577,0.00014304603,0.0030400322,0.00056805194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014121936,0.001272487,0.0048161456,0.00264901,0.00061643875,0.0022812854,0.0029374799,0.004275138,0.0015329242],"category_scores_gemma":[0.011370379,0.0006540377,0.0024907154,0.0026923555,0.0009039187,0.002206031,0.00199132,0.0068249833,0.0009121964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003958288,0.00010307815,0.0025712063,0.034258187,0.0012487038,0.00028946006,0.00028612677,0.0004722042,0.0009394118,0.0047841123,0.17887668,0.7757751],"study_design_scores_gemma":[0.0005086843,0.0001724597,0.011286958,0.107531495,0.0033837634,0.0014178933,0.0005513282,0.000425015,0.00056773284,0.007190223,0.86680335,0.0001610392],"about_ca_topic_score_codex":0.008205501,"about_ca_topic_score_gemma":0.019065777,"teacher_disagreement_score":0.014121936,"about_ca_system_score_codex":0.0024489302,"about_ca_system_score_gemma":0.008929359,"threshold_uncertainty_score":0.0746848},"labels":[],"label_agreement":null},{"id":"W2490307463","doi":"10.1016/s2213-8587(16)30145-0","title":"De-evolution of diagnostic testing for adrenal insufficiency","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia, Okanagan Campus; University of British Columbia; University of Calgary","funders":"","keywords":"Medicine; Adrenal insufficiency; Diagnostic test; Intensive care medicine; MEDLINE; Internal medicine; Pediatrics","score_opus":0.03170536410616449,"score_gpt":0.2827121624994056,"score_spread":0.25100679839324114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2490307463","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15222807,0.36071014,0.05565477,0.33389837,0.020634135,0.00017196202,0.0012331984,0.001664037,0.07380533],"genre_scores_gemma":[0.79538006,0.06604402,0.02299754,0.083465576,0.026799105,0.00005636684,0.0010336164,0.00027134432,0.0039523332],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9951273,0.0014404607,0.0006948628,0.0007640459,0.0014369222,0.0005364313],"domain_scores_gemma":[0.9547512,0.025054742,0.0023480244,0.003509455,0.010904504,0.0034321446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010036291,0.00066475105,0.0010313144,0.0033060058,0.00064173253,0.0024807882,0.0022352408,0.0025035846,0.0027071522],"category_scores_gemma":[0.038720023,0.00043581746,0.001131551,0.001121656,0.0015148997,0.0029897161,0.0013738078,0.005600046,0.0012776107],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057782786,0.00024220104,0.13297768,0.0009702332,0.00024292278,0.007957232,0.00077086006,0.0010652294,0.005438997,0.013458753,0.061079785,0.7752183],"study_design_scores_gemma":[0.00025538617,0.0013797365,0.20489979,0.007885771,0.0010018201,0.12247272,0.0025840015,0.011875734,0.012510224,0.03810844,0.5967558,0.00027057322],"about_ca_topic_score_codex":0.0029011902,"about_ca_topic_score_gemma":0.0033748238,"teacher_disagreement_score":0.010036291,"about_ca_system_score_codex":0.0025410978,"about_ca_system_score_gemma":0.0028043748,"threshold_uncertainty_score":0.05307758},"labels":[],"label_agreement":null},{"id":"W2523634442","doi":"10.1016/s2213-8587(16)30237-6","title":"SGLT2 inhibitors: β blockers for the kidney?","year":2016,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Empagliflozin; Medicine; Renal function; Nephron; Kidney disease; Tubuloglomerular feedback; Diabetes mellitus; Kidney; Type 2 diabetes; Urology; Internal medicine; Endocrinology","score_opus":0.028122738169641774,"score_gpt":0.2737894242405104,"score_spread":0.2456666860708686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523634442","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001765257,0.005366588,0.00006634579,0.9796927,0.013049624,0.0000036987772,0.00004029886,0.000016247885,0.0015879376],"genre_scores_gemma":[0.0027089177,0.0074191857,0.00023389529,0.8724141,0.11288813,0.000019144587,0.00003997815,0.000020039148,0.0042566545],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99708194,0.00073494785,0.0004372236,0.00038670495,0.0010068652,0.00035234122],"domain_scores_gemma":[0.9942274,0.0027803362,0.0006042373,0.00015907717,0.0006990244,0.0015299143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030140264,0.001175785,0.0027663023,0.0010111545,0.0024920497,0.0040283473,0.0014798963,0.046864923,0.011258078],"category_scores_gemma":[0.01636957,0.00070194027,0.0018485959,0.00086776435,0.0027981754,0.0060582394,0.0018472307,0.0457193,0.009494785],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020110268,0.00008266661,0.0007828875,0.00017413285,0.000040384966,0.0020724253,0.00007156806,0.0000871021,0.0002933238,0.004685127,0.9575715,0.033937786],"study_design_scores_gemma":[0.00060253905,0.00020005272,0.0012006403,0.0010933592,0.00007923878,0.0048408816,0.00026463682,0.00041637148,0.00019514028,0.024792202,0.9662247,0.000090170055],"about_ca_topic_score_codex":0.0028771234,"about_ca_topic_score_gemma":0.006853397,"teacher_disagreement_score":0.046864923,"about_ca_system_score_codex":0.0029794262,"about_ca_system_score_gemma":0.0030728022,"threshold_uncertainty_score":0.03766197},"labels":[],"label_agreement":null},{"id":"W2550203760","doi":"10.1016/s2213-8587(16)30373-4","title":"Cardiovascular effects of incretin-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis","year":2016,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Incretin; Type 2 diabetes; Metformin; Placebo; Internal medicine; Meta-analysis; Alogliptin; Diabetes mellitus; Stroke (engine); Cochrane Library; Myocardial infarction; Linagliptin; Saxagliptin; Exenatide; Adverse effect; Odds ratio; Sitagliptin; Insulin; Endocrinology","score_opus":0.030809290791371076,"score_gpt":0.27701789372438546,"score_spread":0.2462086029330144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550203760","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0058289883,0.9927409,0.00046017783,0.00011212296,0.00017708051,0.00011066334,0.00037361938,0.000022512102,0.00017391467],"genre_scores_gemma":[0.19203444,0.80238485,0.0024935522,0.0011166797,0.00036692817,0.00041400376,0.00076537766,0.000032547832,0.00039160473],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9953296,0.0019370953,0.0013255121,0.00065965834,0.00053994317,0.00020816702],"domain_scores_gemma":[0.9917424,0.006007951,0.00129952,0.0003443674,0.00046587086,0.00013983618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007186419,0.0025568292,0.015756296,0.0032576972,0.00046073744,0.0021311105,0.0017897997,0.001965534,0.0033590135],"category_scores_gemma":[0.015787518,0.0015041499,0.030113844,0.004144291,0.0005114682,0.0015676409,0.0016400535,0.0024912213,0.00028435333],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033072608,0.00004030942,0.0036101083,0.18840452,0.79171705,0.00009822537,0.000062510975,0.00035299492,0.00024234902,0.00008307969,0.00057427725,0.011507269],"study_design_scores_gemma":[0.0008116827,0.00013590354,0.003030796,0.0057178442,0.9890703,0.000051802836,0.000028040116,0.00010060311,0.00005963971,0.00010440427,0.0008696068,0.000019403587],"about_ca_topic_score_codex":0.0061483136,"about_ca_topic_score_gemma":0.017460333,"teacher_disagreement_score":0.015756296,"about_ca_system_score_codex":0.0015901028,"about_ca_system_score_gemma":0.0016580344,"threshold_uncertainty_score":0.03800583},"labels":[],"label_agreement":null},{"id":"W2553740625","doi":"10.1016/s2213-8587(16)30316-3","title":"Association of insulin dosage with mortality or major adverse cardiovascular events: a retrospective cohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Newfoundland and Labrador Centre for Applied Health Research; Memorial University of Newfoundland","funders":"Canadian Institutes of Health Research; Sanofi","keywords":"Medicine; Metformin; Insulin; Type 2 diabetes; Confounding; Proportional hazards model; Diabetes mellitus; Internal medicine; Stroke (engine); Cohort study; Cohort; Retrospective cohort study; Adverse effect; Hazard ratio; Myocardial infarction; Marginal structural model; Observational study; Endocrinology; Confidence interval","score_opus":0.016920589904538277,"score_gpt":0.2589785261817467,"score_spread":0.24205793627720845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553740625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977976,0.0007610454,0.00021603602,0.000044951954,0.000024672428,0.000018701128,0.0007435919,0.000009181166,0.0003842514],"genre_scores_gemma":[0.9984024,0.00031591713,0.00022203944,0.000065610584,0.000033645803,0.000019697878,0.000672782,0.000009810032,0.00025803444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858934,0.00037571954,0.00015302509,0.0005312267,0.00016048338,0.00019028905],"domain_scores_gemma":[0.9966319,0.00052930077,0.0011350517,0.00092344545,0.00030338802,0.00047683096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014946032,0.0008474684,0.0011705796,0.00082968414,0.00084839074,0.0015098404,0.00091867836,0.0014761391,0.0018586975],"category_scores_gemma":[0.0025931762,0.001702391,0.0018646236,0.00206624,0.0007193794,0.0012710437,0.0006955148,0.0019587919,0.0005684887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001442148,0.00013984452,0.99600995,0.000017056564,0.0008946977,0.0001389224,0.00007683761,0.00004845672,0.00051040965,0.000025300133,0.0001302935,0.00056611653],"study_design_scores_gemma":[0.0001245154,0.00043924619,0.99782914,0.000008493631,0.000452755,0.00040157474,0.00019231676,0.00025399274,0.000065590604,0.00004614651,0.00016522392,0.000020979458],"about_ca_topic_score_codex":0.007840621,"about_ca_topic_score_gemma":0.006211345,"teacher_disagreement_score":0.007840621,"about_ca_system_score_codex":0.00052578276,"about_ca_system_score_gemma":0.00056372985,"threshold_uncertainty_score":0.015590012},"labels":[],"label_agreement":null},{"id":"W2554342207","doi":"10.1016/s2213-8587(16)30366-7","title":"1 year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Program: a randomised trial","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Gestational diabetes; Randomized controlled trial; Diabetes mellitus; Weight loss; Clinical trial; Physical therapy; Intervention (counseling); Pediatrics; Family medicine; Pregnancy; Gerontology; Obesity; Gestation; Nursing; Surgery; Internal medicine","score_opus":0.0377457741755283,"score_gpt":0.33075668103972894,"score_spread":0.2930109068642006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554342207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822213,0.0115556205,0.0004360694,0.0011886645,0.0011150311,0.0016426197,0.00049119914,0.00007071058,0.00127891],"genre_scores_gemma":[0.9908489,0.0035228694,0.0005550681,0.0009085791,0.0004084132,0.0018400403,0.0004140288,0.000010235732,0.0014917935],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998703,0.0006067123,0.00009860909,0.0002625997,0.00007732457,0.00025176918],"domain_scores_gemma":[0.9990225,0.0002700472,0.00022910413,0.0001204605,0.00004053871,0.00031732276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018760542,0.0015595425,0.004521872,0.00042974355,0.0006778335,0.0011619494,0.0013084674,0.002686853,0.0054864557],"category_scores_gemma":[0.0026058871,0.0010000179,0.0036155444,0.00073324714,0.001465542,0.0011260257,0.00079039636,0.0038002026,0.00048177116],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9832972,0.0024919873,0.0013663919,0.0010701495,0.0028606518,0.000041564996,0.000059018952,0.00018743702,0.00049304304,0.00010461194,0.00034698978,0.007680844],"study_design_scores_gemma":[0.97439325,0.016746232,0.004861544,0.00010026274,0.0032276963,0.000012892561,0.000049833907,0.00019131145,0.00007621377,0.00013266096,0.00019185885,0.000016315515],"about_ca_topic_score_codex":0.0059231296,"about_ca_topic_score_gemma":0.0070358,"teacher_disagreement_score":0.0059231296,"about_ca_system_score_codex":0.0012522032,"about_ca_system_score_gemma":0.0015871109,"threshold_uncertainty_score":0.018354058},"labels":[],"label_agreement":null},{"id":"W2555589501","doi":"10.1016/s2213-8587(16)30370-9","title":"Stroke risk in treatment of type 2 diabetes in China: a 7 year retrospective cohort study","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Metformin; Diabetes mellitus; Stroke (engine); Type 2 diabetes; Internal medicine; Retrospective cohort study; Logistic regression; Cohort; Cohort study; Risk factor; Insulin; Endocrinology","score_opus":0.013517256126619,"score_gpt":0.2680827595210014,"score_spread":0.2545655033943824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555589501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882203,0.00027612172,0.000059537353,0.000062620544,0.000015083636,0.0000131836505,0.0005024476,0.0000035535088,0.0002454407],"genre_scores_gemma":[0.9988023,0.00016675661,0.0000635317,0.000056965902,0.000017238975,0.000016389464,0.0006318246,0.0000028415557,0.00024218624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908423,0.00015537672,0.00010019092,0.00027759612,0.00011397934,0.00026868514],"domain_scores_gemma":[0.99835724,0.00011507699,0.0004623692,0.0002562073,0.000251516,0.0005576551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010600681,0.00084151735,0.0010588609,0.0012811561,0.0016222502,0.0013672613,0.0009888728,0.001141383,0.0012826455],"category_scores_gemma":[0.0014471511,0.0012848593,0.0016118615,0.0032325168,0.00060813624,0.0009155231,0.0009930473,0.0014836129,0.0002486828],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014236127,0.00005650737,0.9986419,0.000008699395,0.00020747488,0.00014111285,0.00013329217,0.000026702071,0.00012329685,0.000018831595,0.00011476442,0.0003850558],"study_design_scores_gemma":[0.000016076177,0.000056273104,0.9992524,0.0000048759634,0.00010665731,0.00009411209,0.00023095416,0.00011017077,0.000019726118,0.000015432674,0.00008620552,0.000007076544],"about_ca_topic_score_codex":0.08029514,"about_ca_topic_score_gemma":0.07784536,"teacher_disagreement_score":0.08029514,"about_ca_system_score_codex":0.001563528,"about_ca_system_score_gemma":0.0021189093,"threshold_uncertainty_score":0.15965557},"labels":[],"label_agreement":null},{"id":"W2559592043","doi":"10.1016/s2213-8587(16)30396-5","title":"PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study","year":2016,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":391,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Sanofi; University College London Hospitals NHS Foundation Trust; Economic and Social Research Council; Lundbeckfonden; National Cancer Institute; British Heart Foundation; University College London; AstraZeneca; Amgen; National Institute for Health and Care Research; Medical Research Council; Foundation for the National Institutes of Health","keywords":"Medicine; Mendelian randomization; Type 2 diabetes; PCSK9; Mendelian inheritance; Diabetes mellitus; MEDLINE; Internal medicine; Bioinformatics; Genetic variants; Genetics; Endocrinology; Cholesterol; Genotype; Gene","score_opus":0.02064260349654017,"score_gpt":0.2663447683854673,"score_spread":0.2457021648889271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2559592043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9229402,0.024508903,0.038395207,0.00093371916,0.00089704513,0.0043636737,0.004839304,0.0003979114,0.002724099],"genre_scores_gemma":[0.98926467,0.001311342,0.0046552136,0.00042561596,0.00008878804,0.0018426465,0.001182023,0.000045798275,0.0011839166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.986024,0.008884402,0.001209954,0.002508312,0.00091222825,0.00046103977],"domain_scores_gemma":[0.991987,0.0038708914,0.0012351464,0.0022315162,0.00048268872,0.00019273844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013433512,0.0016804673,0.004022916,0.0008601893,0.0006700372,0.0012370911,0.0014974916,0.0017953927,0.0054153535],"category_scores_gemma":[0.02508889,0.0013095401,0.0067759487,0.0020794591,0.00080251397,0.0006521036,0.00076324755,0.0016912081,0.0006095678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.29869562,0.0013247173,0.38696477,0.007286053,0.2395281,0.0037208549,0.00067805726,0.0057247384,0.0047662063,0.004149732,0.010000175,0.03716101],"study_design_scores_gemma":[0.2549675,0.012253855,0.42220223,0.0014718837,0.24805641,0.00593092,0.00029970167,0.034427203,0.0016463547,0.009690707,0.008626286,0.0004269425],"about_ca_topic_score_codex":0.0050887833,"about_ca_topic_score_gemma":0.003348295,"teacher_disagreement_score":0.013433512,"about_ca_system_score_codex":0.00085123786,"about_ca_system_score_gemma":0.0009668169,"threshold_uncertainty_score":0.07104409},"labels":[],"label_agreement":null},{"id":"W2560403714","doi":"10.1016/s2213-8587(16)30398-9","title":"PCSK9 inhibition and diabetes: turning to Mendel for clues","year":2016,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Diabetes mellitus; MEDLINE; Bioinformatics; Endocrinology","score_opus":0.030734306734960692,"score_gpt":0.2845203620672843,"score_spread":0.2537860553323236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560403714","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00086539844,0.36981544,0.0033196295,0.57989705,0.03149879,0.000018851522,0.00033671357,0.00033283408,0.013915202],"genre_scores_gemma":[0.032575734,0.59283215,0.0075032245,0.28798708,0.04969239,0.00010763463,0.00040933094,0.0004183075,0.028474147],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960674,0.0014989083,0.0003145003,0.00045152567,0.0013627765,0.0003047634],"domain_scores_gemma":[0.98361015,0.010578787,0.000843168,0.0008440099,0.0024972034,0.0016266825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076245284,0.0009802586,0.0019887707,0.0027955938,0.001421403,0.004018379,0.0021217766,0.006692135,0.020674007],"category_scores_gemma":[0.027270328,0.00051808316,0.0015009285,0.0013915992,0.0064085773,0.010820771,0.002782159,0.018610425,0.008210955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004201536,0.00010507948,0.0006250347,0.0014011338,0.00014730968,0.000822431,0.00047254527,0.00032137334,0.00043818812,0.07301075,0.6621166,0.26011938],"study_design_scores_gemma":[0.0001011402,0.00010901199,0.00039493034,0.0031628916,0.000076136246,0.0006786471,0.0005435214,0.0002650246,0.0002339231,0.135141,0.8592267,0.00006706779],"about_ca_topic_score_codex":0.0044364263,"about_ca_topic_score_gemma":0.0068416065,"teacher_disagreement_score":0.020674007,"about_ca_system_score_codex":0.0026219196,"about_ca_system_score_gemma":0.004124196,"threshold_uncertainty_score":0.069161475},"labels":[],"label_agreement":null},{"id":"W2572398654","doi":"10.1016/s2213-8587(17)30013-x","title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":707,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Semaglutide; Medicine; Placebo; Tolerability; Type 2 diabetes; Randomized controlled trial; Diabetes mellitus; Dulaglutide; Internal medicine; Clinical trial; Adverse effect; Physical therapy; Exenatide; Liraglutide; Endocrinology; Alternative medicine","score_opus":0.03132321637257893,"score_gpt":0.3149938320151195,"score_spread":0.2836706156425406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2572398654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895359,0.005271294,0.00043052333,0.0006643821,0.0005279756,0.0011878297,0.0009082309,0.0001854212,0.0012884212],"genre_scores_gemma":[0.9896678,0.0024494324,0.0010477945,0.0010605879,0.00056820305,0.0017719852,0.0011057773,0.000054221964,0.0022742478],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999244,0.00036291083,0.00005526459,0.000173361,0.000055140816,0.00010937787],"domain_scores_gemma":[0.9988463,0.0003317753,0.00028490182,0.000113548216,0.00006548619,0.00035796332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021045674,0.0024300076,0.005786975,0.00063847203,0.0006528803,0.001706624,0.0013855228,0.0028911505,0.006879088],"category_scores_gemma":[0.0021501991,0.0010642785,0.0028485034,0.00058277254,0.0017228525,0.0022416732,0.000628574,0.0043133935,0.0013399847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9913101,0.0021957608,0.00029667813,0.00022619902,0.0004775041,0.000012935698,0.000029736319,0.00011004292,0.000831789,0.000029195255,0.00025034606,0.004229603],"study_design_scores_gemma":[0.9593051,0.038471974,0.0011331885,0.000020554702,0.0003809145,0.000016228987,0.00002090238,0.00023663772,0.00016436246,0.00008452662,0.00015165177,0.000013943774],"about_ca_topic_score_codex":0.0010220746,"about_ca_topic_score_gemma":0.0015618979,"teacher_disagreement_score":0.006879088,"about_ca_system_score_codex":0.00082933076,"about_ca_system_score_gemma":0.00093121047,"threshold_uncertainty_score":0.023012877},"labels":[],"label_agreement":null},{"id":"W2580463185","doi":"10.1016/s2213-8587(17)30014-1","title":"Exercise management in type 1 diabetes: a consensus statement","year":2017,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":890,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal; York University","funders":"","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Aerobic exercise; Diabetes management; Population; Physical therapy; Endocrinology; Environmental health","score_opus":0.17890817576619625,"score_gpt":0.4277048627118327,"score_spread":0.24879668694563647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2580463185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000044611937,0.9912348,0.00012478695,0.0062381253,0.0019856584,0.000021358488,0.00006922983,0.0000054268858,0.00027597623],"genre_scores_gemma":[0.00055825716,0.98945016,0.0006027814,0.007393625,0.0015677761,0.00005169405,0.00010872072,0.0000030783185,0.00026392427],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99690574,0.00067477423,0.0009607644,0.0003902585,0.0008282821,0.00024018357],"domain_scores_gemma":[0.9927642,0.004120304,0.0011543494,0.00011868262,0.0014301501,0.00041233815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010424898,0.0017089222,0.006195368,0.003673455,0.0006225538,0.003758239,0.0031084039,0.0064712293,0.0038285914],"category_scores_gemma":[0.00910925,0.0008749132,0.004761048,0.0037868172,0.0011109123,0.0039738906,0.003190476,0.008628248,0.0017213123],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044296467,0.00014524703,0.0005109123,0.12624478,0.0018648915,0.00021993706,0.00015186075,0.00046978157,0.00059504213,0.0043842676,0.17445026,0.69052017],"study_design_scores_gemma":[0.00068866566,0.00024535574,0.002353831,0.20582366,0.0046297484,0.00067861023,0.0002543386,0.0002465207,0.00023090465,0.004787697,0.7799663,0.00009439931],"about_ca_topic_score_codex":0.003981364,"about_ca_topic_score_gemma":0.009179081,"teacher_disagreement_score":0.010424898,"about_ca_system_score_codex":0.0024453762,"about_ca_system_score_gemma":0.009654875,"threshold_uncertainty_score":0.055132806},"labels":[],"label_agreement":null},{"id":"W2585220979","doi":"10.1016/s2213-8587(17)30034-7","title":"Elimination of iodine deficiency disorders from the Americas: a public health triumph","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Stem Cell Network","funders":"","keywords":"Iodine deficiency; Medicine; Micronutrient; Latin Americans; Public health; Micronutrient deficiency; Environmental health; Iodine; Gerontology; Economic growth; Development economics; Political science; Endocrinology; Pathology; Law; Thyroid","score_opus":0.06094045561239831,"score_gpt":0.32944888159444596,"score_spread":0.26850842598204766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2585220979","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012690418,0.11685751,0.0005050577,0.8677342,0.010427133,0.0000083739305,0.00034484453,0.00011413852,0.0027397752],"genre_scores_gemma":[0.051694043,0.32329616,0.0028122333,0.5567692,0.06022477,0.00006673396,0.0008017861,0.00012117784,0.0042138086],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9955285,0.0010155231,0.00040830323,0.0005343666,0.0013559103,0.0011574446],"domain_scores_gemma":[0.9773835,0.009422784,0.0016894153,0.0008249728,0.005349738,0.0053295754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011222078,0.0016462143,0.0035273384,0.0026223138,0.0026106008,0.008436184,0.0028663245,0.017317833,0.021634532],"category_scores_gemma":[0.021539412,0.00064666563,0.0023655738,0.0026010307,0.008353989,0.011775118,0.0066758622,0.017238665,0.0038404015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007411204,0.0005398599,0.008337601,0.004856844,0.00052179955,0.00057238824,0.00065903884,0.0008623811,0.001722539,0.050667334,0.62851465,0.30200437],"study_design_scores_gemma":[0.0006423883,0.00057081226,0.021302558,0.0055629085,0.00037946014,0.00071066996,0.0029365167,0.0005920635,0.00059769634,0.06597385,0.9005469,0.00018415092],"about_ca_topic_score_codex":0.029658815,"about_ca_topic_score_gemma":0.033155303,"teacher_disagreement_score":0.029658815,"about_ca_system_score_codex":0.008064104,"about_ca_system_score_gemma":0.025215352,"threshold_uncertainty_score":0.0723747},"labels":[],"label_agreement":null},{"id":"W2588614813","doi":"10.1016/s2213-8587(17)30044-x","title":"Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":218,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec","funders":"Amgen","keywords":"Medicine; Evolocumab; Interim analysis; Ezetimibe; Internal medicine; Adverse effect; PCSK9; LDL apheresis; Familial hypercholesterolemia; Cholesterol; Clinical trial; Lipoprotein","score_opus":0.05832711720972705,"score_gpt":0.34472170470917196,"score_spread":0.2863945874994449,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588614813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970661,0.0016510026,0.00022659042,0.00009144723,0.00008449199,0.000052131603,0.00045026417,0.00001581736,0.0003621473],"genre_scores_gemma":[0.9966028,0.00041388907,0.00027843568,0.00024200785,0.00012865584,0.00009224577,0.0017672399,0.000012460794,0.0004622961],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99801755,0.0009570752,0.00012364626,0.00034167705,0.00023693475,0.00032314245],"domain_scores_gemma":[0.9973621,0.0008468622,0.0006170156,0.00067573786,0.00015837177,0.00033987308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039978414,0.0014500618,0.0037479443,0.0003290125,0.00048080113,0.0019991144,0.00089604576,0.00133381,0.0011804871],"category_scores_gemma":[0.0027598292,0.00073615625,0.005043406,0.0004816596,0.0009108104,0.0015911653,0.0005972221,0.0029479868,0.00044452868],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89025843,0.001842491,0.06902315,0.00033839184,0.011350382,0.0003490044,0.00017990127,0.0011433552,0.004916023,0.00014658656,0.0010516796,0.019400537],"study_design_scores_gemma":[0.21570915,0.13479416,0.5919554,0.00025957954,0.041449208,0.0010972061,0.0006474893,0.004247811,0.004191088,0.0012204789,0.0041223313,0.00030604383],"about_ca_topic_score_codex":0.0005702891,"about_ca_topic_score_gemma":0.0012755583,"teacher_disagreement_score":0.0039978414,"about_ca_system_score_codex":0.0007340344,"about_ca_system_score_gemma":0.0006300984,"threshold_uncertainty_score":0.0211429},"labels":[],"label_agreement":null},{"id":"W2591631347","doi":"10.1016/s2213-8587(17)30067-0","title":"Does fetal exposure to vitamin D programme childhood bone mass?","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Calcitriol; Calcitriol receptor; Vitamin D and neurology; Endocrinology; Rickets; Calcium metabolism; Internal medicine; Medicine; Osteomalacia; Bone remodeling; Calcium; vitamin D deficiency","score_opus":0.028359246283053745,"score_gpt":0.2959302140544903,"score_spread":0.2675709677714366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591631347","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007379087,0.008099242,0.00003600092,0.97895765,0.010849623,0.0000033077204,0.00014240935,0.000010265703,0.0011635829],"genre_scores_gemma":[0.013814996,0.01332526,0.00017034588,0.8822416,0.08743849,0.000043540083,0.00011633998,0.0000307952,0.0028186208],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99413645,0.002476159,0.000857611,0.0005741673,0.0013932699,0.00056221726],"domain_scores_gemma":[0.94994694,0.04027557,0.00311333,0.0010517068,0.0029521328,0.0026603197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009183678,0.0006993742,0.0019700376,0.001101758,0.0018810647,0.0023718805,0.0019964145,0.03313006,0.008030186],"category_scores_gemma":[0.058899153,0.0007007479,0.0012117444,0.0011689217,0.0033785016,0.0025419185,0.0018611443,0.022746824,0.003998865],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00085648947,0.00012577945,0.013448058,0.00059626845,0.00031337104,0.0022528614,0.00031225267,0.000111106616,0.0003925253,0.006838748,0.90016127,0.07459127],"study_design_scores_gemma":[0.0015502062,0.00047523333,0.015636345,0.0031387068,0.0006272201,0.0024440242,0.0011848598,0.0003101866,0.0007991685,0.030033408,0.94365776,0.00014287951],"about_ca_topic_score_codex":0.012380816,"about_ca_topic_score_gemma":0.01409349,"teacher_disagreement_score":0.03313006,"about_ca_system_score_codex":0.00275347,"about_ca_system_score_gemma":0.004783671,"threshold_uncertainty_score":0.048568487},"labels":[],"label_agreement":null},{"id":"W2595010755","doi":"10.1016/s2213-8587(17)30087-6","title":"Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":355,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Enalapril; Sacubitril, Valsartan; Sacubitril; Medicine; Valsartan; Internal medicine; Diabetes mellitus; Type 2 diabetes; Heart failure; Post-hoc analysis; Endocrinology; Ejection fraction; ACE inhibitor; Cardiology; Angiotensin-converting enzyme; Blood pressure","score_opus":0.01004263881300927,"score_gpt":0.261315251005856,"score_spread":0.25127261219284674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2595010755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830047,0.007858053,0.0008047445,0.0016559522,0.0013709859,0.0005584944,0.0019266872,0.00012133706,0.0026989826],"genre_scores_gemma":[0.9898756,0.0024703287,0.001040328,0.0011060623,0.0010596666,0.0005868494,0.0018038364,0.00005047883,0.002006727],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9979286,0.0012388316,0.00011584544,0.00030816963,0.00009709777,0.00031138473],"domain_scores_gemma":[0.9978834,0.0009268509,0.0003319369,0.00026932673,0.0001368681,0.00045167166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041147135,0.0034508645,0.008128418,0.0003350357,0.0005395421,0.0020674858,0.0016027999,0.0015347638,0.00505396],"category_scores_gemma":[0.0037875131,0.0009873192,0.0077481014,0.00044068228,0.001201164,0.0023234289,0.0010156711,0.0053146146,0.0008882639],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9848697,0.0007874182,0.000926937,0.0003624444,0.0072551267,0.00003297283,0.000020200492,0.00044381918,0.000578561,0.000097236,0.0006617059,0.0039639873],"study_design_scores_gemma":[0.91269124,0.052274726,0.010662861,0.000095143005,0.020029908,0.000063510386,0.00011043352,0.0017571151,0.00059000135,0.0007523507,0.00089799333,0.00007465418],"about_ca_topic_score_codex":0.001723207,"about_ca_topic_score_gemma":0.0037885446,"teacher_disagreement_score":0.008128418,"about_ca_system_score_codex":0.0011381384,"about_ca_system_score_gemma":0.0014702443,"threshold_uncertainty_score":0.02176094},"labels":[],"label_agreement":null},{"id":"W2597545061","doi":"10.1016/s2213-8587(17)30104-3","title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","year":2017,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":528,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Cilag; Medical Research Council; National Health and Medical Research Council; Michigan Diabetes Research Center, University of Michigan; Servier; AstraZeneca Australia; Monash University; Novartis Australia; Novo Nordisk; National Institute for Health and Care Research; Intarcia Therapeutics; Amgen Australia; Office of Research and Development; Sanofi; GlaxoSmithKline; AstraZeneca; Bristol-Myers Squibb; Eli Lilly and Company; McMaster University; National Institute of Diabetes and Digestive and Kidney Diseases; Amgen; U.S. Department of Veterans Affairs","keywords":"Medicine; Diabetic retinopathy; Diabetes mellitus; Meta-analysis; Randomized controlled trial; Retinopathy; Nephropathy; Type 1 diabetes; Internal medicine; Type 2 diabetes; Kidney disease; Endocrinology","score_opus":0.2610826419163918,"score_gpt":0.41161466678297365,"score_spread":0.15053202486658185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2597545061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013242823,0.98457944,0.00094968715,0.00016041184,0.0002621784,0.00017034115,0.0003308859,0.000040024446,0.0002642591],"genre_scores_gemma":[0.35067326,0.6413393,0.004233412,0.0013045039,0.00039270788,0.00051664317,0.0009974145,0.00007579999,0.0004669205],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9891872,0.005916927,0.0024772305,0.0011623774,0.0008688851,0.00038744914],"domain_scores_gemma":[0.9807298,0.015576578,0.0020324942,0.00083984586,0.00056724536,0.0002540052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015261207,0.0029546828,0.018315753,0.0022608407,0.0004144218,0.0028553512,0.0021683078,0.0022080832,0.0031644173],"category_scores_gemma":[0.028903771,0.001607456,0.035260033,0.0030366294,0.0007934686,0.0019356367,0.0017956516,0.003954645,0.00025476777],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012619864,0.00004441662,0.0024670057,0.10920945,0.859417,0.0000722257,0.00007174707,0.0005549069,0.0002332137,0.000121943835,0.00042550365,0.014762737],"study_design_scores_gemma":[0.003434457,0.0003820349,0.0034782735,0.0052012666,0.98574543,0.000052524414,0.000039314295,0.00014794712,0.00011282779,0.0003146732,0.0010661731,0.000025067666],"about_ca_topic_score_codex":0.004003241,"about_ca_topic_score_gemma":0.0072436226,"teacher_disagreement_score":0.018315753,"about_ca_system_score_codex":0.0018069416,"about_ca_system_score_gemma":0.0016081701,"threshold_uncertainty_score":0.080709934},"labels":[],"label_agreement":null},{"id":"W2604761574","doi":"10.1016/s2213-8587(17)30102-x","title":"Corrections needed to 2016 ESC guideline and AHA scientific statement on heart failure","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Canadian VIGOUR Centre","funders":"","keywords":"Medicine; Guideline; Statement (logic); Heart failure; MEDLINE; Intensive care medicine; Cardiology; Epistemology; Pathology; Law","score_opus":0.034596081187273496,"score_gpt":0.30894695214025825,"score_spread":0.27435087095298477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2604761574","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046611123,0.0005780206,0.00007790306,0.79440796,0.20119368,0.00003008106,0.00019408212,0.00007462927,0.0033970424],"genre_scores_gemma":[0.0005593476,0.00046904135,0.0001747274,0.8841018,0.10229436,0.000081384904,0.00012684442,0.00005776268,0.012134756],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9749263,0.0041846237,0.0050327913,0.0017910076,0.010284122,0.0037811492],"domain_scores_gemma":[0.91737247,0.03476623,0.006963235,0.003291011,0.030179488,0.007427598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012013399,0.0023260368,0.0042105746,0.0036050451,0.0077232243,0.010382468,0.004398511,0.106411256,0.03990279],"category_scores_gemma":[0.16738331,0.0020293735,0.0063334904,0.0021665525,0.005302099,0.005114263,0.005263091,0.07792828,0.04509124],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008832938,0.000005935178,0.000034581528,0.00001962757,0.000004867189,0.00014107775,0.000019439536,0.000008042068,0.000010437435,0.00039505455,0.99825364,0.0010983936],"study_design_scores_gemma":[0.00018838256,0.000023097418,0.0007647607,0.0008403143,0.000050033366,0.0003418464,0.00026580086,0.00014617507,0.00007343362,0.004470571,0.9927643,0.000071306305],"about_ca_topic_score_codex":0.027525771,"about_ca_topic_score_gemma":0.042667013,"teacher_disagreement_score":0.106411256,"about_ca_system_score_codex":0.012292922,"about_ca_system_score_gemma":0.018476432,"threshold_uncertainty_score":0.13348806},"labels":[],"label_agreement":null},{"id":"W2607067254","doi":"10.1016/s2213-8587(17)30114-6","title":"Analysis of the MAVIDOS trial","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Memorial University of Newfoundland","funders":"","keywords":"Medicine; Placebo; Vitamin D and neurology; Pediatrics; Pregnancy; Gestational diabetes; Clinical trial; Randomized controlled trial; Offspring; Gestation; Cholecalciferol; Gestational age; Internal medicine; Alternative medicine","score_opus":0.048576371339355016,"score_gpt":0.3237987000983701,"score_spread":0.2752223287590151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607067254","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012149306,0.019607145,0.0005883565,0.9132582,0.02865107,0.0001398133,0.0053130602,0.00012820488,0.020164829],"genre_scores_gemma":[0.08949099,0.0057492745,0.00093057455,0.83581686,0.05258196,0.0004824917,0.0020509877,0.00016023402,0.012736622],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98633504,0.009642815,0.0006888522,0.0008565589,0.0015908363,0.0008858531],"domain_scores_gemma":[0.96966225,0.023207966,0.002225942,0.001448136,0.0014125631,0.0020431606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012569184,0.0007563006,0.0022161915,0.00043030598,0.0006853992,0.0027234994,0.0017464567,0.011304552,0.009757846],"category_scores_gemma":[0.056308664,0.00047362808,0.001992281,0.0007254743,0.00095127546,0.0017165941,0.0009971429,0.013141589,0.0042086537],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035177037,0.00015000268,0.005748395,0.00068913563,0.0018530128,0.00095332286,0.00010998508,0.0004318561,0.00053248776,0.0069434065,0.9005447,0.046866566],"study_design_scores_gemma":[0.10281397,0.003800475,0.021521615,0.003971441,0.007506992,0.0017753922,0.00048477636,0.003755125,0.0019053746,0.060214393,0.79194206,0.00030833576],"about_ca_topic_score_codex":0.0025668067,"about_ca_topic_score_gemma":0.0060881744,"teacher_disagreement_score":0.012569184,"about_ca_system_score_codex":0.0022103176,"about_ca_system_score_gemma":0.0030643386,"threshold_uncertainty_score":0.06647301},"labels":[],"label_agreement":null},{"id":"W2610389201","doi":"10.1016/s2213-8587(17)30150-x","title":"PCSK9 inhibitors: smooth sailing or a little turbulence ahead?","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials","funders":"","keywords":"Medicine; Scopus; Web of science; Internal medicine; MEDLINE; Meta-analysis","score_opus":0.04458113329424931,"score_gpt":0.313264644494611,"score_spread":0.2686835112003617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610389201","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005305327,0.48628998,0.0014791765,0.46834457,0.026937755,0.00003345343,0.00042551736,0.00024658605,0.010937671],"genre_scores_gemma":[0.09199741,0.5558433,0.0030328536,0.23594318,0.08923869,0.000097958306,0.00049887295,0.00021306225,0.023134748],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815613,0.000504304,0.00020206712,0.00027811588,0.0005324892,0.0003268844],"domain_scores_gemma":[0.99477,0.0023702027,0.00074484816,0.00026417474,0.00089289085,0.0009579823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048490735,0.00094465644,0.0029250293,0.0008909192,0.0008398387,0.0057876226,0.0011210628,0.0061991354,0.013508745],"category_scores_gemma":[0.009297153,0.0005358916,0.0015584262,0.00075566693,0.003729037,0.008165052,0.0025645518,0.0125045935,0.0058353115],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004298307,0.00028360495,0.0015234135,0.0032602753,0.00095242274,0.0006778422,0.00028313187,0.00039936468,0.0028482017,0.035905335,0.3727309,0.5768372],"study_design_scores_gemma":[0.0042292243,0.002789711,0.00814612,0.006258529,0.0013119691,0.0013027453,0.0018067193,0.0009177741,0.0016551932,0.14548923,0.82572746,0.00036538852],"about_ca_topic_score_codex":0.0010738412,"about_ca_topic_score_gemma":0.0027858326,"teacher_disagreement_score":0.013508745,"about_ca_system_score_codex":0.001052569,"about_ca_system_score_gemma":0.0020832275,"threshold_uncertainty_score":0.04519123},"labels":[],"label_agreement":null},{"id":"W2614965600","doi":"10.1016/s2213-8587(17)30168-7","title":"Exercise and physical activity in patients with type 1 diabetes – Authors' reply","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Clinical Research Institute; York University; LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Medicine; Glycemic; Type 2 diabetes; Diabetes mellitus; Population; Scopus; MEDLINE; Type 1 diabetes; Diabetes management; Physical therapy; Gerontology; Internal medicine; Endocrinology","score_opus":0.027936576885833907,"score_gpt":0.2957409080603756,"score_spread":0.2678043311745417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2614965600","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029226212,0.0020524436,0.000017414684,0.97433406,0.022721455,0.0000042251145,0.00007330199,0.0000064177684,0.00049848104],"genre_scores_gemma":[0.0035515921,0.0017170669,0.000048186757,0.9298648,0.063305,0.0000353919,0.000051105766,0.000009843049,0.0014169976],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99656576,0.001417633,0.000555017,0.00039196244,0.0006699985,0.0003995781],"domain_scores_gemma":[0.98072845,0.013309658,0.0013829214,0.0004887917,0.0022721137,0.0018181019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036596674,0.0007818398,0.002265297,0.0010081456,0.0025670656,0.0032764566,0.001737935,0.043992095,0.006743495],"category_scores_gemma":[0.038341552,0.00082188577,0.0014542546,0.0010083017,0.0025939494,0.0034432802,0.0023360848,0.042284686,0.0041450863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010985473,0.000033757107,0.0019418466,0.00011600294,0.000055960176,0.000769455,0.0001520327,0.000032513963,0.000046631834,0.00067377754,0.9895347,0.0065333797],"study_design_scores_gemma":[0.00085829507,0.00029072943,0.009212531,0.0018749703,0.00031323213,0.0034294268,0.0024202433,0.00050708104,0.00025216409,0.0103961425,0.970214,0.00023120291],"about_ca_topic_score_codex":0.0047004437,"about_ca_topic_score_gemma":0.006013706,"teacher_disagreement_score":0.043992095,"about_ca_system_score_codex":0.0025082044,"about_ca_system_score_gemma":0.003258947,"threshold_uncertainty_score":0.022559226},"labels":[],"label_agreement":null},{"id":"W2615150331","doi":"10.1016/s2213-8587(17)30167-5","title":"Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials","year":2017,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":457,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Toronto","funders":"","keywords":"Medicine; Artificial pancreas; Meta-analysis; Randomized controlled trial; Insulin; Diabetes mellitus; Internal medicine; Crossover study; Type 1 diabetes; Glucagon; MEDLINE; Hypoglycemia; Clinical trial; Endocrinology; Placebo; Pathology","score_opus":0.12174633569873759,"score_gpt":0.39376914580437467,"score_spread":0.27202281010563706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615150331","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008183628,0.990617,0.00032204032,0.00009664757,0.00016319493,0.00017971416,0.0002502068,0.000017137547,0.00017037531],"genre_scores_gemma":[0.18652156,0.80885035,0.0022682904,0.00085747207,0.00024424717,0.0004350495,0.00049998163,0.000026665723,0.00029646503],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99437535,0.0025289464,0.0016709188,0.00064836827,0.00055301783,0.00022343632],"domain_scores_gemma":[0.9910698,0.006563731,0.0015733112,0.00027809155,0.00037659818,0.00013841555],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0072627333,0.0023717822,0.017429642,0.0021620102,0.0004323977,0.002733898,0.0017849868,0.0023148672,0.0035374525],"category_scores_gemma":[0.018154036,0.0012647375,0.025961807,0.003215361,0.0007377639,0.0015977321,0.001381895,0.0028822033,0.00023595196],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014255666,0.00008293263,0.0023121403,0.37156013,0.58952814,0.00009107003,0.00009756934,0.00040760965,0.00033006872,0.00011965669,0.0005439809,0.020671003],"study_design_scores_gemma":[0.0053293854,0.00065751123,0.0039227866,0.018415593,0.96950847,0.000074715725,0.00006448618,0.00014997862,0.00013238545,0.00019097935,0.001520527,0.000033079104],"about_ca_topic_score_codex":0.0045547816,"about_ca_topic_score_gemma":0.0101012755,"teacher_disagreement_score":0.98257035,"about_ca_system_score_codex":0.0017335856,"about_ca_system_score_gemma":0.0018209725,"threshold_uncertainty_score":0.03840947},"labels":[],"label_agreement":null},{"id":"W2618542302","doi":"10.1016/s2213-8587(17)30096-7","title":"Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université Laval; Université de Montréal; Western University; University of Ottawa","funders":"National Institute of General Medical Sciences; British Heart Foundation; National Institute of Nursing Research; National Heart, Lung, and Blood Institute; National Institute for Health and Care Research","keywords":"Medicine; Internal medicine; Hazard ratio; Diabetes mellitus; Single-nucleotide polymorphism; Proportional hazards model; Population; Cardiology; Lipoprotein; Blood pressure; Lipoprotein(a); Coronary artery disease; Cholesterol; Endocrinology; Genotype; Genetics; Confidence interval; Biology","score_opus":0.011135084700190754,"score_gpt":0.25313532937448807,"score_spread":0.24200024467429732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2618542302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988244,0.00034098254,0.00016341169,0.00010110174,0.000020939568,0.000004679973,0.00021383754,0.00000644656,0.00032423227],"genre_scores_gemma":[0.9992874,0.000094189105,0.00013472886,0.000046823858,0.00005085339,0.0000066012426,0.00016048395,0.0000040081654,0.0002148428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990558,0.0003688834,0.000097036274,0.00024747316,0.00011292962,0.00011787322],"domain_scores_gemma":[0.99783605,0.0007254006,0.00049000856,0.00039236384,0.00014974634,0.00040648246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014026118,0.00081149046,0.0008504064,0.00070508063,0.0009457137,0.0013118127,0.0008580883,0.0017455867,0.0023626],"category_scores_gemma":[0.002735403,0.0010548176,0.0012923719,0.0014275339,0.00089572964,0.0006795073,0.0006902217,0.0024747704,0.00038229336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002331625,0.0002476396,0.9930353,0.000015699454,0.0010796321,0.00026011976,0.00012414159,0.00012423289,0.0015383428,0.00008575508,0.00014439951,0.0010131247],"study_design_scores_gemma":[0.00013589842,0.00037640758,0.99729306,0.000006108034,0.0005751755,0.00040011198,0.00015426705,0.00058671954,0.0001512413,0.00015807335,0.00014695579,0.000016008293],"about_ca_topic_score_codex":0.0047328975,"about_ca_topic_score_gemma":0.004005761,"teacher_disagreement_score":0.0047328975,"about_ca_system_score_codex":0.00036722491,"about_ca_system_score_gemma":0.00038791852,"threshold_uncertainty_score":0.009410739},"labels":[],"label_agreement":null},{"id":"W2619448414","doi":"10.1016/s2213-8587(17)30138-9","title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":961,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université Laval","funders":"","keywords":"Denosumab; Medicine; Placebo; Osteoporosis; Adverse effect; Incidence (geometry); Femoral neck; Randomized controlled trial; Bristol-Myers; Clinical endpoint; Physical therapy; Internal medicine; Surgery; Alternative medicine","score_opus":0.07123181860959384,"score_gpt":0.3673927548464625,"score_spread":0.2961609362368687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619448414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97215897,0.017431093,0.0006839376,0.0017704851,0.0009449136,0.00096860016,0.003188185,0.00014344916,0.0027103303],"genre_scores_gemma":[0.9824378,0.005952637,0.0009614181,0.0022272046,0.00079094846,0.0013413195,0.0030246205,0.00004014504,0.0032238227],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989298,0.00048742848,0.00006866846,0.00015598425,0.00009108777,0.00026701274],"domain_scores_gemma":[0.99785477,0.0008686224,0.0003858089,0.00019326933,0.000090858295,0.0006067149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032616123,0.001290367,0.0036583568,0.00041500153,0.000517007,0.0012103042,0.0008555982,0.002753821,0.008756937],"category_scores_gemma":[0.0029567778,0.0006413932,0.0040624402,0.00051459105,0.0013099768,0.0018670363,0.0006813636,0.0047947867,0.0011369577],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9798686,0.0029783694,0.00071449776,0.00040055907,0.000934304,0.000026453785,0.000070028706,0.00025577843,0.0009507255,0.000078099416,0.0006868389,0.013035784],"study_design_scores_gemma":[0.9374344,0.05240181,0.0070699495,0.000085243235,0.0011450348,0.00004044979,0.00006487382,0.00019774862,0.00018404059,0.0003138851,0.0010366476,0.000025974447],"about_ca_topic_score_codex":0.002223391,"about_ca_topic_score_gemma":0.0043536425,"teacher_disagreement_score":0.008756937,"about_ca_system_score_codex":0.0006060468,"about_ca_system_score_gemma":0.0012508079,"threshold_uncertainty_score":0.029294848},"labels":[],"label_agreement":null},{"id":"W2624031057","doi":"10.1016/s2213-8587(17)30194-8","title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":347,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; St Joseph's Health Care","funders":"British Heart Foundation; Steno Diabetes Center Copenhagen","keywords":"Medicine; Metformin; Type 2 diabetes; Placebo; Diabetes mellitus; Internal medicine; Randomized controlled trial; MEDLINE; Endocrinology; Alternative medicine","score_opus":0.02280929518301,"score_gpt":0.28236733182863816,"score_spread":0.25955803664562815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2624031057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96790904,0.022113146,0.00067031814,0.00089521415,0.0016313242,0.003247151,0.0010460825,0.00014785501,0.0023398781],"genre_scores_gemma":[0.97736645,0.011000301,0.0014738641,0.0015987615,0.0015772177,0.0027919456,0.00089277996,0.000029279157,0.0032693835],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99913883,0.00037752217,0.0001011982,0.00018722276,0.0000660772,0.00012909928],"domain_scores_gemma":[0.9987801,0.00043386716,0.00031692456,0.00010312317,0.00007001687,0.00029598657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019287079,0.0022322054,0.005307715,0.0006881242,0.0007100716,0.0016085192,0.0010714903,0.0037911064,0.00869421],"category_scores_gemma":[0.002833086,0.001329798,0.003751678,0.0006836027,0.0014896464,0.0015741296,0.00064856606,0.0032317054,0.0010120079],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9921421,0.0013702726,0.00026406295,0.0008776957,0.000896302,0.000022111746,0.00002147475,0.000050780465,0.0006208029,0.000023657916,0.00017128131,0.003539582],"study_design_scores_gemma":[0.98298967,0.014553866,0.0011911705,0.00004524393,0.000832107,0.00001375504,0.000010658609,0.00006778537,0.00008155799,0.000037098005,0.00016717802,0.0000098648525],"about_ca_topic_score_codex":0.0013695027,"about_ca_topic_score_gemma":0.0024309256,"teacher_disagreement_score":0.00869421,"about_ca_system_score_codex":0.0006546679,"about_ca_system_score_gemma":0.0008334507,"threshold_uncertainty_score":0.02908498},"labels":[],"label_agreement":null},{"id":"W2733849831","doi":"10.1016/s2213-8587(17)30182-1","title":"Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":373,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network; Lunenfeld-Tanenbaum Research Institute; Toronto General Hospital","funders":"Sanofi","keywords":"Empagliflozin; Medicine; Albuminuria; Microalbuminuria; Type 2 diabetes; Placebo; Internal medicine; Diabetes mellitus; Creatinine; Renal function; Endocrinology","score_opus":0.016893468684284544,"score_gpt":0.25567587485054005,"score_spread":0.2387824061662555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2733849831","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96461964,0.027953086,0.0011262019,0.0009649194,0.00094212627,0.0009398299,0.0012092631,0.00014362072,0.0021013832],"genre_scores_gemma":[0.99106455,0.0044883774,0.00073704595,0.0006902337,0.0006582702,0.00054949365,0.0008351761,0.000018802531,0.00095798675],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99770385,0.0014547692,0.00018283917,0.0002804648,0.00015817347,0.00021999556],"domain_scores_gemma":[0.9973334,0.001430663,0.0005905339,0.00024126502,0.0001271204,0.00027706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043858476,0.0025455784,0.006308925,0.00050993747,0.00035536,0.0015551924,0.0010002418,0.0021135772,0.004098382],"category_scores_gemma":[0.005069235,0.0008996594,0.0068369005,0.00055532804,0.0015007914,0.0017888441,0.0008079581,0.004116303,0.0005379525],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98607254,0.0005094988,0.00085087644,0.00096110074,0.005982491,0.000029277455,0.000020907855,0.0001991277,0.00041215486,0.000050394927,0.00023199979,0.0046795327],"study_design_scores_gemma":[0.95490324,0.026005713,0.007431178,0.00012394376,0.01011823,0.000042654865,0.000032948174,0.0004209037,0.00021944147,0.00020040487,0.00047192123,0.000029452534],"about_ca_topic_score_codex":0.00088796276,"about_ca_topic_score_gemma":0.0015183858,"teacher_disagreement_score":0.006308925,"about_ca_system_score_codex":0.00077509176,"about_ca_system_score_gemma":0.000576049,"threshold_uncertainty_score":0.02319485},"labels":[],"label_agreement":null},{"id":"W2736904519","doi":"10.1016/s2213-8587(17)30185-7","title":"Microvascular outcomes in type 2 diabetes – Authors' reply","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Albuminuria; Type 2 diabetes; Nephropathy; Intensive care medicine; Kidney disease; Surrogate endpoint; Diabetic retinopathy; Retinopathy; Clinical endpoint; Diabetes mellitus; Internal medicine; Clinical trial; MEDLINE; Disease; Endocrinology","score_opus":0.031162459331585412,"score_gpt":0.29277410673987814,"score_spread":0.26161164740829274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2736904519","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017536564,0.0018405786,0.000017672108,0.97433555,0.023077738,0.0000034433397,0.000077098244,0.000008492369,0.00046408613],"genre_scores_gemma":[0.0025721216,0.0015828778,0.000052044325,0.92937577,0.064883366,0.000031154537,0.000049353304,0.000011129721,0.0014423121],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958688,0.0014314813,0.0006442987,0.0005212475,0.0009795642,0.00055466185],"domain_scores_gemma":[0.97957546,0.012803784,0.001775834,0.00053175224,0.002917659,0.0023956562],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042808726,0.00087634823,0.0023244526,0.0012712362,0.0025562781,0.0042835297,0.0018890576,0.04466991,0.008330652],"category_scores_gemma":[0.043439455,0.0008837332,0.0015314638,0.0011060159,0.0031563067,0.004563674,0.0031845171,0.049932618,0.0051031704],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050806913,0.00002324569,0.0011050109,0.00007088977,0.0000318115,0.000460583,0.00008878588,0.000022357548,0.000026029393,0.0007262484,0.9921951,0.0051990966],"study_design_scores_gemma":[0.0007017946,0.0001789094,0.005857853,0.0018278735,0.00023235568,0.0022312049,0.0015190919,0.00048643886,0.00022627616,0.014451529,0.9720461,0.00024061119],"about_ca_topic_score_codex":0.0041173,"about_ca_topic_score_gemma":0.005101694,"teacher_disagreement_score":0.04466991,"about_ca_system_score_codex":0.0025251254,"about_ca_system_score_gemma":0.003972972,"threshold_uncertainty_score":0.027868807},"labels":[],"label_agreement":null},{"id":"W2744253559","doi":"10.1016/s2213-8587(17)30259-0","title":"SGLT2 inhibitors in the real world: too good to be true?","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Empagliflozin; Medicine; Type 2 diabetes; Diabetes mellitus; Disease; Internal medicine; Incidence (geometry); Endocrinology","score_opus":0.04354202120162847,"score_gpt":0.307080378171915,"score_spread":0.26353835697028655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744253559","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009443122,0.0045594205,0.000034812598,0.9856317,0.008855271,0.0000014112796,0.000019942827,0.000010024125,0.0007929737],"genre_scores_gemma":[0.0024773723,0.006838796,0.0001533612,0.90833884,0.080646925,0.000011688838,0.000026509113,0.000018671442,0.0014879523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.994262,0.0022118753,0.0006820593,0.0005738283,0.0017455231,0.00052470644],"domain_scores_gemma":[0.9797792,0.012480602,0.0015390826,0.0004388515,0.0025159377,0.003246356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054554623,0.0010857261,0.0029362387,0.00089936884,0.0029715693,0.00595268,0.001793651,0.045542046,0.00957468],"category_scores_gemma":[0.036755223,0.0006362194,0.0015665374,0.0008068748,0.0044204597,0.008461078,0.0025340698,0.052353635,0.00851981],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012269162,0.00004960936,0.00052972144,0.00016883541,0.000043010612,0.0014791134,0.000098267854,0.000062202234,0.0001291874,0.003872968,0.96887857,0.024565876],"study_design_scores_gemma":[0.00036379296,0.00015326506,0.0008686461,0.0014025449,0.00008317942,0.0030370182,0.0006797231,0.00031904882,0.00017165167,0.026732069,0.96608156,0.00010736976],"about_ca_topic_score_codex":0.0026690124,"about_ca_topic_score_gemma":0.0051344424,"teacher_disagreement_score":0.045542046,"about_ca_system_score_codex":0.0043101795,"about_ca_system_score_gemma":0.0035613396,"threshold_uncertainty_score":0.032030523},"labels":[],"label_agreement":null},{"id":"W2747783283","doi":"10.1016/s2213-8587(17)30237-1","title":"Meta-analysis of artificial pancreas trials: methodological considerations – Authors' reply","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Diabetes Canada; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Scopus; Meta-analysis; Glycemic; Jadad scale; MEDLINE; Internal medicine; Insulin","score_opus":0.49641959484225107,"score_gpt":0.44354854570963775,"score_spread":0.05287104913261331,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747783283","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028574152,0.004969425,0.00022544315,0.9636235,0.0302221,0.000024296203,0.00027032083,0.000026260317,0.0003528228],"genre_scores_gemma":[0.0029055309,0.0017053935,0.00043624963,0.94719756,0.046845548,0.00011855413,0.000055751196,0.00003617673,0.000699269],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96307737,0.02243577,0.006684166,0.002416023,0.0045548393,0.0008318214],"domain_scores_gemma":[0.74537426,0.21789119,0.009445106,0.0057841353,0.018015748,0.0034896422],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.047099475,0.0010256364,0.0044678287,0.002132909,0.002073211,0.004332154,0.003588252,0.035658572,0.0056419517],"category_scores_gemma":[0.25433183,0.001374555,0.0035352681,0.0024211716,0.0040189703,0.004153188,0.0026025777,0.03193409,0.0036380964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039859352,0.00002233112,0.0011701346,0.00094144937,0.0006972871,0.00050418184,0.0001943377,0.00012837663,0.00008511494,0.0013415986,0.9850906,0.009425975],"study_design_scores_gemma":[0.0058280895,0.000385076,0.0057754684,0.0073733004,0.004063571,0.0029758625,0.0012038494,0.0019899872,0.000881457,0.04420676,0.9247927,0.0005237958],"about_ca_topic_score_codex":0.0046326723,"about_ca_topic_score_gemma":0.007345594,"teacher_disagreement_score":0.9529005,"about_ca_system_score_codex":0.0035179113,"about_ca_system_score_gemma":0.0062629306,"threshold_uncertainty_score":0.24908876},"labels":[],"label_agreement":null},{"id":"W2752623014","doi":"10.1016/s2213-8587(17)30283-8","title":"Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":269,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; University of Ottawa; Institut universitaire de cardiologie et de pneumologie de Québec; Hamilton Health Sciences; Impact; McMaster University; Université Laval; Population Health Research Institute","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Cholesterol; Polyunsaturated fatty acid; Nutrient; Saturated fat; Polyunsaturated fat; Blood pressure; Blood lipids; Internal medicine; Saturated fatty acid; Apolipoprotein B; Food science; Endocrinology; Environmental health; Physiology; Fatty acid; Biology; Biochemistry","score_opus":0.024481405792437447,"score_gpt":0.2982653175784135,"score_spread":0.27378391178597605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2752623014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984773,0.00036561143,0.000089421,0.000031791584,0.000008225527,0.000008364491,0.000841205,0.000003902416,0.00017413998],"genre_scores_gemma":[0.99796355,0.00030827476,0.00017811297,0.000054490272,0.000009009302,0.000021164584,0.0013033187,0.0000062790004,0.00015567294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981217,0.0008649079,0.00023094355,0.00040440983,0.00013736835,0.00024073098],"domain_scores_gemma":[0.99675375,0.0006853613,0.0011704414,0.0005896782,0.00037032086,0.00043044108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023579428,0.0010035359,0.001400509,0.0012339873,0.0009394156,0.0017076918,0.0009014781,0.001157305,0.0013850353],"category_scores_gemma":[0.003141332,0.0018323349,0.0022740664,0.0044985656,0.00086301635,0.0009653314,0.0020007466,0.001218632,0.00038765126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004527068,0.00005510534,0.99684936,0.00003127844,0.0013563207,0.00011389934,0.00023725694,0.00007762722,0.00021360487,0.000024890707,0.00013736865,0.0004505277],"study_design_scores_gemma":[0.00003487989,0.00011411671,0.9985127,0.000012794861,0.0004611075,0.000100552366,0.00050348474,0.00006499335,0.000034773966,0.000012931888,0.00013897031,0.000008675835],"about_ca_topic_score_codex":0.028316565,"about_ca_topic_score_gemma":0.026392143,"teacher_disagreement_score":0.028316565,"about_ca_system_score_codex":0.00048196985,"about_ca_system_score_gemma":0.0005297177,"threshold_uncertainty_score":0.0563035},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2754562397","doi":"10.1016/s2213-8587(17)30313-3","title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":596,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"National Institute for Health and Care Research; Amgen","keywords":"Medicine; Evolocumab; PCSK9; Internal medicine; Diabetes mellitus; Type 2 diabetes; Clinical endpoint; Myocardial infarction; Stroke (engine); Cardiology; Endocrinology; Clinical trial; Cholesterol; Lipoprotein","score_opus":0.007369601405536356,"score_gpt":0.23838794260371504,"score_spread":0.23101834119817868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754562397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884659,0.008930069,0.00033985788,0.00024726504,0.00024876036,0.000236914,0.00067703705,0.000027727056,0.00082652044],"genre_scores_gemma":[0.9955622,0.0017765041,0.00038341433,0.00030513422,0.00029179404,0.00021005976,0.0008408206,0.00001170172,0.00061849784],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9971722,0.0017325954,0.00021531973,0.0003991603,0.00022232828,0.00025849728],"domain_scores_gemma":[0.99524,0.0025137053,0.0010783559,0.00057937694,0.00017401925,0.0004145069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004424944,0.0017129455,0.004278219,0.0004931006,0.00036881247,0.0014771332,0.0011498552,0.0016492939,0.0038135792],"category_scores_gemma":[0.0064326692,0.0007464368,0.006778911,0.0005161138,0.0015681194,0.0015287115,0.00085757783,0.0033227818,0.00038682026],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9819307,0.00036508706,0.0036114906,0.0006112402,0.0063885935,0.000048311456,0.000031368883,0.00028551984,0.0006649662,0.00011535263,0.00018452207,0.0057628243],"study_design_scores_gemma":[0.9165544,0.035445713,0.032191835,0.00017385796,0.012737018,0.00013330636,0.000074575895,0.00078123953,0.0006066688,0.00049688615,0.0007267131,0.00007786933],"about_ca_topic_score_codex":0.0007526822,"about_ca_topic_score_gemma":0.0013756492,"teacher_disagreement_score":0.004424944,"about_ca_system_score_codex":0.00085332326,"about_ca_system_score_gemma":0.00060065975,"threshold_uncertainty_score":0.023401618},"labels":[],"label_agreement":null},{"id":"W2756152366","doi":"10.1016/s2213-8587(17)30309-1","title":"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute; Centre Hospitalier de l’Université de Montréal","funders":"National Institute for Health and Care Research; Bayer","keywords":"Acarbose; Medicine; Diabetes mellitus; Placebo; Impaired glucose tolerance; Internal medicine; Coronary heart disease; Double blind; Type 2 diabetes; Cardiology; Impaired fasting glucose; Randomized controlled trial; Clinical trial; Endocrinology; Alternative medicine","score_opus":0.013756135652715646,"score_gpt":0.25266708870099563,"score_spread":0.23891095304828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756152366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96662647,0.020962847,0.0010433304,0.0011578003,0.0019878051,0.003464411,0.0012357038,0.00022595125,0.0032955478],"genre_scores_gemma":[0.97953826,0.009124249,0.0012883941,0.0015216222,0.0015918391,0.0026662815,0.0010454146,0.00003522616,0.0031887058],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.998858,0.00050755456,0.000109079825,0.00024662836,0.00008764718,0.00019119767],"domain_scores_gemma":[0.99871266,0.00047896223,0.00025348703,0.000118026845,0.00009423967,0.00034255115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001961656,0.0028462072,0.0075701126,0.000698449,0.00076580327,0.0018096828,0.0012600512,0.004529522,0.007924228],"category_scores_gemma":[0.0026535743,0.0015159436,0.0039633657,0.0007459941,0.002046912,0.0017970164,0.00071548263,0.0045166053,0.0015988133],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.994197,0.0013025575,0.00017880496,0.0005570656,0.00081367575,0.000016640703,0.000019087229,0.000053281838,0.0005236172,0.000028863877,0.00014915485,0.0021602693],"study_design_scores_gemma":[0.9860677,0.0121385,0.00064712553,0.00002914671,0.0007133002,0.000008127093,0.000010484463,0.00009309955,0.00007914318,0.000051174466,0.00015260122,0.000009564383],"about_ca_topic_score_codex":0.0018429565,"about_ca_topic_score_gemma":0.0021447958,"teacher_disagreement_score":0.007924228,"about_ca_system_score_codex":0.00066324935,"about_ca_system_score_gemma":0.0009172475,"threshold_uncertainty_score":0.026509166},"labels":[],"label_agreement":null},{"id":"W2761192596","doi":"10.1016/s2213-8587(17)30307-8","title":"Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39 740 adults from 20 prospective cohort studies","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":289,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Human Genome Research Institute; National Heart, Lung, and Blood Institute; Medical Research Council; National Institutes of Health; Högskolan Dalarna; Institut National de la Santé et de la Recherche Médicale; Karolinska Institutet; University of New South Wales; Cancer Research UK; University of South Dakota; National Institute for Health and Care Research; University of Washington; AstraZeneca","keywords":"Pooled analysis; Prospective cohort study; Meta-analysis; Cohort study; Cohort; MEDLINE","score_opus":0.10343932015572402,"score_gpt":0.3745042622548038,"score_spread":0.27106494209907983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761192596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797203,0.012884732,0.0016461445,0.000054094857,0.000083191546,0.00005550077,0.0051380214,0.00006172656,0.0003562744],"genre_scores_gemma":[0.9906645,0.0022079386,0.0010656537,0.0000605462,0.000039337265,0.000088641216,0.0055334233,0.000031658943,0.00030839257],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99463177,0.0021989066,0.0008747262,0.0014138554,0.0005227774,0.00035795485],"domain_scores_gemma":[0.9935968,0.002101366,0.0014836751,0.0017573651,0.000760267,0.00030044478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008150422,0.0015706299,0.002901019,0.0030224132,0.0007065207,0.0018258691,0.00083878427,0.0012710855,0.0009405347],"category_scores_gemma":[0.008144099,0.0016037975,0.008487165,0.0047521517,0.0003928319,0.0010703951,0.0018273226,0.000774237,0.0002312448],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048191254,0.00005892519,0.92951655,0.0003643746,0.059065856,0.00013343371,0.00019431143,0.00041727256,0.0009210737,0.00003658839,0.0005050592,0.0039673946],"study_design_scores_gemma":[0.00035717335,0.00037540856,0.9494244,0.00008675361,0.04765932,0.00018283953,0.00034191398,0.00044014916,0.0002838848,0.00008232001,0.000720814,0.000044975346],"about_ca_topic_score_codex":0.015415647,"about_ca_topic_score_gemma":0.018403666,"teacher_disagreement_score":0.015415647,"about_ca_system_score_codex":0.00051552063,"about_ca_system_score_gemma":0.00069095654,"threshold_uncertainty_score":0.043104112},"labels":[],"label_agreement":null},{"id":"W2763024200","doi":"10.1016/s2213-8587(17)30326-1","title":"Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial","year":2017,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pasireotide; Cushing's disease; Clinical endpoint; Mitotane; Internal medicine; Clinical trial; Surgery; Acromegaly; Urology; Gastroenterology; Pediatrics; Disease; Chemotherapy; Hormone; Growth hormone","score_opus":0.06566783101234006,"score_gpt":0.361381509051894,"score_spread":0.29571367803955395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2763024200","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885876,0.0073821764,0.00027926237,0.00069197116,0.00031158427,0.0006435411,0.0005680441,0.00007102718,0.0014647353],"genre_scores_gemma":[0.99238586,0.0024401397,0.0004685262,0.0008175845,0.00043761564,0.00083479274,0.0007055174,0.000021164242,0.0018888307],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989587,0.0005189003,0.00007594611,0.00018771496,0.000090391535,0.00016835696],"domain_scores_gemma":[0.99813974,0.00058373436,0.0003461554,0.00019856055,0.00011175329,0.0006200927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026315828,0.0015269294,0.004480508,0.00035354696,0.00062205794,0.0013313949,0.0008498074,0.003151225,0.004160922],"category_scores_gemma":[0.0025143896,0.0006444431,0.0026660578,0.00041605995,0.0017080316,0.0018001496,0.00040392755,0.004342815,0.0010312118],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97341746,0.00376831,0.0010078145,0.0003273518,0.00087517366,0.000060564096,0.000063864565,0.00029171692,0.0021340246,0.000060168997,0.00047652418,0.017517027],"study_design_scores_gemma":[0.86144817,0.12783022,0.0076219034,0.000056690078,0.00094302435,0.00009268007,0.000050170773,0.00050554745,0.00051151105,0.00018783732,0.00070811226,0.000044123593],"about_ca_topic_score_codex":0.000859773,"about_ca_topic_score_gemma":0.0011957649,"teacher_disagreement_score":0.004480508,"about_ca_system_score_codex":0.00077825174,"about_ca_system_score_gemma":0.000815117,"threshold_uncertainty_score":0.0139196515},"labels":[],"label_agreement":null},{"id":"W2773969925","doi":"10.1016/s2213-8587(17)30412-6","title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","year":2017,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":592,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"AstraZeneca; National Heart, Lung, and Blood Institute; Amylin Pharmaceuticals","keywords":"Medicine; Semaglutide; Liraglutide; Lixisenatide; Exenatide; Glucagon-like peptide 1 receptor; Internal medicine; Type 2 diabetes; Placebo; Myocardial infarction; Dulaglutide; Meta-analysis; Adverse effect; Odds ratio; Stroke (engine); Hazard ratio; Diabetes mellitus; Agonist; Endocrinology; Receptor; Confidence interval","score_opus":0.09996280311863774,"score_gpt":0.32910575817358245,"score_spread":0.2291429550549447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2773969925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014541262,0.9832358,0.00074433075,0.00020024729,0.00036573588,0.000065347995,0.00048556415,0.000042197546,0.00031951396],"genre_scores_gemma":[0.38848424,0.6041635,0.0025162231,0.0017595761,0.00084117986,0.00027468678,0.0012098581,0.000059303802,0.00069139217],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99686724,0.0014243976,0.00071694114,0.00051176257,0.00027824484,0.00020140187],"domain_scores_gemma":[0.99602306,0.0028415306,0.000556007,0.00024937277,0.00023159152,0.00009843766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049972436,0.0026610696,0.012503527,0.0015896184,0.00035685988,0.0020635505,0.0015850676,0.0017567212,0.0032986058],"category_scores_gemma":[0.008016119,0.0014511338,0.03062875,0.0025735497,0.00037994375,0.0012685184,0.0011694144,0.0027031489,0.00038636493],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070289928,0.00004663788,0.0068206713,0.059040796,0.91236216,0.00013148917,0.000039303195,0.00052056735,0.00030828215,0.00010120002,0.0008995119,0.012700344],"study_design_scores_gemma":[0.001400009,0.00023329724,0.005623338,0.0021578835,0.9889014,0.000065928754,0.000030451163,0.00017053,0.000075860306,0.00019832996,0.0011171266,0.000025985351],"about_ca_topic_score_codex":0.0037313642,"about_ca_topic_score_gemma":0.008966545,"teacher_disagreement_score":0.012503527,"about_ca_system_score_codex":0.00091951207,"about_ca_system_score_gemma":0.00092261477,"threshold_uncertainty_score":0.026428223},"labels":[],"label_agreement":null},{"id":"W2778968960","doi":"10.1016/s2213-8587(17)30403-5","title":"Questioning the safety and benefits of evolocumab – Authors' reply","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Evolocumab; Intensive care medicine; Internal medicine","score_opus":0.24156564224394025,"score_gpt":0.38626011474150096,"score_spread":0.1446944724975607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2778968960","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012654127,0.0008827937,0.00003034738,0.9871338,0.0113328155,0.0000039285255,0.00006706854,0.000008010378,0.00041469015],"genre_scores_gemma":[0.0017727461,0.00048313325,0.00006245195,0.97283113,0.02390371,0.000018779248,0.000022355976,0.000012595966,0.00089300086],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9880074,0.004425765,0.0018325951,0.0014873084,0.0031110058,0.0011358339],"domain_scores_gemma":[0.9321962,0.05059899,0.0042119594,0.0016557153,0.0075537697,0.0037834153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0130985,0.00068215013,0.0028823086,0.0012776173,0.0029491112,0.0059375814,0.002770839,0.08144201,0.006694306],"category_scores_gemma":[0.10880597,0.0009322962,0.0021002316,0.0011785553,0.0073519177,0.005955996,0.0035737948,0.06858457,0.0051989257],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014950574,0.00002430376,0.00067716045,0.00008779858,0.00006390986,0.0005710709,0.00013602908,0.000065958644,0.00007520547,0.0037184965,0.98890823,0.005522297],"study_design_scores_gemma":[0.00058283884,0.00011512404,0.001631824,0.0010452406,0.00016021039,0.0012481982,0.00062268355,0.0004514438,0.00040713008,0.028926542,0.96457624,0.00023256894],"about_ca_topic_score_codex":0.005877418,"about_ca_topic_score_gemma":0.005930069,"teacher_disagreement_score":0.08144201,"about_ca_system_score_codex":0.0053988644,"about_ca_system_score_gemma":0.0069594374,"threshold_uncertainty_score":0.06927228},"labels":[],"label_agreement":null},{"id":"W2789044349","doi":"10.1016/s2213-8587(18)30025-1","title":"Do sulphonylureas still have a place in clinical practice?","year":2018,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"Janssen Pharmaceuticals; Collaboration for Leadership in Applied Health Research and Care - Greater Manchester; Merck Sharp and Dohme; National Institutes of Health; University of Leicester; Novo Nordisk; National Institute for Health and Care Research; Amgen; Boehringer Ingelheim; Merck; Sanofi; Loughborough University; AstraZeneca; Eli Lilly and Company; University Hospitals of Leicester NHS Trust","keywords":"Medicine; Observational study; Diabetes mellitus; Incidence (geometry); Internal medicine; Linagliptin; Clinical trial; Hypoglycemia; Type 2 diabetes; Intensive care medicine; Insulin; Endocrinology","score_opus":0.10339826261121242,"score_gpt":0.42102339555231955,"score_spread":0.3176251329411071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789044349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009120957,0.99423486,0.000043695185,0.0044559524,0.0006017111,0.0000016345653,0.000014780572,0.00000400295,0.0005520948],"genre_scores_gemma":[0.0025743875,0.989368,0.00024518845,0.0059453202,0.0015472252,0.000008634462,0.000025966145,0.0000031367617,0.00028209717],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971077,0.0008069503,0.00072389934,0.00031766313,0.00082285184,0.00022096367],"domain_scores_gemma":[0.98911834,0.006873142,0.001995995,0.00020859964,0.001302212,0.00050159905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058684507,0.00066779833,0.0030472698,0.0019721847,0.0004868806,0.0032333557,0.001254359,0.0035939696,0.0074325614],"category_scores_gemma":[0.014500349,0.00047376312,0.0014592627,0.0029062224,0.0019054462,0.003820467,0.0018971366,0.0041749915,0.0016208352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028984246,0.000033451186,0.00056750426,0.034962177,0.00048104225,0.0001279049,0.00016538965,0.00008891812,0.00019276484,0.007743419,0.034443103,0.9209046],"study_design_scores_gemma":[0.00038976094,0.00025750767,0.0028411488,0.05786226,0.0012624792,0.00081862736,0.0004890856,0.00009800107,0.00014028503,0.006219598,0.9295695,0.000051684565],"about_ca_topic_score_codex":0.0038416807,"about_ca_topic_score_gemma":0.00898534,"teacher_disagreement_score":0.0074325614,"about_ca_system_score_codex":0.0017732794,"about_ca_system_score_gemma":0.005686621,"threshold_uncertainty_score":0.031035721},"labels":[],"label_agreement":null},{"id":"W2793842039","doi":"10.1016/s2213-8587(18)30070-6","title":"The many faces of diabetes: addressing heterogeneity of a complex disease","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University","funders":"","keywords":"Medicine; Diabetes mellitus; Disease; MEDLINE; Internal medicine; Endocrinology","score_opus":0.0383208575324413,"score_gpt":0.286053675948,"score_spread":0.24773281841555872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793842039","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022860062,0.008368497,0.00022057662,0.9812564,0.009324495,0.0000025184802,0.000015138273,0.000016365379,0.000567475],"genre_scores_gemma":[0.008611379,0.011868007,0.00079047814,0.8058036,0.17137189,0.000022739288,0.00003226266,0.000026311707,0.0014732606],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99487394,0.0023149769,0.00050930516,0.0005820231,0.0012604004,0.00045946636],"domain_scores_gemma":[0.9661614,0.024958473,0.0011728876,0.0012453996,0.003095793,0.003366195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007524239,0.0009749565,0.002679,0.0010098149,0.0022840393,0.0042393706,0.002199599,0.025269987,0.005406474],"category_scores_gemma":[0.031853165,0.0006448452,0.0010606332,0.00070424826,0.006090899,0.011061206,0.0039544813,0.038686305,0.0028092219],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116773575,0.00007430839,0.0016078602,0.00026082422,0.000062509636,0.0019253683,0.00034596724,0.00011133935,0.00046067045,0.012826336,0.918984,0.06322404],"study_design_scores_gemma":[0.00029940825,0.00013046747,0.0023594606,0.0008673856,0.00010127576,0.004685175,0.001366964,0.0008442364,0.00036425996,0.13778506,0.8510548,0.0001414335],"about_ca_topic_score_codex":0.0013403179,"about_ca_topic_score_gemma":0.0031256285,"teacher_disagreement_score":0.025269987,"about_ca_system_score_codex":0.0025574395,"about_ca_system_score_gemma":0.002424258,"threshold_uncertainty_score":0.03979242},"labels":[],"label_agreement":null},{"id":"W2795790792","doi":"10.1016/s2213-8587(18)30075-5","title":"Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":204,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Amgen","keywords":"Medicine; Denosumab; Osteoporosis; Placebo; Bone mineral; Femoral neck; Glucocorticoid; Prednisone; Internal medicine; Physical therapy","score_opus":0.07859802049889092,"score_gpt":0.3810249539263167,"score_spread":0.30242693342742577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795790792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97652096,0.0137603395,0.0012438267,0.00080402324,0.0014383943,0.0037062587,0.0010526162,0.00014126039,0.0013323338],"genre_scores_gemma":[0.982733,0.0067224978,0.0020014576,0.0012113573,0.0010175796,0.0028215346,0.00067332253,0.000040956475,0.0027782135],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9981066,0.000990146,0.0001873664,0.00027331675,0.00016890522,0.00027353186],"domain_scores_gemma":[0.9979767,0.0007598953,0.00042345433,0.00023858366,0.00013821271,0.0004631783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030668713,0.0021490506,0.007759284,0.000700383,0.00055784633,0.0015269993,0.0012413315,0.0027878243,0.0068592452],"category_scores_gemma":[0.0036015338,0.001164727,0.0036349606,0.00083312986,0.0019413974,0.0014461281,0.0006663075,0.0027271747,0.0011501526],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9921747,0.0014184025,0.0001072866,0.0005671738,0.00071263354,0.000016565693,0.00002411416,0.00007416099,0.0011664374,0.00004117839,0.00012542344,0.0035719578],"study_design_scores_gemma":[0.97900796,0.019345654,0.0005826395,0.000025687874,0.00060142146,0.000012152865,0.000013230893,0.000103161125,0.00011036754,0.000059761132,0.00012596029,0.000012030814],"about_ca_topic_score_codex":0.0017687727,"about_ca_topic_score_gemma":0.0027129296,"teacher_disagreement_score":0.007759284,"about_ca_system_score_codex":0.0008078634,"about_ca_system_score_gemma":0.0011646498,"threshold_uncertainty_score":0.022946477},"labels":[],"label_agreement":null},{"id":"W2797845698","doi":"10.1016/s2213-8587(18)30100-1","title":"Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"Novartis","keywords":"Medicine; Enalapril; Renal function; Diabetes mellitus; Valsartan; Sacubitril; Internal medicine; Type 2 diabetes; Neprilysin; Nephropathy; Heart failure; Endocrinology; Urology; Gastroenterology; Cardiology; Angiotensin-converting enzyme; Blood pressure","score_opus":0.0067479420855913255,"score_gpt":0.22510474663847532,"score_spread":0.218356804552884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797845698","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98724943,0.007191099,0.0004197316,0.0008570796,0.00046596408,0.0002872792,0.0012768195,0.000038977018,0.0022135677],"genre_scores_gemma":[0.99375474,0.0016884195,0.0004401409,0.00090632524,0.00055671076,0.00025109437,0.0015826692,0.000009623998,0.00081027864],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.999151,0.00047737238,0.00005200847,0.00014956821,0.000052916832,0.00011712826],"domain_scores_gemma":[0.99886286,0.0004037716,0.00026151576,0.00013341299,0.000073000054,0.00026544588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017838792,0.0015074672,0.0032381774,0.00021510174,0.0003481408,0.0012554432,0.0007385126,0.0012175152,0.002532159],"category_scores_gemma":[0.0021457716,0.00045454333,0.003788737,0.0002932045,0.0007130781,0.0011961677,0.00058026344,0.00330881,0.00042297455],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9529767,0.0023840244,0.012629633,0.0012550628,0.011996296,0.0001150494,0.00004796979,0.0007720313,0.0020442402,0.00039905138,0.0019131418,0.013466803],"study_design_scores_gemma":[0.8277649,0.06664133,0.077823035,0.00023665126,0.020241855,0.0002328626,0.00012798158,0.0017266001,0.0009784799,0.0018937013,0.0022345772,0.000098063356],"about_ca_topic_score_codex":0.00088516116,"about_ca_topic_score_gemma":0.0021173388,"teacher_disagreement_score":0.0032381774,"about_ca_system_score_codex":0.00052330736,"about_ca_system_score_gemma":0.00059038703,"threshold_uncertainty_score":0.009434164},"labels":[],"label_agreement":null},{"id":"W2800283810","doi":"10.1016/s2213-8587(18)30052-4","title":"Precision medicine in the management of type 2 diabetes","year":2018,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research; Canada Research Chairs; Wellcome Trust","keywords":"Medicine; Type 2 diabetes; MEDLINE; Diabetes mellitus; Intensive care medicine; Endocrinology","score_opus":0.06677750395896741,"score_gpt":0.3539323562698343,"score_spread":0.2871548523108669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800283810","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000014417378,0.9991873,0.00005145332,0.00031327308,0.00020964834,0.0000025914494,0.00000830847,0.0000033421222,0.00020964011],"genre_scores_gemma":[0.00022264972,0.9989672,0.00011830702,0.00034928162,0.00023464322,0.0000037229174,0.000010967776,6.921562e-7,0.000092626215],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998953,0.0002878168,0.00016344147,0.0001094562,0.00041547997,0.00007084798],"domain_scores_gemma":[0.9962446,0.0027814668,0.0003858439,0.0000636838,0.0004036716,0.000120719524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024308353,0.0014208603,0.00392882,0.0036668917,0.0003567832,0.0019938177,0.0015863223,0.0023319388,0.005657368],"category_scores_gemma":[0.004280413,0.00042698317,0.0015862559,0.0031167562,0.0009234925,0.0019865949,0.0016123464,0.0035570187,0.001512893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105040075,0.00004429855,0.0001133499,0.06070675,0.000562983,0.000105736784,0.00005337171,0.00029161051,0.00038053753,0.005127351,0.03038546,0.90212345],"study_design_scores_gemma":[0.00012865689,0.00012465396,0.0009434673,0.05227488,0.0012018486,0.0006589617,0.00010344451,0.00016398085,0.00019998828,0.008566666,0.93558586,0.000047664427],"about_ca_topic_score_codex":0.002823394,"about_ca_topic_score_gemma":0.0051721334,"teacher_disagreement_score":0.005657368,"about_ca_system_score_codex":0.0012671761,"about_ca_system_score_gemma":0.002603568,"threshold_uncertainty_score":0.018925786},"labels":[],"label_agreement":null},{"id":"W2804433462","doi":"10.1016/s2213-8587(18)30107-4","title":"Islet transplantation in type 1 diabetes: moving forward","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Transplantation; Diabetes mellitus; Islet cell transplantation; Type 2 diabetes; Type 1 diabetes; Internal medicine; Hypoglycemia; Islet; Intensive care medicine; Endocrinology","score_opus":0.029577322396437344,"score_gpt":0.2753932574915545,"score_spread":0.24581593509511718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2804433462","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013845967,0.021188553,0.00008702688,0.9328604,0.044314083,0.0000026011571,0.000022432841,0.00002228924,0.0013642855],"genre_scores_gemma":[0.002721976,0.016246948,0.00017105324,0.6810515,0.29722008,0.000012225026,0.00003033524,0.000021721089,0.0025240742],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969708,0.0010639688,0.00031950435,0.00031122027,0.0009416179,0.00039285765],"domain_scores_gemma":[0.9854855,0.008967476,0.00087917264,0.00035352353,0.0017729104,0.0025414038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042462074,0.00090512086,0.0022471093,0.00090130075,0.0018141684,0.003957668,0.0015338822,0.032838408,0.010604516],"category_scores_gemma":[0.019601068,0.00043780578,0.0012812848,0.00064951746,0.003290273,0.0065484843,0.0023059028,0.03799595,0.0073440215],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008982629,0.000049554354,0.0003073171,0.00018040673,0.000018793793,0.0006436439,0.00004385991,0.000046028177,0.00012007723,0.0024994703,0.9653357,0.03066535],"study_design_scores_gemma":[0.00037950007,0.00012462864,0.0010425071,0.0011392006,0.000059258502,0.0016971582,0.00033985917,0.0002626193,0.0001194997,0.016171318,0.97861165,0.00005288606],"about_ca_topic_score_codex":0.0010794618,"about_ca_topic_score_gemma":0.0022021972,"teacher_disagreement_score":0.032838408,"about_ca_system_score_codex":0.0023135913,"about_ca_system_score_gemma":0.0021508161,"threshold_uncertainty_score":0.03547567},"labels":[],"label_agreement":null},{"id":"W2808220657","doi":"10.1016/s2213-8587(18)30125-6","title":"Dulaglutide and renal protection in type 2 diabetes","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; Lunenfeld-Tanenbaum Research Institute; St. Michael's Hospital; Toronto General Hospital","funders":"Canadian Institutes of Health Research; University of Toronto; Juvenile Diabetes Research Foundation Canada","keywords":"Medicine; Dulaglutide; Type 2 diabetes; Insulin glargine; Kidney disease; Internal medicine; Diabetes mellitus; Renal function; Metformin; Insulin; Exenatide; Endocrinology","score_opus":0.030730179965765016,"score_gpt":0.2625737284194719,"score_spread":0.2318435484537069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808220657","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069891755,0.013310858,0.000051272287,0.9566638,0.024097104,0.00000880323,0.00006143855,0.000026357899,0.0050814496],"genre_scores_gemma":[0.011799315,0.012646671,0.00019259068,0.7602766,0.20675793,0.0000412806,0.00006591351,0.000024608336,0.008195019],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862385,0.0004369284,0.00023178209,0.00011272825,0.00039888092,0.0001958065],"domain_scores_gemma":[0.9940498,0.0038171085,0.00052080775,0.00016738352,0.0005910145,0.00085403625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019034386,0.00058604043,0.0016713103,0.00073357427,0.0016385823,0.0022755393,0.0009094757,0.025802087,0.007682648],"category_scores_gemma":[0.0158915,0.00043786585,0.0011208988,0.00061034417,0.0016698661,0.0022474623,0.0011987756,0.022211034,0.0047069383],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029904448,0.0000893595,0.0009591603,0.00019260315,0.00004469839,0.002812685,0.000055701574,0.000059040776,0.00015352323,0.00352337,0.94663435,0.04517632],"study_design_scores_gemma":[0.0015838672,0.00030017918,0.0028987543,0.0011731214,0.00014661369,0.004464059,0.0001896195,0.0004302752,0.0002579098,0.016677933,0.97181815,0.000059341884],"about_ca_topic_score_codex":0.002295521,"about_ca_topic_score_gemma":0.0055345693,"teacher_disagreement_score":0.025802087,"about_ca_system_score_codex":0.0026933954,"about_ca_system_score_gemma":0.0020077568,"threshold_uncertainty_score":0.025701046},"labels":[],"label_agreement":null},{"id":"W2883055530","doi":"10.1016/s2213-8587(18)30205-5","title":"Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Janssen Pharmaceuticals; Department of Surgery; National Institute of General Medical Sciences; Ontario Ministry of Research and Innovation; Canadian Institutes of Health Research; Department of Medicine, Georgetown University; National Center for Research Resources; Eli Lilly Canada; General Research Fund of Shanghai Normal University; National Institutes of Health; Novo Nordisk; Merck; Diagnostic Services Manitoba; National Center for Advancing Translational Sciences; University of Manitoba; McMaster University; Department of Anesthesiology, Medical College of Wisconsin; Heart and Stroke Foundation of Canada; Manitoba Health Research Council; Hamilton Health Sciences; Universiti Malaya; Manitoba Medical Service Foundation; Amgen; Boehringer Ingelheim; Pfizer; Bristol-Myers Squibb Canada; Institute of Clinical and Translational Sciences; Sanofi; American Heart Association; Abbott Laboratories; AstraZeneca","keywords":"Medicine; Diabetes mellitus; Prospective cohort study; Perioperative; Hazard ratio; Odds ratio; Cardiac surgery; Logistic regression; Internal medicine; Cohort; Surgery; Endocrinology; Confidence interval","score_opus":0.009005445890019372,"score_gpt":0.25978140227684515,"score_spread":0.25077595638682576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883055530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867165,0.00023572266,0.00011245511,0.000053112588,0.000025847288,0.000011768992,0.00063485536,0.0000060348043,0.00024863012],"genre_scores_gemma":[0.9982291,0.00018520607,0.00017789498,0.0000784954,0.00003915717,0.000018408655,0.0009250612,0.0000068060535,0.00033980396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999027,0.00023865236,0.00011912646,0.0003046687,0.000104271836,0.00020621286],"domain_scores_gemma":[0.9970471,0.0003394016,0.00094724284,0.0007811791,0.00021807186,0.0006669365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013840128,0.0009153251,0.0007525528,0.00076140196,0.00080115895,0.0017131633,0.00096787227,0.0014730624,0.002553532],"category_scores_gemma":[0.0025224532,0.0014280472,0.0020800834,0.0018836744,0.0005936275,0.0012045399,0.0012512923,0.0021120794,0.000607781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009044023,0.00012648775,0.9970515,0.000013122018,0.0006328756,0.00013649992,0.00006991215,0.000024961797,0.00038347792,0.000025408699,0.00015639901,0.0004749771],"study_design_scores_gemma":[0.00007677876,0.0003702727,0.9984402,0.000008775198,0.00032980635,0.00023892424,0.0002060251,0.00010456499,0.000053227486,0.000027022112,0.00013201422,0.000012480875],"about_ca_topic_score_codex":0.0075513823,"about_ca_topic_score_gemma":0.00878181,"teacher_disagreement_score":0.0075513823,"about_ca_system_score_codex":0.00036916812,"about_ca_system_score_gemma":0.00055565836,"threshold_uncertainty_score":0.015014827},"labels":[],"label_agreement":null},{"id":"W2883578953","doi":"10.1016/s2213-8587(18)30208-0","title":"Hyperglycaemia in pregnancy and the effect of diabetes on cardiovascular risk","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto; Mount Sinai Hospital","funders":"Medical Research Council","keywords":"Medicine; Diabetes mellitus; Prospective cohort study; Cohort study; Population; Demography; Incidence (geometry); Scopus; Cohort; Gerontology; Internal medicine; MEDLINE; Environmental health; Endocrinology","score_opus":0.014430781140987139,"score_gpt":0.26124626036074045,"score_spread":0.2468154792197533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2883578953","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020454072,0.017277177,0.00006003383,0.955619,0.021177594,0.000006427022,0.00009136632,0.00001333797,0.003709664],"genre_scores_gemma":[0.05066469,0.03733519,0.0003080289,0.5219988,0.38326868,0.000062509396,0.00009809005,0.00003071465,0.006233218],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99806374,0.00086935464,0.00021686453,0.00015296032,0.0005251975,0.0001719282],"domain_scores_gemma":[0.99330795,0.0045980006,0.00053492084,0.00019978145,0.0005663053,0.00079296215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024252292,0.00049387536,0.0013461815,0.0005988183,0.0010864468,0.0017651032,0.0010421288,0.015247132,0.0055603534],"category_scores_gemma":[0.022026256,0.00045207748,0.0008191769,0.0007605108,0.0013404998,0.0020315873,0.0008324335,0.017531876,0.0021520793],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084023643,0.0002199258,0.019282917,0.00054927915,0.00020609563,0.0064124684,0.00041881713,0.0001800367,0.000490919,0.006425666,0.878872,0.08610163],"study_design_scores_gemma":[0.0014143967,0.0005967114,0.05644898,0.0029668168,0.00057032536,0.009071803,0.0016203676,0.001243833,0.00041907805,0.03491343,0.89054906,0.00018518518],"about_ca_topic_score_codex":0.0054271007,"about_ca_topic_score_gemma":0.008657996,"teacher_disagreement_score":0.015247132,"about_ca_system_score_codex":0.0016909868,"about_ca_system_score_gemma":0.001651721,"threshold_uncertainty_score":0.018601298},"labels":[],"label_agreement":null},{"id":"W2884107160","doi":"10.1016/s2213-8587(18)30155-4","title":"Advances in the medical treatment of Cushing's syndrome","year":2018,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Pasireotide; Medicine; Cabergoline; Aminoglutethimide; Pituitary tumors; Corticotropic cell; Somatostatin receptor; Cushing syndrome; Somatostatin; Pharmacotherapy; Glucocorticoid receptor; Pharmacology; Internal medicine; Mifepristone; Endocrinology; Glucocorticoid; Pituitary gland; Acromegaly; Cancer","score_opus":0.055591455730214345,"score_gpt":0.366876238931577,"score_spread":0.31128478320136266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884107160","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003308076,0.99920803,0.000034260884,0.0002690944,0.00017120657,0.00000158005,0.000007618042,0.0000025765005,0.00027257166],"genre_scores_gemma":[0.00039919338,0.9987777,0.00008804124,0.00027746835,0.0002833649,0.000002227302,0.000013481298,7.1613476e-7,0.00015779785],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996828,0.00006401813,0.000053995525,0.00004163055,0.00012599266,0.00003161005],"domain_scores_gemma":[0.99917775,0.0005353961,0.00010625554,0.000015408816,0.00012108869,0.000043997807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083493476,0.0006783963,0.0018142487,0.0018617158,0.00026090807,0.0010757225,0.0009331866,0.0011783425,0.004558463],"category_scores_gemma":[0.0014843456,0.00024014528,0.0007230279,0.0016336511,0.00050319143,0.0010111987,0.00073952076,0.0024052763,0.0013498187],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013004309,0.000065557106,0.00013543635,0.026212245,0.00016072164,0.0001527546,0.00003728971,0.00021014316,0.00068785634,0.0031104868,0.029891854,0.9392057],"study_design_scores_gemma":[0.000078252946,0.00014062566,0.0010267436,0.011197304,0.00038872706,0.0010057546,0.00007395596,0.00011452361,0.00024320466,0.0027967042,0.9829077,0.000026508693],"about_ca_topic_score_codex":0.0012312011,"about_ca_topic_score_gemma":0.0024693122,"teacher_disagreement_score":0.004558463,"about_ca_system_score_codex":0.0005611965,"about_ca_system_score_gemma":0.0010033055,"threshold_uncertainty_score":0.01524961},"labels":[],"label_agreement":null},{"id":"W2889089805","doi":"10.1016/s2213-8587(18)30233-x","title":"Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":200,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Simon Fraser University; Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Population Health Research Institute","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Medicine; Metformin; Pharmacy; Environmental health; Audit; Diabetes mellitus; Glibenclamide; Epidemiology; Family medicine; Business; Internal medicine; Accounting; Endocrinology","score_opus":0.04565561249153537,"score_gpt":0.3240000573649068,"score_spread":0.2783444448733714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889089805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963291,0.0012203029,0.0000870373,0.00016481278,0.000011553974,0.000006651311,0.0017625876,0.0000024081733,0.00041564077],"genre_scores_gemma":[0.99879164,0.00033045397,0.000054183434,0.00003412021,0.0000077653085,0.0000050872795,0.000697631,0.0000016610485,0.000077507226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985039,0.00045938793,0.00027095358,0.00028211498,0.00014389248,0.00033972232],"domain_scores_gemma":[0.9931282,0.0013310596,0.0037977274,0.0005482495,0.00045453038,0.0007403472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016097159,0.00036392282,0.00062673184,0.0015493126,0.0005687125,0.001496406,0.00074425415,0.0010151926,0.002666493],"category_scores_gemma":[0.004528997,0.0007916564,0.0019204939,0.0048608785,0.00081853004,0.0014477018,0.0017553705,0.0016624707,0.00030860864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014504523,0.00005397701,0.99851793,0.00002415208,0.00028859553,0.000057667276,0.000115826326,0.0000848191,0.000035592213,0.00008821776,0.00014400968,0.0004441989],"study_design_scores_gemma":[0.000009962965,0.000054495198,0.99878687,0.000021439582,0.000111210706,0.00009840993,0.00050639897,0.00014122407,0.0000179697,0.000065819004,0.00017801019,0.000008151528],"about_ca_topic_score_codex":0.026655557,"about_ca_topic_score_gemma":0.02051129,"teacher_disagreement_score":0.026655557,"about_ca_system_score_codex":0.0005695644,"about_ca_system_score_gemma":0.0004305126,"threshold_uncertainty_score":0.053000808},"labels":[],"label_agreement":null},{"id":"W2898783072","doi":"10.1016/s2213-8587(18)30311-5","title":"The perils of polyvascular disease in type 2 diabetes","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Belvoir Media Group; Regado Biosciences; Bayer Fund; Duke Clinical Research Institute; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Amarin Corporation; Boston Scientific Corporation; Amgen; Boehringer Ingelheim; Biotronik; American College of Cardiology Foundation; Cleveland Clinic; AstraZeneca; Bristol-Myers Squibb; Icahn School of Medicine at Mount Sinai; Mayo Clinic; Merck; Abbott Laboratories","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Internal medicine; Coronary artery disease; Scopus; Disease; MEDLINE; Endocrinology","score_opus":0.02155852450604999,"score_gpt":0.2663066225748478,"score_spread":0.24474809806879777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898783072","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002232883,0.0067120073,0.000032171258,0.9742854,0.017216315,0.000002453975,0.000017606066,0.000006473618,0.0015042645],"genre_scores_gemma":[0.0055395444,0.0073397425,0.00011260111,0.81630445,0.16795534,0.000020620753,0.000024016312,0.00001533448,0.0026883841],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950722,0.002201236,0.00054524175,0.0003365149,0.0013663346,0.00047853272],"domain_scores_gemma":[0.97666854,0.01604097,0.0015239087,0.0005913771,0.0021757218,0.002999514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046235938,0.00073811476,0.0017240964,0.0011094413,0.0029843878,0.004148487,0.0015104078,0.03995092,0.008850537],"category_scores_gemma":[0.037497096,0.00063933554,0.0010257087,0.00089596945,0.005148352,0.006536087,0.0029934878,0.043418687,0.0041054077],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085485175,0.000040022554,0.0011296129,0.00016348735,0.000027282162,0.0015839799,0.00016343543,0.000033063814,0.000073971794,0.0052844645,0.96745545,0.023959693],"study_design_scores_gemma":[0.00035463774,0.00010199462,0.0027578524,0.0016181399,0.00006451464,0.0035749539,0.0007085963,0.00023980819,0.00009392144,0.029281259,0.9611299,0.00007437738],"about_ca_topic_score_codex":0.0030845585,"about_ca_topic_score_gemma":0.005784051,"teacher_disagreement_score":0.03995092,"about_ca_system_score_codex":0.0033056384,"about_ca_system_score_gemma":0.0028268585,"threshold_uncertainty_score":0.029608011},"labels":[],"label_agreement":null},{"id":"W2900584187","doi":"10.1016/s2213-8587(18)30312-7","title":"Insulin use for type 2 diabetes: the challenges of predicting trends and modelling care","year":2018,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"Boehringer Ingelheim; AstraZeneca; Eli Lilly and Company; Sanofi; Abbott Laboratories; Merck; Amgen","keywords":"Medicine; Diabetes mellitus; Type 2 diabetes; Scopus; Population; Disease; Gerontology; MEDLINE; Environmental health; Internal medicine; Endocrinology","score_opus":0.08561460110873703,"score_gpt":0.296513251782073,"score_spread":0.21089865067333596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900584187","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028727166,0.0042669773,0.0006169893,0.989597,0.004689693,0.0000044169906,0.00010124105,0.00002186251,0.000414575],"genre_scores_gemma":[0.023000551,0.026565475,0.0069729597,0.77181697,0.16925523,0.00012862492,0.000314846,0.00011059119,0.001834686],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98584056,0.009108117,0.0018537035,0.0008097907,0.0019701074,0.00041773275],"domain_scores_gemma":[0.80560195,0.17241713,0.0041069356,0.0033939152,0.010283709,0.004196381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020258196,0.0008340382,0.0025309247,0.0010837307,0.0011707932,0.0044906414,0.003212179,0.016041042,0.0040007075],"category_scores_gemma":[0.15298524,0.00077604706,0.0018781349,0.0013705663,0.002389028,0.008364689,0.0024431683,0.03630929,0.0034504186],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024151198,0.00012243059,0.007165604,0.00063589826,0.00023244284,0.0006251125,0.00051926845,0.001021318,0.000085797,0.0103709195,0.8369643,0.14201553],"study_design_scores_gemma":[0.0006440857,0.00020492723,0.00616919,0.0038154395,0.00034449066,0.0017968252,0.0021021743,0.013555435,0.00025017123,0.21081695,0.7599938,0.00030651674],"about_ca_topic_score_codex":0.0107937325,"about_ca_topic_score_gemma":0.012862736,"teacher_disagreement_score":0.020258196,"about_ca_system_score_codex":0.0029539284,"about_ca_system_score_gemma":0.003902893,"threshold_uncertainty_score":0.107136905},"labels":[],"label_agreement":null},{"id":"W2902807692","doi":"10.1016/s2213-8587(18)30308-5","title":"Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study","year":2018,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":394,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; McMaster University; McGill University Health Centre; St. Joseph’s Healthcare Hamilton; University of Calgary; Alberta Bone and Joint Health Institute","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health; National Center for Advancing Translational Sciences; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Novo Nordisk Fonden","keywords":"Medicine; Femoral neck; FRAX; Osteoporosis; Bone mineral; Hazard ratio; Cohort; Bone density; Quantitative computed tomography; Hip fracture; Internal medicine; Prospective cohort study; Framingham Risk Score; Proportional hazards model; Cohort study; Surgery; Confidence interval; Osteoporotic fracture","score_opus":0.010763672847504431,"score_gpt":0.3055207647281193,"score_spread":0.29475709188061483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902807692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988887,0.00033347253,0.00007200133,0.00004771895,0.000014263667,0.000013092935,0.00037088688,0.0000037654754,0.00025608297],"genre_scores_gemma":[0.9988674,0.00013531231,0.00010591089,0.00004652146,0.000033006465,0.000017375347,0.00048514054,0.00000399811,0.0003053148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999445,0.000142127,0.000052005817,0.0001344432,0.00010624191,0.00012020865],"domain_scores_gemma":[0.9987589,0.0001537665,0.00039180403,0.00021570883,0.00015368557,0.0003260755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001249854,0.00088369526,0.0008317291,0.0008262182,0.0009960433,0.001388729,0.000919202,0.0016422223,0.0013050361],"category_scores_gemma":[0.0021516257,0.0011661374,0.0011237239,0.0017063478,0.0005783637,0.0007168507,0.00089876883,0.001793715,0.00032682283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051292736,0.00010124731,0.99822897,0.0000061240717,0.00021085757,0.000042752934,0.000086028085,0.000025372876,0.00020446764,0.000015834676,0.00009156663,0.0004739118],"study_design_scores_gemma":[0.000033027525,0.000115775816,0.9992187,0.000003934705,0.0001523266,0.00009068994,0.00014744524,0.00009859201,0.00002580427,0.000025119163,0.0000834969,0.0000050454823],"about_ca_topic_score_codex":0.014338654,"about_ca_topic_score_gemma":0.019347569,"teacher_disagreement_score":0.014338654,"about_ca_system_score_codex":0.00040909142,"about_ca_system_score_gemma":0.0005096977,"threshold_uncertainty_score":0.028510392},"labels":[],"label_agreement":null},{"id":"W2909182150","doi":"10.1016/s2213-8587(18)30313-9","title":"Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":320,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Center for Research Resources; National Institute of Diabetes and Digestive and Kidney Diseases; Mayo Clinic; Medical Research Council; National Institutes of Health; Kidney Research UK; National Medical Research Council; Emory University; Cleveland Clinic; National Center for Advancing Translational Sciences; Tufts Medical Center; Bristol-Myers Squibb; National Kidney Foundation; National Institute for Health and Care Research; PKD Foundation","keywords":"Albuminuria; Medicine; Kidney disease; Creatinine; Internal medicine; Renal function; Cohort study; Cohort","score_opus":0.621653956587924,"score_gpt":0.46191893850136473,"score_spread":0.15973501808655927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909182150","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007699945,0.99009246,0.0010200235,0.00017041247,0.00021923108,0.00006910903,0.0005584041,0.000045874032,0.0001245874],"genre_scores_gemma":[0.21522549,0.7770363,0.0038625107,0.0010492489,0.00039792198,0.00028755373,0.001553793,0.00008785387,0.0004993555],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9920184,0.0041454323,0.001722985,0.001101633,0.0006821212,0.0003293616],"domain_scores_gemma":[0.9827115,0.013511316,0.0017072444,0.0010049421,0.000821023,0.00024405752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011677365,0.0030420842,0.015287256,0.0028773001,0.0005141373,0.0029483065,0.0024881233,0.0023398385,0.0026736301],"category_scores_gemma":[0.025734968,0.0018887311,0.042528037,0.004397757,0.0005370877,0.0013907573,0.0019757824,0.003097203,0.00035879563],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029404045,0.000021751119,0.0056342296,0.06133765,0.91773236,0.00007635569,0.000043522345,0.00040005497,0.0001905014,0.00008953399,0.00062720844,0.010906502],"study_design_scores_gemma":[0.0005238853,0.000120980505,0.005890482,0.0034874098,0.98830646,0.00006980365,0.000026477557,0.0001714075,0.00007906842,0.00023643185,0.0010635726,0.000023961806],"about_ca_topic_score_codex":0.010008371,"about_ca_topic_score_gemma":0.016608428,"teacher_disagreement_score":0.015287256,"about_ca_system_score_codex":0.0016020332,"about_ca_system_score_gemma":0.0024516387,"threshold_uncertainty_score":0.06175655},"labels":[],"label_agreement":null},{"id":"W2910611591","doi":"10.1016/s2213-8587(18)30336-x","title":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute; National Institutes of Health; Rosetrees Trust","keywords":"Medicine; Natural history; Term (time); Retrospective cohort study; Endocrine system; Intensive care medicine; MEDLINE; Pediatrics; Oncology; Internal medicine; Hormone","score_opus":0.018211743893135394,"score_gpt":0.27046274608711907,"score_spread":0.25225100219398366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2910611591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99882823,0.00052215345,0.000036724265,0.000026770267,0.000003934616,0.00000510014,0.00033508532,0.000001411039,0.00024055841],"genre_scores_gemma":[0.9990741,0.00019454576,0.000032309807,0.0000347155,0.000008928909,0.000008396994,0.0005253039,0.000002216016,0.00011951443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992828,0.00018389367,0.00009620919,0.00019753914,0.00009531648,0.00014421831],"domain_scores_gemma":[0.99814737,0.00033891673,0.00081163686,0.00018319419,0.00013670533,0.00038219566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006214494,0.0003385102,0.0005215299,0.0008997194,0.00080727047,0.0009966908,0.0005801777,0.0008481583,0.0011131485],"category_scores_gemma":[0.002196629,0.0005021751,0.00092650356,0.0019914033,0.000562726,0.0008881552,0.00068421505,0.0008375711,0.0002337798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040156484,0.000063401625,0.99850607,0.000007621204,0.000072744966,0.00014002716,0.00009828689,0.00002521483,0.00015328883,0.000007490694,0.000040397295,0.00048382333],"study_design_scores_gemma":[0.000017996666,0.00017693955,0.99871385,0.0000062237714,0.000065229135,0.0005480657,0.00023768393,0.000051096453,0.000029879744,0.000012933864,0.00013305144,0.000007095924],"about_ca_topic_score_codex":0.008648732,"about_ca_topic_score_gemma":0.0054038265,"teacher_disagreement_score":0.008648732,"about_ca_system_score_codex":0.0007191861,"about_ca_system_score_gemma":0.00042771787,"threshold_uncertainty_score":0.017196774},"labels":[],"label_agreement":null},{"id":"W2912546704","doi":"10.1016/s2213-8587(18)30369-3","title":"Subspecialty training in adult inherited metabolic diseases: a call to action for unmet needs","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital; Centre for Advancing Health Outcomes; Providence Health Care","funders":"","keywords":"Medicine; Subspecialty; Call to action; Life expectancy; Pediatrics; Disease; Family medicine; Incidence (geometry); Population; Gerontology; Pathology; Environmental health","score_opus":0.023277281133993674,"score_gpt":0.28401549239677154,"score_spread":0.26073821126277785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2912546704","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007622041,0.01251948,0.0003124062,0.9709188,0.012818657,0.000015850626,0.00008419549,0.00009570773,0.0024726968],"genre_scores_gemma":[0.027131112,0.039808106,0.0043944838,0.8598253,0.055820327,0.00039534344,0.00055230036,0.00011971121,0.011953337],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98880553,0.0028090635,0.0007496813,0.0010166692,0.0024782238,0.0041408464],"domain_scores_gemma":[0.8616222,0.02227675,0.005318926,0.0019414547,0.010230322,0.09861034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016110506,0.0014157715,0.0024783765,0.0018653717,0.0053221416,0.0070738154,0.0041789864,0.04755786,0.06938555],"category_scores_gemma":[0.036475208,0.00083284016,0.0035220946,0.0010858389,0.0059117693,0.0111788,0.017216189,0.037159476,0.008107895],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014078124,0.00047856878,0.002402844,0.0010982755,0.000079830934,0.0004348242,0.00056247436,0.00018612956,0.00046520386,0.005989254,0.92402625,0.06413554],"study_design_scores_gemma":[0.0012052883,0.0006319651,0.03513731,0.010608257,0.000173447,0.0012301198,0.008377253,0.0007428842,0.00025369736,0.027809326,0.91348755,0.00034291713],"about_ca_topic_score_codex":0.01767666,"about_ca_topic_score_gemma":0.0261984,"teacher_disagreement_score":0.06938555,"about_ca_system_score_codex":0.007957393,"about_ca_system_score_gemma":0.05678749,"threshold_uncertainty_score":0.23211783},"labels":[],"label_agreement":null},{"id":"W2917530505","doi":"10.1016/s2213-8587(19)30029-4","title":"Intensive periodontal therapy and type 2 diabetes","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Oral microbiology and periodontitis research","field":"Dentistry","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Periodontitis; Chronic periodontitis; Clinical trial; Diabetes mellitus; Randomized controlled trial; Type 2 diabetes; Dentistry; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.05025046696741868,"score_gpt":0.2976884483229122,"score_spread":0.2474379813554935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917530505","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00054466515,0.00488953,0.0000332156,0.9680145,0.02335826,0.000005801608,0.000032269494,0.000006390838,0.0031155078],"genre_scores_gemma":[0.008048006,0.0045066397,0.000095735726,0.84384716,0.13642032,0.000028648117,0.000029067944,0.000015063202,0.007009297],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99800617,0.0006371915,0.00029122134,0.00020307081,0.00049700896,0.00036532115],"domain_scores_gemma":[0.9931284,0.0043210597,0.00064167276,0.0001975644,0.00056096737,0.001150385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019654348,0.0007501027,0.0013090401,0.0007708836,0.002962967,0.0030312396,0.0008612912,0.046107963,0.008693146],"category_scores_gemma":[0.018054605,0.0007009195,0.0010290728,0.00082578615,0.002069892,0.0023605735,0.001620393,0.031165794,0.0034217623],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017191177,0.00006986368,0.0016294108,0.00011400446,0.000033764572,0.0060034445,0.0001778553,0.00004571598,0.00022491121,0.003108636,0.97121555,0.01720497],"study_design_scores_gemma":[0.0008369523,0.00021629382,0.008140862,0.0017744272,0.00015668891,0.009661743,0.0009912523,0.00054975506,0.00024822698,0.015068396,0.96225077,0.00010464145],"about_ca_topic_score_codex":0.007355882,"about_ca_topic_score_gemma":0.0138694,"teacher_disagreement_score":0.046107963,"about_ca_system_score_codex":0.0034025398,"about_ca_system_score_gemma":0.0034584615,"threshold_uncertainty_score":0.029081523},"labels":[],"label_agreement":null},{"id":"W2918407168","doi":"10.1016/s2213-8587(19)30066-x","title":"Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":367,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Mount Sinai Hospital","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Placebo; Dulaglutide; Internal medicine; Diabetes mellitus; Randomized controlled trial; Concomitant; Clinical trial; Exenatide; Liraglutide; Endocrinology","score_opus":0.0164886080544158,"score_gpt":0.2803438125386376,"score_spread":0.2638552044842218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918407168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97162217,0.014009683,0.00088604016,0.0011626182,0.0026102292,0.0033003343,0.0021881969,0.00042187425,0.0037988028],"genre_scores_gemma":[0.97502047,0.00840567,0.001458626,0.0018628085,0.0013970764,0.0032353569,0.0017938953,0.000078643236,0.006747459],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99935895,0.00025316988,0.000054123706,0.00015930463,0.0000529539,0.00012159556],"domain_scores_gemma":[0.99931014,0.0001931544,0.000138991,0.00006735513,0.000044922657,0.00024548266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015737009,0.0026220458,0.0060654655,0.00069236115,0.0005534574,0.0018542742,0.0013382249,0.0028127749,0.011313189],"category_scores_gemma":[0.0015733128,0.0010685286,0.003265245,0.0006862335,0.0016862368,0.0019373298,0.0006896,0.0044914344,0.0019818924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99295264,0.0014909237,0.00012265629,0.0004601399,0.0006279041,0.000020527934,0.000016207787,0.000077707205,0.00057823036,0.0000420295,0.0002924894,0.0033184527],"study_design_scores_gemma":[0.9815074,0.01693021,0.00054897077,0.000034148747,0.0004873594,0.000011452194,0.000015574253,0.0001103452,0.000080089645,0.000056146906,0.00020943972,0.000008959428],"about_ca_topic_score_codex":0.0019140654,"about_ca_topic_score_gemma":0.0030955193,"teacher_disagreement_score":0.011313189,"about_ca_system_score_codex":0.0009331462,"about_ca_system_score_gemma":0.0008720388,"threshold_uncertainty_score":0.037846446},"labels":[],"label_agreement":null},{"id":"W2923297316","doi":"10.1016/s2213-8587(19)30077-4","title":"Glucose screening in pregnancy and future risk of cardiovascular disease in women: a retrospective, population-based cohort study","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Mount Sinai Hospital; Health Sciences Centre; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Sunnybrook Health Science Centre","funders":"Boehringer Ingelheim; Institute for Clinical Evaluative Sciences; Sanofi","keywords":"Medicine; Gestational diabetes; Pregnancy; Obstetrics; Population; Diabetes mellitus; Type 2 diabetes; Cohort; Gestation; Cohort study; Internal medicine; Endocrinology; Environmental health","score_opus":0.010609446224793593,"score_gpt":0.25746717417728293,"score_spread":0.24685772795248934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923297316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997703,0.00055832835,0.00019054399,0.00008930558,0.000022610648,0.000015994954,0.0009844494,0.0000075659086,0.00042824974],"genre_scores_gemma":[0.99861777,0.00035846586,0.00015861305,0.00007510163,0.000017905302,0.00001789883,0.0005000114,0.000005314552,0.00024896025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909186,0.00025894702,0.00008154302,0.00031452253,0.000107960936,0.00014521914],"domain_scores_gemma":[0.99829966,0.00029432846,0.00049326906,0.00045724402,0.00015097884,0.00030444076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011481358,0.000652429,0.0007637285,0.0007001568,0.00089439703,0.0013027939,0.000731364,0.0013031587,0.0012365656],"category_scores_gemma":[0.0030855779,0.0015012731,0.0014527265,0.001977408,0.00054374273,0.0009597405,0.00074832496,0.0017127842,0.00038828107],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041517234,0.00007569586,0.99768984,0.000011045181,0.00041542918,0.0001534603,0.000116148214,0.00003623372,0.00037982682,0.000029442639,0.00014659509,0.00053100084],"study_design_scores_gemma":[0.000046148198,0.00022982169,0.9981597,0.000013556215,0.00030533806,0.00047578444,0.0003035678,0.00018078092,0.000053064254,0.00003722465,0.00018231856,0.000012781584],"about_ca_topic_score_codex":0.018599175,"about_ca_topic_score_gemma":0.015820805,"teacher_disagreement_score":0.018599175,"about_ca_system_score_codex":0.00052838697,"about_ca_system_score_gemma":0.0006991136,"threshold_uncertainty_score":0.03698182},"labels":[],"label_agreement":null},{"id":"W2949665037","doi":"10.1016/s2213-8587(19)30180-9","title":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE–TIMI 58 randomised trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":675,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Janssen Research and Development; St. Jude Medical; Duke Clinical Research Institute; Eisai; Daiichi-Sankyo; Deutsche Forschungsgemeinschaft; Regado Biosciences; Medicines Company; Bristol-Myers Squibb; Cleveland Clinic; Society for Academic Continuing Medical Education; Biotronik; AstraZeneca; Amarin Corporation; Boston VA Research Institute; Boston Scientific Corporation; MyoKardia; Bayer; Gilead Sciences; Takeda Pharmaceutical Company; American College of Cardiology Foundation; Novartis; Mayo Clinic; Merck; GlaxoSmithKline; Icahn School of Medicine at Mount Sinai; Eli Lilly and Company; Boehringer Ingelheim; Amgen; MedImmune; Sanofi; Abbott Laboratories","keywords":"Medicine; Dapagliflozin; Renal function; Type 2 diabetes; Internal medicine; Kidney disease; TIMI; Dialysis; Diabetes mellitus; Creatinine; Albuminuria; Urology; Endocrinology; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.00957636408848811,"score_gpt":0.24791610790429294,"score_spread":0.23833974381580483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949665037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97071284,0.0192779,0.0010963344,0.0014415531,0.0013534642,0.0006719552,0.0021776964,0.00012742789,0.0031409815],"genre_scores_gemma":[0.9893526,0.0039457893,0.00086014275,0.0011464934,0.000699656,0.0006114089,0.0017890903,0.000026379295,0.0015683168],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9978654,0.0012009623,0.00019056027,0.00033796497,0.00015166803,0.00025353394],"domain_scores_gemma":[0.9977816,0.0010327569,0.00050077453,0.00026857396,0.000096394295,0.00032003998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003823788,0.0020369473,0.005697597,0.00047246288,0.0003787222,0.001772735,0.0010186121,0.0020469616,0.005610164],"category_scores_gemma":[0.0043771593,0.0010503818,0.007061642,0.000608215,0.0012779703,0.0017780724,0.0010580891,0.004898558,0.00069652864],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98410624,0.00038413538,0.0017985734,0.0008190372,0.0062968913,0.000033110526,0.000025447294,0.0003391653,0.00040667012,0.00011615814,0.00051975076,0.005154904],"study_design_scores_gemma":[0.9583534,0.01611942,0.010677081,0.00014869928,0.012570625,0.000046257224,0.00004478071,0.00066819345,0.00019300425,0.00042474485,0.00071317895,0.000040575746],"about_ca_topic_score_codex":0.0016427203,"about_ca_topic_score_gemma":0.002713136,"teacher_disagreement_score":0.005697597,"about_ca_system_score_codex":0.0009993935,"about_ca_system_score_gemma":0.00083878153,"threshold_uncertainty_score":0.020222366},"labels":[],"label_agreement":null},{"id":"W2953324257","doi":"10.1016/s2213-8587(19)30254-2","title":"Opioid-induced endocrinopathies","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Opioid; Discontinuation; Hyperprolactinaemia; Endocrine system; Intensive care medicine; Hormone replacement therapy (female-to-male); Pediatrics; Hormone; Internal medicine; Testosterone (patch); Prolactin","score_opus":0.143493559839508,"score_gpt":0.37468312804634085,"score_spread":0.23118956820683284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953324257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023121796,0.9991986,0.000014989527,0.00017014987,0.00025997663,0.0000016590034,0.000014320986,0.0000017877596,0.0003154703],"genre_scores_gemma":[0.00022485609,0.998868,0.0000420166,0.0002992116,0.00029320782,0.0000026677121,0.000015906191,5.6335364e-7,0.0002536401],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997081,0.000059092054,0.00005835556,0.000049849077,0.00009047238,0.000034042034],"domain_scores_gemma":[0.99922955,0.00047045323,0.00013602976,0.000018523835,0.000096668686,0.000048664748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007947402,0.0011629,0.002288047,0.0031779623,0.00029336836,0.0015037598,0.0008371235,0.0013633858,0.008237118],"category_scores_gemma":[0.0015355232,0.0003424271,0.0007039359,0.003610139,0.0005561758,0.0013139634,0.0012381155,0.001952035,0.001745949],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001839761,0.000057969643,0.00024007092,0.050718114,0.00033743802,0.00023080966,0.000044507953,0.0001827989,0.0005464497,0.0022389079,0.055607494,0.8896114],"study_design_scores_gemma":[0.00012193844,0.00013215154,0.0018974016,0.03034221,0.0009315569,0.001319973,0.0001538694,0.000073304946,0.00016512327,0.0026638785,0.9621615,0.000036907953],"about_ca_topic_score_codex":0.0022656906,"about_ca_topic_score_gemma":0.007201243,"teacher_disagreement_score":0.008237118,"about_ca_system_score_codex":0.0008465641,"about_ca_system_score_gemma":0.0016736765,"threshold_uncertainty_score":0.027555943},"labels":[],"label_agreement":null},{"id":"W2953700634","doi":"10.1016/s2213-8587(19)30119-6","title":"The role of blood volume in cardiac dysfunction and reduced exercise tolerance in patients with diabetes","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiovascular and exercise physiology","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Diabetes mellitus; Cardiology; Internal medicine; Blood volume; Cardiac dysfunction; Intensive care medicine; Endocrinology; Heart failure","score_opus":0.011130992723685758,"score_gpt":0.23971951421811408,"score_spread":0.22858852149442832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953700634","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006774885,0.99917054,0.00003998113,0.00027606718,0.00020537789,0.0000014178651,0.000017348808,0.0000031802144,0.00021836878],"genre_scores_gemma":[0.0010812032,0.99725217,0.00009233643,0.00043240393,0.0009099557,0.000005467865,0.00003316445,0.0000015144276,0.00019179666],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99966884,0.000059384394,0.0000637211,0.00006471542,0.00011576668,0.000027586511],"domain_scores_gemma":[0.9991283,0.0005379511,0.0001521772,0.000017358765,0.000117890195,0.000046301215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008145893,0.0011546088,0.0038470821,0.0013016224,0.0001531607,0.001273628,0.0010374478,0.0013922275,0.003171567],"category_scores_gemma":[0.0015564427,0.00033628067,0.0009271168,0.0016146338,0.0007093759,0.0010538398,0.0008478449,0.003096429,0.0015292605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039765768,0.00007675894,0.000823907,0.018597625,0.00057413115,0.000109267625,0.00003206362,0.00022268773,0.00039235767,0.0017930274,0.025977666,0.9510029],"study_design_scores_gemma":[0.0006192593,0.00062117726,0.020307241,0.024690645,0.0032255293,0.0021415914,0.00019370568,0.0005654408,0.00051029003,0.0095965555,0.9373645,0.00016413615],"about_ca_topic_score_codex":0.001404619,"about_ca_topic_score_gemma":0.0021716706,"teacher_disagreement_score":0.0038470821,"about_ca_system_score_codex":0.00047115504,"about_ca_system_score_gemma":0.0007609033,"threshold_uncertainty_score":0.010609925},"labels":[],"label_agreement":null},{"id":"W2954453953","doi":"10.1016/s2213-8587(19)30158-5","title":"Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial","year":2019,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":328,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; University of Toronto; University of Alberta; St. Michael's Hospital","funders":"Gilead UK and Ireland Corporate Contributions; Seventh Framework Programme; Daiichi Sankyo Europe; St. Jude Medical; Esperion Therapeutics; Idorsia Pharmaceuticals; Biotronik; Ferring Pharmaceuticals; NIHR Imperial Biomedical Research Centre; Eisai; Daiichi-Sankyo; Hartstichting; Actavis; Bayer HealthCare; Ironwood Pharmaceuticals, Incorporated; Medicines Company; Arrien Pharmaceuticals; Tenax Therapeutics; Janssen Pharmaceuticals; Novo Nordisk; MyoKardia; Assistance publique-Hôpitaux de Paris; Luitpold Pharmaceuticals; Regado Biosciences; Merck Sharp and Dohme; Novartis; Belvoir Media Group; Portola Pharmaceuticals; Boston Scientific Corporation; Bristol-Myers Squibb; Cleveland Clinic; Boehringer Ingelheim; American College of Cardiology Foundation; Sanofi; National Lipid Association; GlaxoSmithKline; Mayo Clinic; Merck; Servier; Abbott Laboratories; Bayer; National Institute for Health and Care Research; CSL Behring; Pfizer; Icahn School of Medicine at Mount Sinai; Eli Lilly and Company; Amarin Corporation; Genentech; AstraZeneca; Roche; Flatiron Health; Duke Clinical Research Institute; Astellas Pharma US; Amgen; Regeneron Pharmaceuticals; American Heart Association","keywords":"Medicine; Alirocumab; Acute coronary syndrome; Diabetes mellitus; Internal medicine; Metabolic syndrome; Randomized controlled trial; MEDLINE; Cardiology; Myocardial infarction; Cholesterol; Endocrinology; Total cholesterol","score_opus":0.00810748051552855,"score_gpt":0.24004475415659474,"score_spread":0.2319372736410662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954453953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97070426,0.021872103,0.0008182341,0.0008887033,0.0008113936,0.00087184086,0.0016376282,0.000098888704,0.002296906],"genre_scores_gemma":[0.99155325,0.0036771325,0.0006891116,0.0008850221,0.00047535528,0.00063599256,0.0009757676,0.000019135325,0.0010891227],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99806374,0.0011120095,0.0001683504,0.00030535064,0.00011468135,0.00023580641],"domain_scores_gemma":[0.9980349,0.0008150531,0.00055073184,0.00020638858,0.00010006995,0.0002929342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025664698,0.002111376,0.005707209,0.00040222594,0.00052265555,0.0016652144,0.00085688557,0.0015854435,0.0044374503],"category_scores_gemma":[0.0044598756,0.00079239823,0.0057219397,0.00046363042,0.0012009025,0.001437847,0.0010426998,0.0031832836,0.00039754744],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9838171,0.0003977771,0.0018003751,0.0013262808,0.007140424,0.000032983797,0.000034427987,0.00016900101,0.00040481004,0.000100479025,0.0003908693,0.004385528],"study_design_scores_gemma":[0.9695705,0.007987384,0.010206531,0.0001464509,0.010661238,0.00003695774,0.00004541451,0.00039035824,0.00015229297,0.00027971985,0.0004906744,0.000032291326],"about_ca_topic_score_codex":0.002562869,"about_ca_topic_score_gemma":0.0047251703,"teacher_disagreement_score":0.005707209,"about_ca_system_score_codex":0.00090599793,"about_ca_system_score_gemma":0.0008216626,"threshold_uncertainty_score":0.014844716},"labels":[],"label_agreement":null},{"id":"W2961683851","doi":"10.1016/s2213-8587(19)30084-1","title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiovascular Disease and Adiposity","field":"Medicine","cited_by":1508,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Queen's University","funders":"Novo Nordisk; California Walnut Commission; Eli Lilly and Company; Université Laval; International Atherosclerosis Society; AstraZeneca; International Chair on Cardiometabolic Risk; Amgen","keywords":"Medicine; Obesity; Disease; Epidemiology; Diabetes mellitus; Adipose tissue; Metabolic syndrome; Public health; Internal medicine; Intensive care medicine; Pathology; Endocrinology","score_opus":0.05889242315486752,"score_gpt":0.33075468401668245,"score_spread":0.2718622608618149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2961683851","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027584025,0.9787375,0.000059657228,0.0125793945,0.008106932,0.000003063106,0.00003934684,0.0000065280296,0.00044007468],"genre_scores_gemma":[0.0002788538,0.97754914,0.00014413519,0.008966913,0.012216607,0.0000090985195,0.000048835023,0.0000033913907,0.0007830365],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990163,0.00017488321,0.00013486814,0.00016283042,0.00040658505,0.00010462791],"domain_scores_gemma":[0.9958954,0.0021480718,0.0004751202,0.00008101737,0.00092429365,0.0004762021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040150136,0.0016862537,0.0036164736,0.0024521064,0.00063871307,0.0034605004,0.0022554928,0.0069248457,0.0066145845],"category_scores_gemma":[0.004750168,0.00058857957,0.0015624348,0.0033303592,0.0016439039,0.005398426,0.003082933,0.010154937,0.0042212903],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021109456,0.00006729926,0.00025531763,0.014278113,0.0003002995,0.00018955383,0.00007911887,0.00020886805,0.00056945113,0.009172858,0.5240103,0.45065776],"study_design_scores_gemma":[0.00011089212,0.00007752076,0.000645113,0.0094454065,0.00030492616,0.0003478657,0.00009149661,0.00007327991,0.00005732831,0.004550249,0.98426276,0.000033068613],"about_ca_topic_score_codex":0.0028146089,"about_ca_topic_score_gemma":0.0058009676,"teacher_disagreement_score":0.0069248457,"about_ca_system_score_codex":0.0013205493,"about_ca_system_score_gemma":0.0059114583,"threshold_uncertainty_score":0.022128046},"labels":[],"label_agreement":null},{"id":"W2969734794","doi":"10.1016/s2213-8587(19)30156-1","title":"Practical definitions of severe versus familial hypercholesterolaemia and hypertriglyceridaemia for adult clinical practice","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Toronto","funders":"","keywords":"Medicine; Hypertriglyceridemia; Cholesterol; Triglyceride; Internal medicine; Intensive care medicine; Bioinformatics; Pediatrics","score_opus":0.2661569581946629,"score_gpt":0.4552828823409667,"score_spread":0.1891259241463038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2969734794","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004884702,0.9950132,0.000293331,0.0028726982,0.0011668858,0.000010286841,0.000028512657,0.000007644887,0.00055861316],"genre_scores_gemma":[0.0020459155,0.98450816,0.0023147305,0.0073232055,0.0029176865,0.0000750306,0.00013110653,0.000008874957,0.00067535916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965243,0.0011758109,0.0011668778,0.00035903667,0.000624484,0.00014945224],"domain_scores_gemma":[0.9932429,0.004316148,0.0011460376,0.0001459801,0.00090477016,0.00024422692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006766027,0.0018786856,0.005287352,0.005303658,0.0005827372,0.003298797,0.0018952081,0.0036292558,0.005030063],"category_scores_gemma":[0.013071468,0.0007245996,0.0017672081,0.00393571,0.003221613,0.003444706,0.0029560036,0.0065630553,0.0021082659],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021992427,0.000051456227,0.0004555577,0.051533997,0.00039395053,0.00016214143,0.00025119784,0.00021126325,0.00035139796,0.018747091,0.07702266,0.8505994],"study_design_scores_gemma":[0.000335492,0.00017465388,0.0024807677,0.09354364,0.0013369358,0.0013806196,0.0004954866,0.00030990186,0.00016948678,0.022632807,0.8770391,0.000101126745],"about_ca_topic_score_codex":0.0027422027,"about_ca_topic_score_gemma":0.0059955535,"teacher_disagreement_score":0.006766027,"about_ca_system_score_codex":0.002482155,"about_ca_system_score_gemma":0.0043130843,"threshold_uncertainty_score":0.035782576},"labels":[],"label_agreement":null},{"id":"W2971414122","doi":"10.1016/s2213-8587(19)30256-6","title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":870,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"AstraZeneca; National Health and Medical Research Council; Verily Life Sciences; Medical Research Council; Bristol-Myers Squibb; Akebia Therapeutics; Gilead Sciences; Servier; Relypsa; Astellas Pharma; University of New South Wales; University of Oxford; MyoKardia; Novo Nordisk; ZOLL Medical Corporation; Janssen Pharmaceuticals; Ablynx; Sanofi; GlaxoSmithKline; Eli Lilly and Company; Boehringer Ingelheim; Amgen; Pfizer; Brigham and Women's Hospital","keywords":"Medicine; Empagliflozin; Albuminuria; Meta-analysis; Kidney disease; Dialysis; Kidney transplantation; Internal medicine; Renal function; Intensive care medicine; Diabetes mellitus; Type 2 diabetes; Transplantation; Endocrinology","score_opus":0.058367977203398036,"score_gpt":0.3210231811762127,"score_spread":0.26265520397281467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971414122","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023638124,0.99669254,0.0002210217,0.00010078046,0.000146861,0.00008244199,0.0002346447,0.00001704912,0.00014076217],"genre_scores_gemma":[0.06623428,0.9309627,0.0009548815,0.00078550115,0.00024145324,0.00019152145,0.00033343464,0.000016633778,0.00027950818],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99734783,0.0009573775,0.0008335286,0.00035890617,0.00035014385,0.00015219211],"domain_scores_gemma":[0.99472165,0.0037367197,0.0009668872,0.00015568188,0.00031318018,0.000105899664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046841227,0.0022993376,0.01665433,0.0029662042,0.0004150516,0.0022425489,0.0017367259,0.001968982,0.0041319546],"category_scores_gemma":[0.0108598955,0.0012522556,0.024955135,0.003897843,0.000508127,0.0014416869,0.001309854,0.0024308087,0.00035481044],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037014217,0.00005343131,0.0021805651,0.4201721,0.547005,0.00011848977,0.00006826373,0.00044798118,0.00029323678,0.00013499951,0.0012499252,0.024574567],"study_design_scores_gemma":[0.0012330004,0.00020625893,0.0028164359,0.019262915,0.9742278,0.000072548835,0.00003698823,0.00013916437,0.00008705239,0.00016819536,0.0017215805,0.000028171517],"about_ca_topic_score_codex":0.0073996265,"about_ca_topic_score_gemma":0.019498488,"teacher_disagreement_score":0.01665433,"about_ca_system_score_codex":0.0014281649,"about_ca_system_score_gemma":0.0021249743,"threshold_uncertainty_score":0.024772286},"labels":[],"label_agreement":null},{"id":"W2972257966","doi":"10.1016/s2213-8587(19)30253-0","title":"Diabetic kidney disease 2.0: the treatment paradigm shifts","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Medicine; Albuminuria; Renal function; Dialysis; Kidney disease; Diabetes mellitus; Type 2 diabetes; Intensive care medicine; Acute kidney injury; Kidney; Kidney transplantation; Disease; Internal medicine; Urology; Diabetic nephropathy; Endocrinology","score_opus":0.02738031076867474,"score_gpt":0.26593630356204073,"score_spread":0.23855599279336598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972257966","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006591807,0.0018193718,0.000041041018,0.9879711,0.008727533,0.000002516281,0.000021875103,0.000013260584,0.0013373469],"genre_scores_gemma":[0.00096757,0.0017487344,0.000105916595,0.952583,0.042666253,0.000012412386,0.000017592063,0.00001492942,0.0018836308],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917612,0.0024584495,0.0008555097,0.00081497064,0.0030266393,0.0010832462],"domain_scores_gemma":[0.979345,0.0116662765,0.0011211996,0.0004934002,0.0027314026,0.0046426184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009617946,0.0013403549,0.002466732,0.0015475036,0.004809691,0.007237281,0.002573906,0.06989376,0.021373838],"category_scores_gemma":[0.036108818,0.00092509965,0.0023297179,0.0012266126,0.006694769,0.009937924,0.0038063377,0.05979659,0.015277511],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006569809,0.000038652277,0.00022879729,0.00009140347,0.000011339813,0.00047820437,0.00007617726,0.000049438808,0.00012650578,0.0058723874,0.97706157,0.015899768],"study_design_scores_gemma":[0.00023302999,0.00008422902,0.0010685168,0.0008317055,0.000029856754,0.0013050238,0.00039550776,0.00046786357,0.00010769737,0.029058015,0.96633554,0.00008304647],"about_ca_topic_score_codex":0.009745414,"about_ca_topic_score_gemma":0.015979324,"teacher_disagreement_score":0.06989376,"about_ca_system_score_codex":0.008364768,"about_ca_system_score_gemma":0.008494897,"threshold_uncertainty_score":0.071502626},"labels":[],"label_agreement":null},{"id":"W2978430228","doi":"10.1016/s2213-8587(19)30264-5","title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Western University","funders":"Janssen Pharmaceuticals; Silence Therapeutics; Akebia Therapeutics; Eli Lilly and Company; Lundbeckfonden; Novartis; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Novo Nordisk; Daiichi-Sankyo; Medicines Company; Ionis Pharmaceuticals; Institut de Cardiologie de Montréal; AstraZeneca; REGENXBIO; Regeneron Pharmaceuticals; Amgen; Boehringer Ingelheim; Unilever; European Commission; Meso Scale Diagnostics; European Atherosclerosis Society; Sanofi; MedImmune; HLS Therapeutics; GlaxoSmithKline; Merck; Pfizer","keywords":"Medicine; Task force; Intensive care medicine; Family medicine","score_opus":0.06134634696561439,"score_gpt":0.31501951223427677,"score_spread":0.25367316526866235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978430228","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008587165,0.99136376,0.0004315103,0.0060294876,0.0013803635,0.00001744512,0.00010469368,0.000015519858,0.0005712373],"genre_scores_gemma":[0.0006586694,0.99224114,0.0010799654,0.0039767404,0.0012199017,0.00004307499,0.00023873644,0.0000063376333,0.00053539046],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99839383,0.0003506818,0.00046084292,0.00020409617,0.000489379,0.00010107936],"domain_scores_gemma":[0.9959954,0.0022911604,0.00056478597,0.00007418795,0.0008706089,0.00020380557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061083273,0.0012695065,0.0046930946,0.0028295454,0.0003464192,0.0020431478,0.002177646,0.0035124295,0.002772745],"category_scores_gemma":[0.0056200796,0.0004996967,0.0020427075,0.0020669037,0.0007910158,0.0018900081,0.0016972666,0.00435515,0.0016834491],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019962247,0.00007310885,0.00049462006,0.033416085,0.0005674147,0.00027768567,0.00008083318,0.0003637287,0.0006205801,0.005083707,0.13063309,0.8281895],"study_design_scores_gemma":[0.00026658183,0.00010638677,0.0020505786,0.061810866,0.0016389732,0.0014166253,0.00012449373,0.0002411278,0.00025518815,0.00444582,0.9275832,0.000060102106],"about_ca_topic_score_codex":0.0027552524,"about_ca_topic_score_gemma":0.0052524223,"teacher_disagreement_score":0.0061083273,"about_ca_system_score_codex":0.0013449603,"about_ca_system_score_gemma":0.0051648268,"threshold_uncertainty_score":0.032304287},"labels":[],"label_agreement":null},{"id":"W2989883260","doi":"10.1016/s2213-8587(19)30382-1","title":"Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Institutes of Health","keywords":"Medicine; Pharmacovigilance; Anaphylactic reactions; Pharmacology; Glucagon; Anaphylaxis; Allergy; Drug; Internal medicine; Immunology; Insulin","score_opus":0.026838217049605005,"score_gpt":0.28738247348020185,"score_spread":0.26054425643059687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989883260","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009867769,0.008587381,0.0004921269,0.9670032,0.007987821,0.000020917894,0.00038916612,0.00004248879,0.005608967],"genre_scores_gemma":[0.12578256,0.008336537,0.0009740447,0.8034353,0.057943296,0.000058137488,0.00037613447,0.000063137086,0.003030888],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9941672,0.0025592498,0.0009514019,0.0004546546,0.0014198143,0.00044759706],"domain_scores_gemma":[0.9674292,0.021760529,0.00375868,0.0006755904,0.0046009775,0.0017749415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051375222,0.00060467306,0.0011073754,0.0018647185,0.0010908007,0.00311272,0.00082328846,0.012878773,0.0031992428],"category_scores_gemma":[0.03378255,0.00053833623,0.0017003047,0.002299083,0.00091815466,0.001598783,0.0008096139,0.008674026,0.0015441887],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018244503,0.00020166724,0.08070838,0.0004671452,0.0011692956,0.018875,0.00039807,0.0004505653,0.00075857266,0.0035657217,0.83002955,0.061551612],"study_design_scores_gemma":[0.0047624274,0.0010902745,0.21542804,0.006907067,0.0056209266,0.062262766,0.0027797995,0.01331485,0.0017489059,0.040148277,0.6453879,0.0005487737],"about_ca_topic_score_codex":0.005446973,"about_ca_topic_score_gemma":0.0074007055,"teacher_disagreement_score":0.012878773,"about_ca_system_score_codex":0.0035993764,"about_ca_system_score_gemma":0.002614383,"threshold_uncertainty_score":0.027170122},"labels":[],"label_agreement":null},{"id":"W2990517472","doi":"10.1016/s2213-8587(19)30351-1","title":"Physical activity and skeletal health in adults","year":2019,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Medicine; Observational study; Randomized controlled trial; Physical therapy; Hip fracture; Psychological intervention; Bone health; Physical activity; Balance (ability); Physical medicine and rehabilitation; Meta-analysis; Osteoporosis; Bone mineral; Internal medicine; Psychiatry","score_opus":0.07743467410875322,"score_gpt":0.4155452207863193,"score_spread":0.33811054667756607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2990517472","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052952397,0.999302,0.000015394413,0.00020516645,0.00020756609,0.000003047906,0.000042686795,0.0000029331866,0.00016820326],"genre_scores_gemma":[0.0006211477,0.9984353,0.000054081007,0.0003933796,0.00026294778,0.000007414282,0.000040606676,9.065375e-7,0.00018417965],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999491,0.00008505217,0.00012547152,0.00008757678,0.00016616347,0.000044725577],"domain_scores_gemma":[0.99904865,0.0005734055,0.00020840135,0.00001793715,0.00010191504,0.00004963632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011388388,0.0012750961,0.0043448815,0.0027706244,0.00020906639,0.0013364543,0.0010276561,0.0017211443,0.007959691],"category_scores_gemma":[0.0021829908,0.000577155,0.0020460035,0.00368896,0.00046283804,0.000840305,0.0010746517,0.0023366716,0.0016537076],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045881706,0.000107153144,0.00081653433,0.11160566,0.0021787793,0.00007243378,0.000049525544,0.00017753209,0.00023961428,0.0010717501,0.0400778,0.8431445],"study_design_scores_gemma":[0.0011248175,0.00071240024,0.02433896,0.16678908,0.013663666,0.0008702951,0.0002732596,0.0003201869,0.00022391969,0.004083142,0.78748935,0.000110962734],"about_ca_topic_score_codex":0.008283145,"about_ca_topic_score_gemma":0.01865024,"teacher_disagreement_score":0.008283145,"about_ca_system_score_codex":0.00087891374,"about_ca_system_score_gemma":0.0017266761,"threshold_uncertainty_score":0.026627839},"labels":[],"label_agreement":null},{"id":"W2995065776","doi":"10.1016/s2213-8587(19)30389-4","title":"LDL cholesterol: lower, faster, younger?","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Ezetimibe; Cholesterol; PCSK9; Internal medicine; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Clinical trial; Relative risk; Ldl cholesterol; Meta-analysis; Statin; Drug class; Endocrinology; Drug; Pharmacology; Confidence interval; Lipoprotein; LDL receptor","score_opus":0.029746175073489114,"score_gpt":0.27137853520218747,"score_spread":0.24163236012869835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995065776","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002939073,0.0015957633,0.00003276836,0.97696066,0.019603971,0.000004953306,0.00006222138,0.00001648649,0.001429239],"genre_scores_gemma":[0.0018749725,0.001387835,0.0001066946,0.9398345,0.052598823,0.000023595714,0.00003289352,0.000019547808,0.0041212165],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99712914,0.000736552,0.0003896538,0.0003735144,0.0008920583,0.00047910598],"domain_scores_gemma":[0.9937558,0.0026250405,0.00058167346,0.00017975859,0.0010125128,0.0018451569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032343594,0.0011346478,0.0020835507,0.00095624925,0.0033319294,0.0036078084,0.0010651306,0.041709833,0.012802216],"category_scores_gemma":[0.024830485,0.00078486075,0.0013712628,0.00087208784,0.0021697837,0.003914902,0.001363115,0.03858017,0.012101008],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105490886,0.000051750194,0.0014265751,0.0000739577,0.000019758887,0.0005968369,0.000073247706,0.000016405846,0.00019433668,0.0011110073,0.985732,0.010598636],"study_design_scores_gemma":[0.00064721855,0.00024097417,0.0065754335,0.0011160091,0.00013259186,0.0033444883,0.0010707247,0.00042432515,0.0003227529,0.011141593,0.9748438,0.00014003918],"about_ca_topic_score_codex":0.01031801,"about_ca_topic_score_gemma":0.014774681,"teacher_disagreement_score":0.041709833,"about_ca_system_score_codex":0.0034594645,"about_ca_system_score_gemma":0.0040720035,"threshold_uncertainty_score":0.042827666},"labels":[],"label_agreement":null},{"id":"W3000040775","doi":"10.1016/s2213-8587(19)30423-1","title":"The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; McMaster University; Population Health Research Institute; Hamilton Health Sciences","funders":"","keywords":"Dulaglutide; Medicine; Placebo; Stroke (engine); Modified Rankin Scale; Randomized controlled trial; Internal medicine; Diabetes mellitus; Clinical trial; Type 2 diabetes; Physical therapy; Exenatide; Ischemic stroke; Endocrinology; Alternative medicine","score_opus":0.029892093681518128,"score_gpt":0.28478468934896,"score_spread":0.2548925956674419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000040775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96563894,0.023828477,0.0010157909,0.0017530023,0.00059108785,0.0005611324,0.0025143537,0.00009924545,0.0039978987],"genre_scores_gemma":[0.98884237,0.0040014517,0.000944058,0.00110181,0.0006504955,0.00042278683,0.001862617,0.000052705414,0.0021217393],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.997168,0.0018129745,0.00015159602,0.00033903267,0.00017592592,0.00035253147],"domain_scores_gemma":[0.99616385,0.0020124584,0.0007632915,0.0005770615,0.00016350183,0.00031981862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044222097,0.0021927373,0.0051256423,0.00030870573,0.00040792665,0.0018551693,0.000940166,0.0015214512,0.0041843574],"category_scores_gemma":[0.0068580955,0.000608346,0.0057049957,0.0005194561,0.0010796346,0.0016871989,0.00076524523,0.0036643194,0.0007339022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95140463,0.00071558374,0.005545145,0.0021512099,0.019753179,0.00015804,0.00009162516,0.00081696594,0.0016385227,0.0006388506,0.001879545,0.015206678],"study_design_scores_gemma":[0.8206918,0.058355648,0.04775639,0.00092229125,0.05999442,0.00027386018,0.00041215128,0.0016694996,0.001242684,0.0031436156,0.0053480538,0.0001895077],"about_ca_topic_score_codex":0.0014587757,"about_ca_topic_score_gemma":0.0029143502,"teacher_disagreement_score":0.0051256423,"about_ca_system_score_codex":0.00071810023,"about_ca_system_score_gemma":0.0009278693,"threshold_uncertainty_score":0.023387134},"labels":[],"label_agreement":null},{"id":"W3010842324","doi":"10.1016/s2213-8587(20)30062-0","title":"Cardiorenal risk reduction guidance in diabetes: can we reach consensus?","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Boehringer Ingelheim","keywords":"Medicine; Guideline; Intensive care medicine; Diabetes mellitus; Consensus conference; MEDLINE; Evidence-based medicine; Alternative medicine; Internal medicine","score_opus":0.031881481092899636,"score_gpt":0.26590802918457024,"score_spread":0.23402654809167062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010842324","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042391967,0.18820843,0.0037680655,0.7856601,0.014450781,0.0000615554,0.00048017473,0.0002184646,0.0067285066],"genre_scores_gemma":[0.02028089,0.25795782,0.032938965,0.63217944,0.049681798,0.0007691406,0.001630467,0.00036855548,0.0041929903],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9683769,0.012859088,0.00591489,0.0028964286,0.007986019,0.0019668026],"domain_scores_gemma":[0.84400195,0.1004818,0.008231303,0.003477426,0.03371043,0.010097011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0566748,0.0029542588,0.009204294,0.004132743,0.0022390117,0.013470683,0.009806996,0.023941752,0.014170222],"category_scores_gemma":[0.14565486,0.0015647947,0.0065688128,0.0026505913,0.005286745,0.010693949,0.0077927336,0.04754678,0.006052537],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007562717,0.00058754545,0.0017841957,0.013338005,0.0017280472,0.00020100638,0.0009833864,0.002106139,0.00026896034,0.038603008,0.6141485,0.32549492],"study_design_scores_gemma":[0.0020647133,0.00036657092,0.0038703468,0.09744648,0.0026799778,0.00026264272,0.0013300969,0.0017814363,0.00034172044,0.12876748,0.7607739,0.00031465275],"about_ca_topic_score_codex":0.020817691,"about_ca_topic_score_gemma":0.0296292,"teacher_disagreement_score":0.0566748,"about_ca_system_score_codex":0.0067622145,"about_ca_system_score_gemma":0.025998114,"threshold_uncertainty_score":0.2997285},"labels":[],"label_agreement":null},{"id":"W3011403229","doi":"10.1016/s2213-8587(20)30105-4","title":"Insulin access and affordability in the USA: anticipating the first interchangeable insulin product","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institutes of Health; Arnold Ventures","keywords":"Medicine; Insulin; Diabetic ketoacidosis; Diabetes mellitus; Insulin delivery; Quarter (Canadian coin); Scopus; Ketoacidosis; Intensive care medicine; MEDLINE; Internal medicine; Endocrinology; Type 1 diabetes","score_opus":0.20502484247822503,"score_gpt":0.40062188686824285,"score_spread":0.19559704439001782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3011403229","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06344902,0.029398149,0.00094134104,0.88182014,0.006234415,0.000021022744,0.0013751809,0.000036018795,0.016724598],"genre_scores_gemma":[0.647543,0.07255464,0.004405146,0.2556441,0.013170364,0.00006272593,0.0016661535,0.00006371638,0.004890139],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99855965,0.00036352934,0.00016717686,0.00013097395,0.00045623325,0.0003224561],"domain_scores_gemma":[0.98323303,0.008026367,0.0031972053,0.00018414811,0.0022262372,0.0031331058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003923045,0.00025997468,0.00042492713,0.00074920297,0.00064743933,0.003816087,0.000634327,0.00539621,0.006599768],"category_scores_gemma":[0.022903897,0.0003031595,0.00086119317,0.0012172027,0.00092595327,0.0045560575,0.0012291045,0.010036144,0.00051938236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017958739,0.0013888539,0.17859878,0.0014594092,0.0003294205,0.0018208192,0.0019344897,0.002589213,0.0013892049,0.039748635,0.49187526,0.27707008],"study_design_scores_gemma":[0.00048045305,0.0015072068,0.29419488,0.007779652,0.000852028,0.0017084404,0.012612769,0.011158018,0.0021665932,0.08209097,0.5850461,0.0004028203],"about_ca_topic_score_codex":0.06587901,"about_ca_topic_score_gemma":0.14403069,"teacher_disagreement_score":0.06587901,"about_ca_system_score_codex":0.003272001,"about_ca_system_score_gemma":0.008812296,"threshold_uncertainty_score":0.1309911},"labels":[],"label_agreement":null},{"id":"W3019508129","doi":"10.1016/s2213-8587(20)30038-3","title":"Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials","year":2020,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Western University; St. Michael's Hospital; Canadian VIGOUR Centre; University of Alberta; University Health Network; University of Toronto; Women's College Hospital","funders":"Women's College Research Institute; University of Toronto; Heart and Stroke Foundation of Canada","keywords":"Medicine; Meta-analysis; Mace; Myocardial infarction; Type 2 diabetes; Heart failure; Internal medicine; Diabetes mellitus; Relative risk; Randomized controlled trial; Clinical trial; Stroke (engine); MEDLINE; Intensive care medicine; Confidence interval; Percutaneous coronary intervention; Endocrinology","score_opus":0.08404563886580996,"score_gpt":0.3274024658709334,"score_spread":0.24335682700512345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019508129","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013501311,0.9976515,0.00022076309,0.00013535513,0.00013279423,0.000078632904,0.00029454724,0.000017461227,0.000118817436],"genre_scores_gemma":[0.035596788,0.96078336,0.0013892401,0.0010652659,0.0002114706,0.00025065403,0.0004685979,0.00001875847,0.00021587522],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9954626,0.0017874443,0.0014512562,0.0004957987,0.0005986207,0.00020425522],"domain_scores_gemma":[0.9907952,0.0066768737,0.0016751428,0.00023690767,0.0004620608,0.00015375792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076904744,0.0021553072,0.016057668,0.003833736,0.00035782313,0.0024658965,0.0017819182,0.00205624,0.003832347],"category_scores_gemma":[0.018541358,0.001329784,0.01981248,0.0046479967,0.00054656476,0.001598649,0.0016452725,0.0024942944,0.0003804169],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028772042,0.000039110557,0.0022887178,0.5146986,0.43683153,0.00009944547,0.0000858893,0.00036156247,0.00029464997,0.0002199306,0.0022831704,0.039920043],"study_design_scores_gemma":[0.0024037191,0.00021077687,0.0044891564,0.038988095,0.9481579,0.00012144216,0.000063189116,0.00013297588,0.000105970714,0.0003908155,0.0048928615,0.000043118198],"about_ca_topic_score_codex":0.007807299,"about_ca_topic_score_gemma":0.02200278,"teacher_disagreement_score":0.016057668,"about_ca_system_score_codex":0.0019457522,"about_ca_system_score_gemma":0.0029741004,"threshold_uncertainty_score":0.040671587},"labels":[],"label_agreement":null},{"id":"W3028550899","doi":"10.1016/s2213-8587(20)30114-5","title":"Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; LMC Diabetes & Endocrinology (Canada)","funders":"Boehringer Ingelheim; Gilead Sciences; Medtronic; Novo Nordisk; Merck; Janssen Pharmaceuticals; Bayer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Insulin pump; Insulin degludec; Insulin; Regimen; Type 1 diabetes; Diabetes mellitus; Type 2 diabetes; Hypoglycemia; Crossover study; Internal medicine; Physical therapy; Endocrinology; Insulin glargine; Placebo","score_opus":0.03800815549740619,"score_gpt":0.28292218559548576,"score_spread":0.24491403009807958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028550899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990399,0.004216756,0.0008633425,0.00030355318,0.0007761643,0.0018660794,0.0005307984,0.00009773715,0.00094661827],"genre_scores_gemma":[0.98839986,0.0026245494,0.0025116706,0.00083148887,0.00069534616,0.0026504935,0.00067746715,0.000026251724,0.0015830057],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990741,0.00033789597,0.00008383644,0.00025628126,0.000074806565,0.00017306411],"domain_scores_gemma":[0.99918014,0.0002265528,0.00017604268,0.00010550525,0.00004543453,0.00026635375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018160699,0.0021658198,0.005178421,0.00058131706,0.00049803837,0.0018145699,0.0011487528,0.0023795338,0.0065866043],"category_scores_gemma":[0.001609659,0.0009288308,0.0032068049,0.0006319667,0.0017781436,0.0020845116,0.00088101916,0.0037241443,0.0011639949],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9843173,0.005740097,0.00025050872,0.00039086852,0.00071440305,0.000017373335,0.000034832516,0.00013279216,0.0010563339,0.000050099974,0.00013012851,0.007165309],"study_design_scores_gemma":[0.9215311,0.076469585,0.0010419742,0.000036956535,0.00032425762,0.000016341972,0.000026212881,0.00017489953,0.000145252,0.00007217654,0.00014550572,0.00001576089],"about_ca_topic_score_codex":0.0011033088,"about_ca_topic_score_gemma":0.0013386842,"teacher_disagreement_score":0.0065866043,"about_ca_system_score_codex":0.00076570915,"about_ca_system_score_gemma":0.00065227016,"threshold_uncertainty_score":0.022034407},"labels":[],"label_agreement":null},{"id":"W3034389083","doi":"10.1016/s2213-8587(20)30153-4","title":"Disease characteristics of MCT8 deficiency: an international, retrospective, multicentre cohort study","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Thyroid Disorders and Treatments","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"ZonMw; National Institute for Health and Care Research; Wellcome Trust","keywords":"Medicine; Retrospective cohort study; Pediatrics; Cohort; Internal medicine; Newborn screening; Cohort study; Underweight; Body mass index","score_opus":0.0262587116503348,"score_gpt":0.2924348689762644,"score_spread":0.26617615732592964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034389083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99856585,0.00026315424,0.000120260054,0.00003453344,0.000007983441,0.0000097038965,0.00075855886,0.000003277404,0.00023667232],"genre_scores_gemma":[0.99883014,0.00013079832,0.00011868731,0.000041087747,0.000010047566,0.000014672477,0.0007184508,0.000003957342,0.00013221674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99927324,0.00016365173,0.00006592747,0.00029004738,0.0000713024,0.000135809],"domain_scores_gemma":[0.9987489,0.00015630008,0.00049117114,0.00025013083,0.00011229854,0.00024129105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081325154,0.0005700828,0.00061948225,0.0006363167,0.0006491981,0.00097208266,0.0006972948,0.0007721099,0.0015347454],"category_scores_gemma":[0.0015901468,0.0007098249,0.00078645017,0.0016711211,0.00047567315,0.0008396963,0.00087440235,0.0009428634,0.00032516694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004552748,0.000036513393,0.9977836,0.000012825734,0.00022318435,0.00019905365,0.00012307534,0.000037644444,0.00043813256,0.000033250963,0.00016650869,0.00049095764],"study_design_scores_gemma":[0.000032517062,0.00012079228,0.9986034,0.000008988509,0.00012395137,0.00052756903,0.000234321,0.000098023775,0.000033700242,0.000031621057,0.00017710331,0.000008052177],"about_ca_topic_score_codex":0.00821635,"about_ca_topic_score_gemma":0.007841753,"teacher_disagreement_score":0.00821635,"about_ca_system_score_codex":0.0004657433,"about_ca_system_score_gemma":0.0003856509,"threshold_uncertainty_score":0.016337037},"labels":[],"label_agreement":null},{"id":"W3034480710","doi":"10.1016/s2213-8587(20)30188-1","title":"Walking the path together: incorporating Indigenous knowledge in diabetes research","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Indigenous Health, Education, and Rights","field":"Social Sciences","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Children's Hospital Research Institute of Manitoba; Assembly of First Nations","funders":"National Health and Medical Research Council","keywords":"Indigenous; Colonisation; Government (linguistics); Poverty; Medicine; Indigenous culture; Economic growth; Socioeconomics; Gender studies; Geography; Sociology; Colonization","score_opus":0.07474282655997846,"score_gpt":0.3658740319269448,"score_spread":0.29113120536696635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034480710","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.076207235,0.10578544,0.027505198,0.7354096,0.0073247184,0.0006182451,0.00043632052,0.00015130056,0.046561953],"genre_scores_gemma":[0.7468203,0.10062991,0.06350128,0.07996732,0.00430469,0.0015723417,0.00024506796,0.00012729487,0.0028318104],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9115217,0.07459152,0.0027241244,0.0023549017,0.005445503,0.003362305],"domain_scores_gemma":[0.7280349,0.23495969,0.006074555,0.011078836,0.00997646,0.00987559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.15581381,0.00069735723,0.002730345,0.006239893,0.009071958,0.0140263,0.0038339787,0.0063667702,0.006027117],"category_scores_gemma":[0.19871451,0.0012056729,0.0016748146,0.005345028,0.02173213,0.032837182,0.02526843,0.014094253,0.0004406084],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025038014,0.0010164136,0.015847707,0.010582414,0.0012227857,0.00039363888,0.33752486,0.0008241616,0.00048958,0.07612028,0.027411683,0.528316],"study_design_scores_gemma":[0.0002919407,0.00065572246,0.016223086,0.038412936,0.0015239725,0.00021621205,0.19456515,0.001012996,0.0006774141,0.6209278,0.12515639,0.00033640838],"about_ca_topic_score_codex":0.03515755,"about_ca_topic_score_gemma":0.07194671,"teacher_disagreement_score":0.15581381,"about_ca_system_score_codex":0.008078661,"about_ca_system_score_gemma":0.053855684,"threshold_uncertainty_score":0.82403207},"labels":[],"label_agreement":null},{"id":"W3035452648","doi":"10.1016/s2213-8587(20)30187-x","title":"Patient data from routinely collected medical records complement evidence from SGLT2 inhibitor outcome trials","year":2020,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"Boehringer Ingelheim; Novo Nordisk; Abbott Laboratories; Sanofi; Merck; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company","keywords":"Canagliflozin; Dapagliflozin; Empagliflozin; Medicine; Type 2 diabetes; Drug class; Diabetes mellitus; Clinical trial; Internal medicine; Glycemic; Pharmacology; Intensive care medicine; Endocrinology; Drug","score_opus":0.23551056235457685,"score_gpt":0.3721536130965929,"score_spread":0.13664305074201605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035452648","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008352278,0.023318404,0.00069917593,0.9376388,0.014074812,0.000055463257,0.0068776174,0.00006784052,0.008915555],"genre_scores_gemma":[0.0692882,0.01812087,0.003595766,0.83492213,0.0660865,0.0002603458,0.004874192,0.00011502852,0.0027370022],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9357943,0.039166808,0.012600919,0.0021577303,0.0086960895,0.001584088],"domain_scores_gemma":[0.38073346,0.5317803,0.03379165,0.016178804,0.031598166,0.0059176497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05904769,0.0007500927,0.003149428,0.0041007586,0.0012157375,0.0077451034,0.0035395254,0.016418086,0.006921616],"category_scores_gemma":[0.32255065,0.0011220996,0.002252099,0.007709529,0.0026679768,0.0063135806,0.0035915372,0.014450691,0.0053540245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003078898,0.00018463533,0.06252976,0.0029228074,0.0023494894,0.0015264648,0.0005150699,0.00024397211,0.00024402309,0.006464849,0.8045955,0.11534449],"study_design_scores_gemma":[0.008650255,0.0009783974,0.12519784,0.021002773,0.0052351295,0.0035885952,0.0018601831,0.002107942,0.00080653955,0.082805336,0.7472499,0.00051707437],"about_ca_topic_score_codex":0.0042108987,"about_ca_topic_score_gemma":0.01027926,"teacher_disagreement_score":0.05904769,"about_ca_system_score_codex":0.0025648251,"about_ca_system_score_gemma":0.005287392,"threshold_uncertainty_score":0.31227773},"labels":[],"label_agreement":null},{"id":"W3035468154","doi":"10.1016/s2213-8587(20)30162-5","title":"Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":274,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University Health Network; University of Toronto","funders":"Novo Nordisk; Diabetes Australia Research Trust; Rijksuniversiteit Groningen; AstraZeneca","keywords":"Medicine; Dapagliflozin; Kidney disease; Renal function; Proteinuria; Albuminuria; Placebo; Diabetes mellitus; Internal medicine; Crossover study; Type 2 diabetes; Urology; Randomized controlled trial; Kidney; Endocrinology; Pathology","score_opus":0.01359334487993476,"score_gpt":0.24622368326784044,"score_spread":0.23263033838790567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035468154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869069,0.0063701505,0.0006030153,0.00067202357,0.0011553639,0.001594926,0.00081710337,0.00011591842,0.0017645756],"genre_scores_gemma":[0.98767567,0.0035905368,0.0013150326,0.0011285025,0.00080435677,0.0020114153,0.0008790141,0.000023081686,0.0025723097],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992786,0.0003259171,0.00005909675,0.00016060808,0.000050895047,0.00012499202],"domain_scores_gemma":[0.99893874,0.00039586026,0.00018921247,0.00009399457,0.00006309805,0.00031907007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019567898,0.001964349,0.005212641,0.00041293507,0.00049104245,0.0013117616,0.00093724765,0.0023126637,0.0063925963],"category_scores_gemma":[0.0022020284,0.0009232554,0.0026114078,0.00045700173,0.001269197,0.0013055737,0.0006355952,0.0030528582,0.00084638305],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99357164,0.0014812596,0.00019203879,0.00035038462,0.0005147821,0.000013125672,0.000018153496,0.00006394194,0.0004975175,0.000037826547,0.00022002726,0.0030393878],"study_design_scores_gemma":[0.98371786,0.014865995,0.00069858646,0.00001735009,0.00034224818,0.000007755046,0.000008334522,0.00009718584,0.0000669958,0.00004422586,0.00012665334,0.0000067656783],"about_ca_topic_score_codex":0.0014655036,"about_ca_topic_score_gemma":0.0019827168,"teacher_disagreement_score":0.0063925963,"about_ca_system_score_codex":0.0007345942,"about_ca_system_score_gemma":0.0008441118,"threshold_uncertainty_score":0.021385372},"labels":[],"label_agreement":null},{"id":"W3035689851","doi":"10.1016/s2213-8587(20)30130-3","title":"Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":93,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Vifor Pharma; Amarin Corporation; Novo Nordisk; Steno Diabetes Center Copenhagen; Sanofi; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; GlaxoSmithKline","keywords":"Medicine; Cohort study; Cohort; Multinational corporation; Internal medicine; Pharmacology","score_opus":0.02227324117206337,"score_gpt":0.25364194466514184,"score_spread":0.23136870349307848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035689851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935055,0.0019505871,0.00020343145,0.00014059337,0.00008005232,0.00002353913,0.003664615,0.000021399701,0.00041020356],"genre_scores_gemma":[0.99374676,0.0006685466,0.00030997046,0.00014645,0.00015654774,0.00006158531,0.0039648023,0.000030177192,0.00091525743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99769384,0.00084783335,0.00018827853,0.00072185794,0.00020176754,0.0003465088],"domain_scores_gemma":[0.99622405,0.00069314195,0.0011985926,0.0009147241,0.0002147868,0.0007545787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030881444,0.0015346484,0.0023485795,0.0009482774,0.00060785166,0.0019268566,0.001538533,0.0019320805,0.0024520562],"category_scores_gemma":[0.0030874806,0.0019234822,0.006982669,0.002209527,0.00051473355,0.0010114879,0.0013758295,0.0030856028,0.00038017146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022200394,0.0002801309,0.9656889,0.00009947783,0.007810443,0.00021011029,0.000097541284,0.00037782252,0.0009919571,0.00006764656,0.0006836173,0.0014919697],"study_design_scores_gemma":[0.00096598256,0.00070083904,0.9941042,0.000018323462,0.0028185963,0.00011662947,0.00012595496,0.00069669605,0.00009912535,0.00005235768,0.00027066085,0.000030647683],"about_ca_topic_score_codex":0.016871389,"about_ca_topic_score_gemma":0.015643334,"teacher_disagreement_score":0.016871389,"about_ca_system_score_codex":0.0006474819,"about_ca_system_score_gemma":0.00076568546,"threshold_uncertainty_score":0.03354639},"labels":[],"label_agreement":null},{"id":"W3044765479","doi":"10.1016/s2213-8587(20)30240-0","title":"Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Novartis Pharma; Novartis Pharmaceuticals Corporation; Novartis","keywords":"Medicine; Cushing's disease; Internal medicine; Clinical trial; Gastroenterology; Surgery; Disease","score_opus":0.020525549475121814,"score_gpt":0.2898927121754603,"score_spread":0.2693671627003385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044765479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889621,0.0034739044,0.0008635101,0.0004639605,0.0002998724,0.00314769,0.0013223516,0.00016051212,0.0013060119],"genre_scores_gemma":[0.9845083,0.0022097798,0.0024371445,0.0014182981,0.00045430858,0.004301791,0.0020532643,0.00008486634,0.0025323376],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99884546,0.00057220436,0.00007064578,0.00016655798,0.000099108816,0.0002461098],"domain_scores_gemma":[0.99817777,0.0004838333,0.0003546085,0.00019689061,0.00009396741,0.0006929301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032487416,0.0020041391,0.0034819199,0.0006595527,0.0008259081,0.0016134459,0.001412232,0.0027298995,0.006946627],"category_scores_gemma":[0.0018994586,0.0008952125,0.003468122,0.0007883079,0.0027229928,0.0018235216,0.0006350411,0.0043519917,0.0012533547],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97381306,0.009571166,0.0006669009,0.00030129406,0.00048826027,0.000031040978,0.000096364965,0.00020684229,0.0032671385,0.00007184706,0.0005290816,0.010956874],"study_design_scores_gemma":[0.91028106,0.086900085,0.0018054125,0.000013187696,0.00018229688,0.000020150032,0.000023757966,0.00011569,0.00032542375,0.000053399173,0.00026409724,0.000015398628],"about_ca_topic_score_codex":0.002282081,"about_ca_topic_score_gemma":0.004215616,"teacher_disagreement_score":0.006946627,"about_ca_system_score_codex":0.001194086,"about_ca_system_score_gemma":0.0024328781,"threshold_uncertainty_score":0.023238778},"labels":[],"label_agreement":null},{"id":"W3085210273","doi":"10.1016/s2213-8587(20)30310-7","title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Dalhousie University; McMaster University; University of Alberta; Alberta Children's Hospital; Sunnybrook Health Science Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; University of Calgary; University Health Network; Health Sciences Centre; Sunnybrook Hospital; University of Toronto","funders":"Roche Diabetes Care; University of Toronto; Department of Medicine, University of Toronto; Novo Nordisk; Canadian Institutes of Health Research; National Institute for Health and Care Research; Sunnybrook Research Institute; Medtronic","keywords":"Medicine; Metformin; Type 2 diabetes; Pregnancy; Postprandial; Placebo; Regimen; Diabetes mellitus; Insulin; Internal medicine; Obstetrics; Endocrinology","score_opus":0.02742699541447207,"score_gpt":0.2904454808768105,"score_spread":0.2630184854623384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085210273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93821925,0.05055155,0.00078831625,0.0019486411,0.0019610946,0.0027146407,0.0010976254,0.00012291866,0.0025960063],"genre_scores_gemma":[0.97334653,0.016341988,0.0014845085,0.0018900419,0.00088074926,0.0028009806,0.0007286124,0.000020704874,0.002505873],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993352,0.0003702782,0.00005354705,0.00010995831,0.00004191108,0.00008910081],"domain_scores_gemma":[0.99925774,0.0002675851,0.00021735248,0.000051628347,0.000035163986,0.00017049343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017146636,0.001470121,0.0034010801,0.00036582028,0.00045618392,0.0010828107,0.0005766436,0.0024286348,0.0047629466],"category_scores_gemma":[0.0032281654,0.00062575564,0.002360358,0.0005138301,0.00076958037,0.00089755916,0.0006106377,0.0020655566,0.00044859707],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98369426,0.00089041615,0.00078852085,0.0019450535,0.0022736378,0.000054741944,0.000039956212,0.000092133545,0.0007518373,0.00008164083,0.000501844,0.008885969],"study_design_scores_gemma":[0.97947854,0.015061648,0.002564423,0.00017514023,0.0018610344,0.000041239997,0.00003058471,0.000105657586,0.00009622948,0.00008216105,0.00049117656,0.000012180549],"about_ca_topic_score_codex":0.0012150187,"about_ca_topic_score_gemma":0.0022749212,"teacher_disagreement_score":0.0047629466,"about_ca_system_score_codex":0.00057463744,"about_ca_system_score_gemma":0.000810794,"threshold_uncertainty_score":0.015933633},"labels":[],"label_agreement":null},{"id":"W3085703194","doi":"10.1016/s2213-8587(20)30230-8","title":"Diabetes in ageing: pathways for developing the evidence base for clinical guidance","year":2020,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute on Aging; National Institutes of Health; MannKind Corporation; Eisai; Insulet Corporation; Amarin Corporation; Novo Nordisk; Dexcom; Intarcia Therapeutics; Bigfoot Biomedical; Sanofi; Merck; GlaxoSmithKline; Takeda Pharmaceuticals U.S.A.; Pfizer; AstraZeneca; Eli Lilly and Company; National Institute of Diabetes and Digestive and Kidney Diseases; Boehringer Ingelheim; Leona M. and Harry B. Helmsley Charitable Trust; U.S. Department of Veterans Affairs","keywords":"Medicine; Life expectancy; Multidisciplinary approach; Comorbidity; Gerontology; MEDLINE; Diabetes mellitus; Health care; Multimorbidity; Geriatrics; Diabetes management; Type 2 diabetes; Psychiatry; Population","score_opus":0.3001917020371686,"score_gpt":0.4297795609243814,"score_spread":0.1295878588872128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3085703194","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003450347,0.9834659,0.00029000815,0.013506609,0.0017510526,0.000029608404,0.00007946594,0.00002181472,0.0008209002],"genre_scores_gemma":[0.0009864592,0.98474586,0.0019498708,0.0100194495,0.0016928385,0.00009065813,0.000116037816,0.000009891435,0.00038904254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99043185,0.0044243108,0.0016863459,0.00065784785,0.002252567,0.0005471339],"domain_scores_gemma":[0.93560237,0.049827386,0.005078759,0.00083199184,0.006541568,0.0021178948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024984807,0.0021550285,0.010643971,0.0069816248,0.000891864,0.008522694,0.0036034903,0.009703054,0.014434639],"category_scores_gemma":[0.046303585,0.0012061835,0.004096926,0.0066142366,0.0023937924,0.008172253,0.004762899,0.011403138,0.0036896525],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042195685,0.00012395871,0.00031858723,0.14227434,0.001576803,0.00018650778,0.00020355212,0.0010334401,0.0003878151,0.023545176,0.1456094,0.6843184],"study_design_scores_gemma":[0.00044370195,0.00019005123,0.0010367364,0.28375593,0.0022591967,0.00020972334,0.00039295774,0.00043548568,0.00011441521,0.035815742,0.6752411,0.00010491492],"about_ca_topic_score_codex":0.009289404,"about_ca_topic_score_gemma":0.0201108,"teacher_disagreement_score":0.024984807,"about_ca_system_score_codex":0.0076192664,"about_ca_system_score_gemma":0.02447946,"threshold_uncertainty_score":0.13213384},"labels":[],"label_agreement":null},{"id":"W3087691613","doi":"10.1016/s2213-8587(20)30313-2","title":"Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk; Novo Nordisk Fonden; Steno Diabetes Center Copenhagen","keywords":"Semaglutide; Medicine; Post-hoc analysis; Type 2 diabetes; Renal function; Diabetes mellitus; Post hoc; MEDLINE; Randomized controlled trial; Internal medicine; Endocrinology; Liraglutide","score_opus":0.010137212375282744,"score_gpt":0.23273598781001736,"score_spread":0.2225987754347346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087691613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94491726,0.044580337,0.0013842669,0.0011044678,0.0017204265,0.001764093,0.001962242,0.00024471962,0.0023222514],"genre_scores_gemma":[0.98719376,0.0062951357,0.0012187483,0.0006902164,0.0006892836,0.0010117054,0.00096712547,0.00006286652,0.0018711617],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99479127,0.003701007,0.00041256464,0.00050130335,0.0002399584,0.00035398576],"domain_scores_gemma":[0.993718,0.0036825081,0.0011598968,0.000622691,0.00035563877,0.0004613245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007107919,0.002710214,0.009082702,0.000702153,0.00047181346,0.0021457288,0.0012899308,0.0018184036,0.006368466],"category_scores_gemma":[0.0085747605,0.0010434218,0.012081863,0.0008085223,0.0016578056,0.0021583491,0.0010015978,0.004541936,0.00060980197],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9733421,0.0002297328,0.0005394853,0.0015437047,0.0194138,0.000028161909,0.000025867306,0.00024321217,0.00040803757,0.000058260524,0.00035918917,0.0038084374],"study_design_scores_gemma":[0.93727314,0.02740177,0.0043298868,0.00023018253,0.028631361,0.000048449372,0.00007389817,0.0007081864,0.00034711612,0.00030311686,0.00059956295,0.000053310418],"about_ca_topic_score_codex":0.0016096798,"about_ca_topic_score_gemma":0.0031618192,"teacher_disagreement_score":0.009082702,"about_ca_system_score_codex":0.001128194,"about_ca_system_score_gemma":0.0010848447,"threshold_uncertainty_score":0.037590683},"labels":[],"label_agreement":null},{"id":"W3093341334","doi":"10.1016/s2213-8587(20)30300-4","title":"Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":131,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Janssen Research and Development; National Health and Medical Research Council; Medical Research Council; University of New South Wales; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Japan Society for the Promotion of Science; Mitsubishi Tanabe Pharma Corporation; Janssen Scientific Affairs","keywords":"Canagliflozin; Medicine; Post-hoc analysis; Placebo; Internal medicine; Kidney disease; Type 2 diabetes; Diabetes mellitus; Erythropoiesis; Anemia; Endocrinology; Pathology","score_opus":0.009670599550727556,"score_gpt":0.23195711636645489,"score_spread":0.22228651681572734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093341334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98500353,0.0060642757,0.0007349957,0.00073393947,0.0006214125,0.0014725632,0.0027255237,0.00006151015,0.002582309],"genre_scores_gemma":[0.9907539,0.00092021754,0.0009095643,0.00063462777,0.00060405827,0.001264573,0.003186989,0.000021647264,0.0017045258],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99514043,0.003440197,0.00027312455,0.00044622278,0.0003380053,0.00036202],"domain_scores_gemma":[0.990774,0.005120726,0.0014229048,0.001238645,0.0005934543,0.0008502243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009376211,0.0014898189,0.0036921233,0.00035131653,0.0004157077,0.0013250136,0.0009082889,0.0012361064,0.0050399136],"category_scores_gemma":[0.011082701,0.0004301319,0.0063302894,0.00041120645,0.00087538344,0.0010776966,0.0006986021,0.0021396922,0.00047298876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9713544,0.0015564554,0.005127132,0.00077722495,0.010227348,0.00006721743,0.000057475307,0.00065353565,0.0005582355,0.00012803242,0.0017212059,0.007771746],"study_design_scores_gemma":[0.8120266,0.10349835,0.05097536,0.0001976084,0.02488214,0.00013052027,0.00011435017,0.0028502324,0.001108145,0.0005235734,0.0035988246,0.00009416888],"about_ca_topic_score_codex":0.0012902712,"about_ca_topic_score_gemma":0.0022937537,"teacher_disagreement_score":0.009376211,"about_ca_system_score_codex":0.0008005824,"about_ca_system_score_gemma":0.0012443305,"threshold_uncertainty_score":0.049586773},"labels":[],"label_agreement":null},{"id":"W3096071972","doi":"10.1016/s2213-8587(20)30337-5","title":"Insulin's centenary: the birth of an idea","year":2020,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada; Western University","funders":"Canadian Institutes of Health Research; Heart and Stroke Foundation of Canada","keywords":"Insulin; Classics; Medicine; Biochemist; Human insulin; History; Library science; Internal medicine; Computer science","score_opus":0.07860023709587693,"score_gpt":0.3626415229952919,"score_spread":0.28404128589941496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096071972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005208299,0.9720629,0.00008352354,0.017248169,0.009490389,0.000002317586,0.000017824277,0.000010281907,0.0010325788],"genre_scores_gemma":[0.0020049002,0.9408962,0.0002868155,0.040197335,0.014780628,0.000015619418,0.00005296746,0.000017621043,0.001747988],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99792,0.00080043875,0.0002130628,0.00019532321,0.00066568505,0.00020554439],"domain_scores_gemma":[0.99308324,0.0049301535,0.0004242912,0.00019226703,0.00080523203,0.00056475564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062589636,0.001364677,0.0032572837,0.002365738,0.00103557,0.0059689656,0.0015922004,0.0075561823,0.006060925],"category_scores_gemma":[0.010135472,0.0005038629,0.0013192351,0.002800622,0.0046722,0.009969215,0.0033504523,0.014078696,0.0024987557],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046835313,0.00006448521,0.0001734852,0.013764283,0.00018127613,0.00029836118,0.00045071435,0.00019349696,0.000564436,0.052503813,0.4582765,0.4730608],"study_design_scores_gemma":[0.00006588671,0.0000607026,0.00022601207,0.0070362883,0.000071787894,0.00027912893,0.00031215613,0.000039560364,0.000051435494,0.014058539,0.97777003,0.0000285304],"about_ca_topic_score_codex":0.0022160902,"about_ca_topic_score_gemma":0.0031994616,"teacher_disagreement_score":0.0075561823,"about_ca_system_score_codex":0.0023479045,"about_ca_system_score_gemma":0.0049155015,"threshold_uncertainty_score":0.033100963},"labels":[],"label_agreement":null},{"id":"W3101690455","doi":"10.1016/s2213-8587(20)30344-2","title":"Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; St. Michael's Hospital; Lunenfeld-Tanenbaum Research Institute","funders":"Abbott Vascular; St. Jude Medical; Boehringer Ingelheim","keywords":"Empagliflozin; Medicine; Internal medicine; Myocardial infarction; Placebo; Diabetes mellitus; Type 2 diabetes; Clinical trial; Adverse effect; Hazard ratio; Cardiology; Confidence interval; Endocrinology","score_opus":0.029464730661604415,"score_gpt":0.2747470569956991,"score_spread":0.24528232633409472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101690455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.982129,0.009834115,0.00044497065,0.00072499627,0.00044969033,0.0003682486,0.00352039,0.000074578595,0.0024540978],"genre_scores_gemma":[0.9882945,0.0026330587,0.00047142364,0.0009464206,0.0008204613,0.0005534529,0.0047200127,0.00002068348,0.00153994],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.998697,0.0006812073,0.00008695807,0.00022216894,0.0001182404,0.00019451462],"domain_scores_gemma":[0.99798167,0.000642854,0.00059645466,0.00024240834,0.00013898585,0.00039762224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032351743,0.0017956627,0.004315827,0.00039208494,0.00038225963,0.0015910873,0.00085389515,0.0014293916,0.0023116989],"category_scores_gemma":[0.002819742,0.0005806753,0.0060466533,0.000546365,0.00072697754,0.0012978023,0.00090006756,0.0040081153,0.00047440414],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9400334,0.002407921,0.01993554,0.0011280775,0.01750088,0.00007511757,0.00004932517,0.0010160179,0.00079733826,0.00020097347,0.0025688075,0.014286603],"study_design_scores_gemma":[0.71007454,0.06232283,0.18645528,0.00027793113,0.032754026,0.00020419517,0.00014253896,0.0028681534,0.00071423803,0.0009902316,0.003069955,0.00012614374],"about_ca_topic_score_codex":0.001699447,"about_ca_topic_score_gemma":0.0029597273,"teacher_disagreement_score":0.004315827,"about_ca_system_score_codex":0.00064692734,"about_ca_system_score_gemma":0.0007159905,"threshold_uncertainty_score":0.017109454},"labels":[],"label_agreement":null},{"id":"W3113238274","doi":"10.1016/s2213-8587(20)30374-0","title":"SGLT2 inhibition and chronic kidney disease outcomes: in diabetes and beyond","year":2020,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Providence Health Care","keywords":"Diabetes mellitus; Medicine; Kidney disease; Type 2 diabetes; Disease; Kidney; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.01780741140234083,"score_gpt":0.253928814049395,"score_spread":0.23612140264705417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113238274","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016100546,0.011040061,0.000041367526,0.96007276,0.026944602,0.0000033796389,0.00006613527,0.000014512272,0.0016560606],"genre_scores_gemma":[0.0024326039,0.008201158,0.00011016157,0.83378744,0.15257862,0.000030530897,0.00004666928,0.000014894679,0.0027978402],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995352,0.0014942336,0.0005974387,0.00042069308,0.0015150903,0.0006205324],"domain_scores_gemma":[0.9738712,0.01729158,0.0017600713,0.0005177828,0.0025347997,0.0040245443],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005726018,0.0012095361,0.0038074628,0.001175106,0.0029069853,0.005634322,0.0018975748,0.05061277,0.013264648],"category_scores_gemma":[0.03296805,0.0008168093,0.0021788327,0.0012473684,0.004103096,0.0066530304,0.0031699545,0.04503339,0.0073376005],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022317593,0.000057367393,0.00044859885,0.0001819002,0.000049836854,0.0004513358,0.000056075525,0.000045224424,0.00010038741,0.0040941094,0.96847254,0.025819436],"study_design_scores_gemma":[0.0009642588,0.0001810286,0.0022670731,0.0017517739,0.00013712014,0.0010124503,0.00033668027,0.00045874095,0.00014740178,0.037360497,0.9552767,0.00010615444],"about_ca_topic_score_codex":0.006036634,"about_ca_topic_score_gemma":0.010726785,"teacher_disagreement_score":0.05061277,"about_ca_system_score_codex":0.0043825735,"about_ca_system_score_gemma":0.0068359296,"threshold_uncertainty_score":0.044374704},"labels":[],"label_agreement":null},{"id":"W3130307224","doi":"10.1016/s2213-8587(20)30402-2","title":"Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Toronto","funders":"Centers for Disease Control and Prevention; National Institutes of Health","keywords":"Medicine; Demography; Incidence (geometry); Diabetes mellitus; Poisson regression; Population; Environmental health; Gerontology","score_opus":0.056064755751702555,"score_gpt":0.32892676483538785,"score_spread":0.2728620090836853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130307224","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0041127824,0.99250597,0.00016555373,0.00039175453,0.0001064323,0.000013700647,0.0024570096,0.00001221267,0.00023454297],"genre_scores_gemma":[0.017077224,0.97913927,0.00061011175,0.00030381486,0.00013239113,0.00002959939,0.002596125,0.0000070736214,0.00010440799],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9984549,0.0003536327,0.00040915445,0.0003106023,0.00036727122,0.00010433623],"domain_scores_gemma":[0.996783,0.0015927837,0.0008053727,0.00012817486,0.00054763537,0.00014294632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027734519,0.0008271107,0.002934734,0.0045051305,0.0001534159,0.0013532985,0.0008832562,0.00066175393,0.001031113],"category_scores_gemma":[0.004916516,0.00049101136,0.0033421365,0.00970574,0.00023380767,0.001264546,0.0011559409,0.00106655,0.00039433927],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061320147,0.000067824,0.06778062,0.10087624,0.017585164,0.00015802312,0.00060409727,0.00078756164,0.00046783165,0.0009340314,0.026676666,0.7834487],"study_design_scores_gemma":[0.00024677604,0.00044773563,0.61882824,0.06832618,0.032552075,0.0015518788,0.0012589624,0.00086350186,0.00052879134,0.0012654058,0.2738644,0.00026604644],"about_ca_topic_score_codex":0.0165992,"about_ca_topic_score_gemma":0.028563602,"teacher_disagreement_score":0.0165992,"about_ca_system_score_codex":0.00090699474,"about_ca_system_score_gemma":0.0030666294,"threshold_uncertainty_score":0.033005178},"labels":[],"label_agreement":null},{"id":"W3134851073","doi":"10.1016/s2213-8587(21)00019-x","title":"Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":178,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Novo Nordisk Fonden; Novo Nordisk","keywords":"Medicine; Liraglutide; Placebo; Type 2 diabetes; Diabetes mellitus; Internal medicine; Antibody; Endocrinology; Immunology; Alternative medicine; Pathology","score_opus":0.01903826276283652,"score_gpt":0.2832448740454684,"score_spread":0.26420661128263184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134851073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9691038,0.021039067,0.00085806457,0.0010809075,0.001575215,0.0026027088,0.0012118662,0.00025407798,0.0022743095],"genre_scores_gemma":[0.9738563,0.01089763,0.0016346977,0.0022670242,0.0011254506,0.0037044806,0.0016007362,0.000046559897,0.004867284],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99958295,0.00017631077,0.000033824588,0.000087901135,0.00003649662,0.00008251785],"domain_scores_gemma":[0.9994634,0.00015857213,0.0001052491,0.00004328825,0.00003655046,0.00019298973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014440425,0.00206193,0.0044893585,0.00045303456,0.00043738235,0.0012202599,0.000994866,0.0026111659,0.0055091013],"category_scores_gemma":[0.0012796256,0.00073500385,0.002403786,0.00048264817,0.0011259243,0.0011643083,0.00042041388,0.0037513736,0.0010340485],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98461455,0.0019489845,0.00027720735,0.0007410517,0.0010253183,0.000037897615,0.000028290282,0.0001221867,0.0018048363,0.000058572554,0.0005663569,0.008774764],"study_design_scores_gemma":[0.9763264,0.02175072,0.0008172481,0.000027328617,0.0004098304,0.000024114086,0.00001140248,0.000112990434,0.00014414257,0.000052187355,0.00031376176,0.000009957691],"about_ca_topic_score_codex":0.0012030315,"about_ca_topic_score_gemma":0.0022721102,"teacher_disagreement_score":0.0055091013,"about_ca_system_score_codex":0.0006262942,"about_ca_system_score_gemma":0.0007291527,"threshold_uncertainty_score":0.018429816},"labels":[],"label_agreement":null},{"id":"W3145956627","doi":"10.1016/s2213-8587(21)00051-6","title":"Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":492,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; St. Michael's Hospital","funders":"Barts Charity","keywords":"Medicine; Meta-analysis; Intensive care medicine; Randomized controlled trial; MEDLINE; Aggregate data; Respiratory tract infections; Respiratory system; Internal medicine; Pathology","score_opus":0.24297030245666074,"score_gpt":0.4648227817449091,"score_spread":0.22185247928824836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3145956627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045097084,0.9939079,0.00047374063,0.00012314298,0.00016605598,0.0002714702,0.00037872692,0.000025000363,0.00014420893],"genre_scores_gemma":[0.13342698,0.8608237,0.0028205903,0.00093909143,0.00020294155,0.0007188784,0.00070121716,0.000041222014,0.00032546246],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9885966,0.005083988,0.0035599486,0.0012191207,0.0011569007,0.00038340563],"domain_scores_gemma":[0.9826134,0.012888713,0.0028651597,0.0006007439,0.0007791468,0.00025274092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014959946,0.0033263082,0.023288336,0.004709899,0.0006077975,0.0036855463,0.0023720542,0.0026650566,0.004219569],"category_scores_gemma":[0.03415057,0.0019932427,0.036817662,0.0052100252,0.0009884881,0.0020822096,0.002387426,0.0031369645,0.00036428295],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044603343,0.000034292494,0.0015799247,0.36426973,0.6152498,0.000068319525,0.000082151,0.00032589494,0.00024853382,0.00009263126,0.00052530103,0.013063095],"study_design_scores_gemma":[0.0024987448,0.00025198428,0.002251146,0.020237513,0.9730031,0.0000634933,0.00004741861,0.00010037849,0.00010011081,0.00017215197,0.0012458665,0.000028064846],"about_ca_topic_score_codex":0.008211239,"about_ca_topic_score_gemma":0.021457901,"teacher_disagreement_score":0.023288336,"about_ca_system_score_codex":0.002841033,"about_ca_system_score_gemma":0.0039116917,"threshold_uncertainty_score":0.0791167},"labels":[],"label_agreement":null},{"id":"W3146122039","doi":"10.1016/s2213-8587(21)00046-2","title":"Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":226,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Robarts Clinical Trials; Université de Montréal","funders":"Akebia Therapeutics; Ionis Pharmaceuticals","keywords":"Medicine; Placebo; Clinical trial; Internal medicine; Triglyceride; Dosing; Randomized controlled trial; Surgery; Physical therapy; Cholesterol","score_opus":0.021223623337175528,"score_gpt":0.2868707706200514,"score_spread":0.26564714728287586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146122039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98794633,0.006936653,0.00041680216,0.0007699282,0.00052602566,0.0011266158,0.00084888114,0.00011955084,0.0013093128],"genre_scores_gemma":[0.9859633,0.0041182493,0.0010637388,0.0014805457,0.0005627793,0.001720719,0.0016130026,0.00003458403,0.0034431336],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9995017,0.00021948629,0.000032058113,0.00010081787,0.000040889907,0.00010509105],"domain_scores_gemma":[0.99924195,0.00016567987,0.0001870479,0.000056246547,0.000048866823,0.0003002565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016282937,0.0023955714,0.0036937601,0.00045653174,0.00051694416,0.0014956817,0.0009391427,0.0022795831,0.006822517],"category_scores_gemma":[0.0013548306,0.00067980826,0.0032893259,0.0004348255,0.0013687283,0.0013334512,0.0005922582,0.0034234847,0.0012445108],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9886946,0.0016135223,0.0005783491,0.0004481181,0.000939355,0.00003706985,0.000046287405,0.0001421949,0.0014968324,0.00006551701,0.00045463396,0.0054835305],"study_design_scores_gemma":[0.96647483,0.030738441,0.0016532872,0.000029913555,0.00038397353,0.000026702925,0.00002486405,0.00012477969,0.00015653149,0.00008207199,0.00029011487,0.000014431742],"about_ca_topic_score_codex":0.00093556405,"about_ca_topic_score_gemma":0.002033126,"teacher_disagreement_score":0.006822517,"about_ca_system_score_codex":0.00060748996,"about_ca_system_score_gemma":0.0009166857,"threshold_uncertainty_score":0.022823632},"labels":[],"label_agreement":null},{"id":"W3154073035","doi":"10.1016/s2213-8587(21)00054-1","title":"Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statement","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Muscle metabolism and nutrition","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"","keywords":"Medicine; Athletes; Type 2 diabetes; Diabetes mellitus; Physical therapy; Type 1 diabetes; Diabetes management; Exercise physiology; Endurance training; Physical medicine and rehabilitation; Intensive care medicine; Endocrinology","score_opus":0.0396287813029562,"score_gpt":0.30524530210711115,"score_spread":0.26561652080415493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154073035","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000065047396,0.9782575,0.00023699907,0.0150107425,0.0056009577,0.000031363204,0.00012336423,0.000013593128,0.0006604471],"genre_scores_gemma":[0.00064468745,0.976356,0.00081547326,0.016814232,0.003862332,0.00009153646,0.000257422,0.000006836331,0.0011515167],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99871564,0.00028233655,0.00029196302,0.00019220621,0.00037064904,0.00014729374],"domain_scores_gemma":[0.99642426,0.0016028974,0.0005191298,0.000059564827,0.0009703728,0.0004238071],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054280525,0.0012850361,0.0035972854,0.0016550756,0.0004792066,0.0021087804,0.0029533838,0.0075716525,0.004393865],"category_scores_gemma":[0.0051414156,0.00047838982,0.0027156943,0.0014604247,0.00072542625,0.0022461675,0.002125755,0.0081300745,0.0027220803],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033860942,0.00015975445,0.00028385327,0.026148181,0.00038393005,0.00020223302,0.000044828495,0.00028283658,0.0004598989,0.003422563,0.34681523,0.6214581],"study_design_scores_gemma":[0.0004963919,0.00023773007,0.0017251207,0.05780082,0.0009852774,0.0006034824,0.0001194378,0.0001439872,0.0001918767,0.0029469011,0.9346974,0.00005157361],"about_ca_topic_score_codex":0.0031558825,"about_ca_topic_score_gemma":0.00643096,"teacher_disagreement_score":0.0075716525,"about_ca_system_score_codex":0.0017512869,"about_ca_system_score_gemma":0.0069601596,"threshold_uncertainty_score":0.02870661},"labels":[],"label_agreement":null},{"id":"W3154717121","doi":"10.1016/s2213-8587(21)00078-4","title":"Towards unified and impactful policies to reduce ultra-processed food consumption and promote healthier eating","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":338,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute on Aging; Division of Research Capacity Development; Bloomberg Family Foundation; South African Medical Research Council; Robert Wood Johnson Foundation; National Institute of Diabetes and Digestive and Kidney Diseases; International Development Research Centre; National Institutes of Health; Bloomberg Philanthropies; Laura and John Arnold Foundation; Arnold Ventures","keywords":"Environmental health; Medicine; Added sugar; Micronutrient; Consumption (sociology); Food processing; Food choice; Food policy; Saturated fat; Obesity; Business; Marketing; Food science; Food security; Agriculture; Geography","score_opus":0.10641426824687417,"score_gpt":0.3895894235756924,"score_spread":0.2831751553288182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154717121","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002056793,0.9866899,0.0004485334,0.009170719,0.0015237575,0.000013761137,0.00008566281,0.00003519815,0.0018267371],"genre_scores_gemma":[0.003863954,0.9822657,0.001221691,0.010519615,0.0010371711,0.000044229357,0.00013262159,0.000012189317,0.00090281933],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99816114,0.000531501,0.00018954017,0.00021748552,0.00060851785,0.0002917798],"domain_scores_gemma":[0.9951239,0.0027369088,0.0009789817,0.00012345589,0.00073001673,0.00030660184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060505783,0.0015099326,0.0031517057,0.002309695,0.00034564792,0.0026288081,0.0016089014,0.005355782,0.0093239155],"category_scores_gemma":[0.007533727,0.00049257494,0.0015514459,0.0028270977,0.0013420103,0.0028106077,0.002363251,0.0062853047,0.0022867795],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016844063,0.00023847021,0.00032662443,0.056267392,0.0007116221,0.000106769745,0.00020806784,0.0006095741,0.00084756943,0.0268307,0.056460805,0.857224],"study_design_scores_gemma":[0.00027843995,0.0002146606,0.003752791,0.073895976,0.0016295669,0.00022767515,0.00030384408,0.00024601573,0.00050712784,0.015008881,0.9038813,0.00005377022],"about_ca_topic_score_codex":0.0061884457,"about_ca_topic_score_gemma":0.009827243,"teacher_disagreement_score":0.0093239155,"about_ca_system_score_codex":0.0033826884,"about_ca_system_score_gemma":0.009682604,"threshold_uncertainty_score":0.031998873},"labels":[],"label_agreement":null},{"id":"W3176374233","doi":"10.1016/s2213-8587(21)00115-7","title":"Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Université Laval; Population Health Research Institute; McMaster University Medical Centre; University of Toronto; Hamilton Health Sciences; LMC Diabetes & Endocrinology (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Placebo; Medicine; Type 2 diabetes; Exploratory analysis; Erectile function; Internal medicine; Physical therapy; Diabetes mellitus; Erectile dysfunction; Endocrinology; Alternative medicine; Exenatide","score_opus":0.031157304752435853,"score_gpt":0.27215442253790983,"score_spread":0.24099711778547397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176374233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9330192,0.054981787,0.0014713046,0.0012160857,0.0013234892,0.0027493618,0.0021367408,0.0001357589,0.002966227],"genre_scores_gemma":[0.9853908,0.0074785943,0.0012817021,0.00087050814,0.00059209345,0.0013642638,0.0009856345,0.00003183139,0.0020046441],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9946853,0.0039061757,0.00037071336,0.0004501889,0.00023567659,0.00035194462],"domain_scores_gemma":[0.99625826,0.0020444782,0.00085308345,0.00042414095,0.00019029582,0.00022974666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061011724,0.0023281933,0.0062862043,0.00057974574,0.00047285712,0.0017082668,0.001054014,0.0021568954,0.0065482454],"category_scores_gemma":[0.008288168,0.000937835,0.008306381,0.000650309,0.0014903467,0.0015017177,0.00084393646,0.00307778,0.0006165307],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97699535,0.00041694488,0.0011184061,0.0022916251,0.012229526,0.000045834837,0.000053794338,0.00015085614,0.00064856437,0.00012303433,0.00030492735,0.005621117],"study_design_scores_gemma":[0.96536136,0.016732125,0.0043982947,0.00026061072,0.011904249,0.000038197653,0.00006635216,0.00016108598,0.00015294559,0.00027282067,0.00062360417,0.000028393775],"about_ca_topic_score_codex":0.0016972771,"about_ca_topic_score_gemma":0.00352646,"teacher_disagreement_score":0.0065482454,"about_ca_system_score_codex":0.0009396824,"about_ca_system_score_gemma":0.000874911,"threshold_uncertainty_score":0.032266498},"labels":[],"label_agreement":null},{"id":"W3183300604","doi":"10.1016/s2213-8587(21)00180-7","title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":245,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk; Bayer Fund; Novartis; Servier; Amgen; Pfizer; Bristol-Myers Squibb; AstraZeneca; Fundação Lemann; Boehringer Ingelheim","keywords":"Medicine; Dapagliflozin; Discontinuation; Placebo; Internal medicine; Adverse effect; Hazard ratio; Population; Kidney disease; Organ dysfunction; Randomized controlled trial; Clinical trial; Diabetes mellitus; Type 2 diabetes; Confidence interval; Sepsis; Endocrinology; Pathology","score_opus":0.030205094319406333,"score_gpt":0.30034683372907833,"score_spread":0.270141739409672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3183300604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619607,0.022170361,0.0014000166,0.0021405981,0.0020606378,0.0030632736,0.0023151676,0.0003614444,0.0045277863],"genre_scores_gemma":[0.9722177,0.010493433,0.002235132,0.0039113704,0.0012191625,0.0030092516,0.0026648566,0.00004545164,0.0042037545],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996086,0.00016114401,0.000030340383,0.000076996475,0.000033463788,0.000089446876],"domain_scores_gemma":[0.9994523,0.0001629986,0.0001125032,0.00003739209,0.000029755534,0.00020501284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001438843,0.0016762129,0.00339256,0.00036694884,0.00033784733,0.0012563505,0.00078540883,0.0018743032,0.006090382],"category_scores_gemma":[0.001498396,0.00062480784,0.0023990234,0.0004109263,0.0009369981,0.0011752817,0.00045971634,0.0038720164,0.00096487894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.979908,0.0020871062,0.00057496474,0.0009414057,0.0012684935,0.00004357954,0.00003156902,0.00016922313,0.0013064859,0.00011996615,0.0012009128,0.012348356],"study_design_scores_gemma":[0.9873882,0.010659149,0.0009967136,0.000029562347,0.00030519217,0.000016541007,0.000010307488,0.00013242493,0.00008085176,0.00006764114,0.00030605495,0.000007289063],"about_ca_topic_score_codex":0.0009332088,"about_ca_topic_score_gemma":0.0020767793,"teacher_disagreement_score":0.006090382,"about_ca_system_score_codex":0.0006116588,"about_ca_system_score_gemma":0.0006721049,"threshold_uncertainty_score":0.020374298},"labels":[],"label_agreement":null},{"id":"W3185437491","doi":"10.1016/s2213-8587(21)00174-1","title":"Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Discontinuation; Type 2 diabetes; Sulfonylurea; Internal medicine; Randomized controlled trial; Diabetes mellitus; Metformin; Physical therapy; Insulin; Endocrinology","score_opus":0.03327913042604658,"score_gpt":0.3050845420511496,"score_spread":0.271805411625103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185437491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98631245,0.0067454297,0.00051165617,0.0009560674,0.00088699895,0.0011253329,0.0010248423,0.0002528779,0.0021843398],"genre_scores_gemma":[0.986893,0.0029467463,0.0010548985,0.0015207774,0.0007114158,0.0014799545,0.0013283729,0.00006009602,0.004004866],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99937916,0.0002956674,0.00003618068,0.00013887977,0.000041195966,0.000108779706],"domain_scores_gemma":[0.99902654,0.0003138979,0.00019981469,0.00008727585,0.00004703148,0.00032537995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017724702,0.0023390239,0.0047969967,0.00048702824,0.00043991965,0.0015877441,0.0012952331,0.0027274587,0.009337678],"category_scores_gemma":[0.0018424989,0.0010456478,0.002857837,0.00044800417,0.0016131741,0.0018722382,0.00052284566,0.004328544,0.0018186545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.991042,0.001514156,0.00021365285,0.00025831908,0.00048955926,0.000016777009,0.000024935553,0.00012637295,0.00089547987,0.00004466758,0.0003753295,0.004998672],"study_design_scores_gemma":[0.9707211,0.027438669,0.0008733523,0.000018508203,0.00028320492,0.000017384344,0.000015471145,0.00023846974,0.00010690891,0.000090478374,0.00018368804,0.000012760804],"about_ca_topic_score_codex":0.0011263636,"about_ca_topic_score_gemma":0.0016277853,"teacher_disagreement_score":0.009337678,"about_ca_system_score_codex":0.00080573035,"about_ca_system_score_gemma":0.00079863856,"threshold_uncertainty_score":0.031237602},"labels":[],"label_agreement":null},{"id":"W3190876990","doi":"10.1016/s2213-8587(21)00173-x","title":"Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; Centre Hospitalier Universitaire Sainte-Justine","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health; National Cancer Institute; Medical Research Council; American Lebanese Syrian Associated Charities; St. Jude Children's Research Hospital","keywords":"Medicine; Childhood cancer; Guideline; Bone mineral; Harmonization; Cancer; Young adult; MEDLINE; Environmental health; Gerontology; Pediatrics; Internal medicine; Pathology; Osteoporosis","score_opus":0.05460489342700565,"score_gpt":0.35299141637266995,"score_spread":0.2983865229456643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190876990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035875692,0.9905211,0.0008125668,0.0047868416,0.00079697877,0.00028499495,0.0012983313,0.000041509626,0.0010989028],"genre_scores_gemma":[0.0036299748,0.98484796,0.0050263987,0.0036772464,0.00025346942,0.00041804407,0.0016458458,0.000013199945,0.00048780636],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99694186,0.0008378654,0.0009510902,0.00020640354,0.00090486614,0.00015780114],"domain_scores_gemma":[0.9956344,0.0019895697,0.0007943147,0.00007063147,0.0013076093,0.00020350955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076193674,0.0013305113,0.0044605196,0.0029874372,0.00034769237,0.0014798103,0.0031410034,0.0024476899,0.002551825],"category_scores_gemma":[0.012642376,0.0006400138,0.0051909415,0.002756597,0.00041241464,0.00090815907,0.0012642383,0.0033458741,0.0007877973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004889676,0.00012091456,0.0018562491,0.14133361,0.0041708583,0.00010599615,0.00014188695,0.0010689746,0.00063373195,0.0030492765,0.09890548,0.7481241],"study_design_scores_gemma":[0.0015866385,0.00037153327,0.014943426,0.40496895,0.021691266,0.000493596,0.0003138424,0.0007684239,0.00078860705,0.0043811835,0.54957736,0.00011521375],"about_ca_topic_score_codex":0.031557497,"about_ca_topic_score_gemma":0.050251517,"teacher_disagreement_score":0.031557497,"about_ca_system_score_codex":0.003006592,"about_ca_system_score_gemma":0.010564526,"threshold_uncertainty_score":0.06274766},"labels":[],"label_agreement":null},{"id":"W3195404919","doi":"10.1016/s2213-8587(21)00203-5","title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","year":2021,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1502,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"British Heart Foundation","keywords":"Medicine; Type 2 diabetes; Meta-analysis; Glucagon-like peptide 1 receptor; Diabetes mellitus; MEDLINE; Internal medicine; Intensive care medicine; Bioinformatics; Pharmacology; Receptor; Endocrinology; Agonist","score_opus":0.11400685831002075,"score_gpt":0.35453262479431596,"score_spread":0.24052576648429522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195404919","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0030915271,0.995748,0.00032496912,0.0001136824,0.00013031825,0.00013166101,0.00031990133,0.000021305237,0.00011873048],"genre_scores_gemma":[0.091357656,0.9044088,0.0018154413,0.00086192065,0.00025714643,0.00046512962,0.0005550876,0.000028401408,0.0002504472],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9940163,0.002583693,0.0018019531,0.0007675556,0.0005884402,0.00024205427],"domain_scores_gemma":[0.99010134,0.0074320254,0.0015823545,0.00031850283,0.00042120932,0.00014453252],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008722563,0.0029965534,0.020780085,0.0036858842,0.00049563753,0.002683857,0.00217103,0.0023606722,0.0037615697],"category_scores_gemma":[0.019550871,0.0017815832,0.0330183,0.0044903345,0.00070574513,0.0016053229,0.0019184228,0.0028010297,0.00032366198],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038855544,0.000032556673,0.002160118,0.36278626,0.611574,0.000087190674,0.00006598353,0.00041611792,0.00023820321,0.000101727615,0.00081751123,0.017834894],"study_design_scores_gemma":[0.0017221865,0.00019721403,0.0028160936,0.017670348,0.9755647,0.000072013165,0.000042646414,0.00011415712,0.000086168344,0.0002064441,0.0014791929,0.000028668035],"about_ca_topic_score_codex":0.006659389,"about_ca_topic_score_gemma":0.015844729,"teacher_disagreement_score":0.020780085,"about_ca_system_score_codex":0.0020251137,"about_ca_system_score_gemma":0.002399253,"threshold_uncertainty_score":0.046129823},"labels":[],"label_agreement":null},{"id":"W3204188022","doi":"10.1016/s2213-8587(21)00235-7","title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":846,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; National Cancer Institute; U.S. Food and Drug Administration; Ipsen Biopharmaceuticals; Pfizer","keywords":"Guideline; MEDLINE; Consensus conference; Disease management; Evidence-based medicine; Disease","score_opus":0.028340897772308072,"score_gpt":0.2987705142329133,"score_spread":0.2704296164606052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3204188022","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00091057323,0.74910045,0.004093594,0.21254553,0.018900057,0.00028853948,0.0011895065,0.00025756576,0.01271416],"genre_scores_gemma":[0.009581181,0.84350234,0.02390389,0.09485976,0.018016499,0.0007153431,0.0045904852,0.000107989326,0.0047225305],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99331915,0.0018837518,0.0018858808,0.00043391003,0.0020596744,0.00041766663],"domain_scores_gemma":[0.97642934,0.008993975,0.0026719687,0.0003691551,0.009895221,0.0016403302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010813108,0.0013920751,0.0035288,0.005943148,0.0009005514,0.0031461795,0.0038466419,0.008268446,0.00440887],"category_scores_gemma":[0.026619412,0.00080394343,0.0036244637,0.0039473074,0.0009778538,0.0033300724,0.0021981564,0.008957951,0.0032916996],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001371874,0.00011462577,0.0011553455,0.008668141,0.00034604353,0.00047089343,0.0002047348,0.0005651144,0.00034086252,0.00185101,0.6094201,0.3767259],"study_design_scores_gemma":[0.00047208858,0.00013676987,0.005067549,0.06752468,0.0012181788,0.0022212102,0.00032595955,0.00069485704,0.00023687785,0.00339122,0.9185985,0.00011201511],"about_ca_topic_score_codex":0.013173909,"about_ca_topic_score_gemma":0.024727741,"teacher_disagreement_score":0.013173909,"about_ca_system_score_codex":0.0036117155,"about_ca_system_score_gemma":0.010988627,"threshold_uncertainty_score":0.05718583},"labels":[],"label_agreement":null},{"id":"W3206152482","doi":"10.1016/s2213-8587(21)00236-9","title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Fonds de Recherche du Québec - Santé; Institut National Du Cancer; Institut National de la Santé et de la Recherche Médicale; Agence Nationale de la Recherche","keywords":"Cohort study; Retrospective cohort study; Hyperplasia; Cohort; Prospective cohort study","score_opus":0.009277805141671366,"score_gpt":0.24207861324822527,"score_spread":0.2328008081065539,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3206152482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99889404,0.00036819093,0.00009863378,0.000027799084,0.00001144024,0.000010400783,0.00036850307,0.000003788097,0.00021723048],"genre_scores_gemma":[0.9993376,0.00012469638,0.00005713641,0.000022752209,0.000012682789,0.000007898021,0.0003073896,0.00000378582,0.00012600922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992625,0.00011959045,0.00005729832,0.00033213332,0.000101518526,0.00012693979],"domain_scores_gemma":[0.99839145,0.00022979965,0.0005212894,0.00036681734,0.0001494977,0.00034110725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007155372,0.0006684153,0.00074521505,0.00088599266,0.0009590188,0.0013279642,0.00086422026,0.00096548395,0.0022281203],"category_scores_gemma":[0.002130785,0.0010102527,0.0009649764,0.0015271904,0.0007551533,0.0009548272,0.0008995879,0.0012021363,0.0004135441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005663089,0.000051833613,0.9963722,0.000018572926,0.0002805706,0.00078355294,0.000152793,0.000027571266,0.00076997007,0.000039167244,0.00012594313,0.0008115622],"study_design_scores_gemma":[0.00004584368,0.00020145421,0.99647516,0.000009171535,0.00016747076,0.0023929155,0.0002600736,0.00010963243,0.000064056854,0.00005072115,0.00021038679,0.0000132005625],"about_ca_topic_score_codex":0.006045026,"about_ca_topic_score_gemma":0.0043846657,"teacher_disagreement_score":0.006045026,"about_ca_system_score_codex":0.0005359034,"about_ca_system_score_gemma":0.00040736338,"threshold_uncertainty_score":0.012019634},"labels":[],"label_agreement":null},{"id":"W3210656179","doi":"10.1016/s2213-8587(21)00286-2","title":"Youth-onset type 2 diabetes among First Nations young people in northern Australia: a retrospective, cross-sectional study","year":2021,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Health and Medical Research Council","keywords":"Medicine; Type 2 diabetes; Scopus; Public health; Diabetes mellitus; Gerontology; Disease; Type 1 diabetes; MEDLINE; Family medicine; Pediatrics; Internal medicine; Nursing; Endocrinology","score_opus":0.04725442723727534,"score_gpt":0.3221647942803334,"score_spread":0.27491036704305805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210656179","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99360365,0.0013060111,0.0001466578,0.0020668786,0.00012539404,0.000077868135,0.0016024351,0.000007697266,0.0010634613],"genre_scores_gemma":[0.99266773,0.0015122081,0.00034497122,0.0029760876,0.0001606044,0.00015952045,0.000820962,0.0000063243792,0.0013516033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988919,0.00033026532,0.00017267647,0.0001496548,0.00023910827,0.00021649168],"domain_scores_gemma":[0.9970817,0.00037782307,0.00094491534,0.00019212064,0.00059821125,0.0008052093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014634862,0.0002966246,0.00069503736,0.00070851354,0.0010091374,0.0010029376,0.00059265795,0.001543578,0.0008325482],"category_scores_gemma":[0.004222026,0.00073507533,0.0006449377,0.0017832544,0.0004273248,0.0007657387,0.00076524925,0.0015634283,0.00028107146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034016364,0.00003853328,0.9971354,0.00002688959,0.000043745036,0.00036917074,0.00038082578,0.000005530368,0.00006460801,0.000012146538,0.0008291424,0.0010599659],"study_design_scores_gemma":[0.000007898658,0.000059860376,0.9984456,0.000032594846,0.000035085784,0.00036308437,0.0006448784,0.00004076797,0.000012737319,0.000012395204,0.00034077064,0.000004376604],"about_ca_topic_score_codex":0.14181751,"about_ca_topic_score_gemma":0.17064147,"teacher_disagreement_score":0.14181751,"about_ca_system_score_codex":0.0012171007,"about_ca_system_score_gemma":0.0016264499,"threshold_uncertainty_score":0.2819841},"labels":[],"label_agreement":null},{"id":"W3211322112","doi":"10.1016/s2213-8587(21)00282-5","title":"RETRACTED: Targeting of vitamin D supplementation to individuals with deficiency","year":2021,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":6,"is_retracted":true,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Biogen; GlaxoSmithKline; Eli Lilly and Company","keywords":"Vitamin D and neurology; vitamin D deficiency; Medicine; Vitamin; Epidemiology; Population; Disease; Physiology; Clinical trial; Randomized controlled trial; Environmental health; Internal medicine","score_opus":0.033351529152129425,"score_gpt":0.3131189412683392,"score_spread":0.2797674121162098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211322112","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016008667,0.0013986297,0.000040371197,0.9647657,0.032716174,0.000009642223,0.000063036816,0.000018927989,0.00082740356],"genre_scores_gemma":[0.00079187955,0.00056795805,0.00008182465,0.96020114,0.035886344,0.00002761818,0.000018465716,0.000013196375,0.0024116589],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98984677,0.0026483112,0.0020103492,0.0013015532,0.002847476,0.001345586],"domain_scores_gemma":[0.945674,0.03394282,0.0034809208,0.0015730012,0.0060364027,0.0092927525],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010717236,0.0017410674,0.00359166,0.0016185674,0.0060916636,0.0053352993,0.0034243325,0.112402685,0.011294621],"category_scores_gemma":[0.07144238,0.0018107299,0.002506593,0.0016165322,0.005395094,0.0051505873,0.003317833,0.07507936,0.009588093],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000890955,0.000033273926,0.0005238478,0.00010179635,0.000034189852,0.00077291107,0.00010368419,0.000027830636,0.00012758143,0.0011587011,0.98929566,0.00773147],"study_design_scores_gemma":[0.0004964895,0.00016393086,0.0027881924,0.0011035446,0.00015480675,0.0014600122,0.0005152004,0.0002732409,0.00025789405,0.0057721585,0.98690736,0.00010724695],"about_ca_topic_score_codex":0.014435188,"about_ca_topic_score_gemma":0.016986448,"teacher_disagreement_score":0.8875973,"about_ca_system_score_codex":0.0063613392,"about_ca_system_score_gemma":0.00981634,"threshold_uncertainty_score":0.05667889},"labels":[],"label_agreement":null},{"id":"W3212157657","doi":"10.1016/s2213-8587(21)00289-8","title":"Opportunities and challenges in closed-loop systems in type 1 diabetes","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Medicine; Insulin delivery; Insulin; Closed loop; Type 1 diabetes; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Artificial pancreas; Internal medicine; Endocrinology","score_opus":0.1748318750155709,"score_gpt":0.3206666045708026,"score_spread":0.1458347295552317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212157657","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08757141,0.24949618,0.37993678,0.21267737,0.00928659,0.00010544452,0.00038328546,0.00090960035,0.05963337],"genre_scores_gemma":[0.87011194,0.06954232,0.035365522,0.0071626604,0.0097473655,0.00015627396,0.0001693498,0.00010263653,0.0076420144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978149,0.0009637844,0.000102387836,0.0003176512,0.0005445037,0.00025670335],"domain_scores_gemma":[0.9809279,0.01583084,0.0005192917,0.0005794819,0.001480764,0.00066167396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068074185,0.0005201175,0.0013440454,0.00043495584,0.00084123114,0.0050288504,0.0012431726,0.0030103433,0.0057329643],"category_scores_gemma":[0.013954818,0.00032754464,0.000637426,0.0005017775,0.0037543129,0.006019118,0.0023579674,0.003876295,0.0008527036],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087404484,0.0004106732,0.005991912,0.002194465,0.00015657138,0.00051570026,0.0016055354,0.056915987,0.0032296774,0.36604556,0.021631947,0.5404279],"study_design_scores_gemma":[0.00014847486,0.0007200981,0.0029945571,0.0009636561,0.000058631642,0.00039242452,0.0022072839,0.10158961,0.0010694115,0.80580485,0.08389892,0.00015215913],"about_ca_topic_score_codex":0.001987466,"about_ca_topic_score_gemma":0.0013268428,"teacher_disagreement_score":0.0068074185,"about_ca_system_score_codex":0.0011905347,"about_ca_system_score_gemma":0.0019134771,"threshold_uncertainty_score":0.036001503},"labels":[],"label_agreement":null},{"id":"W3214498242","doi":"10.1016/s2213-8587(21)00267-9","title":"Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Horizon 2020; Abbott Diabetes Care; Berlin Institute of Health; Roche Diabetes Care; Stiftung Charité; Novo Nordisk Fonden; Region Hovedstaden; Sanofi; European Commission; International Society for Pediatric and Adolescent Diabetes; Novo Nordisk; Dexcom; Insulet Corporation; Technology Agency of the Czech Republic; Wellcome Trust; Steno Diabetes Center Copenhagen; Stanford Maternal and Child Health Research Institute; Deutsche Forschungsgemeinschaft; Eli Lilly and Company","keywords":"Statement (logic); Consensus conference; Insulin delivery; MEDLINE; Evidence-based medicine; Key (lock)","score_opus":0.06494527321973508,"score_gpt":0.4294518418766844,"score_spread":0.3645065686569493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214498242","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001996528,0.076118976,0.093173645,0.76074666,0.024897842,0.0036092596,0.0033320943,0.0022939027,0.033831183],"genre_scores_gemma":[0.028353382,0.13955155,0.5156835,0.24187754,0.018517192,0.013214887,0.012986465,0.0021719707,0.02764356],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9157559,0.03590874,0.017274417,0.0032642812,0.024363244,0.0034333605],"domain_scores_gemma":[0.68973243,0.15140887,0.022609865,0.014968318,0.10490831,0.0163722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.16987734,0.0026993514,0.0032040349,0.0048495545,0.001744193,0.009491436,0.010367178,0.023633009,0.011313498],"category_scores_gemma":[0.20543094,0.0016453399,0.006042906,0.003881776,0.004136731,0.009027512,0.010977366,0.023650857,0.011332122],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046359416,0.00054592243,0.0012830505,0.007916381,0.00024884174,0.00042626506,0.0011022679,0.0017284345,0.0016400382,0.0152087975,0.59490895,0.3745275],"study_design_scores_gemma":[0.0006445936,0.00035054306,0.002924144,0.034832798,0.0003640152,0.00061627716,0.0014282134,0.0020724207,0.0019317773,0.029230941,0.9253483,0.00025604854],"about_ca_topic_score_codex":0.006422352,"about_ca_topic_score_gemma":0.0071207876,"teacher_disagreement_score":0.16987734,"about_ca_system_score_codex":0.004310339,"about_ca_system_score_gemma":0.043905657,"threshold_uncertainty_score":0.89840794},"labels":[],"label_agreement":null},{"id":"W3216543422","doi":"10.1016/s2213-8587(21)00292-8","title":"Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute for Health and Care Research; Boehringer Ingelheim","keywords":"Empagliflozin; Heart failure; Ejection fraction; Benzhydryl compounds; MEDLINE","score_opus":0.045067551808763276,"score_gpt":0.3194892456944029,"score_spread":0.27442169388563964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216543422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819203,0.008688407,0.0015186543,0.00068838237,0.0015250883,0.002353776,0.0012294005,0.00021494753,0.0018610278],"genre_scores_gemma":[0.98462266,0.004106874,0.0023222924,0.0008111733,0.0011893776,0.0024244105,0.0010834428,0.000058231064,0.0033814944],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.997729,0.0014130804,0.00013792391,0.00034262327,0.00011357491,0.0002637195],"domain_scores_gemma":[0.9976441,0.0012503989,0.00030347003,0.00027089225,0.00013193235,0.0003991261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048229746,0.0026328694,0.008245892,0.00061400654,0.0004849219,0.0015120115,0.001282358,0.0020784817,0.007009854],"category_scores_gemma":[0.003555618,0.0010890005,0.005431717,0.00053537317,0.001709705,0.0017326255,0.0008161044,0.0041567553,0.0011623142],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.99488646,0.0007463661,0.00008711872,0.000254721,0.0010540764,0.000010651967,0.000010881696,0.00012368719,0.00052085327,0.000025771727,0.00012287947,0.0021565424],"study_design_scores_gemma":[0.9767115,0.020647775,0.0006267798,0.00001878366,0.0013443005,0.000010101898,0.000009024677,0.00025781308,0.00017534607,0.000047777798,0.000139954,0.000010793938],"about_ca_topic_score_codex":0.0011505346,"about_ca_topic_score_gemma":0.0020746032,"teacher_disagreement_score":0.008245892,"about_ca_system_score_codex":0.0009008448,"about_ca_system_score_gemma":0.001092459,"threshold_uncertainty_score":0.025506616},"labels":[],"label_agreement":null},{"id":"W3217716605","doi":"10.1016/s2213-8587(21)00310-7","title":"SGLT-2 inhibitors: does it matter if they prevent type 2 diabetes","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"","keywords":"Dapagliflozin; Type 2 diabetes; Kidney disease; Diabetes mellitus; Disease; Fluid ounce (US); Population; Incidence (geometry)","score_opus":0.016731972708270423,"score_gpt":0.2671351638708697,"score_spread":0.2504031911625993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3217716605","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015981264,0.51784414,0.00016474763,0.4340871,0.039116513,0.000014046281,0.00056371605,0.000050665105,0.0065609594],"genre_scores_gemma":[0.03419907,0.49201322,0.000727064,0.32125878,0.14521329,0.00006222767,0.00044852917,0.00009297592,0.0059848335],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.995369,0.001548315,0.0006568974,0.0006043124,0.0013626284,0.00045875626],"domain_scores_gemma":[0.97006273,0.019555373,0.0037955227,0.0006039271,0.0032764883,0.0027059608],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0104964925,0.0009628045,0.004826441,0.001333003,0.00085466646,0.005213531,0.0015370592,0.008538879,0.013789476],"category_scores_gemma":[0.03133966,0.0007367932,0.0026755943,0.0016410828,0.0029130355,0.0049502,0.0012403498,0.012779343,0.004635503],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057423543,0.00022878754,0.0027888848,0.008908929,0.0033478378,0.00034696262,0.00017180869,0.00032128542,0.000581818,0.010238582,0.5270602,0.44026265],"study_design_scores_gemma":[0.010014291,0.0016133463,0.021084715,0.03642104,0.008275188,0.0007313999,0.0010536992,0.00063983694,0.0005088616,0.068540365,0.8507867,0.00033057196],"about_ca_topic_score_codex":0.0042677093,"about_ca_topic_score_gemma":0.0096017,"teacher_disagreement_score":0.013789476,"about_ca_system_score_codex":0.0028513612,"about_ca_system_score_gemma":0.0037723333,"threshold_uncertainty_score":0.055511475},"labels":[],"label_agreement":null},{"id":"W4200125385","doi":"10.1016/s2213-8587(21)00325-9","title":"Nutrition-related health taxes: setting expectations","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"National Cancer Institute; Medical Research Council; National Institute of Mental Health; Engineering and Physical Sciences Research Council; National Heart, Lung, and Blood Institute; Wellcome Trust","keywords":"MEDLINE; Health care; Public health; Patient participation","score_opus":0.035324508678129654,"score_gpt":0.3070368767458661,"score_spread":0.27171236806773646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200125385","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15614645,0.0033989898,0.023551013,0.57319385,0.0019968848,0.000139706,0.00057214353,0.00019739619,0.24080355],"genre_scores_gemma":[0.98105836,0.00057759,0.0016428614,0.013073255,0.00040435724,0.000064915504,0.000076014745,0.00004412842,0.0030585732],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9883851,0.007399707,0.00029124756,0.00055494043,0.0013067033,0.002062307],"domain_scores_gemma":[0.957422,0.025493452,0.0028493481,0.0013738632,0.005786161,0.0070751924],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017269073,0.00054151355,0.00076296506,0.0012979159,0.0018627235,0.0106199095,0.0014302719,0.0061786175,0.00951097],"category_scores_gemma":[0.0746111,0.0005269658,0.00040554808,0.00086884864,0.004372463,0.0069742496,0.0040896987,0.0064975894,0.0013136726],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006713263,0.0007798722,0.03765367,0.00020397644,0.000106058,0.00035263016,0.0040902635,0.011002084,0.0004025479,0.8035572,0.07098965,0.07019077],"study_design_scores_gemma":[0.00013303729,0.000102055485,0.0144265685,0.00035960856,0.000034261557,0.00005140513,0.0051452983,0.009225596,0.00049164315,0.94019103,0.029761637,0.000077847544],"about_ca_topic_score_codex":0.007498251,"about_ca_topic_score_gemma":0.007964217,"teacher_disagreement_score":0.017269073,"about_ca_system_score_codex":0.007325254,"about_ca_system_score_gemma":0.008905788,"threshold_uncertainty_score":0.09132868},"labels":[],"label_agreement":null},{"id":"W4200360839","doi":"10.1016/s2213-8587(21)00326-0","title":"Dapagliflozin in patients with COVID-19: mind the kidneys – Authors' reply","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Fundação Lemann; Bayer Fund; Novartis; AstraZeneca; Servier; Amgen; Pfizer; Bristol-Myers Squibb; Novo Nordisk; Merck","keywords":"Acute kidney injury; Dapagliflozin; Clinical endpoint; Renal function; Creatinine; Adverse effect; Renal replacement therapy; Kidney","score_opus":0.02291130481651073,"score_gpt":0.2848254784781782,"score_spread":0.26191417366166747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200360839","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041304226,0.0055766297,0.00006162831,0.94090694,0.052340318,0.000004601654,0.00007909488,0.000018357372,0.00059939886],"genre_scores_gemma":[0.0051911534,0.0036250257,0.00013070225,0.8616686,0.12771349,0.000023536315,0.000053949916,0.000021069303,0.0015724926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99773574,0.00069204805,0.00050418155,0.00032424784,0.00045457616,0.00028918107],"domain_scores_gemma":[0.98078454,0.012960042,0.0011986959,0.0006023965,0.002824822,0.0016294655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003483608,0.0006529416,0.0022313772,0.0006609821,0.0013873588,0.0026903462,0.0017061033,0.030166999,0.006558515],"category_scores_gemma":[0.027276915,0.00069047144,0.001482251,0.0006249624,0.002286949,0.0032863768,0.001840186,0.035396382,0.0038593963],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018449142,0.000027278016,0.0010535285,0.00017695391,0.00009028893,0.0011667365,0.00011801395,0.00005679672,0.00011040593,0.0011149455,0.9861574,0.009743094],"study_design_scores_gemma":[0.00086059544,0.00021355438,0.0031118284,0.000874822,0.0002333268,0.0031970576,0.00073254696,0.0003251955,0.0005085039,0.0066662687,0.98306954,0.00020680699],"about_ca_topic_score_codex":0.0019483328,"about_ca_topic_score_gemma":0.0024468875,"teacher_disagreement_score":0.030166999,"about_ca_system_score_codex":0.0015922413,"about_ca_system_score_gemma":0.0020110176,"threshold_uncertainty_score":0.02194041},"labels":[],"label_agreement":null},{"id":"W4200548235","doi":"10.1016/s2213-8587(21)00284-9","title":"Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia","year":2021,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Toronto General Hospital","funders":"","keywords":"Metabolic syndrome; Diabetes mellitus; Hypertriglyceridemia; Context (archaeology); Disease; Residual risk; Atherosclerotic cardiovascular disease; Triglyceride","score_opus":0.08575000769170334,"score_gpt":0.2942208992942478,"score_spread":0.20847089160254445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200548235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17181887,0.6596963,0.0066203186,0.114250526,0.0069678132,0.00051785505,0.0007495643,0.0004259085,0.038952954],"genre_scores_gemma":[0.64820427,0.26817706,0.010154889,0.05270059,0.011127949,0.0006277582,0.0008593704,0.00004551978,0.008102599],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997192,0.0001008277,0.000032235566,0.00003372509,0.00006447017,0.000049580995],"domain_scores_gemma":[0.99942505,0.00022760854,0.00013111647,0.000020623826,0.00006311329,0.00013240405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068260764,0.0004354788,0.0009352134,0.00041246414,0.0003009757,0.0006991516,0.00043990038,0.0010635215,0.003954158],"category_scores_gemma":[0.00200501,0.000117688905,0.00069079356,0.00026744636,0.0003450515,0.0005120365,0.00042877436,0.0022915406,0.0005083464],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011077166,0.0060308874,0.0074728597,0.0048352326,0.0011339241,0.00056651054,0.0002280534,0.00054739387,0.0076342355,0.0045653763,0.05017829,0.90573],"study_design_scores_gemma":[0.117029734,0.043767896,0.2606348,0.017872734,0.009369316,0.004999296,0.0027674162,0.0036537368,0.008192103,0.06620353,0.4651594,0.00035003858],"about_ca_topic_score_codex":0.0007604514,"about_ca_topic_score_gemma":0.0031076104,"teacher_disagreement_score":0.003954158,"about_ca_system_score_codex":0.00041980654,"about_ca_system_score_gemma":0.0007194754,"threshold_uncertainty_score":0.013227999},"labels":[],"label_agreement":null},{"id":"W4205160401","doi":"10.1016/s2213-8587(21)00327-2","title":"Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"National Institutes of Health; Diabetes Australia; Centers for Disease Control and Prevention; Hospital Authority; Steno Diabetes Center Copenhagen; State Government of Victoria; Regione Lombardia; Istituto di Ricerche Farmacologiche Mario Negri - IRCCS","keywords":"Medicine; Diabetes mellitus; Environmental health; Demography; Population; Gerontology; Aggregate data","score_opus":0.03599371790028712,"score_gpt":0.29816351829307397,"score_spread":0.26216980039278687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205160401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909462,0.0005678394,0.00029442075,0.0002508479,0.000017549648,0.000021449316,0.0076624854,0.000020516405,0.00021869018],"genre_scores_gemma":[0.99073255,0.00033329325,0.00061816815,0.00014203839,0.00003930682,0.000054223183,0.007891232,0.000012656364,0.00017648244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99646676,0.0016727159,0.00043782103,0.0006112236,0.0004480118,0.00036335914],"domain_scores_gemma":[0.99504,0.0010750828,0.0016650144,0.0011609149,0.0007023412,0.0003566543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033927925,0.00054003013,0.001220761,0.0019539979,0.00049151946,0.0014685455,0.0008030231,0.00074904127,0.0006858442],"category_scores_gemma":[0.008357644,0.00070793845,0.002297268,0.005822134,0.00037128862,0.0017481229,0.0023477247,0.0015032872,0.00024057383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016274893,0.000043503453,0.99508744,0.00006175703,0.0009928364,0.000037825484,0.00027637254,0.00023088926,0.00019075916,0.00004178327,0.0008121677,0.002061852],"study_design_scores_gemma":[0.0000077348595,0.00003516466,0.99880517,0.000011402148,0.00012138721,0.000052765197,0.00027658773,0.00041844457,0.000028807475,0.000025555839,0.000208921,0.0000081003445],"about_ca_topic_score_codex":0.046786502,"about_ca_topic_score_gemma":0.067597546,"teacher_disagreement_score":0.046786502,"about_ca_system_score_codex":0.0010230079,"about_ca_system_score_gemma":0.00091604,"threshold_uncertainty_score":0.09302831},"labels":[],"label_agreement":null},{"id":"W4210910136","doi":"10.1016/s2213-8587(22)00036-5","title":"An inter-humanitarian agency study of diabetes care and surveillance in humanitarian settings","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Migration, Health and Trauma","field":"Psychology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Refugee; Forced migration; Medicine; Scopus; Internally displaced person; Population; Humanitarian aid; Humanitarian crisis; Declaration; Displaced person; Economic growth; Political science; Environmental health; MEDLINE; Law; Economics","score_opus":0.02775117999578486,"score_gpt":0.3073087316220232,"score_spread":0.27955755162623835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210910136","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34678897,0.002440945,0.00019993138,0.63578534,0.003970542,0.00011328024,0.0018061564,0.000016474736,0.008878389],"genre_scores_gemma":[0.6241982,0.002577254,0.0004291505,0.36093792,0.003910504,0.0005630253,0.00041740353,0.000037697904,0.006928907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952402,0.0031615167,0.00030779935,0.00021309986,0.00032346183,0.0007540053],"domain_scores_gemma":[0.9783683,0.009411112,0.0029564733,0.0009797383,0.0018169344,0.006467371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057173157,0.0002697691,0.00041704517,0.00056334585,0.004263665,0.0026089647,0.001000839,0.0075662523,0.003552229],"category_scores_gemma":[0.018748162,0.00070062897,0.00046360344,0.002055614,0.001683707,0.0020585125,0.0020508128,0.0083439415,0.00062806025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011558259,0.0010775955,0.5629417,0.0003092835,0.00021681351,0.0042212023,0.02035854,0.00010974902,0.00032138565,0.0019900054,0.38544306,0.021854956],"study_design_scores_gemma":[0.0007689001,0.0011452978,0.7312567,0.0010849338,0.0002306585,0.0022523494,0.14408606,0.00056988077,0.00022688677,0.0026974694,0.11546627,0.00021454183],"about_ca_topic_score_codex":0.066003494,"about_ca_topic_score_gemma":0.14089994,"teacher_disagreement_score":0.066003494,"about_ca_system_score_codex":0.002744402,"about_ca_system_score_gemma":0.007313595,"threshold_uncertainty_score":0.13123864},"labels":[],"label_agreement":null},{"id":"W4210931643","doi":"10.1016/s2213-8587(21)00349-1","title":"Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":133,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Stanford Cardiovascular Institute, School of Medicine, Stanford University; Fogarty International Center; Research Management Centre, International Islamic University Malaysia; Centre for Heart Rhythm Disorders, University of Adelaide; Russian Academy of Sciences; National Health and Medical Research Council; Medical Research Council; Sydney Medical School; Manchester Biomedical Research Centre; Samsung; George Institute for Global Health; Universitas Padjadjaran; Jahrom University of Medical Sciences; University of Jeddah; Universiti Sultan Zainal Abidin; National Institute of Diabetes and Digestive and Kidney Diseases; Menzies Institute for Medical Research; Walailak University; Universität Ulm; Xiamen University; Pomorski Uniwersytet Medyczny W Szczecinie; Division of Mathematical Sciences; Universitas Airlangga; Southeast University; Student Research Committee, Tabriz University of Medical Sciences; Shahjalal University of Science and Technology; Madras Diabetes Research Foundation; University of Health and Allied Sciences; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Universidad Autónoma del Estado de Morelos; China Medical University; National Taiwan Normal University; University of Toronto; Université de Genève; University of Technology Sydney; Universitas Indonesia; United Arab Emirates University; University Of Nigeria Nsukka; Shahid Beheshti University of Medical Sciences; Directorate for Biological Sciences; Göteborgs Universitet; University Grants Commission; Universitetet i Oslo; I.M. Sechenov First Moscow State Medical University; Bangladesh University of Health Sciences; Shahrekord University of Medical Sciences; Kermanshah University of Medical Sciences; Shahrekord University; National Institutes of Health; Chinese University of Hong Kong; Haramaya University; Curtin University of Technology; Universiti Sains Malaysia; Universiti Kebangsaan Malaysia; Università degli Studi del Piemonte Orientale; Centro de Investigación Biomédica en Red de Salud Mental; University of Gondar; University of Tasmania; University of Waterloo; Tehran University of Medical Sciences and Health Services; Universiti Malaya; Sultan Qaboos University; Seoul National University Hospital; King Abdulaziz University; Università degli Studi di Milano; Arak University of Medical Sciences; Karolinska Institutet; Istituto di Ricerche Farmacologiche Mario Negri - IRCCS; National Heart Foundation of Australia; Institució Catalana de Recerca i Estudis Avançats; Uppsala Universitet; University of Calcutta; American University of Sharjah; Universidad Nacional Autónoma de México; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; Kuwait University; Department of Social Services, Australian Government; Universiteit Utrecht; National Natural Science Foundation of China; Khalifa University of Science, Technology and Research; Indian Council of Medical Research; University College London; Amity University; Northwell Health; Tribhuvan University; Mashhad University of Medical Sciences; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja; Anhui Provincial Key Research and Development Plan; Australian Catholic University; Imperial College London; King's College London; Centre Hospitalier Universitaire Vaudois; Seoul National University; University of Oxford; Chandigarh University; Tulane University; Iran University of Medical Sciences; Novo Nordisk Fonden; Department of Health and Social Care; McMaster University; University of Leicester; Akademiska Sjukhuset; Universidade Federal do Rio Grande do Sul; Deutsches Krebsforschungszentrum; Harvard University; University of Wollongong; Babol University of Medical Sciences; York University; Washington University in St. Louis; Monash University; South Eastern Sydney Local Health District; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Social Science Research Council; Trường Đại học Duy Tân; Bill and Melinda Gates Foundation; University of Washington; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Univerzita Karlova v Praze; Imam Abdulrahman Bin Faisal University; University of Georgia; Samara University; Jordan University of Science and Technology; New Mexico State University; U.S. Department of Veterans Affairs; Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Jazan University; University of New South Wales; Department of Biotechnology, Ministry of Science and Technology, India; Hamad Medical Corporation; Universidade Federal de Juiz de Fora; Deakin University; Helsingin Yliopisto; Brigham and Women's Hospital; Department of Anthropology, University of California, Los Angeles; Universidade de São Paulo; Krishna Institute Of Medical Sciences Deemed To Be University; Tufts Medical Center; National Institute for Health and Care Research; Charles Sturt University; Universitatea din București; La Trobe University","keywords":"Burden of disease; Diabetes mellitus; Disease burden; MEDLINE; Disease; Quality-adjusted life year","score_opus":0.0230933414455301,"score_gpt":0.2986359036999356,"score_spread":0.2755425622544055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210931643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73639596,0.038815357,0.001430845,0.00367236,0.0005300634,0.00018090967,0.2125031,0.00012594313,0.006345442],"genre_scores_gemma":[0.9069251,0.0060848817,0.0006193948,0.00067809137,0.00023340108,0.00020147391,0.084595285,0.00003787836,0.0006244946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849343,0.00041463785,0.00027671905,0.00026015885,0.00034610773,0.00020888408],"domain_scores_gemma":[0.997825,0.0003185038,0.00093896803,0.00016607915,0.0005033998,0.00024802025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002667793,0.00048812624,0.00080412725,0.00369406,0.0003314574,0.0009641741,0.00057078747,0.0005379407,0.0016409929],"category_scores_gemma":[0.0045789257,0.00026738312,0.0020246222,0.009970283,0.00024742648,0.00083679444,0.001413857,0.0010379644,0.00049773935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016911657,0.000018376933,0.9853719,0.00031563186,0.00089208776,0.00009592686,0.00015589542,0.0005050894,0.00006498434,0.0002262117,0.006660435,0.0055244304],"study_design_scores_gemma":[0.000014517696,0.000024208799,0.9955167,0.00011600116,0.00019665826,0.00010566358,0.0002035055,0.0005511847,0.000019350979,0.00011340611,0.0031253612,0.000013313221],"about_ca_topic_score_codex":0.04388994,"about_ca_topic_score_gemma":0.037451077,"teacher_disagreement_score":0.04388994,"about_ca_system_score_codex":0.0012946307,"about_ca_system_score_gemma":0.0011332586,"threshold_uncertainty_score":0.08726895},"labels":[],"label_agreement":null},{"id":"W4221054266","doi":"10.1016/s2213-8587(22)00102-4","title":"Diabetes in Pakistan: addressing the crisis","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Diabetes mellitus; Scopus; Type 2 diabetes; Disease; Population; MEDLINE; Global health","score_opus":0.04572336816902314,"score_gpt":0.31325552120111166,"score_spread":0.26753215303208855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221054266","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029728962,0.046982147,0.00012985108,0.9336658,0.011432973,0.000008156645,0.00046651598,0.000031523374,0.004310169],"genre_scores_gemma":[0.14739439,0.22588608,0.0013166347,0.54687333,0.07132837,0.00007690189,0.00084163464,0.000051052273,0.0062315487],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784184,0.00042447538,0.00019863044,0.00017984888,0.00038892546,0.00096618064],"domain_scores_gemma":[0.98786074,0.0021499186,0.0012912255,0.00021450309,0.00176967,0.0067140316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057198885,0.000997837,0.0014111801,0.001227719,0.0028194902,0.0061218003,0.0014091006,0.012235682,0.01607993],"category_scores_gemma":[0.009605568,0.00042465865,0.00080463855,0.001884171,0.0028229419,0.006599562,0.0057294234,0.011522739,0.0025148094],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000543509,0.000410128,0.018531298,0.0027676655,0.00019719204,0.0019389486,0.0014844768,0.00035806658,0.0006988685,0.018150225,0.7325355,0.22238411],"study_design_scores_gemma":[0.00064396666,0.00045198534,0.075137645,0.0050562597,0.0002703374,0.0015370704,0.016091783,0.00054354174,0.00027681031,0.034327358,0.8654904,0.00017274324],"about_ca_topic_score_codex":0.036414143,"about_ca_topic_score_gemma":0.035608362,"teacher_disagreement_score":0.036414143,"about_ca_system_score_codex":0.0043841926,"about_ca_system_score_gemma":0.025343427,"threshold_uncertainty_score":0.072404385},"labels":[],"label_agreement":null},{"id":"W4223922377","doi":"10.1016/s2213-8587(22)00043-2","title":"Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; St. Michael's Hospital","funders":"Janssen Pharmaceuticals; Seventh Framework Programme; Novo Nordisk; Boston Scientific Corporation; AstraZeneca; Biotronik; Bristol-Myers Squibb; Cleveland Clinic; Sanofi; Cardiological Society of India; Novartis; Merck; Mayo Clinic; Bayer; Abbott Laboratories; CSL Behring; Roche; St. Jude Medical; Astellas Pharma US; Philips; Pfizer; Boehringer Ingelheim; Amgen; National Institutes of Health; Regeneron Pharmaceuticals; Hartstichting; American Heart Association","keywords":"Alirocumab; Randomized controlled trial; MEDLINE; Acute coronary syndrome; Diabetes mellitus; Cardiovascular event","score_opus":0.008161324328906525,"score_gpt":0.24630018301507098,"score_spread":0.23813885868616447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223922377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98388356,0.009482116,0.0008185836,0.00066913,0.00088024116,0.0008924141,0.001654056,0.00008652701,0.0016333348],"genre_scores_gemma":[0.9923332,0.0021275703,0.0008388583,0.0005854916,0.00050937536,0.00085961,0.0010089356,0.000034033725,0.0017029591],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99736375,0.0016653485,0.00017177552,0.000377621,0.000121621706,0.00029988508],"domain_scores_gemma":[0.99686027,0.0015848937,0.00059999106,0.00038589866,0.00015959992,0.00040939762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037575818,0.002696312,0.008243591,0.0003972858,0.00057647325,0.002216763,0.0011099413,0.0014228433,0.005864449],"category_scores_gemma":[0.005850809,0.0009938537,0.0067737536,0.00046032848,0.0013637545,0.0015927796,0.0012927325,0.0037005981,0.0004972327],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98837143,0.00032834575,0.0009551653,0.0006989425,0.007012881,0.000025534442,0.000029274264,0.00014352916,0.00029060154,0.000065558896,0.00026358804,0.0018152639],"study_design_scores_gemma":[0.9636994,0.011136362,0.0076033613,0.000104057326,0.01577298,0.00003085377,0.0000702241,0.00061907485,0.00019140971,0.00027511103,0.00045746734,0.000039786806],"about_ca_topic_score_codex":0.0028504138,"about_ca_topic_score_gemma":0.0042399885,"teacher_disagreement_score":0.008243591,"about_ca_system_score_codex":0.0010117954,"about_ca_system_score_gemma":0.0010833844,"threshold_uncertainty_score":0.019872248},"labels":[],"label_agreement":null},{"id":"W4224992810","doi":"10.1016/s2213-8587(22)00132-2","title":"The uncomfortable truth about kidney disease in type 1 diabetes","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Type 1 diabetes; Kidney disease; Diabetes mellitus; MEDLINE; Disease; Kidney","score_opus":0.02614908274759208,"score_gpt":0.2937284711619155,"score_spread":0.26757938841432344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224992810","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003553272,0.075633176,0.00017997267,0.88077587,0.041152835,0.0000023978364,0.00009856424,0.00001560883,0.001786204],"genre_scores_gemma":[0.027572488,0.13851555,0.0006387416,0.56662875,0.26428133,0.000023621,0.00013959491,0.000074870775,0.0021250185],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9803981,0.009422579,0.002454204,0.0013772786,0.0050917827,0.0012560036],"domain_scores_gemma":[0.8736892,0.0937397,0.0070660403,0.0039760605,0.01241727,0.00911167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03183567,0.0008998391,0.0031354348,0.0020239952,0.0032739735,0.009097391,0.0025040135,0.016349396,0.008973323],"category_scores_gemma":[0.12423568,0.00092328526,0.0016448762,0.001821986,0.012782134,0.014339483,0.0051434427,0.041261725,0.0029484075],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029952003,0.00007944154,0.001662025,0.0024287861,0.0003242317,0.00056652265,0.0014392552,0.00017122478,0.0002155326,0.033252217,0.8657579,0.09380338],"study_design_scores_gemma":[0.00040485032,0.00017316036,0.004628605,0.007881557,0.0003638158,0.001482933,0.0033912754,0.00022513811,0.00023295628,0.17300746,0.80800915,0.00019907171],"about_ca_topic_score_codex":0.0067699915,"about_ca_topic_score_gemma":0.0074714064,"teacher_disagreement_score":0.03183567,"about_ca_system_score_codex":0.0038679724,"about_ca_system_score_gemma":0.006991132,"threshold_uncertainty_score":0.16836518},"labels":[],"label_agreement":null},{"id":"W4245779733","doi":"10.1016/s2213-8587(19)30089-0","title":"Change in albuminuria as a surrogate endpoint in chronic kidney disease","year":2019,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Impact; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Albuminuria; Observational study; Randomized controlled trial; Surrogate endpoint; Kidney disease; Clinical endpoint; Diabetes mellitus; Internal medicine; Meta-analysis; Type 2 diabetes; Clinical trial; Scopus; Diabetic nephropathy; MEDLINE; Intensive care medicine; Kidney; Endocrinology","score_opus":0.034776815643785486,"score_gpt":0.3002612151051312,"score_spread":0.2654843994613457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4245779733","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007011398,0.0023920508,0.00011803147,0.9614305,0.03284648,0.000009696544,0.00018561965,0.000018576031,0.0022978364],"genre_scores_gemma":[0.013252178,0.0020267314,0.0003501764,0.83879244,0.14192587,0.000092633665,0.00012956726,0.00003037348,0.0034000177],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9893232,0.005250608,0.0015041007,0.00064447365,0.0024471774,0.000830534],"domain_scores_gemma":[0.9589416,0.027988806,0.0024244634,0.0008382357,0.005570427,0.0042363876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008362118,0.0007197188,0.002573972,0.0013014389,0.0021030607,0.004251913,0.001323018,0.027964924,0.003656501],"category_scores_gemma":[0.06270379,0.00062732317,0.0012762655,0.0014444147,0.002442347,0.0023500847,0.0012428837,0.033555157,0.0046023885],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004140665,0.000082134284,0.005125774,0.00014044612,0.00005697898,0.0008455527,0.00008618105,0.00007320182,0.00016099004,0.0024947007,0.96724343,0.023276692],"study_design_scores_gemma":[0.0025041332,0.00084153423,0.026379978,0.0029925825,0.0004208813,0.003994452,0.0009203832,0.0041833385,0.0008965517,0.03517264,0.9213252,0.00036834308],"about_ca_topic_score_codex":0.006280875,"about_ca_topic_score_gemma":0.009584017,"teacher_disagreement_score":0.027964924,"about_ca_system_score_codex":0.0047044833,"about_ca_system_score_gemma":0.004329329,"threshold_uncertainty_score":0.044223607},"labels":[],"label_agreement":null},{"id":"W4250378947","doi":"10.1016/s2213-8587(17)30115-8","title":"Insulin affordability","year":2017,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Hippocratic Oath; Dilemma; Biography; Oath; Classics; Law; Philosophy; Political science; Psychiatry; History; Epistemology","score_opus":0.10115656115893289,"score_gpt":0.30389343822611214,"score_spread":0.20273687706717924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250378947","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011954549,0.0076228306,0.0004985567,0.917404,0.013577066,0.000012039665,0.00045250906,0.00003625436,0.059201214],"genre_scores_gemma":[0.048588127,0.0048472723,0.00043855645,0.8533963,0.058818873,0.00007321333,0.00037419773,0.00006328911,0.033400167],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961312,0.001003151,0.00027216595,0.0005496677,0.0013725144,0.00067135366],"domain_scores_gemma":[0.98923266,0.006845244,0.00060977315,0.0007053653,0.0011601284,0.001446717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005481998,0.00040061356,0.0010291046,0.00090206496,0.0014916728,0.004210339,0.0010446507,0.017112508,0.0244487],"category_scores_gemma":[0.037475023,0.00034632505,0.0010219684,0.0005879752,0.0035668008,0.002842153,0.0024776738,0.020501515,0.005342103],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022012937,0.000056586054,0.001362124,0.00009656046,0.000037969003,0.0004512587,0.00007380819,0.00017288719,0.00014890877,0.16220063,0.7923737,0.04280544],"study_design_scores_gemma":[0.00021504475,0.00004052646,0.0020545758,0.00042370334,0.000037218128,0.00047967667,0.00011624039,0.0004949651,0.00020632565,0.16258448,0.8333148,0.000032559892],"about_ca_topic_score_codex":0.010176851,"about_ca_topic_score_gemma":0.012717462,"teacher_disagreement_score":0.0244487,"about_ca_system_score_codex":0.00430037,"about_ca_system_score_gemma":0.004270257,"threshold_uncertainty_score":0.08178902},"labels":[],"label_agreement":null},{"id":"W4280552858","doi":"10.1016/s2213-8587(22)00103-6","title":"Risk factors for lower bone mineral density in older adults with type 1 diabetes: a cross-sectional study","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; Abbott Diabetes Care; National Eye Institute; Roche Diabetes Care; Eli Lilly and Company","keywords":"Medicine; Type 1 diabetes; Diabetes mellitus; Bone mineral; Internal medicine; Cohort; Bone density; Type 2 diabetes; Cross-sectional study; Osteoporosis; Physical therapy; Endocrinology; Pathology","score_opus":0.021152129729333117,"score_gpt":0.29249511719444765,"score_spread":0.27134298746511454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280552858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770606,0.0008526993,0.00009902825,0.000108317705,0.00003484686,0.000016563507,0.0007464989,0.000005726663,0.00043019172],"genre_scores_gemma":[0.9981692,0.00041536885,0.00012990796,0.00017170106,0.000047832873,0.000024163639,0.00062872487,0.0000029039272,0.00041012678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993587,0.00016771255,0.00008421335,0.00019011267,0.00009442445,0.00010472138],"domain_scores_gemma":[0.9983662,0.00024188965,0.0005753375,0.00019812548,0.00021155775,0.0004068831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012266512,0.00062397437,0.0007824062,0.000663317,0.0006636047,0.0012287229,0.0006083411,0.0016895344,0.0015933712],"category_scores_gemma":[0.0024187278,0.0011301958,0.0012102725,0.0016272484,0.00033078977,0.00089419,0.0006146052,0.0018052136,0.00039078487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019282973,0.00013504915,0.9985252,0.000017697861,0.0003064252,0.000043762167,0.000078204896,0.000013505308,0.00014470764,0.000007715484,0.000101272424,0.0004335635],"study_design_scores_gemma":[0.000017746604,0.00011958053,0.9993826,0.0000063997168,0.000116734496,0.00007922952,0.00013860264,0.00004466472,0.000010794585,0.000008783656,0.00007118837,0.0000036733875],"about_ca_topic_score_codex":0.017972218,"about_ca_topic_score_gemma":0.020682022,"teacher_disagreement_score":0.017972218,"about_ca_system_score_codex":0.00038941225,"about_ca_system_score_gemma":0.0003583162,"threshold_uncertainty_score":0.03573525},"labels":[],"label_agreement":null},{"id":"W4280558719","doi":"10.1016/s2213-8587(22)00114-0","title":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Immune Tolerance Network; Diabetes Canada; Alberta Diabetes Foundation; University of Alberta; Government of Alberta; Canada Research Chairs; Juvenile Diabetes Research Foundation Canada","keywords":"Medicine; Transplantation; Islet; Pancreas transplantation; Cohort; Diabetes mellitus; Internal medicine; Surgery; Type 1 diabetes; Cohort study; Type 2 diabetes; Kidney transplantation; Insulin; Endocrinology","score_opus":0.0204130542818517,"score_gpt":0.23255893114146117,"score_spread":0.21214587685960948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280558719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941169,0.0016205219,0.00012450528,0.000834981,0.000039272865,0.000037149763,0.001577333,0.000009778632,0.0016395005],"genre_scores_gemma":[0.9957217,0.0018275834,0.00015096973,0.0003522149,0.000022059878,0.000013243167,0.0011273316,0.00001697922,0.00076782535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843377,0.0000912442,0.00006564844,0.00022503009,0.0004187426,0.0007655719],"domain_scores_gemma":[0.996209,0.0002015649,0.0005912886,0.00016524945,0.0014367567,0.001396096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010721224,0.00049701636,0.0008305625,0.0007643521,0.003477074,0.0027948006,0.0017404999,0.00081430725,0.0017812245],"category_scores_gemma":[0.0030759634,0.00055757817,0.00084537274,0.0040078657,0.0012274944,0.00080249715,0.001562368,0.0013148322,0.00037281233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015603783,0.00007552616,0.99089336,0.000036886977,0.00010545478,0.00059978553,0.0019267916,0.000058531707,0.00021642435,0.00007645346,0.0015840975,0.0042706705],"study_design_scores_gemma":[0.000026045724,0.00008481099,0.99182206,0.000084762316,0.00010311201,0.0006412994,0.005640984,0.00017669235,0.00006158649,0.0000516928,0.0012766332,0.000030384106],"about_ca_topic_score_codex":0.97721297,"about_ca_topic_score_gemma":0.98415023,"teacher_disagreement_score":0.97721297,"about_ca_system_score_codex":0.02423146,"about_ca_system_score_gemma":0.033940807,"threshold_uncertainty_score":0.17581242},"labels":[],"label_agreement":null},{"id":"W4280595184","doi":"10.1016/s2213-8587(22)00135-8","title":"Osilodrostat for the treatment of Cushing's disease: efficacy, stability, and persistence – Authors' reply","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"U.S. Food and Drug Administration","keywords":"Medicine; Persistence (discontinuity); Cushing's disease; Intensive care medicine; Disease; Internal medicine","score_opus":0.06136103035449662,"score_gpt":0.29458095468939227,"score_spread":0.23321992433489563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280595184","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00037303322,0.0030817816,0.000046308043,0.9646936,0.030957036,0.000007657521,0.0000802651,0.000015374111,0.00074485363],"genre_scores_gemma":[0.0030511683,0.0014397517,0.00009489095,0.935565,0.057773877,0.000026968557,0.00003282557,0.00001510069,0.0020004802],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966949,0.0011191284,0.00061220425,0.00038271816,0.0008795297,0.00031146486],"domain_scores_gemma":[0.9844715,0.011480925,0.00091614295,0.00035335822,0.0017929906,0.0009851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043556252,0.0006355994,0.0021877727,0.00082500157,0.0020047105,0.0025497223,0.0015992686,0.040580448,0.0034284764],"category_scores_gemma":[0.02600054,0.00069734425,0.0015261633,0.0007588237,0.002329248,0.0031136747,0.0011128399,0.03801735,0.00287925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031073837,0.000046179426,0.0007448289,0.000119782264,0.00006053464,0.0012922626,0.00012086791,0.000055033535,0.00016677624,0.0013948146,0.9850429,0.010645317],"study_design_scores_gemma":[0.0008878051,0.0002749864,0.003599702,0.0006133448,0.00019279083,0.002693702,0.0004891065,0.00052894885,0.0005139339,0.007758398,0.9822521,0.00019509278],"about_ca_topic_score_codex":0.004094983,"about_ca_topic_score_gemma":0.0062487195,"teacher_disagreement_score":0.040580448,"about_ca_system_score_codex":0.0029809477,"about_ca_system_score_gemma":0.00243234,"threshold_uncertainty_score":0.02303499},"labels":[],"label_agreement":null},{"id":"W4286615932","doi":"10.1016/s2213-8587(22)00172-3","title":"Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"NIHR Oxford Biomedical Research Centre; National Heart, Lung, and Blood Institute; Oxford Martin School, University of Oxford; National Health and Medical Research Council; Medical Research Council; National Institutes of Health; National Heart and Lung Institute; British Heart Foundation; University of Bristol; National Institute for Health and Care Research; UK Research and Innovation","keywords":"Medicine; Blood pressure; Type 2 diabetes; Hazard ratio; Diabetes mellitus; Myocardial infarction; Heart failure; Internal medicine; Cardiology; Stroke (engine); Placebo; Proportional hazards model; Intensive care medicine; Emergency medicine; Confidence interval; Endocrinology","score_opus":0.23440019593656794,"score_gpt":0.3462705530180301,"score_spread":0.11187035708146217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286615932","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023541754,0.96031356,0.008366316,0.0008361465,0.0010609297,0.0013962773,0.0032100708,0.00028789116,0.0009870251],"genre_scores_gemma":[0.7031295,0.26287898,0.017662356,0.003568632,0.00088054483,0.0061848336,0.004149053,0.0003213506,0.0012248072],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.96429116,0.025715217,0.0047253305,0.0028594686,0.0018086338,0.00060014334],"domain_scores_gemma":[0.9673535,0.025345024,0.0034362555,0.0020511395,0.0014495231,0.0003645783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.038291987,0.0035755427,0.02411083,0.004701011,0.0005247014,0.0043806457,0.0027589523,0.0027210824,0.0034590815],"category_scores_gemma":[0.060883228,0.0016997408,0.06768404,0.0049444446,0.0009005809,0.0022778497,0.0019274381,0.0034469652,0.00036202586],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003798946,0.0000173442,0.0016392042,0.035090968,0.95526683,0.000037900092,0.000025331534,0.0006630773,0.00012410086,0.0001060468,0.00032736282,0.0029028307],"study_design_scores_gemma":[0.0020651973,0.00021908114,0.0016193757,0.0024450526,0.992094,0.00004145534,0.00001213885,0.00033705798,0.00008583236,0.0003528351,0.00071038975,0.000017583168],"about_ca_topic_score_codex":0.0059823804,"about_ca_topic_score_gemma":0.007066097,"teacher_disagreement_score":0.038291987,"about_ca_system_score_codex":0.0022401828,"about_ca_system_score_gemma":0.0020554007,"threshold_uncertainty_score":0.20250982},"labels":[],"label_agreement":null},{"id":"W4293123356","doi":"10.1016/s2213-8587(22)00215-7","title":"Association between fetal abdominal growth trajectories, maternal metabolite signatures early in pregnancy, and childhood growth and adiposity: prospective observational multinational INTERBIO-21st fetal study","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Medical Research Council; Manchester Biomedical Research Centre; National Institutes of Health; University of Oxford; Department of Health and Social Care; Universidade Federal de Pelotas; National Institute for Health and Care Research; Bill and Melinda Gates Foundation","keywords":"Medicine; Observational study; Fetus; Pregnancy; Fetal growth; Obstetrics; Prospective cohort study; Internal medicine","score_opus":0.01928195400498602,"score_gpt":0.27072988263613584,"score_spread":0.25144792863114984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293123356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978005,0.00018718661,0.00016475988,0.00003107362,0.0000037747193,0.000013561137,0.0016104779,0.000004681252,0.00018383608],"genre_scores_gemma":[0.99722147,0.00017711241,0.00031458528,0.000038131835,0.000006436847,0.00005192987,0.0019590382,0.0000051428174,0.00022614817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942565,0.00019844375,0.00006483668,0.00016332958,0.00007530948,0.00007244832],"domain_scores_gemma":[0.9983475,0.0003412705,0.0006047096,0.00037485917,0.00012054708,0.00021104922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014882534,0.0004575747,0.0003941348,0.0004459269,0.0005085015,0.00064491096,0.00059059216,0.0006230355,0.0009059858],"category_scores_gemma":[0.0026368618,0.0005787304,0.00054652017,0.001045105,0.00032273328,0.0004106843,0.0007416568,0.0008273661,0.00024062245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019251843,0.000034774203,0.9988242,0.0000066338052,0.00007811841,0.00002946296,0.000053865762,0.00004132143,0.00017337296,0.000010364026,0.00006866787,0.000486735],"study_design_scores_gemma":[0.000008876574,0.00009528402,0.9993523,0.000005728284,0.00003604773,0.000093568844,0.00007656206,0.0001726551,0.000045480334,0.00001026058,0.000100282625,0.000002926575],"about_ca_topic_score_codex":0.01335594,"about_ca_topic_score_gemma":0.012344416,"teacher_disagreement_score":0.01335594,"about_ca_system_score_codex":0.00038291325,"about_ca_system_score_gemma":0.00039201244,"threshold_uncertainty_score":0.026556373},"labels":[],"label_agreement":null},{"id":"W4294215976","doi":"10.1016/s2213-8587(22)00245-5","title":"Improving HbA1c levels with advanced hybrid closed-loop therapy","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Medicine; MEDLINE; Closed loop; Loop (graph theory); Intensive care medicine; Control engineering","score_opus":0.0446649232797819,"score_gpt":0.293441512680277,"score_spread":0.24877658940049513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294215976","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019687468,0.007147577,0.0011841947,0.9522377,0.02885111,0.000029425748,0.000082470375,0.00010467673,0.00839408],"genre_scores_gemma":[0.025498439,0.004295371,0.0014188905,0.8652018,0.09707544,0.000088135625,0.00006255435,0.000038993527,0.00632038],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99786973,0.00068455964,0.0002288808,0.00023684949,0.00080190395,0.00017812884],"domain_scores_gemma":[0.9949168,0.0037834079,0.0002192988,0.00013217283,0.0004605988,0.0004876482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022877923,0.00079446915,0.0016458554,0.00042733175,0.0010992651,0.0023880827,0.0008516703,0.018767128,0.004247224],"category_scores_gemma":[0.012326674,0.0003221707,0.0014761413,0.00044187528,0.0018329064,0.0021089069,0.0008915072,0.019100124,0.003574651],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014876942,0.00029132207,0.0020439164,0.00026800158,0.00014824497,0.0045988425,0.00018447361,0.00039936387,0.0010612975,0.006315646,0.83822274,0.14497839],"study_design_scores_gemma":[0.0030491103,0.0013825453,0.0049579763,0.0009294757,0.00020992462,0.010171526,0.00039427742,0.004028623,0.0010970706,0.043015223,0.93060094,0.00016327911],"about_ca_topic_score_codex":0.0017625534,"about_ca_topic_score_gemma":0.0032281731,"teacher_disagreement_score":0.018767128,"about_ca_system_score_codex":0.0021543487,"about_ca_system_score_gemma":0.0009646951,"threshold_uncertainty_score":0.01563096},"labels":[],"label_agreement":null},{"id":"W4294967762","doi":"10.1016/s2213-8587(22)00254-6","title":"PCSK9 inhibition in children with familial hypercholesterolaemia","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Canadian Institutes of Health Research; Academic Medical Organization of Southwestern Ontario; Heart and Stroke Foundation of Canada","keywords":"Medicine; MEDLINE; PCSK9; Pediatrics; Internal medicine; Cholesterol; LDL receptor","score_opus":0.01879361050873658,"score_gpt":0.24641889897606134,"score_spread":0.22762528846732477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294967762","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0126029095,0.01661923,0.00022097267,0.93839,0.022044325,0.00001877227,0.00032518583,0.00009506218,0.00968347],"genre_scores_gemma":[0.11124242,0.017030217,0.00072859006,0.780952,0.077772275,0.00008146156,0.00039541608,0.00007874929,0.011718977],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901354,0.00019136355,0.00016013073,0.000118374024,0.00030325403,0.00021329343],"domain_scores_gemma":[0.9975424,0.0012257436,0.00022551659,0.00005929312,0.00025367044,0.00069354207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007419385,0.00069863035,0.0016524264,0.0005581612,0.001461821,0.0012627208,0.00070050446,0.013194538,0.003428558],"category_scores_gemma":[0.007934713,0.00045946336,0.0012169947,0.0006697653,0.0011945462,0.00077937345,0.0006229518,0.01425295,0.0017845079],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087328244,0.00018083386,0.027071416,0.00038040907,0.00028646158,0.052588224,0.00040174683,0.00025968775,0.0014984885,0.0035896695,0.848085,0.06478471],"study_design_scores_gemma":[0.0034961894,0.0015755007,0.08510819,0.0027594613,0.0011766731,0.1446038,0.0013639048,0.001709853,0.001960583,0.012931325,0.7431001,0.00021436832],"about_ca_topic_score_codex":0.01377666,"about_ca_topic_score_gemma":0.018810613,"teacher_disagreement_score":0.01377666,"about_ca_system_score_codex":0.0025407968,"about_ca_system_score_gemma":0.0023306822,"threshold_uncertainty_score":0.027392924},"labels":[],"label_agreement":null},{"id":"W4294967876","doi":"10.1016/s2213-8587(22)00221-2","title":"Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Chicoutimi; Centre hospitalier universitaire de Québec","funders":"HLS Therapeutics; Amgen; ZonMw; Sanofi; Kowa Company; Novo Nordisk; Medicines Company; F. Hoffmann-La Roche; Abbott Laboratories; Regeneron Pharmaceuticals; Novartis; Pfizer","keywords":"Medicine; Evolocumab; Placebo; Adverse effect; Randomized controlled trial; Clinical endpoint; Internal medicine; Population; Cholesterol; Lipoprotein; Pathology","score_opus":0.03278071262394313,"score_gpt":0.26891457946732217,"score_spread":0.23613386684337903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294967876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98086965,0.012308064,0.00073497713,0.00068676105,0.0005715076,0.0021299347,0.00095435715,0.000065665445,0.0016789647],"genre_scores_gemma":[0.98565996,0.004742766,0.0030169114,0.001000285,0.00033320024,0.0029621474,0.0008518464,0.00002238453,0.0014105224],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.998533,0.0007709197,0.0001435399,0.0002477736,0.00010832233,0.00019644649],"domain_scores_gemma":[0.9988096,0.00036717154,0.00036749244,0.00016169628,0.00007514644,0.00021898755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028211153,0.0014458866,0.0036209987,0.0002894193,0.00041207115,0.0010073786,0.0006173683,0.0017109188,0.005082486],"category_scores_gemma":[0.0029071951,0.00054600555,0.004655954,0.00032982556,0.0009616833,0.0014176605,0.0008700888,0.0024892148,0.00055270985],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9374092,0.0037235392,0.0044728857,0.0043935142,0.0073387753,0.00029361565,0.00028682553,0.00035013922,0.0030145932,0.00040675412,0.001131005,0.037179098],"study_design_scores_gemma":[0.92688644,0.053679824,0.011366942,0.00050859415,0.00464767,0.00020472684,0.00014960405,0.00020338486,0.00041869158,0.00031875103,0.0015655876,0.000049752656],"about_ca_topic_score_codex":0.0012257729,"about_ca_topic_score_gemma":0.0027492389,"teacher_disagreement_score":0.005082486,"about_ca_system_score_codex":0.0006633435,"about_ca_system_score_gemma":0.0011435716,"threshold_uncertainty_score":0.017002642},"labels":[],"label_agreement":null},{"id":"W4296162804","doi":"10.1016/s2213-8587(22)00218-2","title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1092,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juvenile Diabetes Research Foundation","funders":"Sydney Medical School; Abbott Diabetes Care; Juvenile Diabetes Research Foundation United States of America; Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Medicine; Life expectancy; Incidence (geometry); Demography; Type 2 diabetes; Population; Diabetes mellitus; Mortality rate; Public health; Gerontology; Pediatrics; Environmental health; Internal medicine","score_opus":0.044153837155462526,"score_gpt":0.33003364645539196,"score_spread":0.28587980929992945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296162804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96715,0.0007647498,0.007948732,0.0015325141,0.00008366887,0.00008831793,0.017812448,0.00019167454,0.004427903],"genre_scores_gemma":[0.9879233,0.00041082595,0.0028889342,0.000113180424,0.000020128977,0.0001478762,0.0072057075,0.000029794779,0.0012602141],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99928063,0.00042550435,0.00003273371,0.00011144431,0.000045526893,0.00010421379],"domain_scores_gemma":[0.9982029,0.0010576561,0.00021092348,0.00021342096,0.00020403301,0.00011088322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002158537,0.0008589281,0.000787693,0.0007023367,0.00033752833,0.0008722362,0.0016713302,0.0011660713,0.0029957003],"category_scores_gemma":[0.0037289362,0.00072427787,0.0033124085,0.0015058331,0.00038048925,0.0007752004,0.00081630895,0.0013256056,0.0007307101],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026090133,0.00055697147,0.15819989,0.0004283336,0.0024810396,0.00056887296,0.00044513275,0.80585384,0.00043954817,0.005687289,0.010190331,0.01253975],"study_design_scores_gemma":[0.0007007748,0.0006371858,0.14806996,0.00024914843,0.0014852559,0.0006689729,0.0007780355,0.83244914,0.00037717482,0.008849782,0.00553333,0.00020130987],"about_ca_topic_score_codex":0.08602154,"about_ca_topic_score_gemma":0.048584025,"teacher_disagreement_score":0.08602154,"about_ca_system_score_codex":0.0019876144,"about_ca_system_score_gemma":0.0015055335,"threshold_uncertainty_score":0.17104167},"labels":[],"label_agreement":null},{"id":"W4296578151","doi":"10.1016/s2213-8587(22)00243-1","title":"Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":279,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"Eli Lilly and Company","keywords":"Medicine; Insulin glargine; Type 2 diabetes; Post-hoc analysis; Renal function; Internal medicine; Diabetes mellitus; Population; Metformin; Creatinine; Albuminuria; Insulin; Endocrinology","score_opus":0.04109852164761659,"score_gpt":0.3567662093372237,"score_spread":0.3156676876896071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296578151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99038166,0.0044912086,0.0006247971,0.00060757383,0.00056827825,0.0007050246,0.0009265897,0.000110484296,0.0015845294],"genre_scores_gemma":[0.9921038,0.0017504948,0.0009946995,0.0005385305,0.00041735396,0.00087099086,0.0010702057,0.000049092414,0.002204737],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99796474,0.0013766638,0.000096119584,0.00023243015,0.00008916328,0.00024090233],"domain_scores_gemma":[0.99734604,0.001390575,0.00045586893,0.00027181863,0.00012037539,0.0004154217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003906766,0.0031580296,0.0063673584,0.0003604093,0.00041176841,0.002025367,0.0012765932,0.0015224143,0.0075367223],"category_scores_gemma":[0.004084928,0.0008600659,0.0059221494,0.000376869,0.0014822248,0.002095798,0.0008349757,0.005159584,0.0009852172],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.994042,0.00039260244,0.0002234833,0.00025266924,0.00198504,0.000015657939,0.000022214068,0.00018132884,0.00048093894,0.000061194194,0.00018970217,0.0021530655],"study_design_scores_gemma":[0.96259475,0.029775383,0.0028423811,0.000042868396,0.0031661734,0.000025388514,0.00005627233,0.00062516466,0.0002569189,0.0002878146,0.00029679903,0.000030056448],"about_ca_topic_score_codex":0.0016288164,"about_ca_topic_score_gemma":0.0029103665,"teacher_disagreement_score":0.0075367223,"about_ca_system_score_codex":0.0011007037,"about_ca_system_score_gemma":0.0010370234,"threshold_uncertainty_score":0.025212824},"labels":[],"label_agreement":null},{"id":"W4297989537","doi":"10.1016/s2213-8587(22)00252-2","title":"Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"Centers for Disease Control and Prevention; National Institutes of Health; National Health and Medical Research Council; University of Tokyo; National Health Insurance Service; Ministry of Health, Labour and Welfare; Monash University; Diabetes Australia; Steno Diabetes Center Copenhagen","keywords":"Life expectancy; Demography; Type 2 diabetes; Medicine; Population; Jurisdiction; Years of potential life lost; Cohort; Public health; Gerontology; Incidence (geometry); Diabetes mellitus; Environmental health; Political science; Sociology","score_opus":0.014336988114988807,"score_gpt":0.2605917478292352,"score_spread":0.2462547597142464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297989537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99904233,0.00011540893,0.000035827623,0.000041128314,0.0000030280123,0.0000065520935,0.00058325846,0.0000016280453,0.00017090724],"genre_scores_gemma":[0.9989868,0.00012852049,0.00006295766,0.00004617719,0.000008200165,0.000020002017,0.0006333972,0.0000024002338,0.00011160092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991666,0.00036284255,0.00006839935,0.00017104328,0.00010247766,0.0001287785],"domain_scores_gemma":[0.99810493,0.00028838372,0.00073685456,0.00016578185,0.00022733217,0.00047664117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011151843,0.0006334013,0.0005938771,0.0011224326,0.001245234,0.0012567214,0.0009839531,0.0009229317,0.00078242895],"category_scores_gemma":[0.0022004503,0.00053897646,0.0006785199,0.0030094592,0.0007155696,0.0009129142,0.0010786832,0.00094918674,0.00021044818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007651908,0.0000640936,0.9988569,0.000004423475,0.0000946274,0.0000528948,0.00026743923,0.000038884595,0.00005687787,0.0000089410605,0.00012499564,0.00035340246],"study_design_scores_gemma":[0.000010451987,0.000059740352,0.9983726,0.000006054242,0.00006642252,0.000085415835,0.0011310901,0.00015668603,0.000014966285,0.00001220582,0.0000784757,0.000005912067],"about_ca_topic_score_codex":0.09661474,"about_ca_topic_score_gemma":0.09840903,"teacher_disagreement_score":0.09661474,"about_ca_system_score_codex":0.0011352163,"about_ca_system_score_gemma":0.0006414531,"threshold_uncertainty_score":0.19210476},"labels":[],"label_agreement":null},{"id":"W4302759309","doi":"10.1016/s2213-8587(22)00244-3","title":"Acromegaly: pathogenesis, diagnosis, and management","year":2022,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":258,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"Cedars-Sinai Medical Center; Oregon Health and Science University","keywords":"Acromegaly; Medicine; Pathogenesis; Somatotropic cell; Disease; Epidemiology; Growth hormone; Intensive care medicine; Bioinformatics; Hormone; Internal medicine","score_opus":0.0683543178157663,"score_gpt":0.3328417672675932,"score_spread":0.2644874494518269,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302759309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002057453,0.99921024,0.000029900895,0.00026124346,0.00022692875,0.0000018391942,0.000009882278,0.0000032850155,0.00023611647],"genre_scores_gemma":[0.00019266756,0.99890494,0.00006027962,0.0002479569,0.0004030144,0.000002577424,0.000015998945,7.0104795e-7,0.00017177848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996226,0.000076610246,0.00005125339,0.000050705574,0.00016405997,0.00003470529],"domain_scores_gemma":[0.9990277,0.0005253674,0.00016972199,0.000021962805,0.00017522313,0.00008010648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010493972,0.0012754014,0.0026114115,0.0023526328,0.0002543935,0.0016122988,0.0011279554,0.0014030094,0.004966202],"category_scores_gemma":[0.0015872432,0.00036994353,0.0007275112,0.0022551138,0.00067803566,0.0012819201,0.0010254048,0.002801043,0.0022603967],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001693526,0.000056078614,0.00015907991,0.017173221,0.00015082929,0.00013058429,0.000027265138,0.00035326555,0.00057846686,0.0019819918,0.055226695,0.9239932],"study_design_scores_gemma":[0.000108091226,0.00012735142,0.0013634197,0.01332988,0.0003567077,0.0012947657,0.00008180315,0.00015271666,0.00013977883,0.002926712,0.9800796,0.000039126287],"about_ca_topic_score_codex":0.0019295306,"about_ca_topic_score_gemma":0.0043596905,"teacher_disagreement_score":0.004966202,"about_ca_system_score_codex":0.00092705194,"about_ca_system_score_gemma":0.0015609924,"threshold_uncertainty_score":0.016613603},"labels":[],"label_agreement":null},{"id":"W4308374264","doi":"10.1016/s2213-8587(22)00278-9","title":"The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery","year":2022,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"NIHR Leicester Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Medicine; Pandemic; Diabetes mellitus; Psychological intervention; Public health; Disease; Type 2 diabetes; Intensive care medicine; Diabetes management; Environmental health; Gerontology; Coronavirus disease 2019 (COVID-19); Infectious disease (medical specialty); Psychiatry; Internal medicine; Nursing","score_opus":0.22812929012362465,"score_gpt":0.47789464193180814,"score_spread":0.2497653518081835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308374264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006726961,0.98096704,0.000091219554,0.015426152,0.0017848223,0.000009334488,0.00010857629,0.000016497868,0.001529113],"genre_scores_gemma":[0.001224672,0.9899011,0.00025247,0.0071131596,0.0009113748,0.000016911354,0.00009026423,0.000006074337,0.0004839747],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984977,0.00038874766,0.00014158904,0.00010164943,0.0005371754,0.00033309794],"domain_scores_gemma":[0.9940612,0.0033532558,0.00059871614,0.00009298987,0.0011677328,0.0007261489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005073587,0.0013421898,0.0027822147,0.0025154874,0.00063389825,0.003373764,0.0018750117,0.004479783,0.015946673],"category_scores_gemma":[0.008980623,0.00042328695,0.002211281,0.003476484,0.0013403633,0.0037913923,0.0035862462,0.006221345,0.00356824],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018194097,0.0000816509,0.00033420182,0.035360593,0.000567556,0.00014665617,0.00013556599,0.00081864494,0.00031106756,0.02075724,0.20792209,0.73338276],"study_design_scores_gemma":[0.00007670562,0.00010091605,0.0013598407,0.045631405,0.0004062804,0.00017593829,0.00043746558,0.00014568724,0.000104249724,0.009090846,0.94241995,0.00005071131],"about_ca_topic_score_codex":0.018619347,"about_ca_topic_score_gemma":0.036769442,"teacher_disagreement_score":0.018619347,"about_ca_system_score_codex":0.004726047,"about_ca_system_score_gemma":0.018149005,"threshold_uncertainty_score":0.05334699},"labels":[],"label_agreement":null},{"id":"W4308426407","doi":"10.1016/s2213-8587(22)00277-7","title":"Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Genetic and Kidney Cyst Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":182,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institutes of Health","keywords":"Medicine; Placebo; Pediatrics; Internal medicine; Clinical endpoint; Randomized controlled trial; Clinical trial","score_opus":0.017803798191251913,"score_gpt":0.2747634658659727,"score_spread":0.2569596676747208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308426407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269074,0.0037701146,0.00032639212,0.0004387893,0.00034228349,0.0008134567,0.00056710414,0.000070420436,0.0009807816],"genre_scores_gemma":[0.9931599,0.0014650713,0.00061980943,0.00088788685,0.00034930362,0.0012520507,0.0008612234,0.00002092213,0.001383902],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99928504,0.00031761386,0.000059759714,0.0001473676,0.00006001381,0.00013014885],"domain_scores_gemma":[0.9988456,0.0002969413,0.00018995888,0.00009013254,0.000070308386,0.0005072062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018397989,0.0018854756,0.0040534544,0.0005027971,0.0005886691,0.0013382572,0.0009275246,0.003121192,0.005750331],"category_scores_gemma":[0.0018741934,0.0009440172,0.0028424151,0.00039957234,0.0017929741,0.0019834803,0.00050936645,0.0039002206,0.0009576711],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98648816,0.0033817163,0.00046345487,0.000227404,0.00046080767,0.000033112417,0.000036662837,0.00016704547,0.0024038104,0.000040585546,0.00023607023,0.0060611726],"study_design_scores_gemma":[0.9229877,0.0733272,0.0024736307,0.0000201999,0.00028386724,0.000035434252,0.000024142386,0.00025689916,0.00028314127,0.000091175425,0.00019251247,0.000024049456],"about_ca_topic_score_codex":0.00087648974,"about_ca_topic_score_gemma":0.0014038031,"teacher_disagreement_score":0.005750331,"about_ca_system_score_codex":0.00093724317,"about_ca_system_score_gemma":0.00089613,"threshold_uncertainty_score":0.019236743},"labels":[],"label_agreement":null},{"id":"W4308697810","doi":"10.1016/s2213-8587(22)00313-8","title":"Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Population Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Heart failure; Internal medicine; Type 2 diabetes; Glycated hemoglobin; Diabetes mellitus; Coronary artery disease; Impaired glucose tolerance; Cardiology; Endocrinology","score_opus":0.01663995489241324,"score_gpt":0.2617943424152707,"score_spread":0.24515438752285748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308697810","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018940638,0.0058280434,0.0001232342,0.95837176,0.026133418,0.000015241831,0.00031754602,0.00005051848,0.007266233],"genre_scores_gemma":[0.018389335,0.003476127,0.00028745626,0.8666,0.106524125,0.000066992085,0.0002146625,0.000029914718,0.004411378],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997162,0.00085227087,0.0003885634,0.00026332014,0.00087990495,0.00045397517],"domain_scores_gemma":[0.98915684,0.0065359254,0.0008620385,0.00030332428,0.001126865,0.0020150342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003425537,0.0006359302,0.002386821,0.00063954457,0.0014524326,0.002143136,0.0009638017,0.01840657,0.008028645],"category_scores_gemma":[0.02421883,0.0004651554,0.0016859856,0.0008446034,0.0012889127,0.0015171105,0.0009488866,0.01693,0.005388553],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016007365,0.0001774859,0.003639698,0.00028118058,0.00017582445,0.0011834301,0.000070656126,0.000114839015,0.00036439314,0.002271043,0.93688315,0.053237475],"study_design_scores_gemma":[0.009788245,0.001869219,0.042196106,0.0020382341,0.001046592,0.0035840517,0.0004510064,0.001789849,0.00085990014,0.026336215,0.9098521,0.00018841533],"about_ca_topic_score_codex":0.005282461,"about_ca_topic_score_gemma":0.009384567,"teacher_disagreement_score":0.01840657,"about_ca_system_score_codex":0.0026312908,"about_ca_system_score_gemma":0.0025328696,"threshold_uncertainty_score":0.026858509},"labels":[],"label_agreement":null},{"id":"W4308702501","doi":"10.1016/s2213-8587(22)00308-4","title":"Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial","year":2022,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Heart, Lung, and Blood Institute; Respicardia; Sanofi Pasteur; National Institutes of Health; Daiichi-Sankyo; Moderna; Sarepta Therapeutics; Alnylam Pharmaceuticals; MyoKardia; Gilead Sciences; Cytokinetics; American Regent; Sanofi; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca Korea; GlaxoSmithKline; Celladon Corporation; Amgen","keywords":"Medicine; Heart failure; Ejection fraction; Dapagliflozin; Internal medicine; Atrial fibrillation; Placebo; Cardiology; Prediabetes; Type 2 diabetes; Adverse effect; Diabetes mellitus; Endocrinology","score_opus":0.01639903670994819,"score_gpt":0.2730839111137107,"score_spread":0.25668487440376253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308702501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9554992,0.036622144,0.001140793,0.0008508447,0.0011115078,0.0011132283,0.0018152368,0.00013969465,0.0017074653],"genre_scores_gemma":[0.990919,0.004304246,0.00053995196,0.0008641089,0.0006691595,0.0007063132,0.001131818,0.000019346106,0.0008459772],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99898034,0.0003807796,0.0001806766,0.00021387887,0.00009179825,0.00015251903],"domain_scores_gemma":[0.9989974,0.00038923518,0.0002597394,0.00014539108,0.000059503418,0.00014874118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027084772,0.0019130809,0.0061624176,0.00064386876,0.0003713373,0.0016375063,0.0008034583,0.0016182478,0.0031746349],"category_scores_gemma":[0.0030707156,0.00066183845,0.007563928,0.00058125204,0.00061849115,0.0010395958,0.0006854832,0.0022529338,0.00046693799],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9696018,0.00045687813,0.0027146186,0.0015794386,0.014189503,0.000055536453,0.00005144543,0.00031312078,0.0013847096,0.000054683995,0.00046296715,0.009135298],"study_design_scores_gemma":[0.93900764,0.019353895,0.014584182,0.00018414318,0.024622895,0.0000824292,0.00007112783,0.00070071727,0.00045079621,0.0002859555,0.0006048905,0.00005132716],"about_ca_topic_score_codex":0.0010901443,"about_ca_topic_score_gemma":0.0025451886,"teacher_disagreement_score":0.0061624176,"about_ca_system_score_codex":0.00068943284,"about_ca_system_score_gemma":0.00062636187,"threshold_uncertainty_score":0.014324009},"labels":[],"label_agreement":null},{"id":"W4311596863","doi":"10.1016/s2213-8587(22)00319-9","title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","year":2022,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":725,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"European Medicines Agency; European Association for the Study of Diabetes; Japan Diabetes Society; Javna Agencija za Raziskovalno Dejavnost RS; American Association of Clinical Endocrinologists; Juvenile Diabetes Research Foundation International; American Diabetes Association","keywords":"Medicine; Statement (logic); Continuous glucose monitoring; MEDLINE; Intensive care medicine; Consensus conference; Medical physics; Internal medicine; Epistemology; Insulin; Law","score_opus":0.5046467869866073,"score_gpt":0.5550496755933165,"score_spread":0.05040288860670927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311596863","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001882449,0.8676093,0.0070420993,0.10840049,0.012677683,0.0011685127,0.0006239495,0.00015550577,0.0021341261],"genre_scores_gemma":[0.005708509,0.7935438,0.07310134,0.104065225,0.014522124,0.005299178,0.0015448328,0.00020299204,0.0020119476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8970567,0.047804467,0.029493554,0.0047077225,0.018797819,0.002139668],"domain_scores_gemma":[0.63396734,0.2776921,0.029875038,0.008362727,0.042855173,0.007247608],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21768115,0.0034525574,0.014568606,0.007876673,0.0016906898,0.0122294435,0.010589906,0.021892337,0.0044344054],"category_scores_gemma":[0.22808221,0.0027318865,0.011298999,0.007752327,0.0058372538,0.008372203,0.00849746,0.026248604,0.0031682625],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010205917,0.00018191578,0.0007282719,0.09141213,0.00222725,0.00016433027,0.00045419324,0.001016011,0.00073004235,0.02411429,0.26487416,0.6130768],"study_design_scores_gemma":[0.002230078,0.00044179574,0.002664969,0.31035414,0.0059225885,0.00047159113,0.00027144395,0.0012412271,0.00061911205,0.030173033,0.6454035,0.00020654206],"about_ca_topic_score_codex":0.0049971226,"about_ca_topic_score_gemma":0.0070017,"teacher_disagreement_score":0.78231883,"about_ca_system_score_codex":0.012113947,"about_ca_system_score_gemma":0.049800526,"threshold_uncertainty_score":0.9647384},"labels":[],"label_agreement":null},{"id":"W4311772176","doi":"10.1016/s2213-8587(22)00342-4","title":"Mendelian randomisation and vitamin D: the importance of model assumptions","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Mendelian randomization; Medicine; Vitamin D and neurology; Confounding; Disease; Population; Observational study; vitamin D deficiency; Internal medicine; Environmental health; Genetics; Genetic variants; Gene; Genotype","score_opus":0.054126002017471815,"score_gpt":0.32068541280479196,"score_spread":0.26655941078732015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311772176","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029432846,0.0102275135,0.04670144,0.92484075,0.011039965,0.00008967898,0.0004888883,0.00016829118,0.0035002804],"genre_scores_gemma":[0.14979385,0.013680002,0.052183386,0.7048743,0.07351636,0.0010099672,0.00036860665,0.0003552192,0.004218373],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8321724,0.14759064,0.005672963,0.006281434,0.0069724023,0.0013101724],"domain_scores_gemma":[0.26691267,0.7126395,0.005503737,0.009290435,0.0044900966,0.0011636298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14333658,0.0012781718,0.0058323694,0.001641959,0.001633761,0.0037935511,0.0053808154,0.030626372,0.007153659],"category_scores_gemma":[0.52131754,0.001396808,0.0032926698,0.0020530832,0.00932763,0.008654813,0.0022085286,0.036596753,0.0021676992],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043475484,0.00015758531,0.00931775,0.0028976377,0.0037701633,0.006465229,0.0020920439,0.008112652,0.00042472425,0.44287944,0.37400192,0.14553332],"study_design_scores_gemma":[0.001882122,0.00013780856,0.0016727899,0.0010944951,0.0004984134,0.0022016105,0.00018431485,0.01720581,0.00020144712,0.9260054,0.04874805,0.00016778505],"about_ca_topic_score_codex":0.00787068,"about_ca_topic_score_gemma":0.005616398,"teacher_disagreement_score":0.14333658,"about_ca_system_score_codex":0.0046877256,"about_ca_system_score_gemma":0.0036630942,"threshold_uncertainty_score":0.7580453},"labels":[],"label_agreement":null},{"id":"W4311781891","doi":"10.1016/s2213-8587(22)00357-6","title":"Predicting the response to GLP-1 receptor agonists: an unexpected role for β-arrestin-1","year":2022,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill Genome Centre","funders":"","keywords":"Exenatide; Heterotrimeric G protein; G protein-coupled receptor; Gs alpha subunit; Receptor; Medicine; Signal transduction; Intracellular; Adenylyl cyclase; Allosteric regulation; Pharmacology; Cell biology; G protein; Type 2 diabetes; Internal medicine; Endocrinology; Biology; Diabetes mellitus","score_opus":0.029142787363878285,"score_gpt":0.28663356711345067,"score_spread":0.2574907797495724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311781891","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000418756,0.0025570276,0.00017035312,0.98182523,0.013864491,0.000004803241,0.00007159413,0.000021060057,0.0010666919],"genre_scores_gemma":[0.008241431,0.0045791334,0.0005227079,0.89075434,0.093796946,0.000042721695,0.000089009016,0.00004129139,0.0019323489],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99375004,0.0026945958,0.00084212795,0.00071287825,0.0015631389,0.00043716133],"domain_scores_gemma":[0.9502318,0.038864125,0.001468871,0.0009047682,0.0052633174,0.0032671723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007015811,0.0009219662,0.0024158428,0.00079237565,0.0016133746,0.003934002,0.0016520906,0.030090302,0.0036977788],"category_scores_gemma":[0.05026772,0.0008395683,0.001480475,0.00071019575,0.0027422144,0.0037700743,0.001274832,0.047077723,0.0055972426],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037818894,0.000052987758,0.0026577609,0.00015213242,0.00009193743,0.0012514298,0.00012521712,0.00023845915,0.00038394454,0.0033277534,0.9437087,0.04763143],"study_design_scores_gemma":[0.0010305662,0.00035121513,0.0048828335,0.0009978687,0.00021224367,0.0030983856,0.000652368,0.0031560252,0.0007205663,0.04549213,0.9392255,0.0001801397],"about_ca_topic_score_codex":0.004583231,"about_ca_topic_score_gemma":0.005951628,"teacher_disagreement_score":0.030090302,"about_ca_system_score_codex":0.0039928015,"about_ca_system_score_gemma":0.0028687243,"threshold_uncertainty_score":0.037103593},"labels":[],"label_agreement":null},{"id":"W4313554841","doi":"10.1016/s2213-8587(22)00353-9","title":"Long-term efficacy and safety of inclisiran in patients with high cardiovascular risk and elevated LDL cholesterol (ORION-3): results from the 4-year open-label extension of the ORION-1 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":308,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"NIHR Imperial Biomedical Research Centre; Novartis Pharma; National Institute for Health and Care Research; Novartis","keywords":"Medicine; PCSK9; Clinical endpoint; Placebo; Statin; Population; Dosing; Internal medicine; Cholesterol; Adverse effect; Surrogate endpoint; Clinical trial; Lipoprotein; Pathology","score_opus":0.025977539394577646,"score_gpt":0.26660450488717047,"score_spread":0.24062696549259283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313554841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99456453,0.003245925,0.00014732472,0.00018997358,0.00006333542,0.0003672281,0.0004210873,0.000034051194,0.0009666732],"genre_scores_gemma":[0.9940654,0.0015028034,0.0006620033,0.00051372894,0.00021677931,0.0006408611,0.0014113163,0.000015137221,0.0009719086],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99904543,0.0005659377,0.000051652147,0.00012293953,0.00008362379,0.00013038509],"domain_scores_gemma":[0.99837494,0.0003166589,0.0006018105,0.00020419528,0.00010401353,0.00039828874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036392116,0.0010324902,0.0016739634,0.00019341684,0.0002749811,0.0009215355,0.0007581761,0.0011389881,0.0026611418],"category_scores_gemma":[0.0019160778,0.0002764519,0.0017534498,0.0003089077,0.000623939,0.00093875494,0.00046505744,0.002434177,0.0004706714],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92469853,0.009484265,0.009990129,0.00087008276,0.0020269582,0.00015361155,0.00018416709,0.0006966021,0.008947906,0.00013418953,0.001401957,0.041411508],"study_design_scores_gemma":[0.7060678,0.21964453,0.06571153,0.00012844297,0.0024458452,0.0003420201,0.00009624587,0.0007526563,0.0019384336,0.00023620517,0.0025713488,0.00006496714],"about_ca_topic_score_codex":0.00034637345,"about_ca_topic_score_gemma":0.0010647903,"teacher_disagreement_score":0.0036392116,"about_ca_system_score_codex":0.0005210395,"about_ca_system_score_gemma":0.0006907732,"threshold_uncertainty_score":0.01924622},"labels":[],"label_agreement":null},{"id":"W4313621257","doi":"10.1016/s2213-8587(22)00307-2","title":"Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an open‑label, multinational, randomised, controlled, non-inferiority trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"Novo Nordisk","keywords":"Medicine; Insulin detemir; Insulin degludec; Insulin aspart; Insulin; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial; Internal medicine; Insulin glargine; Endocrinology","score_opus":0.057838707920567244,"score_gpt":0.34275435128427173,"score_spread":0.2849156433637045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313621257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9723964,0.018813083,0.00090157235,0.0015422431,0.0015244731,0.0013230371,0.00087845954,0.00012519295,0.0024954453],"genre_scores_gemma":[0.982183,0.007588038,0.0022424455,0.0018682065,0.0007668482,0.0016661849,0.0006959298,0.000033978242,0.0029555066],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991462,0.000521132,0.000059945873,0.0001325303,0.00005262835,0.00008751803],"domain_scores_gemma":[0.9989303,0.00054298894,0.00020554243,0.000079171536,0.000035418707,0.00020661866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020893249,0.0014910196,0.0034145163,0.00034804043,0.00027376213,0.0011250853,0.00071274204,0.0017208329,0.00516334],"category_scores_gemma":[0.0025527852,0.00066903385,0.0023648334,0.00042630133,0.0010986776,0.0012421646,0.00050952693,0.0031483849,0.00066074525],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98871875,0.0008092791,0.00022251303,0.0006550836,0.00081937993,0.000024278605,0.000029130906,0.00011537891,0.00085616374,0.00009078695,0.00024835247,0.0074109747],"study_design_scores_gemma":[0.97795725,0.01997144,0.0006222519,0.000059657952,0.0006063469,0.000029525509,0.00002282795,0.00020059908,0.0001161818,0.00013838783,0.00026472463,0.000010740803],"about_ca_topic_score_codex":0.0008726681,"about_ca_topic_score_gemma":0.0016626875,"teacher_disagreement_score":0.00516334,"about_ca_system_score_codex":0.00067628094,"about_ca_system_score_gemma":0.0005597496,"threshold_uncertainty_score":0.017273128},"labels":[],"label_agreement":null},{"id":"W4319067708","doi":"10.1016/s2213-8587(23)00004-9","title":"Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Alberta Children's Hospital; SickKids Foundation; University of Toronto; University Health Network; Dalhousie University; Sunnybrook Health Science Centre; Women's College Hospital; Lunenfeld-Tanenbaum Research Institute; Sunnybrook Hospital; University of Alberta","funders":"Canadian Institutes of Health Research; University of Guelph","keywords":"Medicine; Metformin; Placebo; Pregnancy; Type 2 diabetes; Anthropometry; Confounding; Diabetes mellitus; Body mass index; Internal medicine; Obstetrics; Endocrinology","score_opus":0.02564788251801934,"score_gpt":0.28473332378248545,"score_spread":0.2590854412644661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319067708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817131,0.014838989,0.00019184196,0.0005712157,0.00055474153,0.000397886,0.0010597061,0.0000332964,0.0006392476],"genre_scores_gemma":[0.99090296,0.004930447,0.0004827322,0.0005570547,0.00041092464,0.00087409135,0.0007263028,0.000013609868,0.0011018276],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9987691,0.00063543615,0.000107269334,0.00022588523,0.00007955183,0.00018270774],"domain_scores_gemma":[0.99811375,0.00065865635,0.0007505245,0.00013191317,0.00008073394,0.0002643854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017999636,0.0015584201,0.0040128273,0.00036369235,0.00042276192,0.0011274538,0.00095443707,0.0026823936,0.0034714642],"category_scores_gemma":[0.0049019037,0.0007913358,0.004519691,0.000476428,0.0009546912,0.0012228248,0.0008375304,0.003028028,0.00030411012],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9759808,0.001166063,0.006319079,0.0019926967,0.005376242,0.000103141916,0.00009918191,0.00016138428,0.00050219224,0.00012148209,0.000718555,0.007459256],"study_design_scores_gemma":[0.91461855,0.044295397,0.02997372,0.000469139,0.008498896,0.0001212536,0.00019134775,0.00029198398,0.00035809985,0.00027425747,0.00085871504,0.000048635273],"about_ca_topic_score_codex":0.0043895827,"about_ca_topic_score_gemma":0.0045159515,"teacher_disagreement_score":0.0043895827,"about_ca_system_score_codex":0.0011348353,"about_ca_system_score_gemma":0.00092716503,"threshold_uncertainty_score":0.01161319},"labels":[],"label_agreement":null},{"id":"W4323036455","doi":"10.1016/s2213-8587(23)00009-8","title":"Effects of dapagliflozin on hospitalisations in people with type 2 diabetes: post-hoc analyses of the DECLARE-TIMI 58 trial","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Eisai; Janssen Pharmaceuticals; Hebrew University of Jerusalem; University of Liverpool; IFM Therapeutics; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; CSL Behring; Alnylam Pharmaceuticals; Brigham and Women's Hospital; Novo Nordisk; Daiichi-Sankyo; Zora Biosciences; Intarcia Therapeutics; Sanofi; Esperion Therapeutics; GlaxoSmithKline; Amgen; Pfizer","keywords":"Medicine; Dapagliflozin; Type 2 diabetes; Diabetes mellitus; Post-hoc analysis; Internal medicine; TIMI; Placebo; Population; Hazard ratio; Disease; Endocrinology; Myocardial infarction; Confidence interval; Pathology; Environmental health","score_opus":0.030754293599564886,"score_gpt":0.3036016177759771,"score_spread":0.2728473241764122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323036455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98431593,0.007659936,0.0006556847,0.00083652395,0.0008225211,0.00031524067,0.0028724885,0.00010316632,0.0024184901],"genre_scores_gemma":[0.9917355,0.0016805129,0.0006404877,0.00070764485,0.0006392956,0.00047207443,0.0021128205,0.00004032358,0.0019713282],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9974089,0.0015167597,0.00016964585,0.0004123682,0.0001402283,0.00035212134],"domain_scores_gemma":[0.9965593,0.0019417909,0.00055948144,0.00044654842,0.00016044054,0.00033245323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046623205,0.002220354,0.006100603,0.00032554477,0.00037219,0.0019644697,0.0010574714,0.0013674898,0.0047409567],"category_scores_gemma":[0.00738267,0.00089558447,0.008624696,0.0005083816,0.0007396798,0.0015286241,0.0011161126,0.0042591123,0.0005983354],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9639974,0.0005884287,0.0058426135,0.00091571826,0.017778719,0.00007600463,0.000055633438,0.00086026726,0.00060400245,0.00014993236,0.0018108526,0.0073203794],"study_design_scores_gemma":[0.7631041,0.060307298,0.09599893,0.00031401057,0.0708337,0.00011894447,0.0002979519,0.0040715104,0.001018787,0.0012575693,0.0025110163,0.00016622322],"about_ca_topic_score_codex":0.0020155215,"about_ca_topic_score_gemma":0.003551674,"teacher_disagreement_score":0.006100603,"about_ca_system_score_codex":0.0007387379,"about_ca_system_score_gemma":0.0010128582,"threshold_uncertainty_score":0.024657011},"labels":[],"label_agreement":null},{"id":"W4328050587","doi":"10.1016/s2213-8587(22)00358-8","title":"Long-term association between homelessness and mortality among people with diabetes","year":2023,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary; St. Michael's Hospital","funders":"M.S.I. Foundation","keywords":"Medicine; Scopus; Diabetes mellitus; Glycemic; Socioeconomic status; MEDLINE; Gerontology; Health care; Type 2 diabetes; Family medicine; Environmental health; Population","score_opus":0.050885796901937654,"score_gpt":0.3563564441300071,"score_spread":0.30547064722806944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328050587","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047755364,0.010006432,0.00013968779,0.908524,0.021972591,0.000026532249,0.0022963425,0.000038036695,0.0092410715],"genre_scores_gemma":[0.26658416,0.011177435,0.00045970612,0.6245827,0.07667039,0.00015840074,0.0015703465,0.000051510302,0.018745339],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99899966,0.00034153284,0.00014922555,0.00008852704,0.00023375654,0.00018725042],"domain_scores_gemma":[0.9919425,0.0031106765,0.0013091946,0.0003862445,0.0012018235,0.0020494033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021252858,0.0002380689,0.00075037684,0.0006311863,0.0018780142,0.0016604395,0.0009569027,0.011374855,0.005162248],"category_scores_gemma":[0.013337228,0.00037798137,0.0009965198,0.0012608423,0.0011481866,0.001272947,0.0009537984,0.0084109325,0.0014811165],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070577575,0.00028181708,0.28331053,0.00040935475,0.00040982777,0.0018668221,0.000887325,0.00010549668,0.0003141785,0.0016207999,0.6728545,0.037233666],"study_design_scores_gemma":[0.0008799188,0.0007936099,0.7856065,0.002293555,0.0010421245,0.0019793124,0.005875921,0.0013548434,0.0002457802,0.006679877,0.19303201,0.0002165427],"about_ca_topic_score_codex":0.040304646,"about_ca_topic_score_gemma":0.100709535,"teacher_disagreement_score":0.040304646,"about_ca_system_score_codex":0.0013539572,"about_ca_system_score_gemma":0.0026316603,"threshold_uncertainty_score":0.080140114},"labels":[],"label_agreement":null},{"id":"W4362466994","doi":"10.1016/s2213-8587(23)00038-4","title":"Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Multiple Sclerosis Society of Canada; Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Child Health and Human Development; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institutes of Health","keywords":"SDHD; Medicine; Paraganglioma; Guideline; Pheochromocytoma; Watchful waiting; Multiple endocrine neoplasia type 2; Disease; Germline mutation; Internal medicine; Surgery; Pathology; Genetics; Cancer","score_opus":0.10734736985363869,"score_gpt":0.3853101991825035,"score_spread":0.2779628293288648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362466994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027875556,0.97259414,0.001677447,0.011915749,0.0041551217,0.00024479686,0.001516167,0.00012525114,0.0074926303],"genre_scores_gemma":[0.0025225775,0.96631247,0.006617513,0.012671627,0.001743865,0.00042507664,0.0037657444,0.00003469788,0.005906422],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99864095,0.00031429724,0.00035301904,0.00012365919,0.0004712746,0.000096744705],"domain_scores_gemma":[0.9976139,0.0008163976,0.00040629628,0.000038572296,0.0009848452,0.00014007372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018610283,0.0011985593,0.0029652133,0.0029496176,0.00042712645,0.0013296094,0.0029077192,0.0034812153,0.0063577024],"category_scores_gemma":[0.0043178806,0.0005031367,0.003051114,0.0019957884,0.00045833236,0.0009452605,0.0009504357,0.0031635796,0.003887219],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019383704,0.00008214522,0.0004753283,0.03519594,0.0005706878,0.00062787783,0.0000773098,0.0005865481,0.0009756345,0.0022627995,0.422025,0.536927],"study_design_scores_gemma":[0.00049829733,0.0001358109,0.0029990508,0.075038925,0.0017314258,0.001979974,0.00008866957,0.00031059215,0.00037867343,0.0030742805,0.91369694,0.00006733298],"about_ca_topic_score_codex":0.010461506,"about_ca_topic_score_gemma":0.019908896,"teacher_disagreement_score":0.010461506,"about_ca_system_score_codex":0.0016718729,"about_ca_system_score_gemma":0.0055709495,"threshold_uncertainty_score":0.021268606},"labels":[],"label_agreement":null},{"id":"W4362517382","doi":"10.1016/s2213-8587(23)00062-1","title":"Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gestational diabetes; Type 2 diabetes; Hazard ratio; Population; Diabetes mellitus; Cohort; Cohort study; Pregnancy; Proportional hazards model; Internal medicine; Obstetrics; Endocrinology; Gestation; Confidence interval; Environmental health","score_opus":0.025143424648330116,"score_gpt":0.30948270586280235,"score_spread":0.2843392812144722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362517382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99644804,0.0009686439,0.00026982898,0.00018216949,0.00005157734,0.00002641951,0.0015508821,0.000012867322,0.00048945745],"genre_scores_gemma":[0.99760926,0.0006391677,0.0002700762,0.00011889254,0.00004254801,0.00004359553,0.0007170353,0.000010826543,0.00054861774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877244,0.00036006843,0.00010137617,0.0004087847,0.00013259992,0.00022473233],"domain_scores_gemma":[0.9971814,0.0004990099,0.0006943005,0.0008041003,0.00023747882,0.00058358844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018956356,0.0010779261,0.0011489382,0.0008497281,0.0012925393,0.0019706048,0.0012467917,0.002374748,0.0020163907],"category_scores_gemma":[0.0036921303,0.0021797058,0.0026122003,0.0025441889,0.0005714475,0.0013488631,0.0012506085,0.0032796022,0.00049606216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012010302,0.0002193457,0.9942549,0.000028977012,0.0014352156,0.000327253,0.00025858474,0.000072342744,0.00069817755,0.00005926913,0.00037680456,0.0010681276],"study_design_scores_gemma":[0.00011025269,0.00025088768,0.99785006,0.000020160493,0.0005844491,0.00036043904,0.00030362417,0.00021008278,0.00004616548,0.000045673656,0.00019816945,0.000020096571],"about_ca_topic_score_codex":0.031951945,"about_ca_topic_score_gemma":0.024574246,"teacher_disagreement_score":0.031951945,"about_ca_system_score_codex":0.0006983016,"about_ca_system_score_gemma":0.000883846,"threshold_uncertainty_score":0.063531935},"labels":[],"label_agreement":null},{"id":"W4365814219","doi":"10.1016/s2213-8587(23)00088-8","title":"BMI versus obesity subtypes in the era of precision medicine","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Cardiovascular Function and Risk Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Institut universitaire de cardiologie et de pneumologie de Québec; Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale; Institut Universitaire en Santé Mentale de Québec","funders":"Institute of Nutrition, Metabolism and Diabetes; Canadian Institutes of Health Research","keywords":"Medicine; Overweight; Scopus; Obesity; Guideline; Task force; Body mass index; Family medicine; MEDLINE; Gerontology; Internal medicine; Pathology","score_opus":0.04082962997764736,"score_gpt":0.3027312542865291,"score_spread":0.26190162430888175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365814219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018824423,0.78369385,0.0036004144,0.1782749,0.008783363,0.000022894172,0.00073068944,0.000075393684,0.0059941052],"genre_scores_gemma":[0.33132052,0.4874034,0.0074327355,0.10517671,0.066425845,0.00007953185,0.00071073265,0.00010215208,0.0013483857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9896729,0.004780367,0.0011707287,0.0016425853,0.0021560614,0.000577399],"domain_scores_gemma":[0.92583257,0.056759253,0.007061306,0.0034136898,0.0042916173,0.0026414925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028591372,0.0008959771,0.0056347735,0.0027711908,0.00081699184,0.006465015,0.001482632,0.0051639746,0.004308821],"category_scores_gemma":[0.06346409,0.0009067791,0.002278024,0.0031712973,0.0037214877,0.007886815,0.0032233559,0.009028514,0.00053221255],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008447178,0.0003227793,0.10933528,0.010673452,0.010703629,0.00039414928,0.0014760856,0.002873817,0.0014151853,0.10413556,0.06545473,0.6847682],"study_design_scores_gemma":[0.0023022464,0.00282402,0.2133666,0.02821256,0.013798146,0.00142472,0.0029017348,0.006191155,0.0012980689,0.52659714,0.2003344,0.00074922194],"about_ca_topic_score_codex":0.0050246483,"about_ca_topic_score_gemma":0.006515878,"teacher_disagreement_score":0.028591372,"about_ca_system_score_codex":0.0021729541,"about_ca_system_score_gemma":0.0028414084,"threshold_uncertainty_score":0.15120745},"labels":[],"label_agreement":null},{"id":"W4366817786","doi":"10.1016/s2213-8587(23)00090-6","title":"BETA-2 score at 28 days after islet allogeneic transplantation in type 1 diabetes for predicting 5-year outcomes","year":2023,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Islet; Transplantation; Retrospective cohort study; Observational study; Diabetes mellitus; Internal medicine; Type 2 diabetes; Cohort study; Cohort; Intensive care medicine; Pediatrics; Endocrinology","score_opus":0.04436149790616794,"score_gpt":0.2829486983708251,"score_spread":0.23858720046465715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366817786","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12854514,0.031565245,0.0007279021,0.7440288,0.06624253,0.000060606086,0.0032691618,0.00010140631,0.025459204],"genre_scores_gemma":[0.5165788,0.0127425855,0.0014885727,0.326983,0.12857132,0.00019444691,0.0023516505,0.00008066925,0.011008933],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987644,0.00044656234,0.00017865312,0.00012061041,0.0002757503,0.00021401705],"domain_scores_gemma":[0.9916632,0.004936411,0.0004725499,0.00021393932,0.0013880288,0.0013258982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022273117,0.00048738671,0.0014297365,0.00080562325,0.00076923764,0.0014343556,0.0008203599,0.0053955344,0.0031340194],"category_scores_gemma":[0.015450534,0.0003404201,0.0010763309,0.0009734311,0.00050406944,0.00083459466,0.0004964129,0.0068984297,0.0018832424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047797244,0.0004202056,0.45516208,0.00033423587,0.0005697254,0.004051937,0.0002197125,0.00058770453,0.000738587,0.000942405,0.4251734,0.107020326],"study_design_scores_gemma":[0.0042964793,0.0022363106,0.78714395,0.004255738,0.0029121158,0.012456639,0.002331015,0.012051768,0.0011734556,0.016818123,0.15388782,0.00043644322],"about_ca_topic_score_codex":0.0063864747,"about_ca_topic_score_gemma":0.0120157525,"teacher_disagreement_score":0.0063864747,"about_ca_system_score_codex":0.0011000506,"about_ca_system_score_gemma":0.0015186382,"threshold_uncertainty_score":0.01269865},"labels":[],"label_agreement":null},{"id":"W4367302347","doi":"10.1016/s2213-8587(23)00094-3","title":"Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Medicine; Thyroid nodules; Pandemic; Retrospective cohort study; Thyroid; Thyroid cancer; Coronavirus disease 2019 (COVID-19); Indeterminate; Thyroidectomy; Cross-sectional study; General surgery; Surgery; Internal medicine; Disease; Pathology; Infectious disease (medical specialty)","score_opus":0.10698540117064269,"score_gpt":0.43483680718135903,"score_spread":0.32785140601071633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367302347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995522,0.0011846633,0.00008874711,0.00026551553,0.00004550947,0.000018768716,0.001875791,0.0000038818303,0.0009951203],"genre_scores_gemma":[0.9983119,0.0002800085,0.00006580044,0.00020746922,0.000028473813,0.000015166175,0.0009447116,0.0000038138253,0.00014269148],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882036,0.00029571296,0.00014672762,0.00032109904,0.0001189318,0.0002971712],"domain_scores_gemma":[0.9968399,0.0004755314,0.0014550989,0.00036367658,0.00025246694,0.0006132259],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012193408,0.00032348582,0.00035106708,0.0005199599,0.0005350571,0.0012630589,0.00057871384,0.001412779,0.0023011412],"category_scores_gemma":[0.003951211,0.00051732594,0.0009420719,0.0014647103,0.00057843706,0.00089952524,0.0013586902,0.0020265568,0.00038655323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001604283,0.00004435906,0.99863523,0.000023824672,0.00012918084,0.00004249873,0.00008343701,0.000022968625,0.00006706718,0.000034581415,0.00023680278,0.0005196524],"study_design_scores_gemma":[0.00001249817,0.0001562354,0.9985821,0.000029270668,0.00008593042,0.00013986805,0.00057680695,0.00006909946,0.000021343314,0.000028746626,0.00028956388,0.000008658385],"about_ca_topic_score_codex":0.012095462,"about_ca_topic_score_gemma":0.011865526,"teacher_disagreement_score":0.012095462,"about_ca_system_score_codex":0.00066158804,"about_ca_system_score_gemma":0.00057812093,"threshold_uncertainty_score":0.024050117},"labels":[],"label_agreement":null},{"id":"W4379380106","doi":"10.1016/s2213-8587(23)00116-x","title":"Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"National Institutes of Health; Javna Agencija za Raziskovalno Dejavnost RS; Fonds Wetenschappelijk Onderzoek; Novo Nordisk; Dexcom; National Institute of Diabetes and Digestive and Kidney Diseases; ZonMw; Insulet Corporation; Diabetes Canada; Sanofi; Leona M. and Harry B. Helmsley Charitable Trust; Tandem Diabetes Care; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Pregnancy; Type 2 diabetes; Gestational diabetes; Diabetes mellitus; Type 1 diabetes; Obstetrics; Aspirin; Intensive care medicine; Weight gain; Gestation; Endocrinology; Internal medicine; Body weight","score_opus":0.11602779950696164,"score_gpt":0.3964174148960811,"score_spread":0.2803896153891195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379380106","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024234252,0.9991204,0.00006623599,0.00032766795,0.00022381697,0.0000030848676,0.000015890997,0.000004363266,0.00021419709],"genre_scores_gemma":[0.00013218928,0.99901974,0.00015527665,0.0003378397,0.00020979116,0.0000038899743,0.000023496088,9.63687e-7,0.000116769814],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999498,0.0001021157,0.0000829106,0.000055201406,0.00021590738,0.00004584858],"domain_scores_gemma":[0.9985049,0.00096336805,0.00017799692,0.000021262067,0.00025725155,0.00007534098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016556563,0.0012613324,0.003001829,0.002183592,0.00022315216,0.0013718362,0.0013232506,0.0016604514,0.0043366547],"category_scores_gemma":[0.0022776157,0.00035654329,0.0013205607,0.0021852166,0.000418098,0.001507099,0.0009127764,0.0034207383,0.001666591],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001523212,0.00007121844,0.00012306418,0.029076785,0.00023854838,0.00010336078,0.000029928333,0.00026384607,0.00047184224,0.0017838612,0.044933822,0.92275137],"study_design_scores_gemma":[0.00018564252,0.0002374415,0.0012058511,0.026749725,0.0007932044,0.0007388946,0.00007190934,0.00023260484,0.000172761,0.0022445144,0.9673287,0.0000386412],"about_ca_topic_score_codex":0.00241357,"about_ca_topic_score_gemma":0.005082807,"teacher_disagreement_score":0.0043366547,"about_ca_system_score_codex":0.00083461136,"about_ca_system_score_gemma":0.0017462798,"threshold_uncertainty_score":0.014507532},"labels":[],"label_agreement":null},{"id":"W4381848342","doi":"10.1016/s2213-8587(23)00168-7","title":"People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Canadian Institutes of Health Research; National Institutes of Health; Sydäntutkimussäätiö; Sigrid Juséliuksen Säätiö; Novo Nordisk; KU Leuven; University of Toronto; Pfizer; Insulet Corporation; Astellas Pharma; MannKind Corporation; Diabetes Canada; Wilhelm och Else Stockmanns Stiftelse; Folkhälsanin Tutkimussäätiö; Foundation for Cardiovascular Research; Eli Lilly and Company; AstraZeneca; CSL Behring; Bayer; Gilead Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; Diabetestutkimussäätiö; Samfundet Folkhälsan","keywords":"Medicine; Call to action; Type 2 diabetes; Kidney disease; Diabetes mellitus; Disease; Intensive care medicine; Action (physics); MEDLINE; Internal medicine; Endocrinology","score_opus":0.04308128163336083,"score_gpt":0.315554828987163,"score_spread":0.2724735473538022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381848342","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019373372,0.041730992,0.00020131485,0.9176977,0.037299365,0.000008582821,0.00010532578,0.00007719707,0.0026857725],"genre_scores_gemma":[0.006090455,0.04912877,0.0012099138,0.84474266,0.09471824,0.00007417567,0.00021923576,0.0000771923,0.0037393672],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97846496,0.0063652038,0.0018497929,0.0021134748,0.007731975,0.0034745773],"domain_scores_gemma":[0.905342,0.044998534,0.0055943127,0.0026942315,0.009587783,0.03178323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025937304,0.0027353247,0.006937643,0.0025039418,0.005100946,0.01574806,0.005741347,0.07518861,0.04418266],"category_scores_gemma":[0.049865402,0.0017212622,0.0070165843,0.0023083626,0.014512237,0.0279477,0.014103712,0.06241509,0.014161498],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037403582,0.0001699311,0.00037215572,0.0014444878,0.00023263313,0.0002403457,0.00032295543,0.0001273252,0.00029236087,0.010279695,0.9308474,0.055296693],"study_design_scores_gemma":[0.0010325474,0.00026574597,0.0022743847,0.005465842,0.00035171994,0.00038351666,0.0024180932,0.0002284089,0.00012223667,0.055153586,0.9320719,0.00023208722],"about_ca_topic_score_codex":0.00538314,"about_ca_topic_score_gemma":0.01063476,"teacher_disagreement_score":0.07518861,"about_ca_system_score_codex":0.00744887,"about_ca_system_score_gemma":0.02763065,"threshold_uncertainty_score":0.14780569},"labels":[],"label_agreement":null},{"id":"W4382051681","doi":"10.1016/s2213-8587(23)00128-6","title":"Predicting and preventing heart failure in type 2 diabetes","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Houston Methodist Research Institute","keywords":"Medicine; Heart failure; Type 2 diabetes; Diabetes mellitus; Intensive care medicine; Psychological intervention; Incidence (geometry); Internal medicine; Psychiatry; Endocrinology","score_opus":0.056194141244418946,"score_gpt":0.33099809991354023,"score_spread":0.2748039586691213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382051681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038445225,0.99910295,0.00004338884,0.00028433572,0.0003187271,0.0000041076496,0.000019349141,0.000005006512,0.00018377697],"genre_scores_gemma":[0.00055073114,0.99824405,0.00010643777,0.00046578416,0.00046569266,0.000007682955,0.000024379731,0.0000013336683,0.00013392675],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993327,0.00015485805,0.0001420193,0.00009364987,0.00022130494,0.00005537475],"domain_scores_gemma":[0.997654,0.0016190022,0.00033113727,0.000034009627,0.00025962005,0.000102285456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001996423,0.0015964959,0.0057817837,0.0025558602,0.00022458249,0.0014866387,0.0013858904,0.0019338035,0.006202303],"category_scores_gemma":[0.004203511,0.0005885406,0.002245922,0.0019758344,0.00054156984,0.0013964124,0.0010105883,0.0040389677,0.0019156447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036191358,0.000107171385,0.00033283478,0.052799486,0.0013576375,0.00007214701,0.000031764812,0.00027886376,0.00025680554,0.0013704521,0.03597873,0.90705204],"study_design_scores_gemma":[0.002362297,0.0012089551,0.011242895,0.13362384,0.01636309,0.0012436593,0.00021975678,0.0008961254,0.00052997627,0.009052626,0.82307327,0.00018352226],"about_ca_topic_score_codex":0.0038499285,"about_ca_topic_score_gemma":0.006801457,"teacher_disagreement_score":0.006202303,"about_ca_system_score_codex":0.0009155663,"about_ca_system_score_gemma":0.0015129087,"threshold_uncertainty_score":0.020748794},"labels":[],"label_agreement":null},{"id":"W4386024295","doi":"10.1016/s2213-8587(23)00193-6","title":"Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Associazione Italiana per la Ricerca sul Cancro; Cancer Research UK; Ministère des Affaires Sociales et de la Santé; Deutsche Forschungsgemeinschaft; Agenzia Italiana del Farmaco, Ministero della Salute; Academy of Medical Sciences","keywords":"Mitotane; Medicine; Adrenocortical carcinoma; Clinical endpoint; Observational study; Adjuvant; Internal medicine; Intention-to-treat analysis; Randomized controlled trial; Surgery; Oncology","score_opus":0.18967628582502905,"score_gpt":0.4136935625130954,"score_spread":0.22401727668806637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386024295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892754,0.006235096,0.0003594098,0.00029457227,0.0002758392,0.002378966,0.00047611655,0.000025768077,0.000678823],"genre_scores_gemma":[0.9916653,0.002113487,0.0009887862,0.00057644985,0.0004779853,0.003007837,0.00061808754,0.0000085680595,0.000543431],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9972248,0.0019848084,0.00015720162,0.00027046484,0.00013256892,0.00023028273],"domain_scores_gemma":[0.9959363,0.0012208103,0.0012607925,0.00034762532,0.00021204511,0.0010225205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052725663,0.0012780572,0.0037931006,0.00037416053,0.000554183,0.0014032766,0.00108766,0.001883039,0.0025182853],"category_scores_gemma":[0.004503089,0.000554598,0.0029595273,0.00069365604,0.0012931925,0.00082990585,0.00070533535,0.0023502838,0.0003475114],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9859261,0.004566074,0.0019288008,0.0004914416,0.00095701806,0.0000162073,0.000045071098,0.00016001737,0.001002593,0.00003858795,0.00016503468,0.004703013],"study_design_scores_gemma":[0.89367735,0.100554325,0.004051346,0.000045511206,0.0008408734,0.00002724566,0.00002687926,0.00016828063,0.00017050396,0.00007426118,0.00035182125,0.000011655853],"about_ca_topic_score_codex":0.0012486492,"about_ca_topic_score_gemma":0.0020599763,"teacher_disagreement_score":0.0052725663,"about_ca_system_score_codex":0.000954087,"about_ca_system_score_gemma":0.0016889161,"threshold_uncertainty_score":0.027884305},"labels":[],"label_agreement":null},{"id":"W4386594957","doi":"10.1016/s2213-8587(23)00223-1","title":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","year":2023,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":211,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Norwegian Institute of Public Health; Faculty of Medicine and Health, University of Sydney; Economic and Social Research Council; Institut universitaire de cardiologie et de pneumologie de Québec, Université Laval; Biogen; Agency for Healthcare Research and Quality; National Institutes of Health; National Health and Medical Research Council; Dementias Platform UK; AstraZeneca; Baker Heart and Diabetes Institute; Hjartavernd; Wellcome Trust; Universität Innsbruck; Terveyden ja hyvinvoinnin laitos; Medizinische Universität Innsbruck; Lunds Universitet; Faculty of Health and Medical Sciences, University of Western Australia; Oulun Yliopisto; Hirosaki University; Göteborgs Universitet; Sahlgrenska Universitetssjukhuset; Netherlands Heart Institute; Universitair Medisch Centrum Groningen; Österreichische Forschungsförderungsgesellschaft; Novo Nordisk; Gentofte Hospital; Rijksinstituut voor Volksgezondheid en Milieu; Massachusetts Medical Society; Yonsei University; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet; Universiteit Utrecht; Rijksuniversiteit Groningen; St. George's, University of London; Institut National de la Santé et de la Recherche Médicale; Fondation Leducq; Istituto Superiore di Sanità; School of Medicine, Duke University; University of Oxford; Medical Research Council; Grifols; Servier; Uppsala Universitet; Amarin Corporation; Tel Aviv University; Novo Nordisk UK Research Foundation; London School of Hygiene and Tropical Medicine; Wake Forest School of Medicine; Department of Health and Social Care; Amsterdam University Medical Centers; Northwell Health; Esperion Therapeutics; Health Services Research and Development; University of Toronto; Kowa Company; Harvard University; Deutsches Krebsforschungszentrum; Queen Mary University of London; Vanderbilt University Medical Center; National Institute for Health and Care Research; Centers for Disease Control and Prevention; Sanofi; Leids Universitair Medisch Centrum; University of Vermont; NIHR Cambridge Biomedical Research Centre; Massachusetts General Hospital; University College London; Diabetes UK; University of Southampton; National Heart, Lung, and Blood Institute; Universiteit Leiden; University of Glasgow; Abbott Laboratories; University of South Carolina; Fiona Stanley Hospital; Háskóli Íslands; British Heart Foundation; University of Pittsburgh; Portland State University; Universitetet i Tromsø; School of Medicine, Boston University; Helsingin Yliopisto; Pfizer; Yale University; University of Bristol; Trakya Üniversitesi; State of Connecticut Department of Public Health; Västra Götalandsregionen; Eli Lilly and Company; University of Tsukuba; Itä-Suomen Yliopisto; Brigham and Women's Hospital; University of California, San Diego; Amgen; Kanazawa Medical University; Mylan; Regeneron Pharmaceuticals; American Heart Association; Universität Heidelberg; Sahlgrenska Akademin; Wake Forest University","keywords":"Medicine; Life expectancy; Gerontology; Demography; Diabetes mellitus; Type 2 diabetes; Environmental health; Population","score_opus":0.029642834997424882,"score_gpt":0.24935513760219197,"score_spread":0.2197123026047671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386594957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93547416,0.008307155,0.0019642683,0.00044246094,0.00011071228,0.0000468535,0.0521166,0.00009930273,0.0014385504],"genre_scores_gemma":[0.97885054,0.0018602174,0.0005558187,0.00013569089,0.000049599243,0.00012994376,0.018222684,0.000013676366,0.00018190187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788433,0.00091286964,0.00022241665,0.00047226498,0.0002508695,0.0002571927],"domain_scores_gemma":[0.99501747,0.0013966766,0.0024301026,0.00041488203,0.0004090081,0.00033197054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030065163,0.000586663,0.0009791394,0.0015623613,0.00032258933,0.00092765753,0.00064646755,0.0006314023,0.0014493426],"category_scores_gemma":[0.009018409,0.0004214124,0.0022295213,0.003361882,0.00033431206,0.0010422798,0.0015765872,0.0011315262,0.0003727571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022151312,0.000021768274,0.99264854,0.00015324916,0.0011062572,0.0000898012,0.00015705357,0.00067484763,0.00004629178,0.000102651014,0.0018587793,0.0029191922],"study_design_scores_gemma":[0.000023813409,0.000046342186,0.99689215,0.00010384242,0.00034475545,0.00022587265,0.00022311683,0.00052807503,0.000062589854,0.00018195633,0.0013488515,0.000018781415],"about_ca_topic_score_codex":0.008451727,"about_ca_topic_score_gemma":0.0048033204,"teacher_disagreement_score":0.008451727,"about_ca_system_score_codex":0.0006840123,"about_ca_system_score_gemma":0.00043199788,"threshold_uncertainty_score":0.016805053},"labels":[],"label_agreement":null},{"id":"W4386595954","doi":"10.1016/s2213-8587(23)00225-5","title":"Current insights and emerging trends in early-onset type 2 diabetes","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":191,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Toronto General Hospital; University of Toronto; University Health Network","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; NIHR Leicester Biomedical Research Centre; NIHR Imperial Biomedical Research Centre; National Institutes of Health; National Institute for Health and Care Research; National Health and Medical Research Council; Wellcome Trust","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Distress; Psychological intervention; Pediatrics; Disease; Type 1 diabetes; Obesity; Age of onset; Psychiatry; Internal medicine; Endocrinology","score_opus":0.10064863402239173,"score_gpt":0.39592956394093487,"score_spread":0.29528092991854316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386595954","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020731926,0.9992648,0.000027992117,0.000305224,0.0002269682,0.0000010036023,0.000013112612,0.0000028389131,0.00013746311],"genre_scores_gemma":[0.0001945284,0.999044,0.00005120922,0.00030020787,0.0003166986,0.000001879357,0.000015607282,6.690824e-7,0.00007523794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930954,0.00013329799,0.00013069098,0.000107749904,0.00024500376,0.00007366604],"domain_scores_gemma":[0.9975636,0.0016328653,0.00032634626,0.00003181691,0.0003038298,0.00014152862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021064098,0.0013436914,0.0039475304,0.0028446135,0.00024335393,0.0022162495,0.001258947,0.0018667316,0.006897218],"category_scores_gemma":[0.003298885,0.00041371406,0.0014213069,0.004034305,0.000667428,0.0022129694,0.0012704313,0.0031414244,0.001910274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022676571,0.000051230993,0.000374164,0.051458284,0.00038722056,0.0001497274,0.000046306217,0.00027115128,0.0003143671,0.0029224064,0.037453495,0.9063449],"study_design_scores_gemma":[0.0001763758,0.00020467113,0.0029986314,0.041186877,0.0015375052,0.0010505202,0.00019430445,0.00020586723,0.00014132082,0.0056758127,0.94657177,0.000056402292],"about_ca_topic_score_codex":0.0024011286,"about_ca_topic_score_gemma":0.0057984954,"teacher_disagreement_score":0.006897218,"about_ca_system_score_codex":0.0011571787,"about_ca_system_score_gemma":0.0023002229,"threshold_uncertainty_score":0.023073494},"labels":[],"label_agreement":null},{"id":"W4387328401","doi":"10.1016/s2213-8587(23)00259-0","title":"Faster and faster: meeting the challenges of delayed insulin action during pregnancy","year":2023,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute","funders":"","keywords":"Medicine; Pregnancy; Action (physics); Insulin; MEDLINE; Intensive care medicine; Obstetrics; Endocrinology","score_opus":0.07438935433203561,"score_gpt":0.31092401180496554,"score_spread":0.23653465747292993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387328401","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019981772,0.003528473,0.00006484058,0.9833682,0.012085764,0.0000028643017,0.000011864426,0.000008926006,0.00072927395],"genre_scores_gemma":[0.004994627,0.0064290576,0.00025262896,0.8605653,0.12571028,0.000031170337,0.0000145605045,0.000028153878,0.0019743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942351,0.002415871,0.00062936055,0.00047439284,0.0016090133,0.0006362864],"domain_scores_gemma":[0.97593224,0.016985452,0.0016166621,0.0005188717,0.0016566716,0.0032901024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006972216,0.0009765206,0.0022305716,0.0008175705,0.0029251322,0.004536508,0.0018099077,0.03714144,0.004988694],"category_scores_gemma":[0.051917348,0.0008552562,0.0012346655,0.000757642,0.004453838,0.0070624845,0.0022672282,0.04921757,0.0038566878],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020088194,0.0000571851,0.0009595073,0.00022052784,0.00004973581,0.00304975,0.00041470784,0.000089381814,0.00030790045,0.006626589,0.9530621,0.03496175],"study_design_scores_gemma":[0.0005062581,0.00030471012,0.0021369013,0.0015497882,0.00011729085,0.007838907,0.001774636,0.0006726694,0.00032713736,0.04312379,0.9414938,0.00015396168],"about_ca_topic_score_codex":0.0042738374,"about_ca_topic_score_gemma":0.0069959764,"teacher_disagreement_score":0.03714144,"about_ca_system_score_codex":0.0038225006,"about_ca_system_score_gemma":0.0046150913,"threshold_uncertainty_score":0.036872983},"labels":[],"label_agreement":null},{"id":"W4387749254","doi":"10.1016/s2213-8587(23)00224-3","title":"Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer's disease","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Canadian Institutes of Health Research; Helse Sør-Øst RHF; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Disease; Depression (economics); Sex characteristics; Gerontology; Biological sex; Psychiatry; Internal medicine; Developmental psychology; Psychology","score_opus":0.09532368868807573,"score_gpt":0.3939945599924252,"score_spread":0.2986708713043495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387749254","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042002448,0.9996377,0.000011427868,0.00013479446,0.000061243365,6.4089096e-7,0.000012355999,0.0000010794442,0.00009882938],"genre_scores_gemma":[0.00043922273,0.9992361,0.000023077679,0.00011237379,0.00008994714,0.0000014829237,0.000010684813,3.947935e-7,0.00008679418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997956,0.0000465841,0.000027102184,0.00003475568,0.000074481875,0.00002157266],"domain_scores_gemma":[0.9994387,0.00036222453,0.00008719103,0.000009884952,0.00006908681,0.000032841515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008367917,0.0008406935,0.002730841,0.0015240388,0.00021098323,0.0013075019,0.0007620176,0.0011627271,0.0045712143],"category_scores_gemma":[0.001404742,0.00025223603,0.0008039457,0.0022807352,0.00050012965,0.0009522162,0.0008011746,0.0016992802,0.0009614158],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024673864,0.000043664157,0.0006026047,0.026783263,0.00067851605,0.00013616211,0.00006644257,0.00026914218,0.00056757085,0.0027369154,0.022661854,0.9452071],"study_design_scores_gemma":[0.00017346373,0.00024306592,0.009720245,0.024467373,0.001644446,0.0014674081,0.0003295729,0.00014670393,0.0003041684,0.007164342,0.9542696,0.00006966473],"about_ca_topic_score_codex":0.0040969225,"about_ca_topic_score_gemma":0.009418304,"teacher_disagreement_score":0.0045712143,"about_ca_system_score_codex":0.0007237411,"about_ca_system_score_gemma":0.0014564903,"threshold_uncertainty_score":0.015292287},"labels":[],"label_agreement":null},{"id":"W4388278575","doi":"10.1016/s2213-8587(23)00267-x","title":"C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute of Child Health and Human Development; National Institute of Allergy and Infectious Diseases; JDRF; Wake Forest School of Medicine; Novo Nordisk; Linköpings Universitet; Harvard University; Diabetes UK; Juvenile Diabetes Research Foundation United States of America; National Institutes of Health; University of Birmingham; University of Florida; Eunice Kennedy Shriver National Institute of Child Health and Human Development; Sanofi; George Washington University; University of California; Immune Tolerance Network; National Institute of Diabetes and Digestive and Kidney Diseases; University of Exeter; University of Colorado; GlaxoSmithKline","keywords":"Medicine; Type 2 diabetes; Internal medicine; C-peptide; Diabetes mellitus; Insulin; Clinical endpoint; Metabolic control analysis; Randomized controlled trial; Endocrinology","score_opus":0.32101691920626435,"score_gpt":0.4159748924202482,"score_spread":0.09495797321398386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388278575","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07659372,0.9151735,0.0037761906,0.0005151185,0.00086058915,0.00059940707,0.0015269975,0.00020216557,0.0007523786],"genre_scores_gemma":[0.87497616,0.11537621,0.003963425,0.0011986909,0.0005719962,0.0016802598,0.0012583005,0.00011910299,0.0008557834],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9799604,0.013513505,0.0027254187,0.0020409783,0.0012217694,0.0005379239],"domain_scores_gemma":[0.97723114,0.016778301,0.003026512,0.0014383466,0.0010662404,0.00045937108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023165926,0.0035660416,0.020446328,0.003226156,0.0006954505,0.0042510997,0.0021650873,0.0032165546,0.0029006177],"category_scores_gemma":[0.033472937,0.0017300773,0.049460124,0.004182987,0.0007403261,0.0017872526,0.0019968904,0.002814158,0.0002894149],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0108304955,0.000028350338,0.006342273,0.015437245,0.96416026,0.00007403287,0.000022614155,0.000623857,0.00017733785,0.000046433994,0.00018576662,0.0020712176],"study_design_scores_gemma":[0.0020522946,0.0002947653,0.0045675007,0.00079830195,0.99121606,0.000047115023,0.000016152508,0.00042897245,0.00008123706,0.00013313892,0.0003498848,0.000014581223],"about_ca_topic_score_codex":0.005178919,"about_ca_topic_score_gemma":0.0058503957,"teacher_disagreement_score":0.023165926,"about_ca_system_score_codex":0.0014903971,"about_ca_system_score_gemma":0.0013664243,"threshold_uncertainty_score":0.122514606},"labels":[],"label_agreement":null},{"id":"W4389304068","doi":"10.1016/s2213-8587(23)00352-2","title":"New clarity for managing statin intolerance in diabetes","year":2023,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Heart and Stroke Foundation of Canada","keywords":"Medicine; Statin; Diabetes mellitus; Dyslipidemia; Internal medicine; Ezetimibe; Scopus; MEDLINE; Disease; Intensive care medicine; Physical therapy; Endocrinology","score_opus":0.04077186506000876,"score_gpt":0.30051341303082385,"score_spread":0.2597415479708151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389304068","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047628553,0.003674246,0.000056729503,0.9744028,0.020816194,0.0000034322952,0.000014560952,0.000012274923,0.0009721847],"genre_scores_gemma":[0.0009909286,0.0020891163,0.00016051887,0.8915592,0.10324682,0.000018040853,0.000013025927,0.000015465293,0.0019069143],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9872531,0.004100216,0.0018176718,0.0012905607,0.0039399667,0.0015982887],"domain_scores_gemma":[0.9416118,0.033683427,0.0035020548,0.0015835933,0.007450673,0.012168475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014865289,0.0018282719,0.0039115897,0.0021900441,0.006948134,0.010859026,0.003100161,0.11575423,0.012991042],"category_scores_gemma":[0.07371834,0.0015860022,0.0030947381,0.0014453352,0.010067037,0.011542335,0.005699756,0.10440868,0.008165639],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000068425616,0.00003966472,0.00021704903,0.00012264229,0.000032951863,0.0006506344,0.0001415997,0.000047325,0.000100347665,0.0044168704,0.9831955,0.0109670395],"study_design_scores_gemma":[0.00047709863,0.00009386516,0.0010636661,0.0014294012,0.00009124311,0.0009568432,0.0004910422,0.00037049918,0.00008743656,0.024708265,0.97011167,0.000118865646],"about_ca_topic_score_codex":0.009290014,"about_ca_topic_score_gemma":0.016824646,"teacher_disagreement_score":0.11575423,"about_ca_system_score_codex":0.008628583,"about_ca_system_score_gemma":0.010987901,"threshold_uncertainty_score":0.07861614},"labels":[],"label_agreement":null},{"id":"W4389938368","doi":"10.1016/s2213-8587(23)00347-9","title":"Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations","year":2023,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Diabetes Victoria; Novo Nordisk Fonden; Deakin University; Steno Diabetes Center Copenhagen","keywords":"Medicine; Stigma (botany); Prejudice (legal term); Social stigma; Blame; Psychiatry; Social psychology; Family medicine; Psychology","score_opus":0.36051325391205835,"score_gpt":0.5461487006412896,"score_spread":0.18563544672923127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389938368","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001429266,0.9189834,0.0006414506,0.075128816,0.0039102235,0.00012060088,0.00023167572,0.000020728841,0.00082021113],"genre_scores_gemma":[0.0037669463,0.9405542,0.005179055,0.046066754,0.0030690124,0.00040421815,0.0003535812,0.000029586081,0.000576633],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.97434014,0.008840281,0.0071051843,0.0019857748,0.0063897073,0.0013389601],"domain_scores_gemma":[0.89366794,0.08015437,0.0094310185,0.0014337532,0.0123633975,0.0029494963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06584904,0.0024092796,0.01301039,0.00816803,0.0018964497,0.01050845,0.006409161,0.013511744,0.0073525608],"category_scores_gemma":[0.09662954,0.0017733579,0.008212886,0.0067190835,0.004778516,0.009268451,0.007315399,0.016948614,0.0018921259],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004734351,0.00016210036,0.0010678609,0.23457944,0.004787505,0.0002154782,0.0009999776,0.0005930136,0.0004277542,0.01595056,0.13830586,0.60243714],"study_design_scores_gemma":[0.00049838575,0.000112421665,0.0020130065,0.5753021,0.008158771,0.00023208607,0.00095720676,0.0003040887,0.00023411759,0.02003101,0.39202425,0.00013252904],"about_ca_topic_score_codex":0.0145159485,"about_ca_topic_score_gemma":0.02473528,"teacher_disagreement_score":0.06584904,"about_ca_system_score_codex":0.009962492,"about_ca_system_score_gemma":0.039255623,"threshold_uncertainty_score":0.34824717},"labels":[],"label_agreement":null},{"id":"W4391155287","doi":"10.1016/s2213-8587(23)00344-3","title":"Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100 000 participants","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Food composition and properties","field":"Nursing","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Public Health Ontario; University of Toronto; Hamilton Health Sciences; McMaster University; University of Saskatchewan; Population Health Research Institute; St. Michael's Hospital","funders":"Temerty Faculty of Medicine, University of Toronto; Obesity Canada; Novo Nordisk; University of Toronto; International Sweeteners Association; Alberta Pulse Growers Commission; Canadian Nutrition Society; Danone; Diabetes Canada; Canadian Cardiovascular Society; Centre International de Recherche sur le Cancer; Loblaw Companies Limited; Canola Council of Canada; United Soybean Board; Soy Nutrition Institute; Dairy Farmers of Canada; McMaster University; National Honey Board; International Nut and Dried Fruit Council; Almond Board of California; Harvard University; General Mills; AstraZeneca; Eli Lilly and Company; Canadian Institutes of Health Research; PepsiCo; Kowa Company; Guangdong Provincial Hospital of Traditional Chinese Medicine; World Health Organization; Sanofi","keywords":"Medicine; Meta-analysis; Type 2 diabetes; Disease; Internal medicine; Diabetes mellitus; Mega-; Cohort study; Oncology; Endocrinology","score_opus":0.14288038811393786,"score_gpt":0.3577246968681067,"score_spread":0.21484430875416885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391155287","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012962861,0.98518735,0.0006377271,0.00020071997,0.0002399153,0.000056254048,0.0004915476,0.00003922741,0.00018448528],"genre_scores_gemma":[0.2928782,0.70028526,0.0028951631,0.0013837186,0.00037884287,0.00021567501,0.0011985998,0.000060191403,0.00070426776],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9974353,0.001232304,0.0005056349,0.0004408863,0.0002313698,0.00015454234],"domain_scores_gemma":[0.9959359,0.0028562502,0.0005120054,0.00028232837,0.00029413102,0.00011932835],"candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0053172493,0.0022138245,0.010141181,0.001455713,0.00040429298,0.0018176136,0.0016012783,0.0018679651,0.0024634383],"category_scores_gemma":[0.009697837,0.0013593561,0.027880443,0.0025506855,0.00039626117,0.0008793883,0.0014420309,0.0021762757,0.00037529203],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005194794,0.000044019038,0.009597667,0.07948682,0.8830688,0.000115764546,0.000080245736,0.00044693373,0.00041446657,0.00011642807,0.0011293867,0.020304605],"study_design_scores_gemma":[0.00086600665,0.00023718875,0.009749091,0.0034545998,0.983177,0.00007178068,0.000039116017,0.00012063943,0.000088721456,0.00018578387,0.0019817268,0.000028223396],"about_ca_topic_score_codex":0.009376711,"about_ca_topic_score_gemma":0.01918002,"teacher_disagreement_score":0.9898588,"about_ca_system_score_codex":0.0009552158,"about_ca_system_score_gemma":0.0015863299,"threshold_uncertainty_score":0.028120697},"labels":[],"label_agreement":null},{"id":"W4391544195","doi":"10.1016/s2213-8587(23)00356-x","title":"Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":192,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Boehringer Ingelheim","keywords":"Medicine; Placebo; Agonist; Glucagon-like peptide 1 receptor; Liraglutide; Glucagon-like peptide-1; Double blind; Internal medicine; Diabetes mellitus; Pharmacology; Endocrinology; Type 2 diabetes; Receptor; Alternative medicine","score_opus":0.05994524410212917,"score_gpt":0.343542484035551,"score_spread":0.28359723993342184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391544195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96017575,0.014376808,0.0027579577,0.002593703,0.0035092751,0.008663105,0.0035752608,0.0005081729,0.0038399168],"genre_scores_gemma":[0.9496268,0.00985973,0.004925865,0.004477058,0.0017540815,0.014604325,0.0029085842,0.00015464405,0.011688932],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990206,0.00044273864,0.000057594218,0.00023133786,0.00007739654,0.00017028415],"domain_scores_gemma":[0.9991517,0.00029009176,0.00016813642,0.000084908956,0.000055112858,0.00024990118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027424542,0.003980175,0.006688937,0.00082785316,0.0005986331,0.0018982359,0.0015178561,0.0037057367,0.011033986],"category_scores_gemma":[0.0026346857,0.0014496738,0.003501112,0.0007213297,0.0019137822,0.002210632,0.00068112795,0.0047172587,0.0018135804],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9923652,0.0015080372,0.0000964968,0.0005146194,0.00063585205,0.000023825934,0.000024545216,0.000112656206,0.0011346996,0.00007404278,0.0004463965,0.0030635444],"study_design_scores_gemma":[0.9920684,0.007157231,0.00018864013,0.000015437356,0.00017911363,0.000009790559,0.0000073405977,0.00007832346,0.00006831865,0.00006311901,0.00015683398,0.0000073486176],"about_ca_topic_score_codex":0.0013671252,"about_ca_topic_score_gemma":0.002686388,"teacher_disagreement_score":0.011033986,"about_ca_system_score_codex":0.0010239806,"about_ca_system_score_gemma":0.0013580092,"threshold_uncertainty_score":0.036912322},"labels":[],"label_agreement":null},{"id":"W4393238646","doi":"10.1016/s2213-8587(24)00059-7","title":"How clinically relevant is statin-induced diabetes?","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Diabetes mellitus; Disease; Blindness; Heart failure; Kidney disease; Statin; Type 2 diabetes; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.04807103858403257,"score_gpt":0.3062347696397802,"score_spread":0.25816373105574764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393238646","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001403886,0.00239219,0.000025725958,0.98246807,0.013525602,0.0000035234125,0.000036760874,0.0000065769786,0.0014011834],"genre_scores_gemma":[0.0023295993,0.0024489148,0.00007679091,0.8831907,0.10993586,0.000016021908,0.00003074064,0.00001242072,0.0019589786],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99231416,0.0026720967,0.001294109,0.00078221736,0.0020034926,0.0009339043],"domain_scores_gemma":[0.95804286,0.026498904,0.0031274895,0.0009999785,0.004477487,0.0068532964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071834256,0.0010882388,0.0028276772,0.0016185928,0.004282401,0.0067328736,0.0016675736,0.07181744,0.009241806],"category_scores_gemma":[0.055009972,0.0011142344,0.0021121416,0.0014219466,0.004879343,0.0047891815,0.0028838646,0.05798982,0.00764967],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010800753,0.00003417214,0.0013577677,0.00015605932,0.00005404351,0.0018045774,0.00012060515,0.000035647892,0.0001362931,0.0031256147,0.9787567,0.0143104065],"study_design_scores_gemma":[0.0005890573,0.00014765217,0.0049833707,0.0019879169,0.00021984421,0.0042342255,0.000819474,0.0004529417,0.00021661755,0.028740922,0.95745903,0.000148893],"about_ca_topic_score_codex":0.008789157,"about_ca_topic_score_gemma":0.01356289,"teacher_disagreement_score":0.07181744,"about_ca_system_score_codex":0.0058302185,"about_ca_system_score_gemma":0.0065528257,"threshold_uncertainty_score":0.042301357},"labels":[],"label_agreement":null},{"id":"W4393999792","doi":"10.1016/s2213-8587(24)00069-x","title":"Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127 594 people from 20 countries (PURE): a prospective cohort study","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; St. Michael's Hospital; University of Toronto; Queen's University; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Hazard ratio; Glycaemic index; Prospective cohort study; Type 2 diabetes; Diabetes mellitus; Internal medicine; Cohort; Cohort study; Proportional hazards model; Incidence (geometry); Demography; Glycemic index; Confidence interval; Endocrinology","score_opus":0.009002251241899066,"score_gpt":0.25214847423887865,"score_spread":0.24314622299697958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393999792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977458,0.00029092835,0.00013246438,0.000028921859,0.000017048396,0.000018428998,0.0014080864,0.0000060352445,0.0003523135],"genre_scores_gemma":[0.9969999,0.00031118604,0.00022633004,0.000088693,0.000018510445,0.000043356933,0.0017415425,0.000010220351,0.0005602244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854517,0.0004740958,0.00013079966,0.00042166634,0.00017255054,0.0002557255],"domain_scores_gemma":[0.9976841,0.00037327595,0.00064143783,0.00051720155,0.00030387376,0.0004800895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017090483,0.0010972562,0.0012866252,0.0010990514,0.001273594,0.0018213487,0.0009667556,0.0014596136,0.0014739584],"category_scores_gemma":[0.0025126846,0.0023395603,0.0017361235,0.0042371587,0.0006520653,0.0009429209,0.0012793215,0.001956542,0.0006305355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056566723,0.00011655139,0.9969189,0.00001983191,0.0006710498,0.00014397253,0.0003281536,0.000049285347,0.00033389777,0.000021733409,0.00019787146,0.00063315366],"study_design_scores_gemma":[0.000083469175,0.00022469634,0.99818593,0.000013517957,0.00030781023,0.00015041955,0.0006039393,0.00010298794,0.000053605676,0.000019708938,0.00023748649,0.000016350194],"about_ca_topic_score_codex":0.043819256,"about_ca_topic_score_gemma":0.0412808,"teacher_disagreement_score":0.043819256,"about_ca_system_score_codex":0.0005996344,"about_ca_system_score_gemma":0.00075053534,"threshold_uncertainty_score":0.0871284},"labels":[],"label_agreement":null},{"id":"W4396990859","doi":"10.1016/s2213-8587(24)00102-5","title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Meta-analysis; Heart failure; Medicine; Disease; Internal medicine; Intensive care medicine; Cardiology","score_opus":0.040512222091693965,"score_gpt":0.34716185231502206,"score_spread":0.3066496302233281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396990859","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033620442,0.9955701,0.0002703263,0.00011401091,0.00012912304,0.00007344177,0.0003299468,0.00001676802,0.0001341967],"genre_scores_gemma":[0.09439485,0.9021743,0.001142148,0.00092567294,0.00023351482,0.0002357275,0.0005537122,0.000023704617,0.00031625573],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9969235,0.001110505,0.0009035982,0.00049150723,0.00039366973,0.00017718061],"domain_scores_gemma":[0.99410677,0.0041704853,0.0010410445,0.00018284138,0.0003795031,0.00011934923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005690125,0.002703861,0.01844939,0.0030202358,0.0004656035,0.0024735136,0.0017179349,0.0020178766,0.0038035635],"category_scores_gemma":[0.012478577,0.001334523,0.031251762,0.0042316173,0.00056485104,0.0015072455,0.0015810777,0.0026303828,0.00034060236],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003405414,0.00004039558,0.0027914913,0.27538633,0.6970525,0.000096756194,0.000057331617,0.00043331413,0.0002814119,0.00010258658,0.00090921833,0.019443272],"study_design_scores_gemma":[0.00070048927,0.00013559966,0.0027371163,0.010296531,0.9846186,0.000048794795,0.00002741126,0.00008396473,0.000069193564,0.000118567,0.0011442619,0.000019436327],"about_ca_topic_score_codex":0.009287307,"about_ca_topic_score_gemma":0.023001436,"teacher_disagreement_score":0.01844939,"about_ca_system_score_codex":0.0018569591,"about_ca_system_score_gemma":0.002323326,"threshold_uncertainty_score":0.030092657},"labels":[],"label_agreement":null},{"id":"W4398161950","doi":"10.1016/s2213-8587(24)00100-1","title":"Small Island Developing States: addressing the intersecting challenges of non-communicable diseases, food insecurity, and climate change","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medical Research Council","keywords":"Food insecurity; Climate change; Environmental health; Non-communicable disease; Developing country; Geography; Food security; Environmental planning; Medicine; Economic growth; Public health; Biology; Ecology; Economics","score_opus":0.27589191933026147,"score_gpt":0.3781368852415118,"score_spread":0.10224496591125032,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4398161950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058587946,0.9983327,0.000036315134,0.0010401509,0.00017441307,0.0000035436683,0.000044388064,0.0000043232867,0.00030563775],"genre_scores_gemma":[0.00046483916,0.99904877,0.00007694177,0.00020072005,0.000079737205,0.0000036764702,0.000026609718,8.023225e-7,0.00009794403],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995697,0.00009522562,0.000068420675,0.00004239537,0.0001710198,0.000053272302],"domain_scores_gemma":[0.99831355,0.0008770495,0.00029456397,0.000028074308,0.00033455147,0.00015223607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017448132,0.0013552506,0.0019351367,0.003121851,0.0003776696,0.0023868857,0.0012838017,0.0015356753,0.005742139],"category_scores_gemma":[0.0030791438,0.0004104401,0.0010692369,0.006618013,0.0007229063,0.001923579,0.0017469259,0.002014996,0.0010377305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005010441,0.000043377633,0.0005156636,0.047079593,0.0004462168,0.00007679471,0.000102323975,0.00036323178,0.00022979792,0.004079585,0.040491946,0.9065214],"study_design_scores_gemma":[0.000045226097,0.00009037274,0.0053623803,0.06313891,0.0011061423,0.00036768755,0.00055974163,0.00023772588,0.00016163778,0.004472538,0.92440575,0.000051976745],"about_ca_topic_score_codex":0.029425697,"about_ca_topic_score_gemma":0.06842572,"teacher_disagreement_score":0.029425697,"about_ca_system_score_codex":0.0017746632,"about_ca_system_score_gemma":0.011364082,"threshold_uncertainty_score":0.058508873},"labels":[],"label_agreement":null},{"id":"W4399722924","doi":"10.1016/s2213-8587(24)00158-x","title":"Call for effective therapies for preventing dementia in people with type 2 diabetes","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Dementia; Type 2 diabetes; Diabetes mellitus; MEDLINE; Gerontology; Intensive care medicine; Internal medicine; Disease; Endocrinology","score_opus":0.017646837611785687,"score_gpt":0.29206074020070744,"score_spread":0.27441390258892173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399722924","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033755274,0.3272445,0.0002897388,0.6229758,0.028613374,0.00011727799,0.00096299226,0.00008046918,0.01634023],"genre_scores_gemma":[0.046714596,0.233075,0.0030203837,0.68178093,0.027462453,0.0007062908,0.00087233447,0.00006510315,0.006302857],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9913932,0.004381302,0.001129959,0.0004897481,0.0018766555,0.00072914246],"domain_scores_gemma":[0.9499653,0.033273548,0.0035597307,0.0019220344,0.006512821,0.004766595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018560626,0.0011372361,0.003975677,0.0020250704,0.0018743353,0.007112294,0.0018885245,0.011221406,0.03854383],"category_scores_gemma":[0.042225167,0.00086729816,0.0049195033,0.0015050862,0.0026554314,0.00789962,0.0032422862,0.011858735,0.0045643435],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033004005,0.0014526513,0.0039476897,0.014469632,0.003652291,0.000323876,0.0004696439,0.00033930116,0.0006220371,0.022723263,0.5311119,0.41758722],"study_design_scores_gemma":[0.010585841,0.0023746686,0.03334975,0.04141677,0.008590737,0.0004673521,0.0035800578,0.0002505451,0.00054153363,0.03694693,0.8616367,0.00025918646],"about_ca_topic_score_codex":0.009562502,"about_ca_topic_score_gemma":0.0159155,"teacher_disagreement_score":0.03854383,"about_ca_system_score_codex":0.0033671933,"about_ca_system_score_gemma":0.008251478,"threshold_uncertainty_score":0.12894195},"labels":[],"label_agreement":null},{"id":"W4399993403","doi":"10.1016/s2213-8587(24)00153-0","title":"The potential role for artificial intelligence in fracture risk prediction","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Manitoba; Alberta Children's Hospital","funders":"","keywords":"Medicine; Osteoporosis; Optimism; Leverage (statistics); Wearable computer; Artificial intelligence; Workload; Machine learning; Risk assessment; Risk analysis (engineering); Intervention (counseling); Physical therapy; Computer science; Computer security; Nursing; Pathology","score_opus":0.13289283565239984,"score_gpt":0.43470291422698765,"score_spread":0.3018100785745878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399993403","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011304467,0.99708897,0.00037741885,0.0013159865,0.00028815892,0.0000036011581,0.000027573635,0.000008555895,0.00077666354],"genre_scores_gemma":[0.0019689943,0.9954442,0.00080491253,0.000983168,0.0004926612,0.0000085717875,0.000040361625,0.0000024436304,0.00025472505],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930584,0.0002668846,0.00006570729,0.00009574095,0.00022757228,0.000038285663],"domain_scores_gemma":[0.9945755,0.00467214,0.00019672263,0.00007002097,0.0004101131,0.00007550226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024596925,0.0010231516,0.0024062982,0.0019807543,0.00022089598,0.002010321,0.0013088102,0.002225528,0.0038360842],"category_scores_gemma":[0.0054483577,0.00031892618,0.0014169329,0.002098781,0.001109705,0.001830839,0.0010878106,0.0034655982,0.0010889035],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009559924,0.00008350393,0.0004652335,0.01796005,0.00062289956,0.0001151078,0.00004677593,0.0013031188,0.0003273882,0.012176095,0.020701356,0.94610286],"study_design_scores_gemma":[0.00021032566,0.00039071168,0.0046758233,0.03462207,0.0015910083,0.001024484,0.00020451397,0.002685605,0.00064084894,0.054213528,0.89959264,0.00014833751],"about_ca_topic_score_codex":0.0036662873,"about_ca_topic_score_gemma":0.00387282,"teacher_disagreement_score":0.0038360842,"about_ca_system_score_codex":0.0010673378,"about_ca_system_score_gemma":0.0017452858,"threshold_uncertainty_score":0.013008237},"labels":[],"label_agreement":null},{"id":"W4400405364","doi":"10.1016/s2213-8587(24)00155-4","title":"Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; Toronto General Hospital; University of Toronto","funders":"Sanofi; Medical Research Council; Ramaciotti Foundations; AstraZeneca; Defense Acquisition Program Administration; National Health and Medical Research Council; Pfizer","keywords":"Medicine; Meta-analysis; MEDLINE; Library science; Internal medicine; Pharmacology; Biochemistry","score_opus":0.07908310206695787,"score_gpt":0.3579486775459569,"score_spread":0.27886557547899904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400405364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0125995055,0.9838748,0.0011713371,0.00022987345,0.00045995938,0.0002912726,0.00093066314,0.00007126786,0.00037134264],"genre_scores_gemma":[0.3574532,0.63129395,0.0041142902,0.002178187,0.0006038345,0.00088232395,0.0021407506,0.00016452608,0.0011689863],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.992912,0.0035005785,0.0016818737,0.0009853038,0.0005875617,0.00033273624],"domain_scores_gemma":[0.9909679,0.006649691,0.001359465,0.0004271165,0.00040461088,0.00019122289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0106909685,0.0033744986,0.022146108,0.002250515,0.00038825686,0.0031695552,0.00214825,0.0022509154,0.0048123254],"category_scores_gemma":[0.018133327,0.0016547889,0.037615713,0.0029572125,0.0007883763,0.0016789793,0.0015138008,0.0036166764,0.0004695672],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022494197,0.000031558153,0.0012951279,0.124843135,0.83695674,0.000063645224,0.000044832905,0.0006062073,0.0003636288,0.00014502207,0.00084478117,0.012311157],"study_design_scores_gemma":[0.008719039,0.00040947297,0.0021605568,0.004676264,0.9818397,0.000051773117,0.000028405144,0.00018268179,0.00011810221,0.0003138631,0.0014686337,0.000031451284],"about_ca_topic_score_codex":0.004472408,"about_ca_topic_score_gemma":0.008407291,"teacher_disagreement_score":0.022146108,"about_ca_system_score_codex":0.002061725,"about_ca_system_score_gemma":0.0016182206,"threshold_uncertainty_score":0.056539953},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W4400901124","doi":"10.1016/s2213-8587(24)00188-8","title":"Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality – Authors' reply","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Type 2 diabetes; Disease; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.03298948662715839,"score_gpt":0.2862749919852486,"score_spread":0.2532855053580902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400901124","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041494,0.00219199,0.000065309956,0.94652265,0.05004638,0.000007352753,0.00021331433,0.00001736844,0.0005206415],"genre_scores_gemma":[0.0026627835,0.00119617,0.000116901014,0.9286414,0.06524638,0.00003628176,0.00008864444,0.000016342417,0.001995064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970517,0.001139359,0.0004665314,0.0004275437,0.00068415696,0.00023074173],"domain_scores_gemma":[0.9819326,0.012772265,0.0010020033,0.00061244227,0.0023171518,0.0013636128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005507015,0.0008632603,0.0023810703,0.001023548,0.0020853737,0.0025868681,0.0020100637,0.031522248,0.004429375],"category_scores_gemma":[0.029854828,0.0009836096,0.0014395185,0.0010688916,0.0018226296,0.0029310402,0.0015138605,0.041381374,0.0046882597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001907975,0.000029512834,0.0016959113,0.000086875334,0.00006573253,0.0004343831,0.00009587763,0.000038591304,0.00009762451,0.0006322121,0.99153477,0.0050977804],"study_design_scores_gemma":[0.0008826338,0.00022723374,0.01269628,0.00088348903,0.00031435268,0.0021045108,0.001239042,0.0007207589,0.0004632152,0.010178867,0.9700117,0.00027792712],"about_ca_topic_score_codex":0.006497011,"about_ca_topic_score_gemma":0.009030152,"teacher_disagreement_score":0.031522248,"about_ca_system_score_codex":0.0019715868,"about_ca_system_score_gemma":0.002598339,"threshold_uncertainty_score":0.02912426},"labels":[],"label_agreement":null},{"id":"W4400901428","doi":"10.1016/s2213-8587(24)00190-6","title":"Association of glycaemic index and glycaemic load with type 2 diabetes in the PURE study – Authors' reply","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Population Health Research Institute","funders":"","keywords":"Medicine; Glycaemic index; Type 2 diabetes; Association (psychology); Index (typography); Diabetes mellitus; Internal medicine; Endocrinology; Glycemic index; Psychotherapist; World Wide Web","score_opus":0.01924760007878476,"score_gpt":0.2741374424820921,"score_spread":0.25488984240330737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400901428","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008984262,0.0017372204,0.000070264425,0.9585682,0.037647225,0.000010749422,0.00036035833,0.000020855454,0.0006865489],"genre_scores_gemma":[0.004521891,0.00075591874,0.00012094446,0.94851136,0.044207938,0.00006146774,0.00011543594,0.000023301416,0.0016817382],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952437,0.002194325,0.0006516418,0.0006188995,0.000840835,0.0004506107],"domain_scores_gemma":[0.9708986,0.022128386,0.0015289627,0.0009617622,0.002306592,0.0021756936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007783114,0.0009406225,0.003031241,0.0010552644,0.0024843593,0.002854184,0.0025588863,0.03222871,0.0047559063],"category_scores_gemma":[0.04212346,0.0011950925,0.0013423306,0.001337205,0.0021631555,0.0025398508,0.0017744385,0.03573994,0.0041320194],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002725608,0.000032246757,0.0028182107,0.000109038934,0.0001003695,0.0006264485,0.00013404244,0.00003445178,0.000079257035,0.0006538687,0.99107134,0.004068112],"study_design_scores_gemma":[0.0024280269,0.00042575866,0.025107298,0.0019001997,0.0008981507,0.003421963,0.0021094067,0.0013166239,0.0006765749,0.016706994,0.9445231,0.00048592873],"about_ca_topic_score_codex":0.0073717865,"about_ca_topic_score_gemma":0.010798663,"teacher_disagreement_score":0.03222871,"about_ca_system_score_codex":0.0021277051,"about_ca_system_score_gemma":0.0030085894,"threshold_uncertainty_score":0.041161537},"labels":[],"label_agreement":null},{"id":"W4401067215","doi":"10.1016/s2213-8587(24)00182-7","title":"Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; LMC Diabetes & Endocrinology (Canada)","funders":"Steno Diabetes Center Aarhus; Novo Nordisk","keywords":"Medicine; Semaglutide; Prediabetes; Placebo; Double blind; Physical therapy; Internal medicine; Diabetes mellitus; Type 2 diabetes; Alternative medicine; Endocrinology","score_opus":0.02610063540675881,"score_gpt":0.2991046831145682,"score_spread":0.2730040477078094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401067215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98907006,0.0037336736,0.00052342506,0.000674849,0.0007117141,0.0019386446,0.0011423302,0.00025409204,0.0019512698],"genre_scores_gemma":[0.98539066,0.002322999,0.0013950994,0.0017620302,0.0005069055,0.0031313794,0.0013319477,0.000055123313,0.00410402],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993511,0.0003039136,0.0000385988,0.00014061798,0.000053210544,0.000112529466],"domain_scores_gemma":[0.99905473,0.00030678225,0.00019404189,0.00007626741,0.00005616976,0.00031194667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019634883,0.002508196,0.004685775,0.00047795408,0.00046793427,0.0015094603,0.0011532694,0.0029484665,0.008213686],"category_scores_gemma":[0.0017778145,0.0010165365,0.003316624,0.00038207148,0.0014421366,0.0014377225,0.00063334574,0.0044011157,0.0018930229],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9915167,0.0020207088,0.00022639509,0.00031745867,0.0006505188,0.000019304498,0.000025324682,0.00010614953,0.0010120183,0.000029496005,0.0003222363,0.0037537033],"study_design_scores_gemma":[0.9714588,0.026343232,0.0012253429,0.000024345829,0.0004166936,0.000011972362,0.0000135684695,0.00017106469,0.00012192329,0.00006789374,0.00013285737,0.000012374219],"about_ca_topic_score_codex":0.0013189224,"about_ca_topic_score_gemma":0.00227288,"teacher_disagreement_score":0.008213686,"about_ca_system_score_codex":0.000741719,"about_ca_system_score_gemma":0.0009844402,"threshold_uncertainty_score":0.027477562},"labels":[],"label_agreement":null},{"id":"W4401825270","doi":"10.1016/s2213-8587(24)00179-7","title":"Meat consumption and incident type 2 diabetes: an individual-participant federated meta-analysis of 1·97 million adults with 100 000 incident cases from 31 cohorts in 20 countries","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Nutritional Studies and Diet","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Key Research and Development Program of China; European Regional Development Fund; Instituto de Salud Carlos III; Medical Research Council; Seventh Framework Programme; Kadoorie Charitable Foundation; Chinese Society of Clinical Oncology; NIHR Cambridge Biomedical Research Centre; Tehran University of Medical Sciences and Health Services; Ministry of Health, Labour and Welfare; National Institute on Aging; National Institute for Health and Care Research; Department of Health and Aged Care, Australian Government; European Commission; University of Oxford; British Heart Foundation; Wellcome Trust; Cancer Research UK; National Natural Science Foundation of China; Vetenskapsrådet; Australian Government; Consejo Nacional de Ciencia y Tecnología; National Cancer Center; Centre International de Recherche sur le Cancer; GlaxoSmithKline; FP7 Health; Cancer Council Victoria; Office of Research and Development; U.S. Department of Veterans Affairs; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; National Institute of Diabetes and Digestive and Kidney Diseases; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Science Foundation; American Diabetes Association; National Institutes of Health; Health Services Research and Development; Bloomberg Philanthropies","keywords":"Medicine; Type 2 diabetes; Meta-analysis; Consumption (sociology); Environmental health; Diabetes mellitus; MEDLINE; Gerontology; Demography; Internal medicine; Endocrinology","score_opus":0.17913932926069784,"score_gpt":0.3716981970797779,"score_spread":0.19255886781908008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401825270","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20768611,0.76914334,0.010902676,0.00086305686,0.0007422524,0.0006892231,0.008220594,0.0003955613,0.0013571609],"genre_scores_gemma":[0.90939975,0.07596464,0.00816571,0.00084489706,0.00019395028,0.0008975589,0.0036752683,0.00010626514,0.0007520197],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.990227,0.005784977,0.0017024078,0.0013863792,0.00061458757,0.00028473107],"domain_scores_gemma":[0.990767,0.0060763317,0.0011213344,0.0010196618,0.0008227885,0.00019296182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01572571,0.0026239168,0.008157305,0.0038765399,0.00068699033,0.0027380667,0.0015902808,0.0017283807,0.0018452562],"category_scores_gemma":[0.023781992,0.0017936493,0.044361748,0.0047794958,0.0004949942,0.0010432717,0.0016882401,0.002014068,0.00028953797],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052288366,0.000035638273,0.024517955,0.011967505,0.9516094,0.00015365673,0.0000652426,0.0013268961,0.00031509224,0.00007374703,0.00053231005,0.0041736313],"study_design_scores_gemma":[0.00083777966,0.00023282388,0.011059213,0.0010157645,0.9851459,0.00009759237,0.000033943605,0.0005337553,0.00012970879,0.00015523116,0.0007373375,0.000020962245],"about_ca_topic_score_codex":0.010792252,"about_ca_topic_score_gemma":0.013484879,"teacher_disagreement_score":0.01572571,"about_ca_system_score_codex":0.0013298735,"about_ca_system_score_gemma":0.0015756013,"threshold_uncertainty_score":0.08316654},"labels":[],"label_agreement":null},{"id":"W4401825293","doi":"10.1016/s2213-8587(24)00240-7","title":"Closed-loop systems: a bridge to cell therapy for type 1 diabetes?","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Medical Research Council","keywords":"Medicine; Type 2 diabetes; Closed loop; Bridge (graph theory); Diabetes mellitus; MEDLINE; Intensive care medicine; Internal medicine; Endocrinology; Control engineering; Biochemistry","score_opus":0.0619580491677977,"score_gpt":0.3238697753986138,"score_spread":0.2619117262308161,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401825293","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013071442,0.4894537,0.27080986,0.15805244,0.029716386,0.000084356056,0.0004221157,0.0012059525,0.037183788],"genre_scores_gemma":[0.35332644,0.4445576,0.07039105,0.06315125,0.03271639,0.00035885593,0.00047124494,0.00035181333,0.034675486],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9991117,0.00026529742,0.000042805274,0.00018079809,0.00029059852,0.00010884938],"domain_scores_gemma":[0.9966479,0.0023662976,0.00020102887,0.00019439266,0.00036749424,0.00022292267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002800907,0.0008057514,0.0015078821,0.0003499705,0.00037592102,0.0031111122,0.0013269212,0.0038144577,0.0138360225],"category_scores_gemma":[0.0053796694,0.00024650793,0.0008119576,0.0002881385,0.0031301545,0.0056300513,0.0015348843,0.005621716,0.003084925],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015842345,0.00044836028,0.00071083085,0.0025854853,0.00026801942,0.00025661578,0.00038978577,0.0056671603,0.010150735,0.25255507,0.047211025,0.67817265],"study_design_scores_gemma":[0.0005120733,0.002193755,0.000944186,0.0017087979,0.00016544318,0.0004855792,0.00038901053,0.009997107,0.0055382694,0.55087316,0.42704114,0.00015154104],"about_ca_topic_score_codex":0.0005490748,"about_ca_topic_score_gemma":0.00036385065,"teacher_disagreement_score":0.0138360225,"about_ca_system_score_codex":0.0008659719,"about_ca_system_score_gemma":0.0010734634,"threshold_uncertainty_score":0.046286106},"labels":[],"label_agreement":null},{"id":"W4401825468","doi":"10.1016/s2213-8587(24)00186-4","title":"Association of age with gaps in diabetes-related care and hospitalisations from childhood to young adulthood in Quebec, Canada: a cohort study","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institut National de Santé Publique du Québec; McGill University Health Centre","funders":"Diabetes Canada; Fonds de Recherche du Québec - Santé; Ministère de la Santé et des Services sociaux","keywords":"Medicine; Cohort; Cohort study; Diabetes mellitus; Young adult; Early adulthood; Demography; Association (psychology); Pediatrics; MEDLINE; Gerontology; Internal medicine","score_opus":0.0134316441151939,"score_gpt":0.2926620349015571,"score_spread":0.27923039078636325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401825468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8662166,0.009983073,0.00037784316,0.07750579,0.001432442,0.00014898494,0.032509267,0.000091281436,0.0117347045],"genre_scores_gemma":[0.9572729,0.0036836423,0.00054519856,0.023979876,0.00067062996,0.00014117424,0.003914217,0.000045586006,0.009746737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983387,0.00015127157,0.00016570983,0.00023353662,0.0003573473,0.00075344206],"domain_scores_gemma":[0.99198145,0.00066298764,0.001237942,0.0003542617,0.0035877004,0.0021755742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011867875,0.00038380479,0.0007848922,0.0008695708,0.0033788981,0.0018810083,0.0018771216,0.0031702556,0.0033848512],"category_scores_gemma":[0.005867969,0.0005509148,0.0012050925,0.0035147835,0.0007228877,0.00075113494,0.0008900617,0.0029056822,0.0004256494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013410502,0.00004617627,0.96900314,0.00004303941,0.00014441695,0.0002790831,0.00045764688,0.00006135356,0.00007729596,0.00012025775,0.025743917,0.003889498],"study_design_scores_gemma":[0.000044926892,0.000030399202,0.99413246,0.00015089,0.00013799054,0.0001506661,0.00122329,0.00027928472,0.000033847395,0.00005932409,0.0037260146,0.000030882835],"about_ca_topic_score_codex":0.9937431,"about_ca_topic_score_gemma":0.99654204,"teacher_disagreement_score":0.022598853,"about_ca_system_score_codex":0.022598853,"about_ca_system_score_gemma":0.03596809,"threshold_uncertainty_score":0.16396695},"labels":[],"label_agreement":null},{"id":"W4402289378","doi":"10.1016/s2213-8587(24)00219-5","title":"Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Toronto; St. Michael's Hospital","funders":"Public Health Scotland; National Heart, Lung, and Blood Institute; NIHR Nottingham Biomedical Research Centre; Medical Research Council; Swansea University; National Institutes of Health; Public Health England; National Institute for Health and Care Research; AstraZeneca; UK Research and Innovation; National Heart and Lung Institute; NIHR Oxford Biomedical Research Centre; Wellcome Trust; World Health Organization; Bill and Melinda Gates Foundation","keywords":"Medicine; Placebo; Coronavirus disease 2019 (COVID-19); Meta-analysis; Randomized controlled trial; MEDLINE; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Intensive care medicine; Pharmacology; Alternative medicine; Virology; Disease","score_opus":0.12741284742750297,"score_gpt":0.3928776897507555,"score_spread":0.2654648423232525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402289378","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012759993,0.98173964,0.0019141814,0.00031937662,0.00035171642,0.0013098863,0.0010976662,0.00007271953,0.00043473262],"genre_scores_gemma":[0.43565837,0.54023576,0.00972401,0.002097969,0.0005810773,0.007720761,0.0029526264,0.00013752539,0.00089187146],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97378707,0.014636763,0.006741691,0.0023526235,0.0018433597,0.0006384786],"domain_scores_gemma":[0.9662762,0.023588467,0.0065028802,0.0014339077,0.0017882562,0.00041023496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031921767,0.0038085538,0.025822982,0.0056611407,0.000692194,0.004769196,0.0025939236,0.003015788,0.0051960805],"category_scores_gemma":[0.05375122,0.002095137,0.06421009,0.007132807,0.0009062367,0.0027558291,0.00212672,0.003086295,0.0005318322],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007756279,0.000034366258,0.0027132116,0.15658644,0.8270348,0.00007586712,0.00004631207,0.0005143615,0.00011610951,0.000116210664,0.00040663005,0.0045994422],"study_design_scores_gemma":[0.002769162,0.00030938358,0.0019889453,0.010500991,0.9831297,0.00005605994,0.000025605408,0.0002472587,0.00007407298,0.00022973244,0.00064591394,0.000023178933],"about_ca_topic_score_codex":0.0049712164,"about_ca_topic_score_gemma":0.007285939,"teacher_disagreement_score":0.031921767,"about_ca_system_score_codex":0.0035218901,"about_ca_system_score_gemma":0.0030794071,"threshold_uncertainty_score":0.16882044},"labels":[],"label_agreement":null},{"id":"W4402346997","doi":"10.1016/s2213-8587(24)00272-9","title":"Muscle matters: the effects of medically induced weight loss on skeletal muscle","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta","funders":"","keywords":"Medicine; Skeletal muscle; MEDLINE; Weight loss; Physical medicine and rehabilitation; Internal medicine; Obesity; Biochemistry","score_opus":0.02436494382285738,"score_gpt":0.3125383633487066,"score_spread":0.28817341952584924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402346997","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02543368,0.8480381,0.00047020367,0.10261099,0.013805954,0.000020334555,0.000350887,0.00005137271,0.009218494],"genre_scores_gemma":[0.25606683,0.591693,0.001375245,0.086323224,0.04726504,0.00006885694,0.00031651367,0.00008915613,0.01680217],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99911267,0.00035675635,0.00005354794,0.00013055762,0.00026478607,0.00008168934],"domain_scores_gemma":[0.9979086,0.0012271013,0.00035638013,0.000113195114,0.00018660103,0.0002080379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001852838,0.00044971265,0.0010458212,0.00038830665,0.00033446093,0.001533964,0.00056195096,0.0029893834,0.009131805],"category_scores_gemma":[0.004436361,0.0001472914,0.0008308989,0.00038391896,0.0013139202,0.0010123767,0.0007336288,0.0028633808,0.0010892147],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007185912,0.0006941775,0.008137683,0.006545438,0.0023698874,0.00059156824,0.0002806956,0.00050057727,0.011111662,0.012332599,0.1246192,0.82563055],"study_design_scores_gemma":[0.0028482655,0.009816965,0.31064972,0.012798112,0.0043663173,0.0029520772,0.0020303645,0.0010333904,0.0049323556,0.05308506,0.59521055,0.00027681916],"about_ca_topic_score_codex":0.001344861,"about_ca_topic_score_gemma":0.0037150402,"teacher_disagreement_score":0.009131805,"about_ca_system_score_codex":0.0005077849,"about_ca_system_score_gemma":0.00068388385,"threshold_uncertainty_score":0.03054899},"labels":[],"label_agreement":null},{"id":"W4402737275","doi":"10.1016/s2213-8587(24)00200-6","title":"Aberrant hormone receptors regulate a wide spectrum of endocrine tumors","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Université de Montréal","keywords":"Medicine; Endocrine system; Somatostatin receptor; Endocrinology; Internal medicine; Pheochromocytoma; G protein-coupled receptor; Paraganglioma; Hormone; Receptor; Cancer research; Pathology","score_opus":0.03895178644335421,"score_gpt":0.3150462902382269,"score_spread":0.27609450379487266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402737275","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006609677,0.9980326,0.00007980003,0.00039904282,0.00034506572,0.0000032117057,0.000026823,0.000007406565,0.0010399319],"genre_scores_gemma":[0.0005070458,0.9978662,0.00012847652,0.00043358054,0.00028342937,0.000004478916,0.000036501307,0.0000013737599,0.00073896616],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998437,0.000025324402,0.000018087147,0.000021453427,0.00007130202,0.000020123323],"domain_scores_gemma":[0.99972874,0.00014075982,0.00004105234,0.000008638222,0.000055389613,0.000025471387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054457365,0.0009126532,0.0014723529,0.0013131766,0.00016156166,0.0009941832,0.0005521094,0.00092531525,0.0053325826],"category_scores_gemma":[0.00071574113,0.0002447447,0.0004794526,0.0013296023,0.0003290244,0.00074131234,0.0006206737,0.0018252147,0.0022427049],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015617348,0.000042271866,0.00015857098,0.010284372,0.00015697817,0.00014659295,0.000024853643,0.0002375226,0.0014929917,0.0031805611,0.054632086,0.929487],"study_design_scores_gemma":[0.00007583066,0.00008050453,0.0007093762,0.0034540433,0.00023769977,0.00048365546,0.000038783,0.000064451604,0.00027399862,0.0016785458,0.99288756,0.0000155342],"about_ca_topic_score_codex":0.0010333833,"about_ca_topic_score_gemma":0.0029708927,"teacher_disagreement_score":0.0053325826,"about_ca_system_score_codex":0.0005244376,"about_ca_system_score_gemma":0.00076366076,"threshold_uncertainty_score":0.017839313},"labels":[],"label_agreement":null},{"id":"W4403115981","doi":"10.1016/s2213-8587(24)00221-3","title":"Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Key Research and Development Program of China; Fundação para a Ciência e a Tecnologia; Esperion Therapeutics; Silence Therapeutics; Servier; Health Systems Research Institute; National Natural Science Foundation of China; HLS Therapeutics; Imperial College London; Amryt Pharma; Ultragenyx Pharmaceutical; Medpace; Alexion Pharmaceuticals; Javna Agencija za Raziskovalno Dejavnost RS; AstraZeneca; Amarin Corporation; Novo Nordisk; Abbott Laboratories; National Institute for Health and Care Research; Medical Research Council; Teva Pharmaceutical Industries; Sanofi; European Atherosclerosis Society; Bayer Vital; Bristol-Myers Squibb; Eli Lilly and Company; Amgen; Pfizer; Chulalongkorn University; Universidad de Sevilla; Kowa Company; Regeneron Pharmaceuticals","keywords":"Medicine; Cross-sectional study; Type 2 diabetes; Diabetes mellitus; Medication adherence; Body mass index; Internal medicine; Pediatrics; Environmental health; Endocrinology; Pathology","score_opus":0.013872151055652185,"score_gpt":0.27606482593131165,"score_spread":0.26219267487565945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403115981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99871004,0.00039982694,0.00008170681,0.00004185775,0.000009536297,0.000005716736,0.00038019693,0.0000055679125,0.0003655366],"genre_scores_gemma":[0.9992017,0.00015528982,0.00008037635,0.000045587032,0.000013778733,0.00000689119,0.00031439727,0.0000036237425,0.00017831389],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999385,0.00020080579,0.00007601976,0.00017346305,0.000081497274,0.00008322482],"domain_scores_gemma":[0.99835557,0.00026872204,0.00069595844,0.00022642867,0.00016125035,0.00029198723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001009967,0.00050235516,0.0006942892,0.00094665255,0.0004488223,0.0009310127,0.00050473463,0.0012160526,0.0013496676],"category_scores_gemma":[0.0019737114,0.0008532026,0.0009136674,0.0015938727,0.00038064452,0.0007879914,0.00063475186,0.0012323203,0.00030537744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013667638,0.000034450488,0.99911183,0.0000054137445,0.00014767659,0.000037894995,0.000050114453,0.000014144034,0.00015491745,0.0000056341514,0.000036012534,0.00026521218],"study_design_scores_gemma":[0.0000052085,0.000050114813,0.9996499,0.000002067458,0.000040583713,0.000076971985,0.000078216704,0.00005307555,0.000009606219,0.000005868144,0.000025736423,0.0000027443125],"about_ca_topic_score_codex":0.014309469,"about_ca_topic_score_gemma":0.012620117,"teacher_disagreement_score":0.014309469,"about_ca_system_score_codex":0.00032140774,"about_ca_system_score_gemma":0.00027569963,"threshold_uncertainty_score":0.028452337},"labels":[],"label_agreement":null},{"id":"W4403460684","doi":"10.1016/s2213-8587(24)00277-8","title":"Lomitapide for the treatment of homozygous familial hypercholesterolaemia in children","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of British Columbia","funders":"","keywords":"Medicine; Familial hypercholesterolemia; MEDLINE; Intensive care medicine; Pediatrics; Internal medicine; Cholesterol","score_opus":0.028896982794405685,"score_gpt":0.2845322833172575,"score_spread":0.2556353005228518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403460684","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019106414,0.021413745,0.0004927461,0.9191705,0.023138735,0.00004902223,0.0003036048,0.00011896897,0.016206352],"genre_scores_gemma":[0.14299133,0.022160852,0.0015752293,0.70621336,0.100992575,0.00015421158,0.0003134832,0.00013522405,0.025463715],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927145,0.0001824682,0.00008822524,0.00006506525,0.0002682971,0.0001244624],"domain_scores_gemma":[0.9986443,0.00066891144,0.00014883514,0.000033882057,0.00013995456,0.00036407157],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007727683,0.0005678802,0.0012222606,0.0004977861,0.0013665961,0.00087877817,0.00055602554,0.009877373,0.0019253873],"category_scores_gemma":[0.0052450155,0.0004011612,0.00091789046,0.00039612217,0.0009908859,0.0006377891,0.00040701282,0.009177741,0.0014029925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062935904,0.00017906206,0.013261181,0.00036055638,0.00015141103,0.06292899,0.00033882834,0.0003053314,0.0019161282,0.005223417,0.85704947,0.057656292],"study_design_scores_gemma":[0.0021319324,0.0014756905,0.04626482,0.0023504142,0.0004561699,0.12206774,0.0007851615,0.002465662,0.002098988,0.009870576,0.80988336,0.0001494022],"about_ca_topic_score_codex":0.01084674,"about_ca_topic_score_gemma":0.019504488,"teacher_disagreement_score":0.01084674,"about_ca_system_score_codex":0.0021342095,"about_ca_system_score_gemma":0.0019157196,"threshold_uncertainty_score":0.021567225},"labels":[],"label_agreement":null},{"id":"W4403714936","doi":"10.1016/s2213-8587(24)00248-1","title":"Diabetes subtypes and patient-reported outcomes","year":2024,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"HLS Therapeutics; Ultragenyx Pharmaceutical; Amgen","keywords":"Medicine; MEDLINE; Diabetes mellitus; Intensive care medicine; Endocrinology","score_opus":0.032781906331710936,"score_gpt":0.2970231164502841,"score_spread":0.26424121011857316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403714936","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015878032,0.004198408,0.000073156196,0.9658463,0.021987157,0.0000095005935,0.0016816382,0.000023355073,0.004592648],"genre_scores_gemma":[0.029107623,0.0047412924,0.00030552864,0.84916854,0.10824784,0.00015779541,0.0014673952,0.000041799503,0.0067622396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904186,0.004474455,0.0014850064,0.0006154245,0.001999391,0.0010070688],"domain_scores_gemma":[0.9401787,0.041222136,0.004970203,0.0017645395,0.00568232,0.0061820922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00982922,0.0006491263,0.0020217511,0.001674122,0.0021206744,0.0034883355,0.0018130253,0.023295911,0.010888432],"category_scores_gemma":[0.0782167,0.0008099029,0.0016992941,0.0030348285,0.0014414623,0.0028801237,0.0017357483,0.021025663,0.005198196],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025625192,0.000052687978,0.0139711015,0.0001302371,0.00010934959,0.00040300327,0.00011358137,0.00006777573,0.000034870256,0.001976888,0.9686083,0.014276001],"study_design_scores_gemma":[0.0024520329,0.00034910569,0.1300484,0.004302348,0.0010157991,0.0024794228,0.0023653156,0.002885651,0.00028443523,0.04704586,0.80626273,0.0005089568],"about_ca_topic_score_codex":0.022747397,"about_ca_topic_score_gemma":0.040547926,"teacher_disagreement_score":0.023295911,"about_ca_system_score_codex":0.0032115285,"about_ca_system_score_gemma":0.005068994,"threshold_uncertainty_score":0.051982522},"labels":[],"label_agreement":null},{"id":"W4404404303","doi":"10.1016/s2213-8587(24)00287-0","title":"Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort study","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Sheba Medical Center","keywords":"Medicine; Overweight; Retrospective cohort study; Obesity; Young adult; Cohort; Pediatrics; Cohort study; MEDLINE; Adolescent Obesity; Environmental health; Demography; Gerontology; Internal medicine","score_opus":0.009798897785092991,"score_gpt":0.2640731411272716,"score_spread":0.25427424334217863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404404303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981761,0.00031171838,0.000052211893,0.000060852693,0.000010155782,0.000009829775,0.00096682704,0.00000254233,0.00040980667],"genre_scores_gemma":[0.99852496,0.00025817443,0.00005912634,0.000057719404,0.000013716032,0.000016930226,0.0007865406,0.0000022151949,0.00028074032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970645,0.000059358714,0.000030011986,0.00008195246,0.000043532586,0.00007868411],"domain_scores_gemma":[0.99925023,0.00007213689,0.00024428839,0.00009613507,0.000105008316,0.0002321233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000649928,0.000372248,0.00039064966,0.00084513833,0.00061887706,0.00092399155,0.0004368407,0.0007522778,0.0010128455],"category_scores_gemma":[0.00085690967,0.0007373362,0.00068639056,0.0015307581,0.00025917604,0.00065146753,0.000513871,0.0010693729,0.0002716403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004149531,0.000030256326,0.99942744,0.0000027978801,0.000060302005,0.00002917789,0.00004444653,0.000006416957,0.00005773874,0.000008252741,0.000067681794,0.00022407691],"study_design_scores_gemma":[0.0000057889893,0.00003010826,0.9995036,0.0000041703956,0.000041207622,0.00006304643,0.00020493288,0.00003679809,0.000012656802,0.000005864723,0.00008934098,0.0000024130554],"about_ca_topic_score_codex":0.027987037,"about_ca_topic_score_gemma":0.03102326,"teacher_disagreement_score":0.027987037,"about_ca_system_score_codex":0.0004918576,"about_ca_system_score_gemma":0.00061817054,"threshold_uncertainty_score":0.055648267},"labels":[],"label_agreement":null},{"id":"W4404685978","doi":"10.1016/s2213-8587(24)00271-7","title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","year":2024,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":268,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Meta-analysis; Glucagon-like peptide 1 receptor; Randomized controlled trial; MEDLINE; Semaglutide; Internal medicine; Type 2 diabetes; Disease; Diabetes mellitus; Intensive care medicine; Liraglutide; Agonist; Endocrinology; Receptor","score_opus":0.10556002575108235,"score_gpt":0.36492264539185565,"score_spread":0.2593626196407733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404685978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006889957,0.9910952,0.0007299981,0.0001796816,0.00021956049,0.0001899335,0.00042779386,0.000044476226,0.00022342957],"genre_scores_gemma":[0.18389314,0.8091398,0.0031120575,0.0012301103,0.00033778246,0.00059683697,0.0010042654,0.00006833923,0.0006176261],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99224806,0.0039481074,0.0017703278,0.0009615752,0.00071839034,0.0003535579],"domain_scores_gemma":[0.98612136,0.011183241,0.0015861384,0.0004504953,0.00045505314,0.0002037181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012339261,0.0035093867,0.021949861,0.0027996833,0.00043521737,0.0028931457,0.0022870535,0.002415951,0.004767327],"category_scores_gemma":[0.021848796,0.0017714654,0.034165397,0.0035108095,0.00078574155,0.0018499347,0.0016980682,0.003466565,0.0004031993],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012708872,0.000037637386,0.0016808867,0.19119933,0.7754145,0.00009183981,0.00005099244,0.0006492428,0.0003153938,0.00013235769,0.00080220576,0.016916802],"study_design_scores_gemma":[0.0041489624,0.00028464757,0.0023428488,0.007948683,0.9833323,0.00006390181,0.000033284683,0.00014662338,0.000116498835,0.00028595273,0.001272152,0.000024174999],"about_ca_topic_score_codex":0.0049464973,"about_ca_topic_score_gemma":0.009531264,"teacher_disagreement_score":0.021949861,"about_ca_system_score_codex":0.002155618,"about_ca_system_score_gemma":0.0018619604,"threshold_uncertainty_score":0.06525707},"labels":[],"label_agreement":null},{"id":"W4405467041","doi":"10.1016/s2213-8587(24)00375-9","title":"Barriers to care for refugees and migrants with diabetes","year":2024,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Migration, Health and Trauma","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Refugee; Diabetes mellitus; MEDLINE; Gerontology; Family medicine; Nursing; Endocrinology","score_opus":0.01718669554345504,"score_gpt":0.3175438163189397,"score_spread":0.30035712077548465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405467041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6706283,0.016125672,0.00031065667,0.28993487,0.0024450845,0.0000968743,0.0004656041,0.000027697413,0.019965146],"genre_scores_gemma":[0.962289,0.010196392,0.00039700945,0.023640893,0.00066057115,0.00013720842,0.00022092309,0.00003545103,0.0024226638],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99493825,0.0019281153,0.00028443607,0.00014877602,0.00026907583,0.00243136],"domain_scores_gemma":[0.9856102,0.0030649705,0.0022919953,0.00025784702,0.0009994049,0.0077756513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044288323,0.00035657745,0.0008343899,0.00086036883,0.005804615,0.0048770835,0.0015649245,0.0026282743,0.01220098],"category_scores_gemma":[0.026751215,0.0005306425,0.0011588058,0.0016757008,0.0027137296,0.0036457342,0.008770229,0.007515897,0.00055345474],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062713615,0.0013518776,0.49247405,0.0025717523,0.00081809855,0.004198541,0.19378573,0.00030706442,0.00050984736,0.014378902,0.13986853,0.14910854],"study_design_scores_gemma":[0.00015665503,0.0005087166,0.27600694,0.008162222,0.00027197378,0.0018851017,0.6559891,0.0001865706,0.0000898387,0.008093059,0.04849221,0.00015773952],"about_ca_topic_score_codex":0.055861793,"about_ca_topic_score_gemma":0.07868345,"teacher_disagreement_score":0.055861793,"about_ca_system_score_codex":0.0032252516,"about_ca_system_score_gemma":0.012013716,"threshold_uncertainty_score":0.111073315},"labels":[],"label_agreement":null},{"id":"W4406315151","doi":"10.1016/s2213-8587(24)00317-6","title":"Halving heart failure outcomes by finerenone-mediated type 2 diabetes prevention","year":2025,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute","funders":"","keywords":"Medicine; Type 2 diabetes; MEDLINE; Diabetes mellitus; Heart failure; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.026868285444354927,"score_gpt":0.28785844414974193,"score_spread":0.260990158705387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406315151","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00092156976,0.011454671,0.00016048056,0.945583,0.035879042,0.000016890654,0.00013767429,0.000052465235,0.005794281],"genre_scores_gemma":[0.008475474,0.006343712,0.00031701973,0.8512527,0.12697269,0.00005507317,0.000072047806,0.000027519087,0.0064839073],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982691,0.0005992465,0.00018149833,0.00014600331,0.00058027636,0.0002239688],"domain_scores_gemma":[0.99372464,0.004067885,0.00029571034,0.0001846679,0.00068349484,0.0010435513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028861882,0.00077031075,0.002180272,0.0007653878,0.0017890357,0.002074023,0.0010589745,0.021479318,0.0088698035],"category_scores_gemma":[0.014499217,0.0005034188,0.0016253988,0.00048062307,0.0018652129,0.0020089773,0.0010960104,0.024036393,0.0070862924],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067115825,0.00020867595,0.0014515196,0.00022603804,0.00011131389,0.0010701345,0.00008166165,0.00010136869,0.000531214,0.004353689,0.9259464,0.065246776],"study_design_scores_gemma":[0.0035830266,0.000724228,0.007360754,0.0013271215,0.00031898278,0.0016872023,0.0003416583,0.00086680806,0.00059413764,0.02578346,0.95729077,0.00012183502],"about_ca_topic_score_codex":0.0044708713,"about_ca_topic_score_gemma":0.011307078,"teacher_disagreement_score":0.021479318,"about_ca_system_score_codex":0.001981902,"about_ca_system_score_gemma":0.0024723515,"threshold_uncertainty_score":0.029672444},"labels":[],"label_agreement":null},{"id":"W4406352689","doi":"10.1016/s2213-8587(24)00308-5","title":"Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Centre Hospitalier de l’Université de Montréal; University of Ottawa","funders":"Agencia Nacional de Investigación y Desarrollo; Pontificia Universidad Católica de Chile; National Health and Medical Research Council; Hudson Institute of Medical Research; National Heart, Lung, and Blood Institute; State Government of Victoria; National Institute on Aging; Agenția Națională pentru Cercetare și Dezvoltare; Ministry of Health, Labour and Welfare; Deutsche Forschungsgemeinschaft; National Institute for Health and Care Research; Hudson Institute","keywords":"Medicine; Primary aldosteronism; Cohort; MEDLINE; Cohort study; Intensive care medicine; Internal medicine; Aldosterone","score_opus":0.03479493122060188,"score_gpt":0.3537968431540736,"score_spread":0.3190019119334717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406352689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91383135,0.06384302,0.0022782837,0.006583599,0.0005943082,0.00015931313,0.0071046473,0.000034876077,0.0055704867],"genre_scores_gemma":[0.9870165,0.0066392096,0.00070338557,0.0009240245,0.0002124711,0.00011371175,0.0042288043,0.000022592112,0.0001393462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9897367,0.0040662424,0.0018929468,0.001649649,0.0019577718,0.0006967794],"domain_scores_gemma":[0.9713443,0.013009673,0.008593482,0.0023812053,0.0036093409,0.0010619237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020890925,0.0004582602,0.0019636762,0.0023574615,0.0005156612,0.0019010514,0.0014433269,0.0009918011,0.0006375821],"category_scores_gemma":[0.028707217,0.00028975835,0.0026303364,0.003264196,0.00072090916,0.0010778958,0.0013605452,0.0016055409,0.00012694906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016058673,0.00009343552,0.9624855,0.00063823094,0.0069455784,0.000056531375,0.0006553891,0.0003404674,0.00016534199,0.00044110356,0.0031730712,0.023399426],"study_design_scores_gemma":[0.0001841594,0.00013369723,0.9919887,0.00059596816,0.0030909427,0.00009433854,0.00072165707,0.00034893327,0.00012970857,0.00031868994,0.0023616822,0.00003143516],"about_ca_topic_score_codex":0.009471862,"about_ca_topic_score_gemma":0.0116321165,"teacher_disagreement_score":0.020890925,"about_ca_system_score_codex":0.0013509806,"about_ca_system_score_gemma":0.0017596085,"threshold_uncertainty_score":0.11048305},"labels":[],"label_agreement":null},{"id":"W4406352787","doi":"10.1016/s2213-8587(24)00316-4","title":"Definition and diagnostic criteria of clinical obesity","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":1324,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster Children's Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of General Medical Sciences; World Health Organization","keywords":"Medicine; MEDLINE; Intensive care medicine; Obesity; Internal medicine","score_opus":0.30242526656903984,"score_gpt":0.5601540238261928,"score_spread":0.257728757257153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406352787","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007719499,0.9973023,0.0003236267,0.001187703,0.00047860757,0.000025991652,0.00010771011,0.000006948689,0.00048975786],"genre_scores_gemma":[0.0018466235,0.99271303,0.0020137397,0.0017762184,0.00088495266,0.00007814597,0.0003515229,0.000006457608,0.00032934087],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99681455,0.0007112123,0.0010189308,0.00045313413,0.0008567947,0.00014539612],"domain_scores_gemma":[0.99260277,0.0045181145,0.0014223821,0.00013695368,0.0011050069,0.00021467572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064603123,0.0025052498,0.00652169,0.010906035,0.0005694645,0.0029488814,0.0032012402,0.0023074916,0.0043193162],"category_scores_gemma":[0.011139664,0.0010035512,0.004423776,0.007046652,0.0028549563,0.002888911,0.00194618,0.005190887,0.0015698366],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027660298,0.00008035746,0.0022886079,0.069865085,0.000894199,0.00018846952,0.00017851169,0.00044868246,0.00033007067,0.01452917,0.055565916,0.8553544],"study_design_scores_gemma":[0.0006597193,0.00037207722,0.019948257,0.20285855,0.005268358,0.003793498,0.00074021105,0.0013903094,0.00051606895,0.036860447,0.72724223,0.0003502991],"about_ca_topic_score_codex":0.010305066,"about_ca_topic_score_gemma":0.013031973,"teacher_disagreement_score":0.010906035,"about_ca_system_score_codex":0.003463608,"about_ca_system_score_gemma":0.0067583146,"threshold_uncertainty_score":0.0341658},"labels":[],"label_agreement":null},{"id":"W4406606896","doi":"10.1016/s2213-8587(24)00304-8","title":"Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"American Regent; Vifor Pharma; Horizon Therapeutics; Impulse Dynamics; National Institutes of Health; Regeneron Pharmaceuticals; Dexcom; ReCor Medical; Astellas Pharma; Cytokinetics; Prothena; AstraZeneca; Amarin Corporation; Boston Scientific Corporation; Eli Lilly and Company; U.S. Department of Defense; Sanofi; HLS Therapeutics; LivaNova; GlaxoSmithKline; CSL Behring; Bristol-Myers Squibb; Edwards Lifesciences; Amgen; Moderna; Pfizer; Tenax Therapeutics; Esperion Therapeutics; Alnylam Pharmaceuticals; Novo Nordisk; MyoKardia; Gilead Sciences","keywords":"Medicine; Heart failure; Heart failure with preserved ejection fraction; Ejection fraction; Internal medicine; Cardiology; Semaglutide; Obesity; Type 2 diabetes; Baseline (sea); Diabetes mellitus; Endocrinology","score_opus":0.017476821309334672,"score_gpt":0.2834660659037371,"score_spread":0.26598924459440243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406606896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840826,0.011758021,0.0005290635,0.00044526125,0.00061382476,0.0005965919,0.0006581342,0.00010518027,0.00121146],"genre_scores_gemma":[0.9924213,0.0035865884,0.00063179294,0.00069372373,0.00048238982,0.00046316598,0.0006593364,0.000015829643,0.0010459364],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99899274,0.0005409224,0.00008797374,0.00017157255,0.00006589765,0.00014093131],"domain_scores_gemma":[0.9989875,0.00041033464,0.0002316183,0.0000990391,0.00005647083,0.00021501502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002305237,0.0019355153,0.005247158,0.00043493058,0.0003859116,0.0014358726,0.0008364458,0.0017085319,0.0043654875],"category_scores_gemma":[0.00213404,0.0007525807,0.0041273283,0.0005118928,0.0011325998,0.0013739628,0.00059755857,0.0027258757,0.0005618752],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.987288,0.00073736144,0.0011391634,0.000672664,0.0038146847,0.000032757427,0.000025876709,0.00018815433,0.0008458721,0.000068827765,0.0002490133,0.0049376353],"study_design_scores_gemma":[0.96530247,0.023175338,0.005871685,0.00008256448,0.004440676,0.000036674257,0.000040632196,0.00032413154,0.00021089247,0.0001681314,0.00032394734,0.000022756585],"about_ca_topic_score_codex":0.0014113797,"about_ca_topic_score_gemma":0.0037434923,"teacher_disagreement_score":0.005247158,"about_ca_system_score_codex":0.00071099587,"about_ca_system_score_gemma":0.00063242734,"threshold_uncertainty_score":0.014603972},"labels":[],"label_agreement":null},{"id":"W4406788773","doi":"10.1016/s2213-8587(24)00347-4","title":"Protein-binding therapy: a new approach to lower cholesterol","year":2025,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cholesterol; MEDLINE; Internal medicine; Biochemistry","score_opus":0.040997041786902784,"score_gpt":0.2831626981905293,"score_spread":0.24216565640362653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406788773","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023621517,0.012442776,0.0002388442,0.9488019,0.034942918,0.000010889727,0.00003992873,0.00003273119,0.003253868],"genre_scores_gemma":[0.002730222,0.0072885393,0.00034413848,0.86009413,0.123343125,0.00004373843,0.00003505624,0.00002228542,0.006098811],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960516,0.0011298863,0.00041962933,0.0004939809,0.0014640149,0.00044090286],"domain_scores_gemma":[0.9921244,0.004822897,0.0005600855,0.00025046212,0.00083410967,0.001408014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039673867,0.0017993315,0.0029799445,0.0012335336,0.0029532574,0.0050006635,0.0019049984,0.06396029,0.011525987],"category_scores_gemma":[0.014376402,0.0009354602,0.0026707607,0.00081993797,0.0054067336,0.0070284386,0.0026695596,0.062096108,0.00980158],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017988814,0.00009278251,0.00033900165,0.00017501591,0.00005561483,0.0012126178,0.000088082794,0.00008802535,0.00038802437,0.00819336,0.9618826,0.027305074],"study_design_scores_gemma":[0.00070137257,0.00019712988,0.000918764,0.00056447723,0.00008557572,0.0016947039,0.00018608272,0.00040854554,0.000214641,0.021384126,0.9735725,0.00007219219],"about_ca_topic_score_codex":0.0025560863,"about_ca_topic_score_gemma":0.0056270496,"teacher_disagreement_score":0.06396029,"about_ca_system_score_codex":0.004026773,"about_ca_system_score_gemma":0.003218261,"threshold_uncertainty_score":0.038558245},"labels":[],"label_agreement":null},{"id":"W4407568618","doi":"10.1016/s2213-8587(24)00362-0","title":"Effect of sotagliflozin on major adverse cardiovascular events: a prespecified secondary analysis of the SCORED randomised trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Women's College Hospital; University of Toronto; St. Michael's Hospital","funders":"National Institutes of Health","keywords":"Medicine; Adverse effect; Randomized controlled trial; Internal medicine; MEDLINE; Intensive care medicine","score_opus":0.012227653886428429,"score_gpt":0.2715166031842844,"score_spread":0.25928894929785595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407568618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96707433,0.011464987,0.0026734313,0.0017349295,0.0018095803,0.0022363164,0.0054746075,0.0003031365,0.007228577],"genre_scores_gemma":[0.9895621,0.0015467398,0.0010098529,0.0012978575,0.0006752549,0.00097417046,0.0026514689,0.000035090026,0.0022474658],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99638605,0.0023451676,0.0002360755,0.00043257218,0.00025866032,0.00034138636],"domain_scores_gemma":[0.9967728,0.0013220584,0.0008137551,0.0004647102,0.00025668263,0.00036997776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052366406,0.002797642,0.0058120578,0.00052643917,0.00043920524,0.0018429435,0.0009136804,0.0018869702,0.008800279],"category_scores_gemma":[0.006143182,0.0006913059,0.0083489185,0.00059079373,0.0012893816,0.0016338223,0.00093393377,0.003675118,0.0009968441],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9856215,0.00027562227,0.0008804705,0.00075729575,0.006147246,0.000028028899,0.000015249458,0.00039598485,0.0006840576,0.00017136525,0.0006479184,0.004375233],"study_design_scores_gemma":[0.9593859,0.019911144,0.009680216,0.00010688868,0.008284798,0.000035765104,0.0000249659,0.0009220649,0.00022948388,0.000644114,0.00072844635,0.000046232093],"about_ca_topic_score_codex":0.0017025336,"about_ca_topic_score_gemma":0.0032745725,"teacher_disagreement_score":0.008800279,"about_ca_system_score_codex":0.0010766571,"about_ca_system_score_gemma":0.0009808559,"threshold_uncertainty_score":0.029439807},"labels":[],"label_agreement":null},{"id":"W4407631637","doi":"10.1016/s2213-8587(24)00372-3","title":"Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Trillium Health Centre","funders":"National Center for Advancing Translational Sciences; National Institute on Aging; National Institutes of Health; Abbott Laboratories; Sanofi; National Institute of Diabetes and Digestive and Kidney Diseases; Dexcom","keywords":"Medicine; Deprescribing; Diabetes mellitus; Polypharmacy; Intensive care medicine; MEDLINE; Gerontology; Endocrinology","score_opus":0.04096049604617223,"score_gpt":0.3578353991457552,"score_spread":0.31687490309958294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407631637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011650211,0.9871193,0.00043629314,0.009776936,0.0009630904,0.000053112315,0.00008026753,0.00004027684,0.0014142458],"genre_scores_gemma":[0.0018459015,0.98522526,0.0029520765,0.008139137,0.0010161225,0.00007984525,0.00014236249,0.0000106891885,0.0005885469],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961777,0.0013500066,0.00071112876,0.00025123174,0.001225043,0.00028496806],"domain_scores_gemma":[0.9907286,0.004993504,0.0017354809,0.00015811229,0.0018338716,0.0005502837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073547014,0.0015871585,0.0045948187,0.0032603554,0.00051440566,0.0035261381,0.0022049723,0.0041191634,0.0098665105],"category_scores_gemma":[0.015267435,0.0006722583,0.0035498415,0.0021372887,0.00062525045,0.0029191761,0.0023189732,0.006744766,0.0026935413],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017501011,0.00013475084,0.00027835357,0.042089198,0.0007003469,0.00008279769,0.00012114691,0.00040130035,0.00016202593,0.0045344825,0.055944253,0.8953762],"study_design_scores_gemma":[0.0008208793,0.00041967898,0.00260604,0.24393575,0.0031820072,0.0004084952,0.00031513575,0.0006587094,0.00020528915,0.0073783635,0.73997265,0.0000971072],"about_ca_topic_score_codex":0.009722235,"about_ca_topic_score_gemma":0.022813428,"teacher_disagreement_score":0.0098665105,"about_ca_system_score_codex":0.0035548748,"about_ca_system_score_gemma":0.01288816,"threshold_uncertainty_score":0.038895845},"labels":[],"label_agreement":null},{"id":"W4407805683","doi":"10.1016/s2213-8587(24)00348-6","title":"Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; St. Michael's Hospital","funders":"National Center for Complementary and Integrative Health; Barts Charity","keywords":"Medicine; Meta-analysis; Intensive care medicine; MEDLINE; Vitamin D and neurology; Internal medicine","score_opus":0.16134388234045613,"score_gpt":0.44543376408052415,"score_spread":0.284089881740068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407805683","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033091935,0.9938419,0.0007137769,0.00013634407,0.00013902526,0.000651869,0.0009621099,0.000028602064,0.00021719819],"genre_scores_gemma":[0.14067017,0.84638566,0.005344367,0.0010500625,0.0002900097,0.0036967578,0.002160411,0.0000500716,0.00035236342],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97973835,0.010505715,0.0059190933,0.0015728918,0.0018291599,0.00043486667],"domain_scores_gemma":[0.9767432,0.01685445,0.0038008394,0.00088685687,0.001501499,0.00021309525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02127855,0.003170806,0.026392872,0.011114007,0.0006607594,0.003603115,0.002230667,0.002068047,0.0035455448],"category_scores_gemma":[0.04729842,0.0018448111,0.038184173,0.010200669,0.0008066434,0.0018540829,0.0018792937,0.0018268503,0.0003666056],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016426113,0.000021044923,0.0017601267,0.4308396,0.5561016,0.00008653428,0.00006462904,0.0005023276,0.00018868838,0.0001108952,0.0004893448,0.008192613],"study_design_scores_gemma":[0.00077961996,0.00016952957,0.0020685669,0.03140436,0.96342057,0.00008203365,0.0000295916,0.00014966325,0.00012961011,0.0002512045,0.0014918695,0.000023348104],"about_ca_topic_score_codex":0.0065911207,"about_ca_topic_score_gemma":0.014922974,"teacher_disagreement_score":0.026392872,"about_ca_system_score_codex":0.0029695285,"about_ca_system_score_gemma":0.004962101,"threshold_uncertainty_score":0.11253303},"labels":[],"label_agreement":null},{"id":"W4407931352","doi":"10.1016/s2213-8587(25)00029-4","title":"Type 1 diabetes screening: need for ethical, equity, and health systems perspective","year":2025,"lang":"en","type":"letter","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Management and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"Direktion für Entwicklung und Zusammenarbeit","keywords":"Medicine; Perspective (graphical); Equity (law); Type 2 diabetes; MEDLINE; Diabetes mellitus; Health equity; Family medicine; Nursing; Endocrinology; Public health","score_opus":0.13289991826021094,"score_gpt":0.4174519800715645,"score_spread":0.2845520618113535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407931352","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000064339656,0.0005130652,0.000025309007,0.99650085,0.0023280755,0.0000012938976,0.0000043414543,0.000002610788,0.00056003866],"genre_scores_gemma":[0.0030586894,0.00049202476,0.00013570348,0.98231274,0.013037265,0.000017133803,0.000006768261,0.000008167842,0.0009314608],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96789336,0.014456129,0.0022394499,0.0022981938,0.007941062,0.0051718536],"domain_scores_gemma":[0.82483244,0.11641074,0.005652637,0.003298818,0.016339686,0.033465642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03509552,0.00091474055,0.0027654765,0.0014655672,0.01170616,0.01571907,0.0037590656,0.12491438,0.014163621],"category_scores_gemma":[0.13143495,0.0011365777,0.0020482508,0.0011716651,0.021538917,0.015796507,0.0081991665,0.107272476,0.0046138074],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055555436,0.00008028912,0.00053197006,0.00011614358,0.00003701231,0.0006152855,0.00065602106,0.00006569044,0.00011968145,0.030046018,0.956167,0.011509405],"study_design_scores_gemma":[0.00036127973,0.00009665133,0.0018273197,0.0017684966,0.000066524044,0.001316628,0.0055928035,0.00056480494,0.00016817049,0.14513592,0.8429004,0.00020095074],"about_ca_topic_score_codex":0.013803243,"about_ca_topic_score_gemma":0.021550447,"teacher_disagreement_score":0.12491438,"about_ca_system_score_codex":0.012975906,"about_ca_system_score_gemma":0.036137834,"threshold_uncertainty_score":0.18560511},"labels":[],"label_agreement":null},{"id":"W4408830362","doi":"10.1016/s2213-8587(25)00028-2","title":"Futility of plasmapheresis, insulin in normoglycaemic individuals, or heparin in the treatment of hypertriglyceridaemia-induced acute pancreatitis","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pancreatitis Pathology and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Diabetes Canada; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Plasmapheresis; Heparin; Pancreatitis; Insulin; Acute pancreatitis; Internal medicine; Intensive care medicine; Endocrinology; Gastroenterology; Immunology","score_opus":0.06538229844568082,"score_gpt":0.35709232177869493,"score_spread":0.2917100233330141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408830362","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051451985,0.99958736,0.00002630676,0.000093598006,0.00007997193,0.0000014860022,0.000007120475,0.0000014625315,0.000151322],"genre_scores_gemma":[0.00064831885,0.9988182,0.00007538353,0.00019621478,0.00014609534,0.000003093862,0.000017044778,9.1262007e-7,0.00009458504],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997093,0.00007820256,0.00006301095,0.000038953505,0.0000900951,0.000020371932],"domain_scores_gemma":[0.99912304,0.00060940144,0.00014077264,0.00001224984,0.00008360078,0.00003091504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009990295,0.000654569,0.0025446997,0.0012760066,0.00016149913,0.0009460715,0.0010524101,0.0010803748,0.0035690966],"category_scores_gemma":[0.0016087237,0.00023961283,0.0009795504,0.0012300555,0.00039525158,0.0008187095,0.0004896634,0.0020657622,0.001000178],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033296642,0.000048677586,0.00015192674,0.034916263,0.00043234936,0.00015442024,0.00003227164,0.00027417217,0.00045081403,0.0016530614,0.018399931,0.9431531],"study_design_scores_gemma":[0.00072868756,0.0007362719,0.0038859907,0.050743066,0.002760359,0.0025547256,0.00014937046,0.00040092686,0.00061290496,0.004794983,0.9325303,0.00010241234],"about_ca_topic_score_codex":0.0010882663,"about_ca_topic_score_gemma":0.0029055357,"teacher_disagreement_score":0.0035690966,"about_ca_system_score_codex":0.0004825585,"about_ca_system_score_gemma":0.000706207,"threshold_uncertainty_score":0.011939824},"labels":[],"label_agreement":null},{"id":"W4409656874","doi":"10.1016/s2213-8587(25)00089-0","title":"Compassionate care in obesity management: reclaiming humanity in health care","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Humanity; Health care; MEDLINE; Obesity; Nursing; Internal medicine; Economic growth","score_opus":0.05194853436021688,"score_gpt":0.4309319674851735,"score_spread":0.3789834331249566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409656874","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011506827,0.025035994,0.0013048621,0.9585865,0.007233002,0.000014041926,0.000009440466,0.000031458887,0.0066340882],"genre_scores_gemma":[0.17217432,0.047652178,0.0057260767,0.7356132,0.032508925,0.00027761084,0.000035004672,0.00020387175,0.0058088438],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9623514,0.022180608,0.0014385122,0.0021741807,0.0071895197,0.0046658427],"domain_scores_gemma":[0.871889,0.080918506,0.005785841,0.0051679267,0.009382963,0.026855804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.055099513,0.0010932538,0.0024734547,0.0018665201,0.011449174,0.025579704,0.004843297,0.030721236,0.0101571325],"category_scores_gemma":[0.057414804,0.0009872081,0.0014847359,0.0017154269,0.092924885,0.029267095,0.026185997,0.061259497,0.0019662674],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014291068,0.0003430535,0.0019082599,0.0022854742,0.00018790818,0.0006065351,0.036658097,0.00042941337,0.00035222623,0.40702647,0.435025,0.11503464],"study_design_scores_gemma":[0.00024685886,0.00020341002,0.0023300834,0.007184685,0.000068810914,0.00076136785,0.031468157,0.0004918738,0.00024586034,0.38787895,0.5688806,0.00023932337],"about_ca_topic_score_codex":0.012307491,"about_ca_topic_score_gemma":0.021906657,"teacher_disagreement_score":0.055099513,"about_ca_system_score_codex":0.018740507,"about_ca_system_score_gemma":0.07321634,"threshold_uncertainty_score":0.29139757},"labels":[],"label_agreement":null},{"id":"W4412647992","doi":"10.1016/s2213-8587(25)00405-x","title":"Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries","year":2025,"lang":"en","type":"preprint","venue":"The Lancet Diabetes & Endocrinology","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McGill University; Hamilton Health Sciences; University of Toronto; McMaster University; Population Health Research Institute","funders":"National Center for Advancing Translational Sciences; National Human Genome Research Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute on Aging; Manchester Biomedical Research Centre; American Diabetes Association; National Institute of Neurological Disorders and Stroke; National Institute for Health and Care Research; Novo Nordisk UK Research Foundation; National Institutes of Health; U.S. Department of Health and Human Services; Foundation for the National Institutes of Health","keywords":"Polygenic risk score; Type 2 diabetes; Computational biology; Genetics; Demography; Diabetes mellitus; Medicine; Biology; Gerontology; Evolutionary biology; Gene; Endocrinology; Single-nucleotide polymorphism; Genotype; Sociology","score_opus":0.05627410835963777,"score_gpt":0.3163311507240522,"score_spread":0.26005704236441446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412647992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8617765,0.009700427,0.121404596,0.0012411708,0.00016110943,0.0002039417,0.0031728721,0.0005903551,0.0017491141],"genre_scores_gemma":[0.97847694,0.0007849684,0.019223072,0.000093375806,0.00007921498,0.000111533256,0.0009929797,0.00005593134,0.00018199916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9872591,0.009102418,0.00064279087,0.0020810382,0.0006844157,0.00023025714],"domain_scores_gemma":[0.9734605,0.01815566,0.0031541362,0.003866619,0.00095922046,0.00040389964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023390342,0.001482632,0.0013814804,0.0033827703,0.00062653,0.0015700288,0.0012442275,0.0007555435,0.0022049577],"category_scores_gemma":[0.029292932,0.0006356679,0.0059034526,0.0039171353,0.00085103634,0.0009027618,0.0017217982,0.0016844904,0.00025816317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012469307,0.00006095724,0.91471124,0.00024328961,0.027907245,0.00019195092,0.00014746556,0.017909173,0.00061213685,0.0014284179,0.0009405753,0.034600638],"study_design_scores_gemma":[0.00060487224,0.0010318368,0.7397299,0.000336143,0.032505978,0.00073851936,0.00020969032,0.20329803,0.0012616717,0.016779551,0.0033621402,0.00014162375],"about_ca_topic_score_codex":0.0048441454,"about_ca_topic_score_gemma":0.0045039565,"teacher_disagreement_score":0.023390342,"about_ca_system_score_codex":0.00046163905,"about_ca_system_score_gemma":0.00074563414,"threshold_uncertainty_score":0.12370139},"labels":[],"label_agreement":null},{"id":"W4413140592","doi":"10.1016/s2213-8587(25)00163-9","title":"The central role of recovery of β-cell function in the remission of prediabetes: a prospective cohort study in Canada","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Canadian Institutes of Health Research","keywords":"Prediabetes; Medicine; Gestational diabetes; Insulin resistance; Prospective cohort study; Internal medicine; Population; Diabetes mellitus; Homeostatic model assessment; Cohort; Cohort study; Glucose tolerance test; Pregnancy; Type 2 diabetes; Insulin; Obstetrics; Endocrinology; Gestation; Environmental health","score_opus":0.008158616106466414,"score_gpt":0.25239409147146075,"score_spread":0.24423547536499432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413140592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844823,0.004257027,0.00021839044,0.0023752586,0.0001153739,0.000057071535,0.005255368,0.000022448308,0.003216831],"genre_scores_gemma":[0.9962436,0.0010806434,0.00012163489,0.00025229738,0.000027457378,0.000012060817,0.0010495883,0.000015754504,0.0011970248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976782,0.00020913593,0.00012952424,0.00046658976,0.0004124351,0.0011041356],"domain_scores_gemma":[0.99322903,0.0005116725,0.0013277006,0.0006329277,0.002187954,0.002110768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017737251,0.0006346454,0.0010993211,0.0011743137,0.004228868,0.0029421372,0.0032142224,0.0015439264,0.0041178255],"category_scores_gemma":[0.0057138014,0.0008448705,0.0014635399,0.0046565686,0.0015955999,0.0007563525,0.001477582,0.0027409513,0.00030686706],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005632251,0.000040977473,0.9926358,0.0000357671,0.00022624893,0.00021804075,0.0008492127,0.00008558294,0.0002139493,0.00038864554,0.0015164514,0.003226143],"study_design_scores_gemma":[0.00003202651,0.00002808221,0.99786997,0.00004145147,0.00013367218,0.0000686716,0.0008039748,0.00016664654,0.00003440337,0.000076968405,0.00072374707,0.000020367426],"about_ca_topic_score_codex":0.9938678,"about_ca_topic_score_gemma":0.99391866,"teacher_disagreement_score":0.023550535,"about_ca_system_score_codex":0.023550535,"about_ca_system_score_gemma":0.03806579,"threshold_uncertainty_score":0.17087185},"labels":[],"label_agreement":null},{"id":"W4413547117","doi":"10.1016/s2213-8587(25)00227-x","title":"Prolactin-secreting adenomas: pathogenesis, diagnosis, and management","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Medicine; Prolactin; Pathogenesis; MEDLINE; Intensive care medicine; Bioinformatics; Internal medicine; Hormone","score_opus":0.04254029183216959,"score_gpt":0.3269108296853808,"score_spread":0.2843705378532112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413547117","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002073918,0.99948287,0.000020572312,0.00019233352,0.00011909777,0.0000013059602,0.00000937715,0.000002267068,0.00015144708],"genre_scores_gemma":[0.00019510859,0.99924004,0.000053959928,0.00018407268,0.00019146845,0.0000020356883,0.0000150819205,5.558622e-7,0.0001176602],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996295,0.000070742644,0.000053264364,0.000051673665,0.00016290955,0.00003191073],"domain_scores_gemma":[0.9990037,0.00056356215,0.00018399826,0.000018662677,0.00016685927,0.000063262974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009941335,0.0010920219,0.002774878,0.0021171053,0.0002217612,0.001375135,0.0012012692,0.0013133767,0.0042925715],"category_scores_gemma":[0.0016303051,0.00033983722,0.0008255937,0.002173976,0.0005288856,0.0011570234,0.00080397597,0.0025395886,0.0018462077],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017388922,0.00004647589,0.00016863408,0.023544276,0.0002159878,0.0001467711,0.00002956473,0.0002800477,0.0006091777,0.0018408771,0.04130302,0.9316413],"study_design_scores_gemma":[0.0001322661,0.0001474165,0.0015766404,0.018126948,0.0006542457,0.0015601687,0.00010160681,0.00015542677,0.0001931278,0.0029827543,0.9743285,0.00004091774],"about_ca_topic_score_codex":0.0022124955,"about_ca_topic_score_gemma":0.005686918,"teacher_disagreement_score":0.0042925715,"about_ca_system_score_codex":0.0009220888,"about_ca_system_score_gemma":0.0015335133,"threshold_uncertainty_score":0.01436013},"labels":[],"label_agreement":null},{"id":"W4414189723","doi":"10.1016/s2213-8587(25)00225-6","title":"Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk","keywords":"Semaglutide; Type 2 diabetes; Obesity; Diabetes mellitus; Clinical trial; MEDLINE","score_opus":0.013636066117558401,"score_gpt":0.27955186139662896,"score_spread":0.26591579527907055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414189723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9773547,0.01051669,0.0008390599,0.0012867346,0.0014912636,0.0031149997,0.0018282578,0.00034917428,0.003219204],"genre_scores_gemma":[0.97273266,0.006921085,0.002102793,0.003494551,0.00086685224,0.0045159645,0.0023581402,0.00006420147,0.0069437027],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996123,0.00015750299,0.000026470465,0.00008689246,0.000034022873,0.000082838276],"domain_scores_gemma":[0.9995728,0.00010380597,0.00007698125,0.000032472173,0.00002922235,0.00018470468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012025594,0.001984161,0.00394649,0.00041947194,0.0004210313,0.0011969706,0.00084233726,0.0022597043,0.008601996],"category_scores_gemma":[0.0011555947,0.0007594255,0.0026721635,0.00048237178,0.0009030642,0.0012289814,0.0005241093,0.004074017,0.0016455874],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9817447,0.0027919714,0.0004698467,0.000755089,0.0013221769,0.000039597086,0.000037433176,0.00016618296,0.0012719254,0.00007422691,0.0010381904,0.01028881],"study_design_scores_gemma":[0.9833347,0.014555935,0.0011015508,0.000030261186,0.0004067516,0.000016215994,0.000015795998,0.00013513282,0.000070669856,0.00006686473,0.0002578331,0.000008328162],"about_ca_topic_score_codex":0.0019798232,"about_ca_topic_score_gemma":0.0036306283,"teacher_disagreement_score":0.008601996,"about_ca_system_score_codex":0.0005637283,"about_ca_system_score_gemma":0.00073235645,"threshold_uncertainty_score":0.028776526},"labels":[],"label_agreement":null},{"id":"W4414189914","doi":"10.1016/s2213-8587(25)00226-8","title":"Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk","keywords":"Semaglutide; Obesity; German; MEDLINE; Diabetes mellitus; Clinical trial","score_opus":0.01465677988245434,"score_gpt":0.28648707511636473,"score_spread":0.2718302952339104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414189914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980734,0.008662625,0.0007454027,0.001037043,0.0010949847,0.002952717,0.0016153546,0.00032758975,0.0028303242],"genre_scores_gemma":[0.9745696,0.0065220334,0.0021319345,0.003182727,0.00068343536,0.004307409,0.002171042,0.00006429438,0.0063675093],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99965787,0.00013838007,0.00002053982,0.00007684417,0.000031523134,0.00007487747],"domain_scores_gemma":[0.9995524,0.00011282189,0.000079699304,0.000036262198,0.000030871655,0.00018793653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011260975,0.0018325296,0.003892716,0.00040533993,0.00036494265,0.0010980311,0.0007800563,0.0018517051,0.008078917],"category_scores_gemma":[0.0011115464,0.00063235837,0.0024521004,0.00042968272,0.0008225365,0.0010510494,0.0005197919,0.0036893107,0.0014663496],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98171264,0.002649504,0.0004764491,0.00073766854,0.0013149129,0.000041021274,0.000036150122,0.00015635563,0.0015068738,0.00006964059,0.0010093297,0.010289358],"study_design_scores_gemma":[0.98012733,0.017207969,0.0015035489,0.00003631624,0.0004974582,0.000018820863,0.000017681912,0.00015453645,0.00008617349,0.000071348484,0.00026901046,0.000009725298],"about_ca_topic_score_codex":0.0017924784,"about_ca_topic_score_gemma":0.0034798773,"teacher_disagreement_score":0.008078917,"about_ca_system_score_codex":0.0005229645,"about_ca_system_score_gemma":0.00070492574,"threshold_uncertainty_score":0.027026594},"labels":[],"label_agreement":null},{"id":"W4414708467","doi":"10.1016/s2213-8587(25)00216-5","title":"Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome: a double-blind, randomised, placebo-controlled, phase 2a trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Inversago Pharma (Canada); Université Laval","funders":"National Institutes of Health; Novo Nordisk","keywords":"Obesity; MEDLINE; Phase (matter); Clinical trial; Diabetes mellitus","score_opus":0.01761303373829149,"score_gpt":0.31190151615145645,"score_spread":0.29428848241316496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414708467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9657386,0.017857743,0.0015653245,0.0019165592,0.0019311085,0.0045287996,0.0024149264,0.00035527683,0.0036917536],"genre_scores_gemma":[0.9746516,0.008137764,0.0022227794,0.0023821506,0.0009499704,0.0048394892,0.0017786288,0.0000778397,0.004959798],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992525,0.00030509834,0.000067935965,0.0001895217,0.00006363833,0.00012134156],"domain_scores_gemma":[0.9990897,0.00026116712,0.0002251442,0.00009007679,0.000072127434,0.00026172213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020215414,0.0029270505,0.005110734,0.0005479677,0.00074606447,0.001774001,0.001161313,0.0033899269,0.009497773],"category_scores_gemma":[0.0028534853,0.0012570956,0.0030077414,0.00048178056,0.0017323656,0.002105029,0.0005914422,0.0046310653,0.0019960562],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98903394,0.0016807169,0.00020190049,0.00074032584,0.0010203725,0.000030919804,0.00003971541,0.00007578962,0.0015909908,0.000068922134,0.0005160058,0.0050004697],"study_design_scores_gemma":[0.9824991,0.015318584,0.00077928655,0.00003639579,0.00055094645,0.000029239205,0.000018983179,0.00012372709,0.00017454608,0.00010212037,0.00035099764,0.000016147114],"about_ca_topic_score_codex":0.00090946665,"about_ca_topic_score_gemma":0.0017988647,"teacher_disagreement_score":0.009497773,"about_ca_system_score_codex":0.00082675304,"about_ca_system_score_gemma":0.0009669961,"threshold_uncertainty_score":0.03177315},"labels":[],"label_agreement":null},{"id":"W4415224168","doi":"10.1016/s2213-8587(25)00260-8","title":"Managing adults with screen-detected islet autoantibody positivity: a pragmatic framework","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Autoantibody; Islet; Type 1 diabetes; Diabetes mellitus; CLARITY; MEDLINE","score_opus":0.009093133503021069,"score_gpt":0.2767513570405053,"score_spread":0.26765822353748425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415224168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009630612,0.99257714,0.00043388866,0.005267597,0.000720277,0.00001074464,0.0000150519,0.000008225452,0.00087066996],"genre_scores_gemma":[0.0026704113,0.98757577,0.001530861,0.00563016,0.0020810456,0.000048787606,0.000043505508,0.000004417075,0.00041505348],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886334,0.0005080939,0.00015871621,0.000112036694,0.00026524308,0.00009249717],"domain_scores_gemma":[0.997821,0.0014506084,0.00021436515,0.000029042949,0.00032186834,0.00016310156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003801472,0.0011304758,0.0025177128,0.0013124007,0.00037300878,0.0023100192,0.001744188,0.0036021683,0.0019522615],"category_scores_gemma":[0.0059717726,0.0003013863,0.001029668,0.0007639993,0.0007590276,0.0018909096,0.0015796361,0.0056410367,0.0007208285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024247722,0.00010923771,0.00046122677,0.020325849,0.00034018312,0.0007642454,0.0001728793,0.0007060842,0.00038214182,0.012989595,0.06666863,0.8968375],"study_design_scores_gemma":[0.0004536621,0.00030380036,0.0021934938,0.07019696,0.000847074,0.0037597737,0.0006208057,0.00063587324,0.00020708377,0.025153058,0.8955419,0.00008646922],"about_ca_topic_score_codex":0.001825042,"about_ca_topic_score_gemma":0.0033796707,"teacher_disagreement_score":0.003801472,"about_ca_system_score_codex":0.0013274489,"about_ca_system_score_gemma":0.0023580256,"threshold_uncertainty_score":0.020104289},"labels":[],"label_agreement":null},{"id":"W4415450658","doi":"10.1016/s2213-8587(25)00286-4","title":"Recent advances in research and care of familial hypercholesterolaemia","year":2025,"lang":"en","type":"review","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Universidad de Sevilla","keywords":"Familial hypercholesterolemia; Risk stratification; Clinical Practice; Ldl cholesterol; Atherosclerotic cardiovascular disease; Cardiovascular health","score_opus":0.1133343352357879,"score_gpt":0.4203352713989604,"score_spread":0.3070009361631725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415450658","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002342246,0.99908257,0.000040336443,0.00043400063,0.0002555064,0.0000014027579,0.000006622233,0.000003689517,0.00015241219],"genre_scores_gemma":[0.00027500576,0.99839205,0.00009524123,0.00054415665,0.0005784951,0.0000031802833,0.0000141182845,9.916488e-7,0.00009679634],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991014,0.00020779156,0.00017097409,0.00013147524,0.00029553197,0.00009279667],"domain_scores_gemma":[0.9969104,0.001926618,0.00042644073,0.000054555363,0.00047193232,0.0002100812],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027055189,0.0013111613,0.003742788,0.0030719172,0.0002838214,0.0017864199,0.0012219329,0.0020930474,0.0054789213],"category_scores_gemma":[0.0046182615,0.0004011851,0.0012587905,0.0036671788,0.0008189326,0.0016955701,0.001458234,0.0035217633,0.0016247088],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024542524,0.00006191772,0.0003292017,0.03381268,0.00033389445,0.00012176479,0.00004985845,0.0002493191,0.00033279264,0.0025271974,0.042892635,0.9190432],"study_design_scores_gemma":[0.00033327294,0.0002692792,0.0031551528,0.02673319,0.001445536,0.0009411325,0.00015980413,0.0002623064,0.0001509366,0.0038568843,0.9626341,0.000058357415],"about_ca_topic_score_codex":0.00359231,"about_ca_topic_score_gemma":0.007439382,"teacher_disagreement_score":0.0054789213,"about_ca_system_score_codex":0.0014893373,"about_ca_system_score_gemma":0.0023083482,"threshold_uncertainty_score":0.018328786},"labels":[],"label_agreement":null},{"id":"W4416021875","doi":"10.1016/s2213-8587(25)00265-7","title":"Time trends in mortality from heart failure and atherosclerotic cardiovascular disease in people with and without diabetes: a multi-national population-based study","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; Canadian VIGOUR Centre; University of Alberta; Toronto General Hospital; University Health Network; Alberta Health Services; Institute for Clinical Evaluative Sciences","funders":"Centers for Disease Control and Prevention; Eli Lilly and Company; Science Foundation Ireland; Diabetes Australia; National Health and Medical Research Council; Australian Institute of Health and Welfare, Australian Government; Ontario Ministry of Health and Long-Term Care; Institute for Clinical Evaluative Sciences; Fondation de France; Novo Nordisk; Sanofi; National Heart Foundation of Australia; Baker Heart and Diabetes Institute; Mylan; National Health Insurance Service; State Government of Victoria; Pfizer","keywords":"Heart failure; Diabetes mellitus; Disease; Government (linguistics); Atherosclerotic cardiovascular disease; MEDLINE; Heart disease","score_opus":0.02768364782512464,"score_gpt":0.3123284678318541,"score_spread":0.2846448200067294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416021875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533635,0.0003255841,0.00014819027,0.00010732774,0.000009141242,0.000023769555,0.00365459,0.000007140081,0.00038802365],"genre_scores_gemma":[0.99618727,0.00018702322,0.00034538424,0.00009782224,0.000014553475,0.000055257602,0.0029670622,0.0000035124958,0.00014218155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988875,0.00026532638,0.00016439585,0.00032475003,0.0002241614,0.00013387486],"domain_scores_gemma":[0.9979081,0.00022855043,0.0007974258,0.00020480526,0.0004607846,0.00040040934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013284435,0.00027440183,0.00040306518,0.0013351109,0.0008085631,0.0008407492,0.00071344717,0.0005723537,0.0007350792],"category_scores_gemma":[0.0024798599,0.00038436445,0.00074781984,0.0031249642,0.0003449931,0.000952463,0.0010311514,0.0010248892,0.0002197928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026023077,0.000023081986,0.99916625,0.000009385996,0.000078680896,0.00001890794,0.000110853245,0.00002227494,0.000034148637,0.000010780029,0.00012226088,0.00037731696],"study_design_scores_gemma":[0.0000033806034,0.000021502925,0.9994648,0.0000047556764,0.000030435645,0.000048222708,0.00018960953,0.0000746816,0.000010757099,0.00000935564,0.00013930342,0.0000033221222],"about_ca_topic_score_codex":0.05326568,"about_ca_topic_score_gemma":0.07393878,"teacher_disagreement_score":0.05326568,"about_ca_system_score_codex":0.0010274667,"about_ca_system_score_gemma":0.0008170989,"threshold_uncertainty_score":0.105911314},"labels":[],"label_agreement":null},{"id":"W4417297764","doi":"10.1016/s2213-8587(25)00331-6","title":"Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; McGill University Health Centre","funders":"JDRF","keywords":"Diabetic ketoacidosis; Ketoacidosis; Medical diagnosis; Ketone; Anxiety; Diabetes mellitus","score_opus":0.01127745767893358,"score_gpt":0.27905649803717403,"score_spread":0.26777904035824046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417297764","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011742773,0.43454048,0.013536655,0.4887005,0.040289246,0.0005828879,0.0022407093,0.0005395736,0.018395616],"genre_scores_gemma":[0.016918823,0.41800603,0.09989949,0.41729227,0.030605633,0.002488092,0.0044310647,0.00032754938,0.01003111],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97637194,0.0074543464,0.0051244334,0.0014197585,0.0083007235,0.0013287745],"domain_scores_gemma":[0.92801124,0.033988036,0.0074808034,0.0017929255,0.02408629,0.0046406994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03892123,0.0027240524,0.004861091,0.0035723096,0.0013626582,0.0048727808,0.0077475784,0.019823944,0.004845952],"category_scores_gemma":[0.052257985,0.0010857742,0.00847946,0.0031139483,0.0036192483,0.0042404453,0.0038744025,0.024888283,0.003672589],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012543018,0.0004545554,0.002526145,0.012314873,0.0009611533,0.0005488745,0.0004293156,0.001309433,0.0017367305,0.012596459,0.5913639,0.37450424],"study_design_scores_gemma":[0.0011597673,0.00046923905,0.009890147,0.06488226,0.002188238,0.00059565064,0.0006419434,0.0012004514,0.0012172993,0.014766199,0.9027211,0.00026775192],"about_ca_topic_score_codex":0.019685242,"about_ca_topic_score_gemma":0.017478142,"teacher_disagreement_score":0.03892123,"about_ca_system_score_codex":0.0038714134,"about_ca_system_score_gemma":0.016011732,"threshold_uncertainty_score":0.20583755},"labels":[],"label_agreement":null},{"id":"W4417442786","doi":"10.1016/s2213-8587(25)00335-3","title":"Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Gestational Diabetes Research and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Lunenfeld-Tanenbaum Research Institute; University of Calgary","funders":"","keywords":"Gestational diabetes; Pregnancy; Type 2 diabetes; Type 1 diabetes; Diabetes mellitus; Insulin resistance; Randomized controlled trial; Blood Glucose Self-Monitoring; Insulin","score_opus":0.0241666148435305,"score_gpt":0.32585145716838154,"score_spread":0.30168484232485104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417442786","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004586791,0.48224226,0.026713155,0.42816806,0.03277713,0.0013588638,0.0013466642,0.00034087195,0.022466246],"genre_scores_gemma":[0.059024952,0.52158403,0.18694983,0.19299443,0.02255429,0.0033444655,0.005149125,0.00033133,0.008067521],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.93876535,0.016873209,0.018721879,0.003397911,0.019914418,0.002327237],"domain_scores_gemma":[0.8536046,0.073373504,0.017184403,0.0036760333,0.04535239,0.0068091145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.09517517,0.0020818163,0.0043365825,0.0043286323,0.0018508373,0.0053142696,0.010324317,0.015882479,0.0016571585],"category_scores_gemma":[0.07518999,0.0013721981,0.0073943227,0.0031985585,0.0037681567,0.0033995481,0.0052705607,0.020148624,0.0011754591],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071027776,0.0006915428,0.0076438338,0.030740878,0.0014528179,0.00069203565,0.001582521,0.002362362,0.0041129426,0.014866565,0.22087167,0.7142727],"study_design_scores_gemma":[0.0007322864,0.00086835027,0.020752301,0.10544487,0.003379667,0.0016409017,0.00215288,0.0028339047,0.0041676103,0.012316631,0.84536624,0.00034443435],"about_ca_topic_score_codex":0.013459106,"about_ca_topic_score_gemma":0.014137944,"teacher_disagreement_score":0.09517517,"about_ca_system_score_codex":0.0055447137,"about_ca_system_score_gemma":0.03319649,"threshold_uncertainty_score":0.5033404},"labels":[],"label_agreement":null},{"id":"W4417485603","doi":"10.1016/s2213-8587(25)00290-6","title":"Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Diabetes & Endocrinology","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Université de Montréal; Université Laval","funders":"Arrowhead Pharmaceuticals","keywords":"RNA interference; Clinical trial; Phase (matter); MEDLINE; Hydroxymethylglutaryl-CoA Reductase Inhibitors","score_opus":0.040678481061447495,"score_gpt":0.3483097237388609,"score_spread":0.3076312426774134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417485603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95152366,0.029011851,0.0016669914,0.0032833305,0.0018058077,0.0036314453,0.0029991828,0.00038944115,0.005688193],"genre_scores_gemma":[0.9590747,0.015257636,0.0037248742,0.0053626527,0.0008019989,0.0047975546,0.003239446,0.00007019062,0.007670924],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996915,0.00012953188,0.000019537189,0.00006313409,0.000031843756,0.000064484746],"domain_scores_gemma":[0.999632,0.00011060832,0.00007033576,0.000025357605,0.000029601973,0.00013210323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013949522,0.0015493718,0.0025450226,0.00036851532,0.0003043883,0.00093572447,0.0006254161,0.0019391582,0.00696432],"category_scores_gemma":[0.001055401,0.00048722533,0.0023960515,0.00032961523,0.0007783092,0.0009338039,0.00033580523,0.003000121,0.00090516877],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9430464,0.0038572485,0.00091477344,0.0018220266,0.0030103133,0.000104920946,0.00007246263,0.00032414604,0.0076214187,0.0003686644,0.0034209834,0.035436768],"study_design_scores_gemma":[0.97225595,0.023327896,0.0015236861,0.000057476827,0.00092123955,0.0000483596,0.00002932898,0.00019047048,0.00028729974,0.00021301655,0.0011291052,0.000016161604],"about_ca_topic_score_codex":0.0012646399,"about_ca_topic_score_gemma":0.00372591,"teacher_disagreement_score":0.00696432,"about_ca_system_score_codex":0.0006404958,"about_ca_system_score_gemma":0.00065440376,"threshold_uncertainty_score":0.023297966},"labels":[],"label_agreement":null}]}